<?xml version="1.0" encoding="UTF-8"?>
<ekb complete="true" id="4052680" timestamp="20160614T192453">
  <input>
    <paragraphs>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/0T.xml" id="paragraph0" sec-type="title">&lt;article-title&gt;Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells&lt;/article-title&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/1A_01a_01.xml" id="paragraph1" sec-type="abstract">&lt;p&gt;The insulin/IGF-1 (insulin-like growth factor 1)-activated protein kinase Akt (also known as protein kinase B) phosphorylates Ser&lt;sup&gt;487&lt;/sup&gt; in the ‘ST loop’ (serine/threonine-rich loop) within the C-terminal domain of AMPK-α1 (AMP-activated protein kinase-α1), leading to inhibition of phosphorylation by upstream kinases at the activating site, Thr&lt;sup&gt;172&lt;/sup&gt;. Surprisingly, the equivalent site on AMPK-α2, Ser&lt;sup&gt;491&lt;/sup&gt;, is not an Akt target and is modified instead by autophosphorylation. Stimulation of HEK (human embryonic kidney)-293 cells with IGF-1 caused reduced subsequent Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation and activation of AMPK-α1 in response to the activator A769662 and the Ca&lt;sup&gt;2+&lt;/sup&gt; ionophore A23187, effects we show to be dependent on Akt activation and Ser&lt;sup&gt;487&lt;/sup&gt; phosphorylation. Consistent with this, in three PTEN (phosphatase and tensin homologue deleted on chromosome 10)-null tumour cell lines (in which the lipid phosphatase PTEN that normally restrains the Akt pathway is absent and Akt is thus hyperactivated), AMPK was resistant to activation by A769662. However, full AMPK activation could be restored by pharmacological inhibition of Akt, or by re-expression of active PTEN. We also show that inhibition of Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation is due to interaction of the phosphorylated ST loop with basic side chains within the αC-helix of the kinase domain. Our findings reveal that a previously unrecognized effect of hyperactivation of Akt in tumour cells is to restrain activation of the LKB1 (liver kinase B1)–AMPK pathway, which would otherwise inhibit cell growth and proliferation.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_01i_01.xml" id="paragraph2" sec-type="introduction">&lt;p&gt;AMPK (AMP-activated protein kinase) is a ubiquitously expressed sensor of cellular energy status [&lt;xref&gt;1&lt;/xref&gt;], which exists in essentially all eukaryotic cells as heterotrimeric complexes comprising a catalytic α subunit and regulatory β and γ subunits. The α subunits are phosphorylated by upstream kinases at conserved threonine residues within the activation loop (Thr&lt;sup&gt;172&lt;/sup&gt; in rat α1/α2), causing &amp;gt;100-fold activation [&lt;xref&gt;2&lt;/xref&gt;]. Kinases that phosphorylate Thr&lt;sup&gt;172&lt;/sup&gt; include the tumour suppressor LKB1 (liver kinase B1) [&lt;xref&gt;3&lt;/xref&gt;–&lt;xref&gt;5&lt;/xref&gt;], and the Ca&lt;sup&gt;2+&lt;/sup&gt;-dependent kinase CaMKKβ (calmodulin-dependent kinase kinase β) [&lt;xref&gt;6&lt;/xref&gt;–&lt;xref&gt;8&lt;/xref&gt;]. The γ subunits contain up to three sites where ADP or AMP bind in competition with ATP [&lt;xref&gt;9&lt;/xref&gt;–&lt;xref&gt;12&lt;/xref&gt;]. Binding of AMP or ADP causes conformational changes that enhance net phosphorylation at Thr&lt;sup&gt;172&lt;/sup&gt; by inhibiting dephosphorylation, whereas binding of AMP, but not ADP, promotes phosphorylation by LKB1 and causes allosteric activation [&lt;xref&gt;10&lt;/xref&gt;,&lt;xref&gt;13&lt;/xref&gt;–&lt;xref&gt;15&lt;/xref&gt;]. The drug A769662 and the natural product salicylate mimic the ability of AMP to inhibit Thr&lt;sup&gt;172&lt;/sup&gt; dephosphorylation and cause allosteric activation, but bind at a different site involving the β subunit [&lt;xref&gt;16&lt;/xref&gt;–&lt;xref&gt;18&lt;/xref&gt;].&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_01i_02.xml" id="paragraph3" sec-type="introduction">&lt;p&gt;AMPK is thus activated by metabolic stresses that deplete ATP, and increase ADP and AMP. Such stresses include compounds inhibiting mitochondrial ATP synthesis, such as the anti-diabetic drugs metformin and phenformin, and the natural products galegine, resveratrol and berberine [&lt;xref&gt;19&lt;/xref&gt;]. Once activated, AMPK switches on catabolic pathways that generate ATP while switching off anabolic pathways and other ATP-requiring processes such as progress through the cell cycle [&lt;xref&gt;1&lt;/xref&gt;]. Thus AMPK has a cytostatic effect on proliferating cells, suggesting that it might exert some of the tumour suppressor effects of its upstream kinase, LKB1. This was supported by recent studies of a mouse B-cell lymphoma model, in which AMPK appeared to act as a negative regulator both of the rapid glycolysis (Warburg effect) and the high growth rate of the tumours [&lt;xref&gt;20&lt;/xref&gt;].&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_01i_03.xml" id="paragraph4" sec-type="introduction">&lt;p&gt;If the LKB1–AMPK pathway acts as a tumour suppressor, one might expect many tumour cells to have been selected for mechanisms that down-regulate it. Indeed, somatic loss-of-function mutations in the gene encoding LKB1 (&lt;italic&gt;STK11&lt;/italic&gt;) occur in approximately 30% of non-small-cell lung cancers [&lt;xref&gt;21&lt;/xref&gt;,&lt;xref&gt;22&lt;/xref&gt;] and 20% of cervical cancers [&lt;xref&gt;23&lt;/xref&gt;]. In the HeLa cell, derived from a cervical cancer that had undergone a large deletion in &lt;italic&gt;STK11&lt;/italic&gt; [&lt;xref&gt;23&lt;/xref&gt;], increases in AMP and ADP do not enhance Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation [&lt;xref&gt;4&lt;/xref&gt;] because the basal activity of CaMKKβ is too low to support this unless intracellular Ca&lt;sup&gt;2+&lt;/sup&gt; is also elevated [&lt;xref&gt;24&lt;/xref&gt;]. Somatic mutations in genes encoding AMPK appear to be less frequent in tumours than those in &lt;italic&gt;STK11&lt;/italic&gt;, perhaps due to redundancy between multiple AMPK isoforms. However, there may be epigenetic or non-genetic mechanisms by which AMPK is down-regulated in tumour cells. For example, AMPK-α2 expression appears to be frequently down-regulated in hepatocellular carcinoma [&lt;xref&gt;25&lt;/xref&gt;].&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_01i_04.xml" id="paragraph5" sec-type="introduction">&lt;p&gt;The PI3K (phosphoinositide 3-kinase)–Akt (protein kinase B) signalling pathway is frequently activated in tumour cells, often via loss of the tumour suppressor PTEN (phosphatase and tensin homologue deleted on chromosome 10), but also via activating mutations in subunits of PI3K or upstream receptors [&lt;xref&gt;26&lt;/xref&gt;]. Interestingly, Akt phosphorylates the α1 subunit of rat AMPK at Ser&lt;sup&gt;485&lt;/sup&gt; (equivalent to Ser&lt;sup&gt;487&lt;/sup&gt; in human α1), and this was reported to reduce subsequent Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation and activation by LKB1 [&lt;xref&gt;27&lt;/xref&gt;]. Additionally, PKA (protein kinase A; also known as cAMP-dependent protein kinase) was reported to phosphorylate Ser&lt;sup&gt;485&lt;/sup&gt; with similar effects [&lt;xref&gt;28&lt;/xref&gt;]. High glucose and IGF-1 (insulin-like growth factor 1) also caused phosphorylation of AMPK-α1 at Ser&lt;sup&gt;487&lt;/sup&gt; in porcine vascular smooth muscle cells, and this was associated with reduced Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation in response to metformin [&lt;xref&gt;29&lt;/xref&gt;]. This mechanism has also been invoked to account for down-regulation of AMPK in human hepatoma cells infected with hepatitis C virus [&lt;xref&gt;30&lt;/xref&gt;]. However, these studies did not provide definitive proof that the Ser&lt;sup&gt;485&lt;/sup&gt;/Ser&lt;sup&gt;487&lt;/sup&gt; phosphorylation and the reduced Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation observed in the intact cells were causally related.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_01i_05.xml" id="paragraph6" sec-type="introduction">&lt;p&gt;Ser&lt;sup&gt;487&lt;/sup&gt; is located in a loop (residues 472–525 in human α1) that is present in the sequences of α subunits from vertebrates and &lt;italic&gt;Caenorhabditis elegans&lt;/italic&gt;, but is truncated or absent in insects (&lt;italic&gt;Drosophila melanogaster&lt;/italic&gt;) and fungi (Saccharomyces &lt;italic&gt;cerevisiae&lt;/italic&gt;) (Supplementary Figure S1 at &lt;ext-link/&gt;). This loop was disordered in the crystal structure of a partial mammalian αβγ complex expressed in bacteria [&lt;xref&gt;11&lt;/xref&gt;]. We now refer to it as the ‘ST loop’ because it is rich in serine and threonine residues, and it has recently been shown to be phosphorylated by GSK3 (glycogen synthase kinase 3) at Thr&lt;sup&gt;481&lt;/sup&gt; and Ser&lt;sup&gt;477&lt;/sup&gt; (human numbering), which appeared to promote Thr&lt;sup&gt;172&lt;/sup&gt; dephosphorylation [&lt;xref&gt;31&lt;/xref&gt;]. In the present study, we have examined whether phosphorylation of this loop causes down-regulation of AMPK in tumour cells in which the Akt pathway is hyperactivated. We also provide evidence that the ST loop binds to the kinase domain when phosphorylated at Ser&lt;sup&gt;487&lt;/sup&gt; by interactions with the αC helix, thus physically blocking access to Thr&lt;sup&gt;172&lt;/sup&gt;.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r-F1_01.xml" id="paragraph7" sec-type="results">&lt;p&gt;(&lt;bold&gt;A&lt;/bold&gt;) Alignment of sequences around Ser&lt;sup&gt;487&lt;/sup&gt; on α1 and Ser&lt;sup&gt;491&lt;/sup&gt; on α2 with the consensus for Akt phosphorylation [&lt;xref rid="B39" ref-type="bibr"&gt;39&lt;/xref&gt;] and with sequences around established Akt target sites. The right-hand column shows the percentile score for the sequence as a potential Akt target computed using Scansite (&lt;ext-link ext-link-type="uri" xlink:href="http://scansite.mit.edu/"&gt;http://scansite.mit.edu/&lt;/ext-link&gt;). (&lt;bold&gt;B&lt;/bold&gt;) Phosphorylation of GSK3β by the indicated amounts of Akt. Incubations were analysed by Western blotting with the indicated antibodies, or by autoradiography to detect &lt;sup&gt;32&lt;/sup&gt;P radioactivity. (&lt;bold&gt;C&lt;/bold&gt;) As with (&lt;bold&gt;B&lt;/bold&gt;), but analysing phosphorylation of AMPK (α1β2γ1 complex). (&lt;bold&gt;D&lt;/bold&gt;) As with (&lt;bold&gt;B&lt;/bold&gt;), but analysing phosphorylation of AMPK (α2β2γ1 complex). (&lt;bold&gt;E&lt;/bold&gt;) Rate of phosphorylation by LKB1 (signal using an anti-pT172 antibody expressed as a ratio of signal using an anti-AMPK-α antibody) obtained using the indicated mutants of the α1β2γ1 complex. Results are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=2). (&lt;bold&gt;F&lt;/bold&gt;) Rate of phosphorylation by LKB1 (signal obtained using an anti-pT172 antibody expressed as a ratio of signal using an anti-AMPK-α antibody) following pre-incubation with MgATP with or without Akt (30 units/ml, 20 min), for the inactive (D157A) α1β2γ1 complex or an S487A/D157A double mutant. Results are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=4); **&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.01; ns, not significant.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r-F2_01.xml" id="paragraph8" sec-type="results">&lt;p&gt;(&lt;bold&gt;A&lt;/bold&gt;) AMPK (α1β2γ1 or α2β2γ1 complex) was incubated with MgATP and the indicated concentrations of Akt for 20 min at 30°C, and aliquots (20 μl) analysed by Western blotting using the indicated antibodies. (&lt;bold&gt;B&lt;/bold&gt;) AMPK (α1β2γ1 or α2β2γ1, WT or inactive D157A mutant) was incubated with MgATP and increasing concentrations of LKB1 (0, 8.2, 28, 82, 280 and 820 ng) or Akt (0, 0.15, 0.5, 1.5, 5 and 15 units/ml) for 10 min at 30°C. (&lt;bold&gt;C&lt;/bold&gt;) AMPK (α2β2γ1 complex, WT, S491A or S491D mutant) was incubated with MgATP and the indicated amount of LKB1 in a final volume of 20 μl for 10 min at 30°C, and AMPK activity determined. (&lt;bold&gt;D&lt;/bold&gt;) Phosphorylation of synthetic peptides by three different preparations of AMPK. AMPK (0.1 unit, either α1β2γ1, α2β2γ1 complexes or purified from rat liver [&lt;xref rid="B2" ref-type="bibr"&gt;2&lt;/xref&gt;]) was incubated with 5 nmol of the SAMS, S485 or S491 peptides in the presence of 5 mM MgCl&lt;sub&gt;2&lt;/sub&gt; and 200 μM [γ-&lt;sup&gt;32&lt;/sup&gt;P]ATP in a final volume of 25 μl for 30 min at 30°C, before SDS/PAGE and autoradiography.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r-F3_01.xml" id="paragraph9" sec-type="results">&lt;p&gt;AMPK (α1β2γ1 complex, WT or S487A mutant) was pre-incubated with MgATP and Akt for 30 min, and then with LKB1 (50 ng) or CaMKKβ (23 ng) for 10 min at 30°C in a final volume of 40 μl. (&lt;bold&gt;A&lt;/bold&gt;) Phosphorylation of AMPK by LKB1 in the absence or presence of Akt. (&lt;bold&gt;B&lt;/bold&gt;) Activation of AMPK by LKB1 in the absence or presence of Akt. (&lt;bold&gt;C&lt;/bold&gt;) Activation/phosphorylation by LKB1/CaMKKβ in the absence or presence of Akt. Phosphorylation (&lt;bold&gt;A&lt;/bold&gt; and &lt;bold&gt;C&lt;/bold&gt;) was assessed in duplicate samples by Western blotting, and AMPK activity (&lt;bold&gt;B&lt;/bold&gt; and &lt;bold&gt;C&lt;/bold&gt;) by kinase assays. Results in (&lt;bold&gt;B&lt;/bold&gt;) and (&lt;bold&gt;C&lt;/bold&gt;) are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=4); ***&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001; ns, not significant.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r-F4_01.xml" id="paragraph10" sec-type="results">&lt;p&gt;HEK-293 cells stably expressing WT AMPK (&lt;bold&gt;A&lt;/bold&gt;) or an S487A mutant (&lt;bold&gt;B&lt;/bold&gt;) were serum-starved overnight and then incubated with IGF-1 in the presence or absence of MK2206 as described in the Experimental section. The cells were then treated with or without A769662 (300 μM for 40 min) and lysates prepared for immunoprecipitate kinase assay and Western blots. Blots are samples from separate dishes (&lt;italic&gt;n&lt;/italic&gt;=2), whereas activity data are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=4); ***&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001 compared with relevant control without A769662; †††&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001; ns, not significant, for IGF-1-treated against relevant serum-starved control. (&lt;bold&gt;C&lt;/bold&gt;) Cells expressing WT AMPK-α1 or AMPK-α2 were treated with IGF-1 (30 ng/ml) or berberine (300 μM) and lysates analysed by immunoprecipitate kinase assays and Western blotting (two separate dishes). Activity data are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=4); ***&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001; ns, not significant, compared with control without IGF-1 or berberine. (&lt;bold&gt;D&lt;/bold&gt;) Cells expressing WT AMPK-α1 or AMPK-α2 were treated with IGF-1 in the absence or presence of rapamycin (100 μM) and lysates analysed by immunoprecipitate kinase assays and Western blotting. Activity data are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=2); duplicate blots were from separate dishes.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r-F5_01.xml" id="paragraph11" sec-type="results">&lt;p&gt;G361 cells were serum-starved overnight and then incubated with IGF-1 in the presence or absence of MK2206 as described in the Experimental section. Cells were then treated with or without A23817 (30 nM for 30 min) and lysates prepared for immunoprecipitate kinase assay and Western blots. Blots are samples from separate dishes, whereas activity data are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=4); ***&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001 compared with the relevant control without A23187; †††&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001; ns, not significant, for IGF-1-treated against relevant serum-starved control.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r-F6_01.xml" id="paragraph12" sec-type="results">&lt;p&gt;(&lt;bold&gt;A&lt;/bold&gt;) Glioblastoma (DBTRG-05MG) cells were incubated for 20 min with or without MK2206 (3 μM), followed by 60 min with or without A769662 (300 μM). Lysates were then analysed for AMPK activity. Results are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=2); ***&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001; **&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.01. (&lt;bold&gt;B&lt;/bold&gt;) Analysis of the samples from (&lt;bold&gt;A&lt;/bold&gt;) by Western blotting using the indicated antibodies (duplicate dishes). (&lt;bold&gt;C&lt;/bold&gt;) WT PTEN or a phosphatase-inactive (C124S) mutant were expressed in DBTRG-05MG cells using lentiviral vectors, and the effects of A769662 tested as in (&lt;bold&gt;A&lt;/bold&gt;). Results are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=2 for WT PTEN, &lt;italic&gt;n&lt;/italic&gt;=4 for C124S PTEN); ***&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001; **&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.01. (&lt;bold&gt;D&lt;/bold&gt;) Analysis of the samples from (&lt;bold&gt;C&lt;/bold&gt;) by Western blotting using the antibodies shown (duplicate dishes). (&lt;bold&gt;E&lt;/bold&gt; and &lt;bold&gt;F&lt;/bold&gt;) Glioblastoma (U373-MG) cells were incubated and analysed as in (&lt;bold&gt;A&lt;/bold&gt; and &lt;bold&gt;B&lt;/bold&gt;). (&lt;bold&gt;G&lt;/bold&gt; and &lt;bold&gt;H&lt;/bold&gt;) Breast cancer (MDA-MB-468) cells were incubated and analysed as in (&lt;bold&gt;A&lt;/bold&gt; and &lt;bold&gt;B&lt;/bold&gt;). For (&lt;bold&gt;E&lt;/bold&gt;) and (&lt;bold&gt;G&lt;/bold&gt;), results are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=2); ***&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001; **&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.01; *&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.05.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r-F7_01.xml" id="paragraph13" sec-type="results">&lt;p&gt;(&lt;bold&gt;A&lt;/bold&gt;) Model for the structure of an AMPK heterotrimer (PDB code 2Y8L, space-filling model made using PyMOL; &lt;ext-link ext-link-type="uri" xlink:href="http://pymol.org"&gt;http:://pymol.org&lt;/ext-link&gt;) showing the location of the ends of the ST loop (Glu&lt;sup&gt;469&lt;/sup&gt; and Val&lt;sup&gt;524&lt;/sup&gt;), with Glu&lt;sup&gt;469&lt;/sup&gt; particularly close to Thr&lt;sup&gt;172&lt;/sup&gt;; the intervening residues of the ST loop were deleted from the construct used to produce this structure. (&lt;bold&gt;B&lt;/bold&gt;) Inhibition of activation of the human α1β2γ1 complex by LKB1 by peptide corresponding to the sequence from Arg&lt;sup&gt;466&lt;/sup&gt; to Asp&lt;sup&gt;525&lt;/sup&gt;, either with (P-peptide) or without (deP-peptide) prior phosphorylation by Akt. Results are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=4). (&lt;bold&gt;C&lt;/bold&gt;) Inhibition of activation and phosphorylation by LKB1 of α1β2γ1 complex (left-hand side) and BRSK2 (right-hand side) by P-peptide and deP-peptide as in (&lt;bold&gt;B&lt;/bold&gt;). Results for kinase activity are expressed as a percentage of activities obtained without either peptide, and are means±S.E.M. (&lt;italic&gt;n&lt;/italic&gt;=2); ***&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001 relative to controls without LKB1; †††&lt;italic&gt;P&lt;/italic&gt;&amp;lt;0.001 relative to control without P-peptide. Results of Western blots are from duplicate incubations. (&lt;bold&gt;D&lt;/bold&gt;) Human AMPK (α1β2γ1 complex, either WT, S487A or AAA mutant) was incubated with LKB1 following prior incubation with ATP with or without Akt. AMPK activation (top panel) and phosphorylation of Thr&lt;sup&gt;172&lt;/sup&gt; and Ser&lt;sup&gt;487&lt;/sup&gt; (bottom panel) was monitored.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_01.xml" id="paragraph14" sec-type="results">&lt;p&gt;Akt phosphorylates serine or threonine residues within the sequence motif RXRXXS/TΦ, where Φ is a bulky hydrophobic residue [&lt;xref&gt;39&lt;/xref&gt;]. &lt;xref&gt;Figure 1&lt;/xref&gt;(A) shows an alignment of this consensus with sequences around some established Akt targets, the ST loop sequence containing Ser&lt;sup&gt;487&lt;/sup&gt; in human α1, and the equivalent site on α2 (Ser&lt;sup&gt;491&lt;/sup&gt;). Both of the latter have a serine residue at P-2, with Akt having a preference for the serine or threonine residue at this position [&lt;xref&gt;39&lt;/xref&gt;]. However, both also have a proline residue rather than arginine at the P-5 position, and Ser&lt;sup&gt;491&lt;/sup&gt; also has an alanine residue rather than a bulky hydrophobic residue at P+1. Neither is therefore a perfect fit to the Akt consensus; Scansite 2.0 [&lt;xref&gt;40&lt;/xref&gt;] identifies Ser&lt;sup&gt;487&lt;/sup&gt; as a potential Akt site only at medium stringency, and Ser&lt;sup&gt;491&lt;/sup&gt; only at low stringency.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_02.xml" id="paragraph15" sec-type="results">&lt;p&gt;To avoid complications caused by autophosphorylation, we initially used inactive mutants of human AMPK complexes (α1-D159A/β2/γ1 and α2-D157A/β2/γ1), with or without α1-S487A or α2-S491A mutations, as substrates for phosphorylation by human Akt. For comparison, we used an inactive (D200A) mutant of the known Akt substrate GSK3β, with or without mutation of the Akt site (Ser&lt;sup&gt;9&lt;/sup&gt;). Interestingly, AMPK-α1 was a reasonable substrate for Akt although not as good as GSK3, whereas AMPK-α2 was a very poor substrate. Using either an anti-pS9 antibody or by &lt;sup&gt;32&lt;/sup&gt;P-labelling, phosphorylation of GSK3β was saturated at 0.5 unit/ml Akt, when the phosphorylation stoichiometry by &lt;sup&gt;32&lt;/sup&gt;P-labelling was 1.03 mol/mol (&lt;xref&gt;Figure 1&lt;/xref&gt;B). The phosphorylation of AMPK-α1 within the α1β2γ1 complex was only saturated at 5 units/ml, when the stoichiometry was 0.96 mol/mol (&lt;xref&gt;Figure 1&lt;/xref&gt;C). For both GSK3β and AMPK-α1, the signals obtained using phospho-specific antibodies (pS9/pS487) or &lt;sup&gt;32&lt;/sup&gt;P-labelling were abolished by mutation of the respective sites to alanine (S9A/S487A). By contrast, there was much less phosphorylation of Ser&lt;sup&gt;491&lt;/sup&gt; within the α2β2γ1 complex (&lt;xref&gt;Figure 1&lt;/xref&gt;D). By &lt;sup&gt;32&lt;/sup&gt;P-labelling, the stoichiometry of α2 phosphorylation was only 0.18 mol/mol, even with Akt at 30- and 300-fold higher concentrations than those required to obtain stoichiometric phosphorylation of α1 and GSK3β respectively. Although we did detect some phosphorylation of Ser&lt;sup&gt;491&lt;/sup&gt; using a phospho-specific antibody and this was abolished in a S491A mutant, &lt;sup&gt;32&lt;/sup&gt;P-labelling was not affected by the S491A mutation, suggesting that the low level of α2 phosphorylation by Akt was mainly accounted for by modification at other site(s).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_03.xml" id="paragraph16" sec-type="results">&lt;p&gt;We next tested the ability of the human LKB1–STRADα–MO25α complex to phosphorylate Thr&lt;sup&gt;172&lt;/sup&gt; in an inactive (α1-D157A) human α1β2γ1 complex. Before phosphorylation by Akt, the rate of phosphorylation of Thr&lt;sup&gt;172&lt;/sup&gt; by the LKB1 complex was unaffected by an S487A mutation, although an S487D mutation reduced the rate of Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation by approximately 30% (&lt;xref&gt;Figure 1&lt;/xref&gt;E). When the inactive (D157A) mutant complex was first phosphorylated by Akt under conditions that yielded stoichiometric Ser&lt;sup&gt;487&lt;/sup&gt; phosphorylation, subsequent phosphorylation of Thr&lt;sup&gt;172&lt;/sup&gt; was reduced by approximately 40%, an effect abolished by an S487A mutation (&lt;xref&gt;Figure 1&lt;/xref&gt;F).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_04.xml" id="paragraph17" sec-type="results">&lt;p&gt;We next tested the effects of Akt on either WT, S487A or S491A mutants of active α1β2γ1 and α2β2γ1 complexes. &lt;xref&gt;Figure 2&lt;/xref&gt;(A) shows that with the α1β2γ1 complex there was slight phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; even in the absence of Akt, although phosphorylation of this site increased markedly with increasing Akt. By contrast, Ser&lt;sup&gt;491&lt;/sup&gt; in an α2β2γ1 complex appeared to be fully phosphorylated in the absence of Akt, and addition of Akt had no further effect. These results suggested that Ser&lt;sup&gt;491&lt;/sup&gt; was modified by autophosphorylation, whereas Ser&lt;sup&gt;487&lt;/sup&gt; is phosphorylated by Akt, with a small degree of autophosphorylation. Consistent with this, there was substantial phosphorylation of Ser&lt;sup&gt;491&lt;/sup&gt; in a human α2β2γ1 complex, and slight phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; in a human α1β2γ1 complex, when they were incubated with MgATP alone; these effects were completely abolished by D157A mutations that rendered the complexes inactive, although Ser&lt;sup&gt;487&lt;/sup&gt; could still be phosphorylated by Akt in the inactive complex (&lt;xref&gt;Figure 2&lt;/xref&gt;B). Unlike the equivalent α1β2γ1 complexes, where the S487D mutant was phosphorylated at a lower rate (&lt;xref&gt;Figure 1&lt;/xref&gt;E), the WT, S491A and S491D mutant α2β2γ1 complexes were phosphorylated on Thr&lt;sup&gt;172&lt;/sup&gt; at equal rates by LKB1 (&lt;xref&gt;Figure 2&lt;/xref&gt;C).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_05.xml" id="paragraph18" sec-type="results">&lt;p&gt;We also synthesized peptides corresponding to the sequences around Ser&lt;sup&gt;485&lt;/sup&gt; on rat α1 (S485, TPQRSGSISNYRS) or Ser&lt;sup&gt;491&lt;/sup&gt; on rat/human α2 (S491, TPQRSCSAAGLHR), and compared them as AMPK substrates with the classical SAMS peptide [&lt;xref&gt;36&lt;/xref&gt;]. Although the SAMS peptide was by far the best substrate, the S491 peptide was also phosphorylated, whereas the S485 peptide was not phosphorylated at all. The results were identical with rat liver AMPK (a mixture of α1β1γ1 and α2β1γ1 complexes) or with recombinant human α1β2γ1 and α2β2γ1 complexes (&lt;xref&gt;Figure 2&lt;/xref&gt;D).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_06.xml" id="paragraph19" sec-type="results">&lt;p&gt;We next incubated the active α1β2γ1 complex with Akt under conditions where we obtained stoichiometric phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt;, and subsequently treated with the LKB1 complex under conditions where we could measure the initial rate of Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation and consequent activation. As with the inactive complex (&lt;xref&gt;Figure 1&lt;/xref&gt;F), prior Akt phosphorylation reduced the rate of subsequent Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation (&lt;xref&gt;Figure 3&lt;/xref&gt;A), but using the active complex this could also be seen to be associated with a reduction in activation by LKB1 of approximately 40% (&lt;xref&gt;Figure 3&lt;/xref&gt;B); both effects were abolished by an S487A mutation within the ST loop. &lt;xref&gt;Figure 3&lt;/xref&gt;(C) shows that the inhibitory effect of prior Ser&lt;sup&gt;487&lt;/sup&gt; phosphorylation on Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation and AMPK activation was identical using either LKB1 or CaMKKβ, showing that the effect is independent of the upstream kinase utilized.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_07.xml" id="paragraph20" sec-type="results">&lt;p&gt;To test the effects of Ser&lt;sup&gt;487&lt;/sup&gt; phosphorylation in intact cells, we generated isogenic HEK-293 cells stably expressing FLAG-tagged WT AMPK-α1 or AMPK-α2, or a non-phosphorylatable (S487A) α1 mutant. We have shown previously that when AMPK-β [&lt;xref&gt;16&lt;/xref&gt;] or AMPK-γ [&lt;xref&gt;19&lt;/xref&gt;] subunits are expressed using this system, they largely replace the endogenous subunit because they compete for the available α/γ or α/β partners, with free subunits being unstable. This was also true in the present study because we showed that approximately 70% of the total AMPK activity could be immunoprecipitated using anti-FLAG antibody, with the remaining 30% (representing a small proportion with endogenous α subunits) being subsequently precipitated using anti-α1 or anti-α2 antibodies. The presence of a small amount of endogenous α subunits does not affect interpretation of the kinase assays shown in &lt;xref&gt;Figure 4&lt;/xref&gt;, which were conducted in anti-FLAG antibody immunoprecipitates, but a small proportion of AMPK-α subunits detected in the Western blots (e.g. the faint signal obtained using the anti-pS487 antibody in the cells expressing the S487A mutant) may be due to these endogenous subunits.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_08.xml" id="paragraph21" sec-type="results">&lt;p&gt;The cells expressing AMPK-α1 were serum-starved, and some were then treated with IGF-1 to activate Akt. As expected, IGF-1 resulted in marked increases in phosphorylation of the activating sites on Akt (Thr&lt;sup&gt;308&lt;/sup&gt; and Ser&lt;sup&gt;473&lt;/sup&gt;), which were blocked by the Akt inhibitor MK2206 [&lt;xref&gt;41&lt;/xref&gt;], as was the phosphorylation of Ser&lt;sup&gt;9&lt;/sup&gt;/Ser&lt;sup&gt;21&lt;/sup&gt; on GSK3-α/β (markers of Akt activation) and Ser&lt;sup&gt;487&lt;/sup&gt; on AMPK-α1 (&lt;xref&gt;Figure 4&lt;/xref&gt;A). When cells expressing WT α1 were treated with A769662, the activation of AMPK, and Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation, was markedly blunted if the cells had been exposed previously to IGF-1, an effect abolished by MK2206. The effect of IGF-1 to reduce AMPK activation and phosphorylation of Thr&lt;sup&gt;172&lt;/sup&gt; correlated with increased Ser&lt;sup&gt;487&lt;/sup&gt; phosphorylation, and was absent in cells expressing the S487A mutant (&lt;xref&gt;Figure 4&lt;/xref&gt;B).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_09.xml" id="paragraph22" sec-type="results">&lt;p&gt;&lt;xref&gt;Figure 4&lt;/xref&gt;(C) shows results obtained when serum-starved cells expressing WT AMPK-α1 or AMPK-α2 were treated either with IGF-1 or with berberine, which activates AMPK by inhibiting mitochondrial ATP synthesis [&lt;xref&gt;19&lt;/xref&gt;]. As expected, treatment of α1-expressing cells with IGF-1 caused increased phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt;, but not Thr&lt;sup&gt;172&lt;/sup&gt;, whereas treatment with berberine caused increased phosphorylation of Thr&lt;sup&gt;172&lt;/sup&gt;, accompanied by AMPK activation, but not Ser&lt;sup&gt;487&lt;/sup&gt;. This contrasted markedly with results in α2-expressing cells, where treatment with IGF-1 did not increase phosphorylation of Ser&lt;sup&gt;491&lt;/sup&gt;, whereas treatment with berberine caused increased phosphorylation of both Ser&lt;sup&gt;491&lt;/sup&gt; and Thr&lt;sup&gt;172&lt;/sup&gt;, together with AMPK activation. The results for phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; and Ser&lt;sup&gt;491&lt;/sup&gt; were very similar whether we used in-house phospho-specific antibodies that are isoform-specific, or a commercial antibody that recognizes the equivalent sites on both α1 and α2. These results are consistent with the results in &lt;xref&gt;Figures 2&lt;/xref&gt; and &lt;xref&gt;3&lt;/xref&gt;, showing that Ser&lt;sup&gt;491&lt;/sup&gt; on α2 is modified by autophosphorylation, and not by Akt as for Ser&lt;sup&gt;487&lt;/sup&gt; on α1. As expected, increased phosphorylation of the downstream AMPK target ACC correlated with Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation and AMPK activation in both cell lines.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_10.xml" id="paragraph23" sec-type="results">&lt;p&gt;To confirm that Ser&lt;sup&gt;487&lt;/sup&gt; was phosphorylated directly by Akt in the cells, and not by a downstream kinase such as p70 S6K1, we tested the effects of rapamycin, an inhibitor of mTORC1. Rapamycin did not block the IGF-1-stimulated phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; on α1 or Ser&lt;sup&gt;473&lt;/sup&gt; on Akt although, as expected, it blocked phosphorylation of an established mTORC1 substrate, Thr&lt;sup&gt;389&lt;/sup&gt; on the p70/p85 isoforms of S6K1 (&lt;xref&gt;Figure 4&lt;/xref&gt;D).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_11.xml" id="paragraph24" sec-type="results">&lt;p&gt;To show that phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; on AMPK-α1 by Akt could also reduce subsequent activation by CaMKKβ, we used the LKB1-null G361 melanoma cell line. The cells were serum-starved, and some were then treated with IGF-1 to activate Akt. As expected, IGF-1 resulted in marked increases in phosphorylation of Thr&lt;sup&gt;308&lt;/sup&gt; and Ser&lt;sup&gt;473&lt;/sup&gt; on Akt, Ser&lt;sup&gt;9&lt;/sup&gt;/Ser&lt;sup&gt;21&lt;/sup&gt; on GSK3α/β and Ser&lt;sup&gt;487&lt;/sup&gt; on AMPK-α1, all of which were blocked or reduced by MK2206 (&lt;xref&gt;Figure 5&lt;/xref&gt;). When the cells were treated with the Ca&lt;sup&gt;2+&lt;/sup&gt; ionophore A23187 to activate CaMKKβ, the activation of AMPK and Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation, was significantly blunted if the cells had been exposed previously to IGF-1, an effect completely abolished by MK2206 (&lt;xref&gt;Figure 5&lt;/xref&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_12.xml" id="paragraph25" sec-type="results">&lt;p&gt;To examine whether hyperactivation of Akt in tumour cells due to PTEN loss might also inhibit AMPK activation, we initially examined the PTEN-null glioblastoma cell line DBTRG-05MG. We first tested a range of AMPK activators to see whether any interfered with Akt activation. Surprisingly, phenformin and quercetin blocked phosphorylation of Akt at Ser&lt;sup&gt;473&lt;/sup&gt;, although berberine, A769662 and A23187 did not (Supplementary Figure S2A at &lt;ext-link/&gt;). As expected, all agents also increased the phosphorylation of ACC1 at Ser&lt;sup&gt;79&lt;/sup&gt; and AMPK at Thr&lt;sup&gt;172&lt;/sup&gt; in MEFs (mouse embryonic fibroblasts), although the effect of A769662 on Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation was small, indicating that it was mainly acting through an allosteric mechanism (Supplementary Figure S2B). The inhibitory effects of phenformin and quercetin on Akt Ser&lt;sup&gt;473&lt;/sup&gt; phosphorylation were observed in WT MEFs, but were ‘off-target’ AMPK-independent effects, because they were also observed in double-knockout (α1&lt;sup&gt;−/−&lt;/sup&gt; α2&lt;sup&gt;−/−&lt;/sup&gt;) MEFs (Supplementary Figure S2B and S2C). To avoid this complication, in subsequent studies we focused on the effects of A769662, which activates AMPK by direct binding to the β subunit [&lt;xref&gt;16&lt;/xref&gt;,&lt;xref&gt;17&lt;/xref&gt;] and does not inhibit ATP synthesis [&lt;xref&gt;19&lt;/xref&gt;] or Akt Ser&lt;sup&gt;473&lt;/sup&gt; phosphorylation (Supplementary Figure S2).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_13.xml" id="paragraph26" sec-type="results">&lt;p&gt;AMPK in DBTRG-05MG cells was activated by A769662, but activation (&lt;xref&gt;Figure 6&lt;/xref&gt;A) and Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation (&lt;xref&gt;Figure 6&lt;/xref&gt;B) were greatly enhanced when the selective Akt inhibitor MK2206 was added before A769662. Thus reduced activation of AMPK in these cells was Akt-dependent. As expected, inhibition of Akt by MK2206 was associated with greatly reduced phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt;, and of the Akt site on GSK3β, Ser&lt;sup&gt;9&lt;/sup&gt; (&lt;xref&gt;Figure 6&lt;/xref&gt;B). As reported previously [&lt;xref&gt;41&lt;/xref&gt;], MK2206 also blocked the phosphorylation of Akt at the activating sites, Thr&lt;sup&gt;308&lt;/sup&gt; and Ser&lt;sup&gt;473&lt;/sup&gt;.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_14.xml" id="paragraph27" sec-type="results">&lt;p&gt;We also examined the effect of re-expressing PTEN in DBTRG-05MG cells, using a lentiviral vector that gives levels of expression similar to normal cells. As a control, we expressed a C124S mutant that has no lipid phosphatase activity. Prior expression of WT PTEN enhanced the activation (&lt;xref&gt;Figure 6&lt;/xref&gt;C) and Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation (&lt;xref&gt;Figure 6&lt;/xref&gt;D) of AMPK in response to A769662. When compared with the C124S mutant, expression of WT PTEN was associated with decreased phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; on AMPK-α1 and Ser&lt;sup&gt;9&lt;/sup&gt; on GSK3β, and markedly decreased phosphorylation of Thr&lt;sup&gt;308&lt;/sup&gt; and Ser&lt;sup&gt;473&lt;/sup&gt; on Akt (&lt;xref&gt;Figure 6&lt;/xref&gt;D).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_15.xml" id="paragraph28" sec-type="results">&lt;p&gt;We also studied two other PTEN-null human cell lines, i.e. U373-MG (another glioblastoma line) and MDA-MB-468 (a breast cancer line). Similar to the DBTRG-05MG cells, there was a modest activation (&lt;xref&gt;Figures 6&lt;/xref&gt;E and &lt;xref&gt;6&lt;/xref&gt;G) and Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation (&lt;xref&gt;Figures 6&lt;/xref&gt;F and &lt;xref&gt;6&lt;/xref&gt;H) of AMPK in response to A769662, but both were enhanced when Akt was inhibited using MK2206.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_16.xml" id="paragraph29" sec-type="results">&lt;p&gt;We next addressed the mechanism by which Ser&lt;sup&gt;487&lt;/sup&gt; phosphorylation inhibits subsequent Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation. In the structure of a partial mammalian α1β2γ1 complex, the ST loop from Ile&lt;sup&gt;470&lt;/sup&gt; to Asp&lt;sup&gt;523&lt;/sup&gt; (rat numbering) was disordered [&lt;xref&gt;11&lt;/xref&gt;]; the complex had been expressed in bacteria, so the ST loop was likely to be unphosphorylated. In a subsequent structure [&lt;xref&gt;10&lt;/xref&gt;], the ST loop was deleted as it was thought that it might hinder crystallization. However, the location of the residues at the ends of the loop (Glu&lt;sup&gt;469&lt;/sup&gt; and Val&lt;sup&gt;524&lt;/sup&gt;) in this structure show that they lie close to the kinase domain, being approximately 20 and 40 Å (1 Å=0.1 nm) from Thr&lt;sup&gt;172&lt;/sup&gt; respectively (&lt;xref&gt;Figure 7&lt;/xref&gt;A). We hypothesized that the ST loop might interact with the kinase domain when phosphorylated on Ser&lt;sup&gt;487&lt;/sup&gt;. We also noticed three basic residues, Arg&lt;sup&gt;62&lt;/sup&gt;, Lys&lt;sup&gt;69&lt;/sup&gt; and Arg&lt;sup&gt;72&lt;/sup&gt; (rat α1 numbering), which are located within the ‘αC helix’ of the small lobe of the kinase domain. An extension of our hypothesis was that phosphate groups on the ST loop interact with these basic side chains, triggering a stable interaction between the ST loop and the kinase domain that physically blocks access of Thr&lt;sup&gt;172&lt;/sup&gt; to upstream kinases.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_17.xml" id="paragraph30" sec-type="results">&lt;p&gt;To test the first hypothesis, we made a construct expressing the peptide from Arg&lt;sup&gt;466&lt;/sup&gt; to Asp&lt;sup&gt;525&lt;/sup&gt; on human α1 as a GST fusion. The protein was expressed in and purified from bacteria, the GST domain removed, and the remaining peptide (Arg&lt;sup&gt;466&lt;/sup&gt;–Asp&lt;sup&gt;525&lt;/sup&gt;) either thiophosphorylated using ATPγS (adenosine 5′-[γ-thio]triphosphate) and Akt (thiophosphate being resistant to protein phosphatases), or left unphosphorylated. Consistent with our hypothesis, the phosphopeptide caused a concentration-dependent inhibition of activation and Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation of the bacterially expressed α1β2γ1 complex by LKB1, although we were unable to generate the peptide at high enough concentrations to fully saturate inhibition. By contrast, the unphosphorylated peptide had no effect (&lt;xref&gt;Figure 7&lt;/xref&gt;B). To confirm that the inhibition of activation loop phosphorylation was specific to AMPK, we showed that neither the phospho- nor the dephospho-peptide inhibited activation and phosphorylation of the AMPK-related kinase BRSK2 by LKB1 (&lt;xref&gt;Figure 7&lt;/xref&gt;C).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_03r_18.xml" id="paragraph31" sec-type="results">&lt;p&gt;To test the extended hypothesis, we made a triple mutation (R64A/K71A/R74A, human α1 numbering, ‘AAA mutant’), in the context of the recombinant human α1β2γ1 complex used in &lt;xref&gt;Figure 3&lt;/xref&gt;, of the three basic residues in the kinase domain that we propose to interact with phosphate groups on the ST loop. Consistent with our hypothesis, prior phosphorylation of the WT complex by Akt reduced subsequent activation and Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation by LKB1, but this effect was completely abolished by either an S487A mutant or an AAA mutant, even though the latter was still phosphorylated on Ser&lt;sup&gt;487&lt;/sup&gt; by Akt (&lt;xref&gt;Figure 7&lt;/xref&gt;D).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_01.xml" id="paragraph32" sec-type="discussion">&lt;p&gt;It has been reported previously that prior phosphorylation of Ser&lt;sup&gt;485&lt;/sup&gt; on rat AMPK-α1 by Akt, within a rat α1β1γ1 complex, caused a 40% reduction in the rate of subsequent phosphorylation of Thr&lt;sup&gt;172&lt;/sup&gt; and activation by LKB1 in cell-free assays, an effect that was abolished by a non-phosphorylatable S485A substitution [&lt;xref&gt;27&lt;/xref&gt;]. In the present study, we have followed up this observation and made several new findings. First, we demonstrated identical effects with the equivalent site (Ser&lt;sup&gt;487&lt;/sup&gt;) on the human α1β2γ1 complex (&lt;xref&gt;Figures 1&lt;/xref&gt;F and &lt;xref&gt;4&lt;/xref&gt;), showing that the effect is conserved in humans and is also independent of the β subunit isoform. Secondly, we show that the effect is not specific to the upstream kinase LKB1, but is also observed with CaMKKβ (&lt;xref&gt;Figure 3&lt;/xref&gt;C). Thirdly, we report that Ser&lt;sup&gt;491&lt;/sup&gt; (the site equivalent to Ser&lt;sup&gt;487&lt;/sup&gt; in AMPK-α2) is an extremely poor substrate for Akt, and that the very low level of α2 phosphorylation obtained using Akt is not affected by an S491A mutation (&lt;xref&gt;Figure 1&lt;/xref&gt;D). It had been shown previously using a bacterially expressed α2β1γ1 complex that Akt phosphorylated AMPK-α2, albeit more slowly than α1 [&lt;xref&gt;27&lt;/xref&gt;] and, although the phosphorylation site(s) had not been identified, it has generally been assumed that this phosphorylation occurred at Ser&lt;sup&gt;491&lt;/sup&gt;. That Ser&lt;sup&gt;491&lt;/sup&gt; is modified instead by autophosphorylation is shown by the following findings: (i) substantial phosphorylation of Ser&lt;sup&gt;491&lt;/sup&gt; occurred with the recombinant human α2β2γ1 complex in the absence of exogenous kinases (&lt;xref&gt;Figures 2&lt;/xref&gt;A and &lt;xref&gt;2&lt;/xref&gt;B); (ii) Ser&lt;sup&gt;491&lt;/sup&gt; phosphorylation did not occur with an inactive (D157A mutant) complex (&lt;xref&gt;Figure 2&lt;/xref&gt;B); (iii) various forms of AMPK, including the human α2β2γ1 complex, phosphorylated a synthetic peptide corresponding to the sequence around Ser&lt;sup&gt;491&lt;/sup&gt;, but not Ser&lt;sup&gt;485&lt;/sup&gt; on rat α1 (&lt;xref&gt;Figure 2&lt;/xref&gt;D); and (iv) Ser&lt;sup&gt;491&lt;/sup&gt; on AMPK-α2 became phosphorylated in response to the AMPK activator berberine in HEK-293 cells, whereas Ser&lt;sup&gt;487&lt;/sup&gt; on AMPK-α1 did not (&lt;xref&gt;Figure 4&lt;/xref&gt;C). Although further work is required to test whether autophosphorylation of Ser&lt;sup&gt;491&lt;/sup&gt; down-regulates Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation, this is not supported by the results in &lt;xref&gt;Figure 2&lt;/xref&gt;(C), where the activation of the human α2β2γ1 complex by LKB1 was not affected by a potentially phosphomimetic S491D mutation. Thus the ability of Akt-activating treatments such as insulin and IGF-1 to restrain activation of AMPK by ST loop phosphorylation is limited to complexes containing the α1 isoform.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_02.xml" id="paragraph33" sec-type="discussion">&lt;p&gt;Although Ser&lt;sup&gt;487&lt;/sup&gt; in the human α1β2γ1 complex also appeared to autophosphorylate to a limited extent in cell-free assays (&lt;xref&gt;Figure 2&lt;/xref&gt;A), increased Ser&lt;sup&gt;487&lt;/sup&gt; phosphorylation did not occur when intact cells were incubated with the AMPK activator berberine (&lt;xref&gt;Figure 4&lt;/xref&gt;C), suggesting that autophosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; is not significant in intact cells. Interestingly, the small degree of Ser&lt;sup&gt;487&lt;/sup&gt; autophosphorylation in cell-free assays did not increase when the α1β2γ1 complex was activated by phosphorylation at Thr&lt;sup&gt;172&lt;/sup&gt; by LKB1 (&lt;xref&gt;Figure 2&lt;/xref&gt;B, top left), suggesting that Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation (unlike its effects on phosphorylation of exogenous substrates) does not enhance Ser&lt;sup&gt;487&lt;/sup&gt; autophosphorylation. Our results show that Ser&lt;sup&gt;487&lt;/sup&gt; in human α1, unlike Ser&lt;sup&gt;491&lt;/sup&gt; in α2, is a good substrate for Akt. Although only phosphorylated in cell-free assays at approximately 10% of the rate of Ser&lt;sup&gt;9&lt;/sup&gt; on GSK3-β (a canonical Akt site), in the intact cells the net phosphorylation status would also be affected by the activity of protein phosphatases acting on Ser&lt;sup&gt;487&lt;/sup&gt;. The results using MK2206 in &lt;xref&gt;Figures 4&lt;/xref&gt; and &lt;xref&gt;6&lt;/xref&gt; clearly confirm that Ser&lt;sup&gt;487&lt;/sup&gt; is phosphorylated in four distinct cell lines in an Akt-dependent manner.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_03.xml" id="paragraph34" sec-type="discussion">&lt;p&gt;In good agreement with previous results obtained with the rat α1β1γ1 complex [&lt;xref&gt;27&lt;/xref&gt;], prior phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; on the human α1β2γ1 complex caused a 40% reduction in subsequent phosphorylation of Thr&lt;sup&gt;172&lt;/sup&gt; both in active (&lt;xref&gt;Figure 3&lt;/xref&gt;A) and inactive (&lt;xref&gt;Figure 1&lt;/xref&gt;F) AMPK complexes, and a reduction in the activation of the active complex (&lt;xref&gt;Figure 3&lt;/xref&gt;B). Although a 40% effect might appear to be quite modest, the effect appears to be larger in intact cells (&lt;xref&gt;Figures 4&lt;/xref&gt; and &lt;xref&gt;6&lt;/xref&gt;), where the activities of phosphatases acting on Ser&lt;sup&gt;487&lt;/sup&gt; would affect the outcome. Another explanation for the different size of the effect in cell-free assays and intact cells is that other sites in the ST loop may be phosphorylated in the intact cells, a possibility discussed further below.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_04.xml" id="paragraph35" sec-type="discussion">&lt;p&gt;By using HEK-293 cells expressing recombinant AMPK-α1, we showed not only that the effect of prior IGF-1 treatment to inhibit subsequent AMPK activation by A769662 was dependent on Akt, but also that it was dependent on phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt;, since the effect was completely abolished in cells expressing a non-phosphorylatable S487A mutant (&lt;xref&gt;Figure 4&lt;/xref&gt;). It has been reported recently that Ser&lt;sup&gt;491&lt;/sup&gt; on AMPK-α2 can be phosphorylated by S6K1 [&lt;xref&gt;42&lt;/xref&gt;], so we considered the possibility that Ser&lt;sup&gt;487&lt;/sup&gt; might have been phosphorylated by a kinase downstream of Akt and mTORC1, such as S6K1, rather than directly by Akt. However, the phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; was not affected by rapamycin (&lt;xref&gt;Figure 4&lt;/xref&gt;D), so was not catalysed by S6K1 or any other kinase downstream of mTORC1.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_05.xml" id="paragraph36" sec-type="discussion">&lt;p&gt;Using the LKB1-null G361 cell line treated with the Ca&lt;sup&gt;2+&lt;/sup&gt; ionophore A23187, we also showed that phosphorylation of Thr&lt;sup&gt;172&lt;/sup&gt;, and activation of AMPK, by CaMKKβ was antagonized by prior phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt;. This supports results obtained in cell-free assays (&lt;xref&gt;Figure 3&lt;/xref&gt;C), and shows that the effect in intact cells is independent of the upstream kinase utilized.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_06.xml" id="paragraph37" sec-type="discussion">&lt;p&gt;Surprisingly, we found that phosphorylation of Akt at the mTORC2 site, Ser&lt;sup&gt;473&lt;/sup&gt;, was blocked by certain AMPK activators including phenformin and quercetin, although not by berberine, A769662 or A23817. Although the mechanism for this effect remains unclear, it is clearly an off-target AMPK-independent effect, because it was still observed in AMPK-knockout MEFs (Supplementary Figure S2).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_07.xml" id="paragraph38" sec-type="discussion">&lt;p&gt;To place our studies in the context of tumour cells, we also addressed whether AMPK activation was down-regulated in three PTEN-null tumour cell lines derived from human cancers. Interestingly, in two glioblastoma cell lines and a breast cancer cell line in which Akt was hyperactivated due to loss of PTEN, AMPK was rather resistant to activation and Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation induced by the activator A769662. However, this effect was reversed by the addition of MK2206, a selective inhibitor of Akt activation that also reduced or abolished the phosphorylation of AMPK-α1 on Ser&lt;sup&gt;487&lt;/sup&gt;, of GSK3β on Ser&lt;sup&gt;9&lt;/sup&gt; and of Akt itself on Thr&lt;sup&gt;308&lt;/sup&gt; and Ser&lt;sup&gt;473&lt;/sup&gt;. These effects could also be reversed in DBTRG-05MG cells by re-expressing WT PTEN, but not a phosphatase-inactive (C124S) mutant. Our results suggest that a previously unrecognized effect of PTEN loss is to reduce the potential restraint on cell growth and proliferation provided by activation of AMPK. This mechanism would also be expected to operate in tumour cells in which Akt is hyperactivated due to activating mutations in subunits of PI3K, or mutation or overexpression of upstream receptors [&lt;xref&gt;26&lt;/xref&gt;]. Previous evidence suggests that this mechanism also operates in human hepatoma (Huh-7) cells infected with the hepatitis C virus [&lt;xref&gt;30&lt;/xref&gt;], where PI3K is activated due to association with a non-structural protein encoded by the viral RNA [&lt;xref&gt;43&lt;/xref&gt;]. In that case, expression of viral proteins was reduced by treating the infected Huh-7 cells with AMPK activators such as AICAR (5-amino-4-imidazolecarboxamide riboside) or metformin [&lt;xref&gt;30&lt;/xref&gt;].&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_08.xml" id="paragraph39" sec-type="discussion">&lt;p&gt;Finally, our results suggest a molecular mechanism by which prior phosphorylation at Ser&lt;sup&gt;487&lt;/sup&gt; inhibits subsequent phosphorylation of Thr&lt;sup&gt;172&lt;/sup&gt;, and hence activation, by upstream kinases. In a partial α1β2γ1 complex containing rat α1, which was expressed in bacteria and where Ser&lt;sup&gt;485&lt;/sup&gt; was therefore most likely unphosphorylated, the ST loop from Glu&lt;sup&gt;469&lt;/sup&gt; to Val&lt;sup&gt;524&lt;/sup&gt; was not resolved, indicating that it was mobile within the crystal [&lt;xref&gt;11&lt;/xref&gt;]. Our hypothesis is that the ST loop interacts with residues within the kinase domain when Ser&lt;sup&gt;487&lt;/sup&gt; is phosphorylated, hindering the ability of upstream kinases to gain access to Thr&lt;sup&gt;172&lt;/sup&gt;. This hypothesis is supported by the results in &lt;xref&gt;Figure 7&lt;/xref&gt;, showing that a peptide corresponding to the sequence from Arg&lt;sup&gt;466&lt;/sup&gt; to Asp&lt;sup&gt;525&lt;/sup&gt; on human α1 inhibits activation and Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation of an α1β2γ1 complex by LKB1, but only when phosphorylated on the residue corresponding to Ser&lt;sup&gt;487&lt;/sup&gt;. This is an extremely specific effect, because the phosphopeptide had no effect on the activation or phosphorylation by LKB1 of BRSK2, which (with BRSK1) has the kinase domain most closely related to AMPK-α1 and AMPK-α2 within the human kinome.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_09.xml" id="paragraph40" sec-type="discussion">&lt;p&gt;The 54 residues of the ST loop in human AMPK-α1 contains 15 serine residues (including Ser&lt;sup&gt;487&lt;/sup&gt;) and five threonine residues, most of which are conserved in α1 subunits from other vertebrates and in &lt;italic&gt;C. elegans&lt;/italic&gt; (Supplementary Figure S1). It has been shown recently that GSK3β phosphorylates the ST loop at multiple sites, with site-directed mutagenesis suggesting that the initial phosphorylation was at Thr&lt;sup&gt;481&lt;/sup&gt;, followed by Ser&lt;sup&gt;477&lt;/sup&gt; and perhaps Thr&lt;sup&gt;473&lt;/sup&gt; (human α1 residue numbering; in rats the equivalent residues are Thr&lt;sup&gt;479&lt;/sup&gt;, Ser&lt;sup&gt;475&lt;/sup&gt; and Thr&lt;sup&gt;471&lt;/sup&gt;). Thr&lt;sup&gt;481&lt;/sup&gt; phosphorylation was proposed to inhibit net Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation by enhancing its sensitivity to dephosphorylation [&lt;xref&gt;31&lt;/xref&gt;]. With most substrates, phosphorylation by GSK3 requires ‘priming’ by another kinase, because the kinase usually phosphorylates a serine or threonine residue located four residues N-terminal to an existing phosphoamino acid [&lt;xref&gt;44&lt;/xref&gt;]. In the case of AMPK it was proposed that phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; on rat AMPK-α1 might promote phosphorylation of Thr&lt;sup&gt;481&lt;/sup&gt;, although not by conventional priming because the residue spacing is not appropriate, and because phosphorylation was not affected by a GSK3β mutation that reduces phosphorylation of primed substrates [&lt;xref&gt;31&lt;/xref&gt;]. If the hypothesis by Suzuki et al. [&lt;xref&gt;31&lt;/xref&gt;] is correct, phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; may lead to additional phosphorylation events within the ST loop. This might explain why we observed a larger effect on AMPK activation and Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation by modulation of Akt in intact cells than in cell-free assays (compare &lt;xref&gt;Figures 1&lt;/xref&gt; and &lt;xref&gt;3&lt;/xref&gt; with &lt;xref&gt;Figures 4&lt;/xref&gt;–&lt;xref&gt;6&lt;/xref&gt;). Although GSK3β was phosphorylated at Ser&lt;sup&gt;9&lt;/sup&gt; in response to Akt treatment and this normally inhibits GSK3 activity [&lt;xref&gt;45&lt;/xref&gt;], this inhibition does not occur with ‘unprimed’ substrates [&lt;xref&gt;46&lt;/xref&gt;] as proposed for Thr&lt;sup&gt;481&lt;/sup&gt; [&lt;xref&gt;31&lt;/xref&gt;]. Thus it is possible that phosphorylation of Ser&lt;sup&gt;487&lt;/sup&gt; in our intact cell experiments promoted additional phosphorylation events, such as phosphorylation of Thr&lt;sup&gt;481&lt;/sup&gt; and Ser&lt;sup&gt;477&lt;/sup&gt; by GSK3.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_10.xml" id="paragraph41" sec-type="discussion">&lt;p&gt;As an extension of this hypothesis, we propose that the side chains of three basic residues located in the αC helix of the small lobe of the kinase domain (Arg&lt;sup&gt;64&lt;/sup&gt;, Lys&lt;sup&gt;71&lt;/sup&gt; and Arg&lt;sup&gt;74&lt;/sup&gt; in human α1) interact with multiple phosphate groups attached to the ST loop, thus anchoring the ST loop to the kinase domain and blocking access of Thr&lt;sup&gt;172&lt;/sup&gt; to upstream kinases. Interestingly, although at least one of these (Arg&lt;sup&gt;64&lt;/sup&gt; or Lys&lt;sup&gt;71&lt;/sup&gt;) is conserved in all 12 AMPK-related kinases, none are conserved in the archetypal serine/threonine kinase domain of PKA. Consistent with our hypothesis, a human α1β2γ1 complex containing an ‘AAA’ mutation (R64A/K71A/K74A) was completely resistant to the ability of previous Akt phosphorylation to reduce the rate of Thr&lt;sup&gt;172&lt;/sup&gt; phosphorylation by LKB1 (&lt;xref&gt;Figure 7&lt;/xref&gt;D). Also consistent with this model was our finding that prior Akt phosphorylation reduced activation by both upstream kinases (LKB1 and CaMKKβ) to very similar extents (&lt;xref&gt;Figure 3&lt;/xref&gt;C). Final confirmation of this model will require structural analysis of AMPK complexes where the ST loop is present in a phosphorylated form, rather than being unphosphorylated or deleted as in existing structures [&lt;xref&gt;10&lt;/xref&gt;,&lt;xref&gt;11&lt;/xref&gt;].&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/4052680/2B_04d_11.xml" id="paragraph42" sec-type="discussion">&lt;p&gt;Since AMPK activators such as AICAR or metformin can overcome the inhibitory effects of Ser&lt;sup&gt;487&lt;/sup&gt; phosphorylation on replication of the hepatitis C virus [&lt;xref&gt;30&lt;/xref&gt;], our present results raise the exciting prospect that AMPK activators such as metformin, which are already used to treat Type 2 diabetes, might also be efficacious in treatment of tumours in which the Akt pathway is hyperactivated. It is already known from retrospective studies that treatment of diabetics with metformin is associated with a lower incidence of cancer compared with other medications [&lt;xref&gt;47&lt;/xref&gt;,&lt;xref&gt;48&lt;/xref&gt;], although it is not yet certain that this effect is mediated by AMPK. Our results suggest that clinical trials to test the efficacy of metformin for cancer treatment might be targeted at specific classes of tumour, such as those in which Akt is hyper-activated.&lt;/p&gt;
</paragraph>
    </paragraphs>
    <sentences>
      <sentence id="1" pid="paragraph0">Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells</sentence>
      <sentence id="2" pid="paragraph1">The insulin/IGF-1 (insulin-like growth factor 1)-activated protein kinase Akt (also known as protein kinase B) phosphorylates Ser 487 in the ‘ST loop’ (serine/threonine-rich loop) within the C-terminal domain of AMPK-α1 (AMP-activated protein kinase-α1), leading to inhibition of phosphorylation by upstream kinases at the activating site, Thr 172 .</sentence>
      <sentence id="3" pid="paragraph1">Surprisingly, the equivalent site on AMPK-α2, Ser 491 , is not an Akt target and is modified instead by autophosphorylation.</sentence>
      <sentence id="4" pid="paragraph1">Stimulation of HEK (human embryonic kidney)-293 cells with IGF-1 caused reduced subsequent Thr 172 phosphorylation and activation of AMPK-α1 in response to the activator A769662 and the Ca 2+ ionophore A23187, effects we show to be dependent on Akt activation and Ser 487 phosphorylation.</sentence>
      <sentence id="5" pid="paragraph1">Consistent with this, in three PTEN (phosphatase and tensin homologue deleted on chromosome 10)-null tumour cell lines  (in which the lipid phosphatase PTEN that normally restrains the Akt pathway is absent and Akt is thus hyperactivated), AMPK was resistant to activation by A769662.</sentence>
      <sentence id="6" pid="paragraph1">However, full AMPK activation could be restored by pharmacological inhibition of Akt, or by re-expression of active PTEN.</sentence>
      <sentence id="7" pid="paragraph1">We also show that inhibition of Thr 172 phosphorylation is due to interaction of the phosphorylated ST loop with basic side chains within the αC-helix of the kinase domain.</sentence>
      <sentence id="8" pid="paragraph1">Our findings reveal that a previously unrecognized effect of hyperactivation of Akt in tumour cells is to restrain activation of the LKB1 (liver kinase B1)–AMPK pathway, which would otherwise inhibit cell growth and proliferation.</sentence>
      <sentence id="9" pid="paragraph2">AMPK (AMP-activated protein kinase) is a ubiquitously expressed sensor of cellular energy status [ 1 ], which exists in essentially all eukaryotic cells as heterotrimeric complexes comprising a catalytic α subunit and regulatory β and γ subunits.</sentence>
      <sentence id="10" pid="paragraph2">The α subunits are phosphorylated by upstream kinases at conserved threonine residues within the activation loop (Thr 172 in rat α1/α2), causing 100-fold activation [ 2 ].</sentence>
      <sentence id="11" pid="paragraph2">Kinases that phosphorylate Thr 172 include the tumour suppressor LKB1 (liver kinase B1) [ 3 – 5 ], and the Ca 2+ -dependent kinase CaMKKβ (calmodulin-dependent kinase kinase β) [ 6 – 8 ].</sentence>
      <sentence id="12" pid="paragraph2">The γ subunits contain up to three sites where ADP or AMP bind in competition with ATP [ 9 – 12 ].</sentence>
      <sentence id="13" pid="paragraph2">Binding of AMP or ADP causes conformational changes that enhance net phosphorylation at Thr 172 by inhibiting dephosphorylation, whereas binding of AMP, but not ADP, promotes phosphorylation by LKB1 and causes allosteric activation [ 10 , 13 – 15 ].</sentence>
      <sentence id="14" pid="paragraph2">The drug A769662 and the natural product salicylate mimic the ability of AMP to inhibit Thr 172 dephosphorylation and cause allosteric activation, but bind at a different site involving the β subunit [ 16 – 18 ].</sentence>
      <sentence id="15" pid="paragraph3">AMPK is thus activated by metabolic stresses that deplete ATP, and increase ADP and AMP.</sentence>
      <sentence id="16" pid="paragraph3">Such stresses include compounds inhibiting mitochondrial ATP synthesis, such as the anti-diabetic drugs metformin and phenformin, and the natural products galegine, resveratrol and berberine [ 19 ].</sentence>
      <sentence id="17" pid="paragraph3">Once activated, AMPK switches on catabolic pathways that generate ATP while switching off anabolic pathways and other ATP-requiring processes such as progress through the cell cycle [ 1 ].</sentence>
      <sentence id="18" pid="paragraph3">Thus AMPK has a cytostatic effect on proliferating cells, suggesting that it might exert some of the tumour suppressor effects of its upstream kinase, LKB1.</sentence>
      <sentence id="19" pid="paragraph3">This was supported by recent studies of a mouse B-cell lymphoma model, in which AMPK appeared to act as a negative regulator both of the rapid glycolysis (Warburg effect) and the high growth rate of the tumours [ 20 ].</sentence>
      <sentence id="20" pid="paragraph4">If the LKB1–AMPK pathway acts as a tumour suppressor, one might expect many tumour cells to have been selected for mechanisms that down-regulate it.</sentence>
      <sentence id="21" pid="paragraph4">Indeed, somatic loss-of-function mutations in the gene encoding LKB1 ( STK11 ) occur in approximately 30% of non-small-cell lung cancers [ 21 , 22 ] and 20% of cervical cancers [ 23 ].</sentence>
      <sentence id="22" pid="paragraph4">In the HeLa cell, derived from a cervical cancer that had undergone a large deletion in STK11 [ 23 ], increases in AMP and ADP do not enhance Thr 172 phosphorylation [ 4 ] because the basal activity of CaMKKβ is too low to support this unless intracellular Ca 2+ is also elevated [ 24 ].</sentence>
      <sentence id="23" pid="paragraph4">Somatic mutations in genes encoding AMPK appear to be less frequent in tumours than those in STK11 , perhaps due to redundancy between multiple AMPK isoforms.</sentence>
      <sentence id="24" pid="paragraph4">However, there may be epigenetic or non-genetic mechanisms by which AMPK is down-regulated in tumour cells.</sentence>
      <sentence id="25" pid="paragraph4">For example, AMPK-α2 expression appears to be frequently down-regulated in hepatocellular carcinoma [ 25 ].</sentence>
      <sentence id="26" pid="paragraph5">The PI3K (phosphoinositide 3-kinase)–Akt (protein kinase B) signalling pathway is frequently activated in tumour cells, often via loss of the tumour suppressor PTEN (phosphatase and tensin homologue deleted on chromosome 10), but also via activating mutations in subunits of PI3K or upstream receptors [ 26 ].</sentence>
      <sentence id="27" pid="paragraph5">Interestingly, Akt phosphorylates the α1 subunit of rat AMPK at Ser 485 (equivalent to Ser 487 in human α1), and this was reported to reduce subsequent Thr 172 phosphorylation and activation by LKB1 [ 27 ].</sentence>
      <sentence id="28" pid="paragraph5">Additionally, PKA (protein kinase A; also known as cAMP-dependent protein kinase) was reported to phosphorylate Ser 485 with similar effects [ 28 ].</sentence>
      <sentence id="29" pid="paragraph5">High glucose and IGF-1 (insulin-like growth factor 1) also caused phosphorylation of AMPK-α1 at Ser 487 in porcine vascular smooth muscle cells, and this was associated with reduced Thr 172 phosphorylation in response to metformin [ 29 ].</sentence>
      <sentence id="30" pid="paragraph5">This mechanism has also been invoked to account for down-regulation of AMPK in human hepatoma cells infected with hepatitis C virus [ 30 ].</sentence>
      <sentence id="31" pid="paragraph5">However, these studies did not provide definitive proof that the Ser 485 /Ser 487 phosphorylation and the reduced Thr 172 phosphorylation observed in the intact cells were causally related.</sentence>
      <sentence id="32" pid="paragraph6">Ser 487 is located in a loop (residues 472–525 in human α1) that is present in the sequences of α subunits from vertebrates and Caenorhabditis elegans , but is truncated or absent in insects ( Drosophila melanogaster ) and fungi (Saccharomyces cerevisiae ) (Supplementary Figure S1 at ).</sentence>
      <sentence id="33" pid="paragraph6">This loop was disordered in the crystal structure of a partial mammalian αβγ complex expressed in bacteria [ 11 ].</sentence>
      <sentence id="34" pid="paragraph6">We now refer to it as the ‘ST loop’ because it is rich in serine and threonine residues, and it has recently been shown to be phosphorylated by GSK3 (glycogen synthase kinase 3) at Thr 481 and Ser 477 (human numbering), which appeared to promote Thr 172 dephosphorylation [ 31 ].</sentence>
      <sentence id="35" pid="paragraph6">In the present study, we have examined whether phosphorylation of this loop causes down-regulation of AMPK in tumour cells in which the Akt pathway is hyperactivated.</sentence>
      <sentence id="36" pid="paragraph6">We also provide evidence that the ST loop binds to the kinase domain when phosphorylated at Ser 487 by interactions with the αC helix, thus physically blocking access to Thr 172 .</sentence>
      <sentence id="37" pid="paragraph7">( A ) Alignment of sequences around Ser 487 on α1 and Ser 491 on α2 with the consensus for Akt phosphorylation [ 39 ] and with sequences around established Akt target sites.</sentence>
      <sentence id="38" pid="paragraph7">The right-hand column shows the percentile score for the sequence as a potential Akt target computed using Scansite ( http://scansite.mit.edu/ ).</sentence>
      <sentence id="39" pid="paragraph7">( B ) Phosphorylation of GSK3β by the indicated amounts of Akt.</sentence>
      <sentence id="40" pid="paragraph7">Incubations were analysed by Western blotting with the indicated antibodies, or by autoradiography to detect 32 P radioactivity.</sentence>
      <sentence id="41" pid="paragraph7">( C ) As with ( B ), but analysing phosphorylation of AMPK (α1β2γ1 complex).</sentence>
      <sentence id="42" pid="paragraph7">( D ) As with ( B ), but analysing phosphorylation of AMPK (α2β2γ1 complex).</sentence>
      <sentence id="43" pid="paragraph7">( E ) Rate of phosphorylation by LKB1 (signal using an anti-pT172 antibody expressed as a ratio of signal using an anti-AMPK-α antibody) obtained using the indicated mutants of the α1β2γ1 complex.</sentence>
      <sentence id="44" pid="paragraph7">Results are means±S.E.M.</sentence>
      <sentence id="45" pid="paragraph7">( n =2).</sentence>
      <sentence id="46" pid="paragraph7">( F ) Rate of phosphorylation by LKB1 (signal obtained using an anti-pT172 antibody expressed as a ratio of signal using an anti-AMPK-α antibody) following pre-incubation with MgATP with or without Akt (30 units/ml, 20 min), for the inactive (D157A) α1β2γ1 complex or an S487A/D157A double mutant.</sentence>
      <sentence id="47" pid="paragraph7">Results are means±S.E.M.</sentence>
      <sentence id="48" pid="paragraph7">( n =4); ** P 0.01; ns, not significant.</sentence>
      <sentence id="49" pid="paragraph8">( A ) AMPK (α1β2γ1 or α2β2γ1 complex) was incubated with MgATP and the indicated concentrations of Akt for 20 min at 30°C, and aliquots (20 μl) analysed by Western blotting using the indicated antibodies.</sentence>
      <sentence id="50" pid="paragraph8">( B ) AMPK (α1β2γ1 or α2β2γ1, WT or inactive D157A mutant) was incubated with MgATP and increasing concentrations of LKB1 (0, 8.2, 28, 82, 280 and 820 ng) or Akt (0, 0.15, 0.5, 1.5, 5 and 15 units/ml) for 10 min at 30°C.</sentence>
      <sentence id="51" pid="paragraph8">( C ) AMPK (α2β2γ1 complex, WT, S491A or S491D mutant) was incubated with MgATP and the indicated amount of LKB1 in a final volume of 20 μl for 10 min at 30°C, and AMPK activity determined.</sentence>
      <sentence id="52" pid="paragraph8">( D ) Phosphorylation of synthetic peptides by three different preparations of AMPK.</sentence>
      <sentence id="53" pid="paragraph8">AMPK (0.1 unit, either α1β2γ1, α2β2γ1 complexes or purified from rat liver [ 2 ]) was incubated with 5 nmol of the SAMS, S485 or S491 peptides in the presence of 5 mM MgCl 2 and 200 μM [γ- 32 P]ATP in a final volume of 25 μl for 30 min at 30°C, before SDS/PAGE and autoradiography.</sentence>
      <sentence id="54" pid="paragraph9">AMPK (α1β2γ1 complex, WT or S487A mutant) was pre-incubated with MgATP and Akt for 30 min, and then with LKB1 (50 ng) or CaMKKβ (23 ng) for 10 min at 30°C in a final volume of 40 μl.</sentence>
      <sentence id="55" pid="paragraph9">( A ) Phosphorylation of AMPK by LKB1 in the absence or presence of Akt.</sentence>
      <sentence id="56" pid="paragraph9">( B ) Activation of AMPK by LKB1 in the absence or presence of Akt.</sentence>
      <sentence id="57" pid="paragraph9">( C ) Activation/phosphorylation by LKB1/CaMKKβ in the absence or presence of Akt.</sentence>
      <sentence id="58" pid="paragraph9">Phosphorylation ( A and C ) was assessed in duplicate samples by Western blotting, and AMPK activity ( B and C ) by kinase assays.</sentence>
      <sentence id="59" pid="paragraph9">Results in ( B ) and ( C ) are means±S.E.M.</sentence>
      <sentence id="60" pid="paragraph9">( n =4); *** P 0.001; ns, not significant.</sentence>
      <sentence id="61" pid="paragraph10">HEK-293 cells stably expressing WT AMPK ( A ) or an S487A mutant ( B ) were serum-starved overnight and then incubated with IGF-1 in the presence or absence of MK2206 as described in the Experimental section.</sentence>
      <sentence id="62" pid="paragraph10">The cells were then treated with or without A769662 (300 μM for 40 min) and lysates prepared for immunoprecipitate kinase assay and Western blots.</sentence>
      <sentence id="63" pid="paragraph10">Blots are samples from separate dishes ( n =2), whereas activity data are means±S.E.M.</sentence>
      <sentence id="64" pid="paragraph10">( n =4); *** P 0.001 compared with relevant control without A769662; ††† P 0.001; ns, not significant, for IGF-1-treated against relevant serum-starved control.</sentence>
      <sentence id="65" pid="paragraph10">( C ) Cells expressing WT AMPK-α1 or AMPK-α2 were treated with IGF-1 (30 ng/ml) or berberine (300 μM) and lysates analysed by immunoprecipitate kinase assays and Western blotting (two separate dishes).</sentence>
      <sentence id="66" pid="paragraph10">Activity data are means±S.E.M.</sentence>
      <sentence id="67" pid="paragraph10">( n =4); *** P 0.001; ns, not significant, compared with control without IGF-1 or berberine.</sentence>
      <sentence id="68" pid="paragraph10">( D ) Cells expressing WT AMPK-α1 or AMPK-α2 were treated with IGF-1 in the absence or presence of rapamycin (100 μM) and lysates analysed by immunoprecipitate kinase assays and Western blotting.</sentence>
      <sentence id="69" pid="paragraph10">Activity data are means±S.E.M.</sentence>
      <sentence id="70" pid="paragraph10">( n =2); duplicate blots were from separate dishes.</sentence>
      <sentence id="71" pid="paragraph11">G361 cells were serum-starved overnight and then incubated with IGF-1 in the presence or absence of MK2206 as described in the Experimental section.</sentence>
      <sentence id="72" pid="paragraph11">Cells were then treated with or without A23817 (30 nM for 30 min) and lysates prepared for immunoprecipitate kinase assay and Western blots.</sentence>
      <sentence id="73" pid="paragraph11">Blots are samples from separate dishes, whereas activity data are means±S.E.M.</sentence>
      <sentence id="74" pid="paragraph11">( n =4); *** P 0.001 compared with the relevant control without A23187; ††† P 0.001; ns, not significant, for IGF-1-treated against relevant serum-starved control.</sentence>
      <sentence id="75" pid="paragraph12">( A ) Glioblastoma (DBTRG-05MG) cells were incubated for 20 min with or without MK2206 (3 μM), followed by 60 min with or without A769662 (300 μM).</sentence>
      <sentence id="76" pid="paragraph12">Lysates were then analysed for AMPK activity.</sentence>
      <sentence id="77" pid="paragraph12">Results are means±S.E.M.</sentence>
      <sentence id="78" pid="paragraph12">( n =2); *** P 0.001; ** P 0.01.</sentence>
      <sentence id="79" pid="paragraph12">( B ) Analysis of the samples from ( A ) by Western blotting using the indicated antibodies (duplicate dishes).</sentence>
      <sentence id="80" pid="paragraph12">( C ) WT PTEN or a phosphatase-inactive (C124S) mutant were expressed in DBTRG-05MG cells using lentiviral vectors, and the effects of A769662 tested as in ( A ).</sentence>
      <sentence id="81" pid="paragraph12">Results are means±S.E.M.</sentence>
      <sentence id="82" pid="paragraph12">( n =2 for WT PTEN, n =4 for C124S PTEN); *** P 0.001; ** P 0.01.</sentence>
      <sentence id="83" pid="paragraph12">( D ) Analysis of the samples from ( C ) by Western blotting using the antibodies shown (duplicate dishes).</sentence>
      <sentence id="84" pid="paragraph12">( E and F ) Glioblastoma (U373-MG) cells were incubated and analysed as in ( A and B ).</sentence>
      <sentence id="85" pid="paragraph12">( G and H ) Breast cancer (MDA-MB-468) cells were incubated and analysed as in ( A and B ).</sentence>
      <sentence id="86" pid="paragraph12">For ( E ) and ( G ), results are means±S.E.M.</sentence>
      <sentence id="87" pid="paragraph12">( n =2); *** P 0.001; ** P 0.01; * P 0.05.</sentence>
      <sentence id="88" pid="paragraph13">( A ) Model for the structure of an AMPK heterotrimer (PDB code 2Y8L, space-filling model made using PyMOL; http:://pymol.org ) showing the location of the ends of the ST loop (Glu 469 and Val 524 ), with Glu 469 particularly close to Thr 172 ; the intervening residues of the ST loop were deleted from the construct used to produce this structure.</sentence>
      <sentence id="89" pid="paragraph13">( B ) Inhibition of activation of the human α1β2γ1 complex by LKB1 by peptide corresponding to the sequence from Arg 466 to Asp 525 , either with (P-peptide) or without (deP-peptide) prior phosphorylation by Akt.</sentence>
      <sentence id="90" pid="paragraph13">Results are means±S.E.M.</sentence>
      <sentence id="91" pid="paragraph13">( n =4).</sentence>
      <sentence id="92" pid="paragraph13">( C ) Inhibition of activation and phosphorylation by LKB1 of α1β2γ1 complex (left-hand side) and BRSK2 (right-hand side) by P-peptide and deP-peptide as in ( B ).</sentence>
      <sentence id="93" pid="paragraph13">Results for kinase activity are expressed as a percentage of activities obtained without either peptide, and are means±S.E.M.</sentence>
      <sentence id="94" pid="paragraph13">( n =2); *** P 0.001 relative to controls without LKB1; ††† P 0.001 relative to control without P-peptide.</sentence>
      <sentence id="95" pid="paragraph13">Results of Western blots are from duplicate incubations.</sentence>
      <sentence id="96" pid="paragraph13">( D ) Human AMPK (α1β2γ1 complex, either WT, S487A or AAA mutant) was incubated with LKB1 following prior incubation with ATP with or without Akt.</sentence>
      <sentence id="97" pid="paragraph13">AMPK activation (top panel) and phosphorylation of Thr 172 and Ser 487 (bottom panel) was monitored.</sentence>
      <sentence id="98" pid="paragraph14">Akt phosphorylates serine or threonine residues within the sequence motif RXRXXS/TΦ, where Φ is a bulky hydrophobic residue [ 39 ].</sentence>
      <sentence id="99" pid="paragraph14">Figure 1 (A) shows an alignment of this consensus with sequences around some established Akt targets, the ST loop sequence containing Ser 487 in human α1, and the equivalent site on α2 (Ser 491 ).</sentence>
      <sentence id="100" pid="paragraph14">Both of the latter have a serine residue at P-2, with Akt having a preference for the serine or threonine residue at this position [ 39 ].</sentence>
      <sentence id="101" pid="paragraph14">However, both also have a proline residue rather than arginine at the P-5 position, and Ser 491 also has an alanine residue rather than a bulky hydrophobic residue at P+1.</sentence>
      <sentence id="102" pid="paragraph14">Neither is therefore a perfect fit to the Akt consensus; Scansite 2.0 [ 40 ] identifies Ser 487 as a potential Akt site only at medium stringency, and Ser 491 only at low stringency.</sentence>
      <sentence id="103" pid="paragraph15">To avoid complications caused by autophosphorylation, we initially used inactive mutants of human AMPK complexes (α1-D159A/β2/γ1 and α2-D157A/β2/γ1), with or without α1-S487A or α2-S491A mutations, as substrates for phosphorylation by human Akt.</sentence>
      <sentence id="104" pid="paragraph15">For comparison, we used an inactive (D200A) mutant of the known Akt substrate GSK3β, with or without mutation of the Akt site (Ser 9 ).</sentence>
      <sentence id="105" pid="paragraph15">Interestingly, AMPK-α1 was a reasonable substrate for Akt although not as good as GSK3, whereas AMPK-α2 was a very poor substrate.</sentence>
      <sentence id="106" pid="paragraph15">Using either an anti-pS9 antibody or by 32 P-labelling, phosphorylation of GSK3β was saturated at 0.5 unit/ml Akt, when the phosphorylation stoichiometry by 32 P-labelling was 1.03 mol/mol ( Figure 1 B).</sentence>
      <sentence id="107" pid="paragraph15">The phosphorylation of AMPK-α1 within the α1β2γ1 complex was only saturated at 5 units/ml, when the stoichiometry was 0.96 mol/mol ( Figure 1 C).</sentence>
      <sentence id="108" pid="paragraph15">For both GSK3β and AMPK-α1, the signals obtained using phospho-specific antibodies (pS9/pS487) or 32 P-labelling were abolished by mutation of the respective sites to alanine (S9A/S487A).</sentence>
      <sentence id="109" pid="paragraph15">By contrast, there was much less phosphorylation of Ser 491 within the α2β2γ1 complex ( Figure 1 D).</sentence>
      <sentence id="110" pid="paragraph15">By 32 P-labelling, the stoichiometry of α2 phosphorylation was only 0.18 mol/mol, even with Akt at 30- and 300-fold higher concentrations than those required to obtain stoichiometric phosphorylation of α1 and GSK3β respectively.</sentence>
      <sentence id="111" pid="paragraph15">Although we did detect some phosphorylation of Ser 491 using a phospho-specific antibody and this was abolished in a S491A mutant, 32 P-labelling was not affected by the S491A mutation, suggesting that the low level of α2 phosphorylation by Akt was mainly accounted for by modification at other site(s).</sentence>
      <sentence id="112" pid="paragraph16">We next tested the ability of the human LKB1–STRADα–MO25α complex to phosphorylate Thr 172 in an inactive (α1-D157A) human α1β2γ1 complex.</sentence>
      <sentence id="113" pid="paragraph16">Before phosphorylation by Akt, the rate of phosphorylation of Thr 172 by the LKB1 complex was unaffected by an S487A mutation, although an S487D mutation reduced the rate of Thr 172 phosphorylation by approximately 30% ( Figure 1 E).</sentence>
      <sentence id="114" pid="paragraph16">When the inactive (D157A) mutant complex was first phosphorylated by Akt under conditions that yielded stoichiometric Ser 487 phosphorylation, subsequent phosphorylation of Thr 172 was reduced by approximately 40%, an effect abolished by an S487A mutation ( Figure 1 F).</sentence>
      <sentence id="115" pid="paragraph17">We next tested the effects of Akt on either WT, S487A or S491A mutants of active α1β2γ1 and α2β2γ1 complexes.</sentence>
      <sentence id="116" pid="paragraph17">Figure 2 (A) shows that with the α1β2γ1 complex there was slight phosphorylation of Ser 487 even in the absence of Akt, although phosphorylation of this site increased markedly with increasing Akt.</sentence>
      <sentence id="117" pid="paragraph17">By contrast, Ser 491 in an α2β2γ1 complex appeared to be fully phosphorylated in the absence of Akt, and addition of Akt had no further effect.</sentence>
      <sentence id="118" pid="paragraph17">These results suggested that Ser 491 was modified by autophosphorylation, whereas Ser 487 is phosphorylated by Akt, with a small degree of autophosphorylation.</sentence>
      <sentence id="119" pid="paragraph17">Consistent with this, there was substantial phosphorylation of Ser 491 in a human α2β2γ1 complex, and slight phosphorylation of Ser 487 in a human α1β2γ1 complex, when they were incubated with MgATP alone; these effects were completely abolished by D157A mutations that rendered the complexes inactive, although Ser 487 could still be phosphorylated by Akt in the inactive complex ( Figure 2 B).</sentence>
      <sentence id="120" pid="paragraph17">Unlike the equivalent α1β2γ1 complexes, where the S487D mutant was phosphorylated at a lower rate ( Figure 1 E), the WT, S491A and S491D mutant α2β2γ1 complexes were phosphorylated on Thr 172 at equal rates by LKB1 ( Figure 2 C).</sentence>
      <sentence id="121" pid="paragraph18">We also synthesized peptides corresponding to the sequences around Ser 485 on rat α1 (S485, TPQRSGSISNYRS) or Ser 491 on rat/human α2 (S491, TPQRSCSAAGLHR), and compared them as AMPK substrates with the classical SAMS peptide [ 36 ].</sentence>
      <sentence id="122" pid="paragraph18">Although the SAMS peptide was by far the best substrate, the S491 peptide was also phosphorylated, whereas the S485 peptide was not phosphorylated at all.</sentence>
      <sentence id="123" pid="paragraph18">The results were identical with rat liver AMPK (a mixture of α1β1γ1 and α2β1γ1 complexes) or with recombinant human α1β2γ1 and α2β2γ1 complexes ( Figure 2 D).</sentence>
      <sentence id="124" pid="paragraph19">We next incubated the active α1β2γ1 complex with Akt under conditions where we obtained stoichiometric phosphorylation of Ser 487 , and subsequently treated with the LKB1 complex under conditions where we could measure the initial rate of Thr 172 phosphorylation and consequent activation.</sentence>
      <sentence id="125" pid="paragraph19">As with the inactive complex ( Figure 1 F), prior Akt phosphorylation reduced the rate of subsequent Thr 172 phosphorylation ( Figure 3 A), but using the active complex this could also be seen to be associated with a reduction in activation by LKB1 of approximately 40% ( Figure 3 B); both effects were abolished by an S487A mutation within the ST loop.</sentence>
      <sentence id="126" pid="paragraph19">Figure 3 (C) shows that the inhibitory effect of prior Ser 487 phosphorylation on Thr 172 phosphorylation and AMPK activation was identical using either LKB1 or CaMKKβ, showing that the effect is independent of the upstream kinase utilized.</sentence>
      <sentence id="127" pid="paragraph20">To test the effects of Ser 487 phosphorylation in intact cells, we generated isogenic HEK-293 cells stably expressing FLAG-tagged WT AMPK-α1 or AMPK-α2, or a non-phosphorylatable (S487A) α1 mutant.</sentence>
      <sentence id="128" pid="paragraph20">We have shown previously that when AMPK-β [ 16 ] or AMPK-γ  [ 19 ] subunits are expressed using this system, they largely replace the endogenous subunit because they compete for the available α/γ or α/β partners, with free subunits being unstable.</sentence>
      <sentence id="129" pid="paragraph20">This was also true in the present study because we showed that approximately 70% of the total AMPK activity could be immunoprecipitated using anti-FLAG antibody, with the remaining 30% (representing a small proportion with endogenous α subunits) being subsequently precipitated using anti-α1 or anti-α2 antibodies.</sentence>
      <sentence id="130" pid="paragraph20">The presence of a small amount of endogenous α subunits does not affect interpretation of the kinase assays shown in Figure 4 , which were conducted in anti-FLAG antibody immunoprecipitates, but a small proportion of AMPK-α subunits detected in the Western blots (e.g. the faint signal obtained using the anti-pS487 antibody in the cells expressing the S487A mutant) may be due to these endogenous subunits.</sentence>
      <sentence id="131" pid="paragraph21">The cells expressing AMPK-α1 were serum-starved, and some were then treated with IGF-1 to activate Akt.</sentence>
      <sentence id="132" pid="paragraph21">As expected, IGF-1 resulted in marked increases in phosphorylation of the activating sites on Akt (Thr 308 and Ser 473 ), which were blocked by the Akt inhibitor MK2206 [ 41 ], as was the phosphorylation of Ser 9 /Ser 21 on GSK3-α/β (markers of Akt activation) and Ser 487 on AMPK-α1 ( Figure 4 A).</sentence>
      <sentence id="133" pid="paragraph21">When cells expressing WT α1 were treated with A769662, the activation of AMPK, and Thr 172 phosphorylation, was markedly blunted if the cells had been exposed previously to IGF-1, an effect abolished by MK2206.</sentence>
      <sentence id="134" pid="paragraph21">The effect of IGF-1 to reduce AMPK activation and phosphorylation of Thr 172 correlated with increased Ser 487 phosphorylation, and was absent in cells expressing the S487A mutant ( Figure 4 B).</sentence>
      <sentence id="135" pid="paragraph22">Figure 4 (C) shows results obtained when serum-starved cells expressing WT AMPK-α1 or AMPK-α2 were treated either with IGF-1 or with berberine, which activates AMPK by inhibiting mitochondrial ATP synthesis [ 19 ].</sentence>
      <sentence id="136" pid="paragraph22">As expected, treatment of α1-expressing cells with IGF-1 caused increased phosphorylation of Ser 487 , but not Thr 172 , whereas treatment with berberine caused increased phosphorylation of Thr 172 , accompanied by AMPK activation, but not Ser 487 .</sentence>
      <sentence id="137" pid="paragraph22">This contrasted markedly with results in α2-expressing cells, where treatment with IGF-1 did not increase phosphorylation of Ser 491 , whereas treatment with berberine caused increased phosphorylation of both Ser 491 and Thr 172 , together with AMPK activation.</sentence>
      <sentence id="138" pid="paragraph22">The results for phosphorylation of Ser 487 and Ser 491 were very similar whether we used in-house phospho-specific antibodies that are isoform-specific, or a commercial antibody that recognizes the equivalent sites on both α1 and α2.</sentence>
      <sentence id="139" pid="paragraph22">These results are consistent with the results in Figures 2 and 3 , showing that Ser 491 on α2 is modified by autophosphorylation, and not by Akt as for Ser 487 on α1.</sentence>
      <sentence id="140" pid="paragraph22">As expected, increased phosphorylation of the downstream AMPK target ACC correlated with Thr 172 phosphorylation and AMPK activation in both cell lines.</sentence>
      <sentence id="141" pid="paragraph23">To confirm that Ser 487 was phosphorylated directly by Akt in the cells, and not by a downstream kinase such as p70 S6K1, we tested the effects of rapamycin, an inhibitor of mTORC1.</sentence>
      <sentence id="142" pid="paragraph23">Rapamycin did not block the IGF-1-stimulated phosphorylation of Ser 487 on α1 or Ser 473 on Akt although, as expected, it blocked phosphorylation of an established mTORC1 substrate, Thr 389 on the p70/p85 isoforms of S6K1 ( Figure 4 D).</sentence>
      <sentence id="143" pid="paragraph24">To show that phosphorylation of Ser 487 on AMPK-α1 by Akt could also reduce subsequent activation by CaMKKβ, we used the LKB1-null G361 melanoma cell line.</sentence>
      <sentence id="144" pid="paragraph24">The cells were serum-starved, and some were then treated with IGF-1 to activate Akt.</sentence>
      <sentence id="145" pid="paragraph24">As expected, IGF-1 resulted in marked increases in phosphorylation of Thr 308 and Ser 473 on Akt, Ser 9 /Ser 21 on GSK3α/β and Ser 487 on AMPK-α1, all of which were blocked or reduced by MK2206 ( Figure 5 ).</sentence>
      <sentence id="146" pid="paragraph24">When the cells were treated with the Ca 2+ ionophore A23187 to activate CaMKKβ, the activation of AMPK and Thr 172 phosphorylation, was significantly blunted if the cells had been exposed previously to IGF-1, an effect completely abolished by MK2206 ( Figure 5 ).</sentence>
      <sentence id="147" pid="paragraph25">To examine whether hyperactivation of Akt in tumour cells due to PTEN loss might also inhibit AMPK activation, we initially examined the PTEN-null glioblastoma cell line DBTRG-05MG.</sentence>
      <sentence id="148" pid="paragraph25">We first tested a range of AMPK activators to see whether any interfered with Akt activation.</sentence>
      <sentence id="149" pid="paragraph25">Surprisingly, phenformin and quercetin blocked phosphorylation of Akt at Ser 473 , although berberine, A769662 and A23187 did not  (Supplementary Figure S2A at ).</sentence>
      <sentence id="150" pid="paragraph25">As expected, all agents also increased the phosphorylation of ACC1 at Ser 79 and AMPK at Thr 172 in MEFs (mouse embryonic fibroblasts), although the effect of A769662 on Thr 172 phosphorylation was small, indicating that it was mainly acting through an allosteric mechanism (Supplementary Figure S2B).</sentence>
      <sentence id="151" pid="paragraph25">The inhibitory effects of phenformin and quercetin on Akt Ser 473 phosphorylation were observed in WT MEFs, but were ‘off-target’ AMPK-independent effects, because they were also observed in double-knockout (α1 −/− α2 −/− ) MEFs (Supplementary Figure S2B and S2C).</sentence>
      <sentence id="152" pid="paragraph25">To avoid this complication, in subsequent studies we focused on the effects of A769662, which activates AMPK by direct binding to the β subunit [ 16 , 17 ] and does not inhibit ATP synthesis [ 19 ] or Akt Ser 473 phosphorylation (Supplementary Figure S2).</sentence>
      <sentence id="153" pid="paragraph26">AMPK in DBTRG-05MG cells was activated by A769662, but activation ( Figure 6 A) and Thr 172 phosphorylation ( Figure 6 B) were greatly enhanced when the selective Akt inhibitor MK2206 was added before A769662.</sentence>
      <sentence id="154" pid="paragraph26">Thus reduced activation of AMPK in these cells was Akt-dependent.</sentence>
      <sentence id="155" pid="paragraph26">As expected, inhibition of Akt by MK2206 was associated with greatly reduced phosphorylation of Ser 487 , and of the Akt site on GSK3β, Ser 9 ( Figure 6 B).</sentence>
      <sentence id="156" pid="paragraph26">As reported previously [ 41 ], MK2206 also blocked the phosphorylation of Akt at the activating sites, Thr 308 and Ser 473 .</sentence>
      <sentence id="157" pid="paragraph27">We also examined the effect of re-expressing PTEN in DBTRG-05MG cells, using a lentiviral vector that gives levels of expression similar to normal cells.</sentence>
      <sentence id="158" pid="paragraph27">As a control, we expressed a C124S mutant that has no lipid phosphatase activity.</sentence>
      <sentence id="159" pid="paragraph27">Prior expression of WT PTEN enhanced the activation ( Figure 6 C) and Thr 172 phosphorylation ( Figure 6 D) of AMPK in response to A769662.</sentence>
      <sentence id="160" pid="paragraph27">When compared with the C124S mutant, expression of WT PTEN was associated with decreased phosphorylation of Ser 487 on AMPK-α1 and Ser 9 on GSK3β, and markedly decreased phosphorylation of Thr 308 and Ser 473 on Akt ( Figure 6 D).</sentence>
      <sentence id="161" pid="paragraph28">We also studied two other PTEN-null human cell lines, i.e. U373-MG (another glioblastoma line) and MDA-MB-468 (a breast cancer line).</sentence>
      <sentence id="162" pid="paragraph28">Similar to the DBTRG-05MG cells, there was a modest activation ( Figures 6 E and 6 G) and Thr 172 phosphorylation ( Figures 6 F and 6 H) of AMPK in response to A769662, but both were enhanced when Akt was inhibited using MK2206.</sentence>
      <sentence id="163" pid="paragraph29">We next addressed the mechanism by which Ser 487 phosphorylation inhibits subsequent Thr 172 phosphorylation.</sentence>
      <sentence id="164" pid="paragraph29">In the structure of a partial mammalian α1β2γ1 complex, the ST loop from Ile 470 to Asp 523 (rat numbering) was disordered [ 11 ]; the complex had been expressed in bacteria, so the ST loop was likely to be unphosphorylated.</sentence>
      <sentence id="165" pid="paragraph29">In a subsequent structure [ 10 ], the ST loop was deleted as it was thought that it might hinder crystallization.</sentence>
      <sentence id="166" pid="paragraph29">However, the location of the residues at the ends of the loop (Glu 469 and Val 524 ) in this structure show that they lie close to the kinase domain, being approximately 20 and 40 Å (1 Å=0.1 nm) from Thr 172 respectively ( Figure 7 A).</sentence>
      <sentence id="167" pid="paragraph29">We hypothesized that the ST loop might interact with the kinase domain when phosphorylated on Ser 487 .</sentence>
      <sentence id="168" pid="paragraph29">We also noticed three basic residues, Arg 62 , Lys 69 and Arg 72 (rat α1 numbering), which are located within the ‘αC helix’ of the small lobe of the kinase domain.</sentence>
      <sentence id="169" pid="paragraph29">An extension of our hypothesis was that phosphate groups on the ST loop interact with these basic side chains, triggering a stable interaction between the ST loop and the kinase domain that physically blocks access of Thr 172 to upstream kinases.</sentence>
      <sentence id="170" pid="paragraph30">To test the first hypothesis, we made a construct expressing the peptide from Arg 466 to Asp 525 on human α1 as a GST fusion.</sentence>
      <sentence id="171" pid="paragraph30">The protein was expressed in and purified from bacteria, the GST domain removed, and the remaining peptide (Arg 466 –Asp 525 ) either thiophosphorylated using ATPγS (adenosine 5′-[γ-thio]triphosphate) and Akt (thiophosphate being resistant to protein phosphatases), or left unphosphorylated.</sentence>
      <sentence id="172" pid="paragraph30">Consistent with our hypothesis, the phosphopeptide caused a concentration-dependent inhibition of activation and Thr 172 phosphorylation of the bacterially expressed α1β2γ1 complex by LKB1, although we were unable to generate the peptide at high enough concentrations to fully saturate inhibition.</sentence>
      <sentence id="173" pid="paragraph30">By contrast, the unphosphorylated peptide had no effect ( Figure 7 B).</sentence>
      <sentence id="174" pid="paragraph30">To confirm that the inhibition of activation loop phosphorylation was specific to AMPK, we showed that neither the phospho- nor the dephospho-peptide inhibited activation and phosphorylation of the AMPK-related kinase BRSK2 by LKB1 ( Figure 7 C).</sentence>
      <sentence id="175" pid="paragraph31">To test the extended hypothesis, we made a triple mutation (R64A/K71A/R74A, human α1 numbering, ‘AAA mutant’), in the context of the recombinant human α1β2γ1 complex used in Figure 3 , of the three basic residues in the kinase domain that we propose to interact with phosphate groups on the ST loop.</sentence>
      <sentence id="176" pid="paragraph31">Consistent with our hypothesis, prior phosphorylation of the WT complex by Akt reduced subsequent activation and Thr 172 phosphorylation by LKB1, but this effect was completely abolished by either an S487A mutant or an AAA mutant, even though the latter was still phosphorylated on Ser 487 by Akt ( Figure 7 D).</sentence>
      <sentence id="177" pid="paragraph32">It has been reported previously that prior phosphorylation of Ser 485 on rat AMPK-α1 by Akt, within a rat α1β1γ1 complex, caused a 40% reduction in the rate of subsequent phosphorylation of Thr 172 and activation by LKB1 in cell-free assays, an effect that was abolished by a non-phosphorylatable S485A substitution [ 27 ].</sentence>
      <sentence id="178" pid="paragraph32">In the present study, we have followed up this observation and made several new findings.</sentence>
      <sentence id="179" pid="paragraph32">First, we demonstrated identical effects with the equivalent site (Ser 487 ) on the human α1β2γ1 complex ( Figures 1 F and 4 ), showing that the effect is conserved in humans and is also independent of the β subunit isoform.</sentence>
      <sentence id="180" pid="paragraph32">Secondly, we show that the effect is not specific to the upstream kinase LKB1, but is also observed with CaMKKβ ( Figure 3 C).</sentence>
      <sentence id="181" pid="paragraph32">Thirdly, we report that Ser 491  (the site equivalent to Ser 487 in AMPK-α2) is an extremely poor substrate for Akt, and that the very low level of α2 phosphorylation obtained using Akt is not affected by an S491A mutation ( Figure 1 D).</sentence>
      <sentence id="182" pid="paragraph32">It had been shown previously using a bacterially expressed α2β1γ1 complex that Akt phosphorylated AMPK-α2, albeit more slowly than α1 [ 27 ] and, although the phosphorylation site(s) had not been identified, it has generally been assumed that this phosphorylation occurred at Ser 491 .</sentence>
      <sentence id="183" pid="paragraph32">That Ser 491 is modified instead by autophosphorylation is shown by the following findings: (i) substantial phosphorylation of Ser 491 occurred with the recombinant human α2β2γ1 complex in the absence of exogenous kinases ( Figures 2 A and 2 B); (ii) Ser 491 phosphorylation did not occur with an inactive (D157A mutant) complex  ( Figure 2 B); (iii) various forms of AMPK, including the human α2β2γ1 complex, phosphorylated a synthetic peptide corresponding to the sequence around Ser 491 , but not Ser 485 on rat α1 ( Figure 2 D); and (iv) Ser 491 on AMPK-α2 became phosphorylated in response to the AMPK activator berberine in HEK-293 cells, whereas Ser 487 on AMPK-α1 did not ( Figure 4 C).</sentence>
      <sentence id="184" pid="paragraph32">Although further work is required to test whether autophosphorylation of Ser 491 down-regulates Thr 172 phosphorylation, this is not supported by the results in Figure 2 (C), where the activation of the human α2β2γ1 complex by LKB1 was not affected by a potentially phosphomimetic S491D mutation.</sentence>
      <sentence id="185" pid="paragraph32">Thus the ability of Akt-activating treatments such as insulin and IGF-1 to restrain activation of AMPK by ST loop phosphorylation is limited to complexes containing the α1 isoform.</sentence>
      <sentence id="186" pid="paragraph33">Although Ser 487 in the human α1β2γ1 complex also appeared to autophosphorylate to a limited extent in cell-free assays ( Figure 2 A), increased Ser 487 phosphorylation did not occur when intact cells were incubated with the AMPK activator berberine ( Figure 4 C), suggesting that autophosphorylation of Ser 487 is not significant in intact cells.</sentence>
      <sentence id="187" pid="paragraph33">Interestingly, the small degree of Ser 487 autophosphorylation in cell-free assays did not increase when the α1β2γ1 complex was activated by phosphorylation at Thr 172 by LKB1 ( Figure 2 B, top left), suggesting that Thr 172 phosphorylation (unlike its effects on phosphorylation of exogenous substrates) does not enhance Ser 487 autophosphorylation.</sentence>
      <sentence id="188" pid="paragraph33">Our results show that Ser 487 in human α1, unlike Ser 491 in α2, is a good substrate for Akt.</sentence>
      <sentence id="189" pid="paragraph33">Although only phosphorylated in cell-free assays at approximately 10% of the rate of Ser 9 on GSK3-β (a canonical Akt site), in the intact cells the net phosphorylation status would also be affected by the activity of protein phosphatases acting on Ser 487 .</sentence>
      <sentence id="190" pid="paragraph33">The results using MK2206 in Figures 4 and 6 clearly confirm that Ser 487 is phosphorylated in four distinct cell lines in an Akt-dependent manner.</sentence>
      <sentence id="191" pid="paragraph34">In good agreement with previous results obtained with the rat α1β1γ1 complex [ 27 ], prior phosphorylation of Ser 487 on the human α1β2γ1 complex caused a 40% reduction in subsequent phosphorylation of Thr 172 both in active ( Figure 3 A) and inactive ( Figure 1 F) AMPK complexes, and a reduction in the activation of the active complex ( Figure 3 B).</sentence>
      <sentence id="192" pid="paragraph34">Although a 40% effect might appear to be quite modest, the effect appears to be larger in intact cells ( Figures 4 and 6 ), where the activities of phosphatases acting on Ser 487 would affect the outcome.</sentence>
      <sentence id="193" pid="paragraph34">Another explanation for the different size of the effect in cell-free assays and intact cells is that other sites in the ST loop may be phosphorylated in the intact cells, a possibility discussed further below.</sentence>
      <sentence id="194" pid="paragraph35">By using HEK-293 cells expressing recombinant AMPK-α1, we showed not only that the effect of prior IGF-1 treatment to inhibit subsequent AMPK activation by A769662 was dependent on Akt, but also that it was dependent on phosphorylation of Ser 487 , since the effect was completely abolished in cells expressing a non-phosphorylatable S487A mutant ( Figure 4 ).</sentence>
      <sentence id="195" pid="paragraph35">It has been reported recently that Ser 491 on AMPK-α2 can be phosphorylated by S6K1 [ 42 ], so we considered the possibility that Ser 487 might have been phosphorylated by a kinase downstream of Akt and mTORC1, such as S6K1, rather than directly by Akt.</sentence>
      <sentence id="196" pid="paragraph35">However, the phosphorylation of Ser 487 was not affected by rapamycin ( Figure 4 D), so was not catalysed by S6K1 or any other kinase downstream of mTORC1.</sentence>
      <sentence id="197" pid="paragraph36">Using the LKB1-null G361 cell line treated with the Ca 2+ ionophore A23187, we also showed that phosphorylation of Thr 172 , and activation of AMPK, by CaMKKβ was antagonized by prior phosphorylation of Ser 487 .</sentence>
      <sentence id="198" pid="paragraph36">This supports results obtained in cell-free assays ( Figure 3 C), and shows that the effect in intact cells is independent of the upstream kinase utilized.</sentence>
      <sentence id="199" pid="paragraph37">Surprisingly, we found that phosphorylation of Akt at the mTORC2 site, Ser 473 , was blocked by certain AMPK activators including phenformin and quercetin, although not by berberine, A769662 or A23817.</sentence>
      <sentence id="200" pid="paragraph37">Although the mechanism for this effect remains unclear, it is clearly an off-target AMPK-independent effect, because it was still observed in AMPK-knockout MEFs (Supplementary Figure S2).</sentence>
      <sentence id="201" pid="paragraph38">To place our studies in the context of tumour cells, we also addressed whether AMPK activation was down-regulated in three PTEN-null tumour cell lines derived from human cancers.</sentence>
      <sentence id="202" pid="paragraph38">Interestingly, in two glioblastoma cell lines and a breast cancer cell line in which Akt was hyperactivated due to loss of PTEN, AMPK was rather resistant to activation and Thr 172 phosphorylation induced by the activator A769662.</sentence>
      <sentence id="203" pid="paragraph38">However, this effect was reversed by the addition of MK2206, a selective inhibitor of Akt activation that also reduced or abolished the phosphorylation of AMPK-α1 on Ser 487 , of GSK3β on Ser 9 and of Akt itself on Thr 308 and Ser 473 .</sentence>
      <sentence id="204" pid="paragraph38">These effects could also be reversed in DBTRG-05MG cells by re-expressing WT PTEN, but not a phosphatase-inactive (C124S) mutant.</sentence>
      <sentence id="205" pid="paragraph38">Our results suggest that a previously unrecognized effect of PTEN loss is to reduce the potential restraint on cell growth and proliferation provided by activation of AMPK.</sentence>
      <sentence id="206" pid="paragraph38">This mechanism would also be expected to operate in tumour cells in which Akt is hyperactivated due to activating mutations in subunits of PI3K, or mutation or overexpression of upstream receptors [ 26 ].</sentence>
      <sentence id="207" pid="paragraph38">Previous evidence suggests that this mechanism also operates in human hepatoma (Huh-7) cells infected with the hepatitis C virus [ 30 ], where PI3K is activated due to association with a non-structural protein encoded by the viral RNA [ 43 ].</sentence>
      <sentence id="208" pid="paragraph38">In that case, expression of viral proteins was reduced by treating the infected Huh-7 cells with AMPK activators such as AICAR (5-amino-4-imidazolecarboxamide riboside) or metformin [ 30 ].</sentence>
      <sentence id="209" pid="paragraph39">Finally, our results suggest a molecular mechanism by which prior phosphorylation at Ser 487 inhibits subsequent phosphorylation of Thr 172 , and hence activation, by upstream kinases.</sentence>
      <sentence id="210" pid="paragraph39">In a partial α1β2γ1 complex containing rat α1, which was expressed in bacteria and where Ser 485 was therefore most likely unphosphorylated, the ST loop from Glu 469 to Val 524 was not resolved, indicating that it was mobile within the crystal [ 11 ].</sentence>
      <sentence id="211" pid="paragraph39">Our hypothesis is that the ST loop interacts with residues within the kinase domain when Ser 487 is phosphorylated, hindering the ability of upstream kinases to gain access to Thr 172 .</sentence>
      <sentence id="212" pid="paragraph39">This hypothesis is supported by the results in Figure 7 , showing that a peptide corresponding to the sequence from Arg 466 to Asp 525 on human α1 inhibits activation and Thr 172 phosphorylation of an α1β2γ1 complex by LKB1, but only when phosphorylated on the residue corresponding to Ser 487 .</sentence>
      <sentence id="213" pid="paragraph39">This is an extremely specific effect, because the phosphopeptide had no effect on the activation or phosphorylation by LKB1 of BRSK2, which  (with BRSK1) has the kinase domain most closely related to AMPK-α1 and AMPK-α2 within the human kinome.</sentence>
      <sentence id="214" pid="paragraph40">The 54 residues of the ST loop in human AMPK-α1 contains 15 serine residues (including Ser 487 ) and five threonine residues, most of which are conserved in α1 subunits from other vertebrates and in C. elegans (Supplementary Figure S1).</sentence>
      <sentence id="215" pid="paragraph40">It has been shown recently that GSK3β phosphorylates the ST loop at multiple sites, with site-directed mutagenesis suggesting that the initial phosphorylation was at Thr 481 , followed by Ser 477 and perhaps Thr 473 (human α1 residue numbering; in rats the equivalent residues are Thr 479 , Ser 475 and Thr 471 ).</sentence>
      <sentence id="216" pid="paragraph40">Thr 481 phosphorylation was proposed to inhibit net Thr 172 phosphorylation by enhancing its sensitivity to dephosphorylation [ 31 ].</sentence>
      <sentence id="217" pid="paragraph40">With most substrates, phosphorylation by GSK3 requires ‘priming’ by another kinase, because the kinase usually phosphorylates a serine or threonine residue located four residues N-terminal to an existing phosphoamino acid [ 44 ].</sentence>
      <sentence id="218" pid="paragraph40">In the case of AMPK it was proposed that phosphorylation of Ser 487 on rat AMPK-α1 might promote phosphorylation of Thr 481 , although not by conventional priming because the residue spacing is not appropriate, and because phosphorylation was not affected by a GSK3β mutation that reduces phosphorylation of primed substrates [ 31 ].</sentence>
      <sentence id="219" pid="paragraph40">If the hypothesis by Suzuki et al. [ 31 ] is correct, phosphorylation of Ser 487 may lead to additional phosphorylation events within the ST loop.</sentence>
      <sentence id="220" pid="paragraph40">This might explain why we observed a larger effect on AMPK activation and Thr 172 phosphorylation by modulation of Akt in intact cells than in cell-free assays  (compare Figures 1 and 3 with Figures 4 – 6 ).</sentence>
      <sentence id="221" pid="paragraph40">Although GSK3β was phosphorylated at Ser 9 in response to Akt treatment and this normally inhibits GSK3 activity [ 45 ], this inhibition does not occur with ‘unprimed’ substrates [ 46 ] as proposed for Thr 481 [ 31 ].</sentence>
      <sentence id="222" pid="paragraph40">Thus it is possible that phosphorylation of Ser 487 in our intact cell experiments promoted additional phosphorylation events, such as phosphorylation of Thr 481 and Ser 477 by GSK3.</sentence>
      <sentence id="223" pid="paragraph41">As an extension of this hypothesis, we propose that the side chains of three basic residues located in the αC helix of the small lobe of the kinase domain (Arg 64 , Lys 71 and Arg 74 in human α1) interact with multiple phosphate groups attached to the ST loop, thus anchoring the ST loop to the kinase domain and blocking access of Thr 172 to upstream kinases.</sentence>
      <sentence id="224" pid="paragraph41">Interestingly, although at least one of these (Arg 64 or Lys 71 ) is conserved in all 12 AMPK-related kinases, none are conserved in the archetypal serine/threonine kinase domain of PKA.</sentence>
      <sentence id="225" pid="paragraph41">Consistent with our hypothesis, a human α1β2γ1 complex containing an ‘AAA’ mutation (R64A/K71A/K74A) was completely resistant to the ability of previous Akt phosphorylation to reduce the rate of Thr 172 phosphorylation by LKB1 ( Figure 7 D).</sentence>
      <sentence id="226" pid="paragraph41">Also consistent with this model was our finding that prior Akt phosphorylation reduced activation by both upstream kinases (LKB1 and CaMKKβ) to very similar extents ( Figure 3 C).</sentence>
      <sentence id="227" pid="paragraph41">Final confirmation of this model will require structural analysis of AMPK complexes where the ST loop is present in a phosphorylated form, rather than being unphosphorylated or deleted as in existing structures [ 10 , 11 ].</sentence>
      <sentence id="228" pid="paragraph42">Since AMPK activators such as AICAR or metformin can overcome the inhibitory effects of Ser 487 phosphorylation on replication of the hepatitis C virus [ 30 ], our present results raise the exciting prospect that AMPK activators such as metformin, which are already used to treat Type 2 diabetes, might also be efficacious in treatment of tumours in which the Akt pathway is hyperactivated.</sentence>
      <sentence id="229" pid="paragraph42">It is already known from retrospective studies that treatment of diabetics with metformin is associated with a lower incidence of cancer compared with other medications  [ 47 , 48 ], although it is not yet certain that this effect is mediated by AMPK.</sentence>
      <sentence id="230" pid="paragraph42">Our results suggest that clinical trials to test the efficacy of metformin for cancer treatment might be targeted at specific classes of tumour, such as those in which Akt is hyper-activated.</sentence>
    </sentences>
  </input>
  <EVENT end="68" id="V32253" paragraph="paragraph0" rule="-RULE60_AGENT_AFFECTED-AGENT" start="15" uttnum="1">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="68" id="V32253" start="15">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Phosphorylation by Akt within the ST loop of AMPK-α1</text>
    </predicate>
    <arg1 id="V32286" role=":AGENT"/>
    <text>Phosphorylation by Akt within the ST loop of AMPK-α1</text>
  </EVENT>
  <TERM end="68" id="V32286" paragraph="paragraph0" rule="-SIMPLE-REF" start="31" uttnum="1">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">by Akt within the ST loop of AMPK-α1</text>
  </TERM>
  <TERM end="68" id="V32318" paragraph="paragraph0" rule="-SIMPLE-REF" start="45" uttnum="1">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop of AMPK-α1</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="52" id="V32309" paragraph="paragraph0" rule="-SIMPLE-REF" start="49" uttnum="1">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <EVENT end="113" id="V32452" paragraph="paragraph0" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="68" uttnum="1">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="113" id="V32452" start="68">
      <type>ONT::INHIBIT</type>
      <text>down-regulates its activation in tumour cells</text>
    </predicate>
    <arg2 id="V32484" role=":AFFECTED"/>
    <text>down-regulates its activation in tumour cells</text>
  </EVENT>
  <CC end="98" id="V32484" paragraph="paragraph0" rule="-RULE5B_AGENT_RESULT-NONE" start="83" uttnum="1">
    <type>ONT::CAUSE</type>
    <text>its activation</text>
  </CC>
  <TERM end="113" id="V32547" paragraph="paragraph0" rule="-SIMPLE-REF" start="101" uttnum="1">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>tumour cells</text>
  </TERM>
  <TERM dbid="UP:P01308" end="14" id="V46649" paragraph="paragraph1" rule="-SIMPLE-REF" start="7" uttnum="2">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin</text>
  </TERM>
  <TERM end="81" id="V46826" paragraph="paragraph1" rule="-SIMPLE-REF" start="62" uttnum="2">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">protein kinase Akt</text>
  </TERM>
  <TERM dbid="GO:0004672|FA:03057" end="77" id="V46821" paragraph="paragraph1" rule="-SIMPLE-REF" start="62" uttnum="2">
    <type>ONT::GENE-PROTEIN</type>
    <name>PROTEIN-KINASE</name>
    <text>protein kinase</text>
  </TERM>
  <TERM dbid="UP:P31749" end="112" id="V46938" paragraph="paragraph1" rule="-SIMPLE-REF" start="96" uttnum="2">
    <type>ONT::GENE-PROTEIN</type>
    <name>PROTEIN-KINASE-B</name>
    <text>protein kinase B</text>
  </TERM>
  <TERM end="150" id="V46954" paragraph="paragraph1" rule="-SIMPLE-REF" start="129" uttnum="2">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser487 in</text>
  </TERM>
  <TERM end="162" id="V47035" paragraph="paragraph1" rule="-SIMPLE-REF" start="150" uttnum="2">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ‘ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="158" id="V47026" paragraph="paragraph1" rule="-SIMPLE-REF" start="155" uttnum="2">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="191" id="V47048" paragraph="paragraph1" rule="-SIMPLE-REF" start="165" uttnum="2">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>serine/threonine-rich loop</text>
  </TERM>
  <TERM end="171" id="V46490" paragraph="paragraph1" rule="-SIMPLE-REF" start="165" uttnum="2">
    <type>ONT::AMINO-ACID</type>
    <name>SERINE</name>
    <text>serine</text>
  </TERM>
  <TERM end="187" id="V46498" paragraph="paragraph1" rule="-SIMPLE-REF" start="172" uttnum="2">
    <type>ONT::AMINO-ACID</type>
    <name>THREONINE</name>
    <text>threonine-rich</text>
  </TERM>
  <TERM end="267" id="V47139" paragraph="paragraph1" rule="-EXPLICIT-REF1" start="200" uttnum="2">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>C-TERMINAL</name>
    <assoc-with id="V47075"/>
    <text>the C-terminal domain of AMPK-α1 (AMP-activated protein kinase-α1),</text>
  </TERM>
  <TERM end="267" id="V47075" paragraph="paragraph1" rule="-SIMPLE-REF" start="200" uttnum="2">
    <type>ONT::TERMINUS</type>
    <name>C-TERMINAL</name>
    <text>the C-terminal domain of AMPK-α1 (AMP-activated protein kinase-α1),</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="229" id="V47151" paragraph="paragraph1" rule="-SIMPLE-REF" start="225" uttnum="2">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM dbid="GO:0004679" end="265" id="V47230" paragraph="paragraph1" rule="-SIMPLE-REF" start="234" uttnum="2">
    <type>ONT::PROTEIN</type>
    <name>AMP-ACTIVATED-PROTEIN-KINASE</name>
    <text>AMP-activated protein kinase-α1</text>
  </TERM>
  <EVENT end="309" id="V57462" paragraph="paragraph1" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="276" uttnum="2">
    <type>ONT::INHIBIT</type>
    <predicate end="309" id="V57462" start="276">
      <type>ONT::INHIBIT</type>
      <text>to inhibition of phosphorylation</text>
    </predicate>
    <arg2 id="V57474" role=":AFFECTED"/>
    <text>to inhibition of phosphorylation</text>
  </EVENT>
  <EVENT end="353" id="V57474" paragraph="paragraph1" rule="-RULE60_AGENT_AFFECTED-LOC7-GD-NONE" start="290" uttnum="2">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="353" id="V57474" start="290">
      <type>ONT::PHOSPHORYLATION</type>
      <text>of phosphorylation by upstream kinases at the activating site,</text>
    </predicate>
    <site end="353" id="V57558" start="332">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">the activating site,</text>
    </site>
    <text>of phosphorylation by upstream kinases at the activating site,</text>
  </EVENT>
  <TERM dbid="GO:0016301" end="329" id="V57518" paragraph="paragraph1" rule="-SIMPLE-REF" start="312" uttnum="2">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>upstream kinases</text>
  </TERM>
  <TERM end="353" id="V57558" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="332" uttnum="2">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <inevent>
        <event id="V57553"/>
      </inevent>
    </features>
    <name>SITE</name>
    <text>the activating site,</text>
  </TERM>
  <EVENT end="353" id="V57553" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AGENT" start="332" uttnum="2">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="353" id="V57553" start="332">
      <type>ONT::ACTIVATE</type>
      <text>the activating site,</text>
    </predicate>
    <arg1 id="V57558" role=":AGENT"/>
    <text>the activating site,</text>
  </EVENT>
  <TERM end="361" id="V57568" paragraph="paragraph1" rule="-SIMPLE-REF" start="353" uttnum="2">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="426" id="V68074" paragraph="paragraph1" rule="-SIMPLE-REF" start="386" uttnum="3">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>the equivalent site on AMPK-α2, Ser</text>
  </TERM>
  <TERM end="426" id="V68111" paragraph="paragraph1" rule="-SIMPLE-REF" start="409" uttnum="3">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>AMPK-α2, Ser</text>
  </TERM>
  <TERM end="458" id="V68166" paragraph="paragraph1" rule="-SIMPLE-REF" start="440" uttnum="3">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>not an Akt target</text>
  </TERM>
  <TERM end="451" id="V68159" paragraph="paragraph1" rule="-SIMPLE-REF" start="447" uttnum="3">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <EVENT end="605" id="V76522" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-LOC13" start="506" uttnum="4">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="605" id="V76522" start="506">
      <type>ONT::PRODUCE</type>
      <text>Stimulation of HEK (human embryonic kidney)-293 cells with IGF-1 caused reduced subsequent Thr</text>
    </predicate>
    <arg1 id="V76417" role=":AGENT"/>
    <site end="605" id="V76541" start="578">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">reduced subsequent Thr</text>
    </site>
    <text>Stimulation of HEK (human embryonic kidney)-293 cells with IGF-1 caused reduced subsequent Thr</text>
  </EVENT>
  <EVENT end="571" id="V76417" paragraph="paragraph1" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="506" uttnum="4">
    <type>ONT::STIMULATE</type>
    <predicate end="571" id="V76417" start="506">
      <type>ONT::STIMULATE</type>
      <text>Stimulation of HEK (human embryonic kidney)-293 cells with IGF-1</text>
    </predicate>
    <arg2 id="V76479" role=":AFFECTED"/>
    <text>Stimulation of HEK (human embryonic kidney)-293 cells with IGF-1</text>
  </EVENT>
  <TERM end="605" id="V76541" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="578" uttnum="4">
    <type>ONT::AMINO-ACID</type>
    <features>
      <inevent>
        <event id="V76529"/>
      </inevent>
    </features>
    <name>THR</name>
    <text>reduced subsequent Thr</text>
  </TERM>
  <TERM end="571" id="V76479" paragraph="paragraph1" rule="-SIMPLE-REF" start="518" uttnum="4">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>of HEK (human embryonic kidney)-293 cells with IGF-1</text>
  </TERM>
  <TERM dbid="UP:P29320" end="549" id="V76430" paragraph="paragraph1" rule="-SIMPLE-REF" start="521" uttnum="4">
    <type>ONT::PROTEIN</type>
    <name>HEK</name>
    <text>HEK (human embryonic kidney)</text>
  </TERM>
  <TERM dbid="UP:P05019" end="571" id="V76517" paragraph="paragraph1" rule="-SIMPLE-REF" start="565" uttnum="4">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <EVENT end="605" id="V76529" paragraph="paragraph1" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="578" uttnum="4">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="605" id="V76529" start="578">
      <type>ONT::DECREASE</type>
      <text>reduced subsequent Thr</text>
    </predicate>
    <arg2 id="V76541" role=":AFFECTED"/>
    <text>reduced subsequent Thr</text>
  </EVENT>
  <TERM end="694" id="V76777" paragraph="paragraph1" rule="-SIMPLE-REF" start="672" uttnum="4">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>the activator A769662</text>
  </TERM>
  <TERM end="694" id="V76693" paragraph="paragraph1" rule="-SIMPLE-REF" start="672" uttnum="4">
    <type>ONT::SUBSTANCE</type>
    <name>ACTIVATOR</name>
    <text>the activator A769662</text>
  </TERM>
  <TERM dbid="CHEBI:24869" end="744" id="V76814" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="718" uttnum="4">
    <type>ONT::CHEMICAL</type>
    <features>
      <inevent>
        <event id="V76910"/>
      </inevent>
    </features>
    <name>IONOPHORE</name>
    <text>ionophore A23187, effects</text>
  </TERM>
  <EVENT end="744" id="V76910" paragraph="paragraph1" rule="-RULE10_AGENT_AFFECTED" start="718" uttnum="4">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="744" id="V76910" start="718">
      <type>ONT::MODULATE</type>
      <text>ionophore A23187, effects</text>
    </predicate>
    <arg1 id="V76898" role=":AGENT"/>
    <arg2 id="V76814" role=":AFFECTED"/>
    <text>ionophore A23187, effects</text>
  </EVENT>
  <TERM end="736" id="V76898" paragraph="paragraph1" rule="-SIMPLE-REF" start="728" uttnum="4">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>23187</pos>
      </site>
    </features>
    <name>A-23187</name>
    <text>A23187,</text>
  </TERM>
  <TERM end="747" id="V76915" paragraph="paragraph1" rule="-ROBUSTPRO" start="744" uttnum="4">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="786" id="V77017" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="771" uttnum="4">
    <type>ONT::ACTIVATE</type>
    <predicate end="786" id="V77017" start="771">
      <type>ONT::ACTIVATE</type>
      <text>Akt activation</text>
    </predicate>
    <arg2 id="V77014" role=":AFFECTED"/>
    <arg id="R000122" role=":RESULT"/>
    <text>Akt activation</text>
  </EVENT>
  <TERM end="798" id="V77034" paragraph="paragraph1" rule="-SIMPLE-REF" start="790" uttnum="4">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="775" id="V77014" paragraph="paragraph1" rule="-SIMPLE-REF" start="771" uttnum="4">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:P60484" end="920" id="V89974" paragraph="paragraph1" rule="-SIMPLE-REF" start="850" uttnum="5">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>three PTEN (phosphatase and tensin homologue deleted on chromosome 10)</text>
  </TERM>
  <TERM dbid="UP:SL-0468|GO:0005694" end="917" id="V90045" paragraph="paragraph1" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="903" uttnum="5">
    <type>ONT::CELL-PART</type>
    <features>
      <active>TRUE</active>
    </features>
    <name>CHROMOSOME</name>
    <text>on chromosome</text>
  </TERM>
  <TERM end="885" id="V89990" paragraph="paragraph1" rule="-LOGICALOP-REF" start="862" uttnum="5">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="AND">
      <member id="V89985"/>
      <member id="V90001"/>
    </aggregate>
    <text normalization="">phosphatase and tensin</text>
  </TERM>
  <TERM dbid="XFAM:PF04536.11|XFAM:PF00300.19" end="874" id="V89985" paragraph="paragraph1" rule="-SIMPLE-REF" start="862" uttnum="5">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PHOSPHATASE</name>
    <text>phosphatase</text>
  </TERM>
  <TERM dbid="UP:Q9HBL0|HGNC:11973" end="885" id="V90001" paragraph="paragraph1" rule="-SIMPLE-REF" start="878" uttnum="5">
    <type>ONT::GENE</type>
    <name>TENSIN</name>
    <text>tensin</text>
  </TERM>
  <TERM dbid="EFO:0000322" end="943" id="V90105" paragraph="paragraph1" rule="-SIMPLE-REF" start="920" uttnum="5">
    <type>ONT::CELL-LINE</type>
    <name>CELL-LINE</name>
    <text>-null tumour cell lines</text>
  </TERM>
  <EVENT end="1061" id="V101458" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1035" uttnum="5">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <mods>
      <degree>
        <type>ONT::DEGREE-MODIFIER-HIGH</type>
        <value>HYPER-</value>
      </degree>
    </mods>
    <predicate end="1061" id="V101458" start="1035">
      <type>ONT::ACTIVATE</type>
      <text>Akt is thus hyperactivated</text>
    </predicate>
    <arg2 id="V101420" role=":AFFECTED"/>
    <arg id="R000127" role=":RESULT"/>
    <text>Akt is thus hyperactivated</text>
  </EVENT>
  <TERM dbid="UP:P60484" end="1021" id="V101339" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="954" uttnum="5">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V101365"/>
      </inevent>
    </features>
    <name>PTEN</name>
    <text>the lipid phosphatase PTEN that normally restrains the Akt pathway</text>
  </TERM>
  <TERM dbid="XFAM:PF00328.19|GO:0016791|XFAM:PF15698.2" end="1021" id="V101325" paragraph="paragraph1" rule="-SIMPLE-REF" start="954" uttnum="5">
    <type>ONT::GENE-PROTEIN</type>
    <name>PHOSPHATASE</name>
    <text>the lipid phosphatase PTEN that normally restrains the Akt pathway</text>
  </TERM>
  <TERM dbid="CHEBI:18059" end="964" id="V101320" paragraph="paragraph1" rule="-SIMPLE-REF" start="958" uttnum="5">
    <type>ONT::MOLECULE</type>
    <name>LIPID</name>
    <text>lipid</text>
  </TERM>
  <EVENT end="1021" id="V101365" paragraph="paragraph1" rule="-RULE30_AGENT_AFFECTED" start="954" uttnum="5">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <mods>
      <frequency>
        <type>ONT::FREQUENCY</type>
        <value>NORMALLY</value>
      </frequency>
    </mods>
    <predicate end="1021" id="V101365" start="954">
      <type>ONT::INHIBIT</type>
      <text>the lipid phosphatase PTEN that normally restrains the Akt pathway</text>
    </predicate>
    <arg1 id="V101339" role=":AGENT"/>
    <arg2 id="V101382" role=":AFFECTED"/>
    <text>the lipid phosphatase PTEN that normally restrains the Akt pathway</text>
  </EVENT>
  <TERM end="1021" id="V101382" paragraph="paragraph1" rule="-EXPLICIT-REF-SEQ0" start="1005" uttnum="5">
    <type>ONT::SIGNALING-PATHWAY</type>
    <components>
      <component id="V101379"/>
    </components>
    <text normalization="">the Akt pathway</text>
  </TERM>
  <TERM end="1021" id="V101379" paragraph="paragraph1" rule="-EXPLICIT-REF-SEQ0-TERM" start="1005" uttnum="5">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">the Akt pathway</text>
  </TERM>
  <TERM end="1039" id="V101420" paragraph="paragraph1" rule="-SIMPLE-REF" start="1035" uttnum="5">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1069" id="V114852" paragraph="paragraph1" rule="-SIMPLE-REF" start="1064" uttnum="5">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="1107" id="V115010" paragraph="paragraph1" rule="-SIMPLE-REF" start="1100" uttnum="5">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662</text>
  </TERM>
  <EVENT end="1229" id="V126591" paragraph="paragraph1" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="1118" uttnum="6">
    <type>ONT::TRANSFORM</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::COULD</modality>
    <predicate end="1229" id="V126591" start="1118">
      <type>ONT::TRANSFORM</type>
      <text>full AMPK activation could be restored by pharmacological inhibition of Akt, or by re-expression of active PTEN</text>
    </predicate>
    <arg2 id="V126563" role=":AFFECTED"/>
    <text>full AMPK activation could be restored by pharmacological inhibition of Akt, or by re-expression of active PTEN</text>
  </EVENT>
  <EVENT end="1139" id="V126563" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1118" uttnum="6">
    <type>ONT::ACTIVATE</type>
    <predicate end="1139" id="V126563" start="1118">
      <type>ONT::ACTIVATE</type>
      <text>full AMPK activation</text>
    </predicate>
    <arg2 id="V126559" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000132"/>
    <text>full AMPK activation</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1128" id="V126559" paragraph="paragraph1" rule="-SIMPLE-REF" start="1123" uttnum="6">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="1229" id="V126623" paragraph="paragraph1" rule="-BMO3-EVENT,-RULE30_AGENT_FORMAL-NONE" start="1118" uttnum="6">
    <type>ONT::INHIBIT</type>
    <predicate end="1229" id="V126623" start="1118">
      <type>ONT::INHIBIT</type>
      <text>full AMPK activation could be restored by pharmacological inhibition of Akt, or by re-expression of active PTEN</text>
    </predicate>
    <arg2 id="V126563" role=":AFFECTED"/>
    <text>full AMPK activation could be restored by pharmacological inhibition of Akt, or by re-expression of active PTEN</text>
  </EVENT>
  <TERM end="1195" id="V126637" paragraph="paragraph1" rule="-SIMPLE-REF" start="1190" uttnum="6">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt,</text>
  </TERM>
  <EVENT end="1229" id="V126686" paragraph="paragraph1" rule="-RULE50_AGENT_AFFECTED-AFFECTED" start="1201" uttnum="6">
    <type>ONT::EXPRESS</type>
    <mods>
      <frequency>
        <type>ONT::REPETITION</type>
        <value>RE-</value>
      </frequency>
    </mods>
    <predicate end="1229" id="V126686" start="1201">
      <type>ONT::EXPRESS</type>
      <text>re-expression of active PTEN</text>
    </predicate>
    <arg2 id="V126713" role=":AFFECTED"/>
    <site end="1229" id="V126623" start="1118">
      <type>ONT::INHIBIT</type>
      <text normalization="">full AMPK activation could be restored by pharmacological inhibition of Akt, or by re-expression of active PTEN</text>
    </site>
    <text>re-expression of active PTEN</text>
  </EVENT>
  <TERM dbid="UP:P60484" end="1229" id="V126713" paragraph="paragraph1" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="1215" uttnum="6">
    <type>ONT::PROTEIN</type>
    <features>
      <active>TRUE</active>
    </features>
    <name>PTEN</name>
    <text>of active PTEN</text>
  </TERM>
  <MODALITY end="1229" id="X144172" paragraph="paragraph1" rule="-MODALITY" start="1118" uttnum="6">
    <type>ONT::CONDITIONAL</type>
    <arg2 id="V126591" role=":EVENT"/>
    <text>full AMPK activation could be restored by pharmacological inhibition of Akt, or by re-expression of active PTEN</text>
  </MODALITY>
  <CC end="1229" id="X144180" paragraph="paragraph1" rule="-BMO3" start="1118" uttnum="6">
    <type>ONT::BY-MEANS-OF</type>
    <arg id="V126623" role=":FACTOR"/>
    <arg id="V126591" role=":OUTCOME"/>
    <text>full AMPK activation could be restored by pharmacological inhibition of Akt, or by re-expression of active PTEN</text>
  </CC>
  <EPI end="1281" id="V142362" paragraph="paragraph1" rule="-RULE50_0_AGENT_FORMAL" start="1231" uttnum="7">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg1 id="V142348" role=":AGENT"/>
    <arg2 id="V142391" role=":FORMAL"/>
    <text>We also show that inhibition of Thr172</text>
  </EPI>
  <TERM end="1234" id="V142348" paragraph="paragraph1" rule="-ROBUSTPRO" start="1231" uttnum="7">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="1249" id="V142382" paragraph="paragraph1" rule="-SIMPLE-REF" start="1244" uttnum="7">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>that</text>
  </TERM>
  <EVENT end="1281" id="V142391" paragraph="paragraph1" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE30_AGENT_AFFECTED-AFFECTED" start="1231" uttnum="7">
    <type>ONT::INHIBIT</type>
    <epistemic-modality id="V142362"/>
    <predicate end="1281" id="V142391" start="1231">
      <type>ONT::INHIBIT</type>
      <text>We also show that inhibition of Thr172</text>
    </predicate>
    <arg2 id="V142405" role=":AFFECTED"/>
    <text>We also show that inhibition of Thr172</text>
  </EVENT>
  <TERM end="1271" id="V142405" paragraph="paragraph1" rule="-SIMPLE-REF" start="1260" uttnum="7">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>of Thr</text>
  </TERM>
  <TERM end="1365" id="V142508" paragraph="paragraph1" rule="-SIMPLE-REF" start="1319" uttnum="7">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>of the phosphorylated ST loop with basic side</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="1344" id="V142499" paragraph="paragraph1" rule="-SIMPLE-REF" start="1341" uttnum="7">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="1365" id="V142527" paragraph="paragraph1" rule="-SIMPLE-REF" start="1354" uttnum="7">
    <type>ONT::OBJECT-DEPENDENT-LOCATION</type>
    <name>SIDE</name>
    <text>basic side</text>
  </TERM>
  <TERM end="1412" id="V142530" paragraph="paragraph1" rule="-SIMPLE-REF" start="1365" uttnum="7">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>CHAIN</name>
    <text>chains within the αC-helix of the kinase domain</text>
  </TERM>
  <TERM end="1412" id="V142636" paragraph="paragraph1" rule="-SIMPLE-REF" start="1395" uttnum="7">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the kinase domain</text>
  </TERM>
  <TERM dbid="GO:0016301" end="1406" id="V142633" paragraph="paragraph1" rule="-SIMPLE-REF" start="1399" uttnum="7">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="1427" id="V154661" paragraph="paragraph1" rule="-SIMPLE-REF" start="1414" uttnum="8">
    <type>ONT::CLINICAL-FINDING</type>
    <name>FINDING</name>
    <text>Our findings</text>
  </TERM>
  <TERM end="1427" id="V154658" paragraph="paragraph1" rule="-ROBUSTPRO" start="1414" uttnum="8">
    <type>ONT::PERSON</type>
    <text>Our findings</text>
  </TERM>
  <EVENT end="1514" id="V154737" paragraph="paragraph1" rule="-RULE10_AGENT_AFFECTED-AGENT" start="1452" uttnum="8">
    <type>ONT::MODULATE</type>
    <predicate end="1514" id="V154737" start="1452">
      <type>ONT::MODULATE</type>
      <text>unrecognized effect of hyperactivation of Akt in tumour cells</text>
    </predicate>
    <arg1 id="V154761" role=":AGENT"/>
    <text>unrecognized effect of hyperactivation of Akt in tumour cells</text>
  </EVENT>
  <EVENT end="1514" id="V154761" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1472" uttnum="8">
    <type>ONT::ACTIVATE</type>
    <mods>
      <degree>
        <type>ONT::DEGREE-MODIFIER-HIGH</type>
        <value>HYPER-</value>
      </degree>
    </mods>
    <predicate end="1514" id="V154761" start="1472">
      <type>ONT::ACTIVATE</type>
      <text>of hyperactivation of Akt in tumour cells</text>
    </predicate>
    <arg2 id="V154779" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000137"/>
    <text>of hyperactivation of Akt in tumour cells</text>
  </EVENT>
  <TERM end="1514" id="V154779" paragraph="paragraph1" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="1491" uttnum="8">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <location id="V154840"/>
      <active>FALSE</active>
    </features>
    <name>AKT</name>
    <text normalization="">of Akt in tumour cells</text>
  </TERM>
  <TERM end="1514" id="V154840" paragraph="paragraph1" rule="-SIMPLE-REF" start="1501" uttnum="8">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>tumour cells</text>
  </TERM>
  <EVENT end="1583" id="V154896" paragraph="paragraph1" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="1517" uttnum="8">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="1583" id="V154896" start="1517">
      <type>ONT::INHIBIT</type>
      <text>to restrain activation of the LKB1 (liver kinase B1)–AMPK pathway,</text>
    </predicate>
    <arg2 id="V155009" role=":AFFECTED"/>
    <text>to restrain activation of the LKB1 (liver kinase B1)–AMPK pathway,</text>
  </EVENT>
  <TERM end="1583" id="V155009" paragraph="paragraph1" rule="-EXPLICIT-REF-SEQ0" start="1529" uttnum="8">
    <type>ONT::SIGNALING-PATHWAY</type>
    <components>
      <component id="V155006"/>
    </components>
    <text normalization="">activation of the LKB1 (liver kinase B1)–AMPK pathway,</text>
  </TERM>
  <EVENT end="1583" id="V154901" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1529" uttnum="8">
    <type>ONT::ACTIVATE</type>
    <predicate end="1583" id="V154901" start="1529">
      <type>ONT::ACTIVATE</type>
      <text>activation of the LKB1 (liver kinase B1)–AMPK pathway,</text>
    </predicate>
    <arg2 id="V154927" role=":AFFECTED"/>
    <arg id="R000142" role=":RESULT"/>
    <text>activation of the LKB1 (liver kinase B1)–AMPK pathway,</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1583" id="V155006" paragraph="paragraph1" rule="-EXPLICIT-REF-SEQ0-TERM" start="1529" uttnum="8">
    <type>ONT::GENE-PROTEIN</type>
    <name>PUNC-EN-DASH-AMPK</name>
    <text>activation of the LKB1 (liver kinase B1)–AMPK pathway,</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="1569" id="V154927" paragraph="paragraph1" rule="-SIMPLE-REF" start="1540" uttnum="8">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>of the LKB1 (liver kinase B1)</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:Q15831|XFAM:PF00069|HGNC:11389" end="1568" id="V154989" paragraph="paragraph1" rule="-SIMPLE-REF" start="1553" uttnum="8">
    <type>ONT::PROTEIN</type>
    <name>LIVER-KINASE-B-1</name>
    <text>liver kinase B1</text>
  </TERM>
  <EVENT end="1643" id="V169913" paragraph="paragraph1" rule="-RULE30_AGENT_AFFECTED" start="1584" uttnum="8">
    <type>ONT::INHIBIT</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::WOULD</modality>
    <predicate end="1643" id="V169913" start="1584">
      <type>ONT::INHIBIT</type>
      <text>which would otherwise inhibit cell growth and proliferation</text>
    </predicate>
    <arg1 id="V169893" role=":AGENT"/>
    <arg2 id="V169948" role=":AFFECTED"/>
    <text>which would otherwise inhibit cell growth and proliferation</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1643" id="V169893" paragraph="paragraph1" rule="-SIMPLE-REF" start="1584" uttnum="8">
    <type>ONT::GENE-PROTEIN</type>
    <name>PUNC-EN-DASH-AMPK</name>
    <text>which would otherwise inhibit cell growth and proliferation</text>
  </TERM>
  <TERM end="1643" id="V169948" paragraph="paragraph1" rule="-LOGICALOP-REF" start="1614" uttnum="8">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <aggregate operator="AND">
      <member id="V169944"/>
      <member id="V169960"/>
    </aggregate>
    <text normalization="">cell growth and proliferation</text>
  </TERM>
  <TERM dbid="GO:0016049" end="1626" id="V169944" paragraph="paragraph1" rule="-SIMPLE-REF" start="1614" uttnum="8">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-GROWTH</name>
    <text>cell growth</text>
  </TERM>
  <TERM end="1643" id="V169960" paragraph="paragraph1" rule="-SIMPLE-REF" start="1630" uttnum="8">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PROLIFERATION</name>
    <text>proliferation</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="39" id="V176517" paragraph="paragraph2" rule="-SIMPLE-REF" start="3" uttnum="9">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK (AMP-activated protein kinase)</text>
  </TERM>
  <TERM end="116" id="V176659" paragraph="paragraph2" rule="-INEVENT2B,-SIMPLE-REF" start="42" uttnum="9">
    <type>ONT::SENSOR</type>
    <features>
      <inevent>
        <event id="V176653"/>
      </inevent>
    </features>
    <name>SENSOR</name>
    <text>a ubiquitously expressed sensor of cellular energy status [1]</text>
  </TERM>
  <TERM dbid="GO:0004679" end="37" id="V176570" paragraph="paragraph2" rule="-SIMPLE-REF" start="9" uttnum="9">
    <type>ONT::PROTEIN</type>
    <name>AMP-ACTIVATED-PROTEIN-KINASE</name>
    <text>AMP-activated protein kinase</text>
  </TERM>
  <EVENT end="67" id="V176653" paragraph="paragraph2" rule="-RULE50_AGENT_AFFECTED-RESULT-NONE" start="44" uttnum="9">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="67" id="V176653" start="44">
      <type>ONT::EXPRESS</type>
      <text>ubiquitously expressed</text>
    </predicate>
    <arg2 id="V176659" role=":AFFECTED"/>
    <text>ubiquitously expressed</text>
  </EVENT>
  <TERM end="116" id="V176685" paragraph="paragraph2" rule="-SIMPLE-REF" start="77" uttnum="9">
    <type>ONT::NONESSENTIAL-CONTRACT</type>
    <name>STATUS</name>
    <text>cellular energy status [1]</text>
  </TERM>
  <TERM end="116" id="V176676" paragraph="paragraph2" rule="-SIMPLE-REF" start="77" uttnum="9">
    <type>ONT::SUBSTANCE</type>
    <name>ENERGY</name>
    <text>cellular energy status [1]</text>
  </TERM>
  <TERM end="134" id="V189296" paragraph="paragraph2" rule="-SIMPLE-REF" start="118" uttnum="9">
    <type>ONT::SENSOR</type>
    <name>SENSOR</name>
    <text>which exists in</text>
  </TERM>
  <TERM dbid="CO:0000255" end="228" id="V189401" paragraph="paragraph2" rule="-SIMPLE-REF" start="146" uttnum="9">
    <type>ONT::CELL</type>
    <name>EUKARYOTIC-CELLS</name>
    <text>all eukaryotic cells as heterotrimeric complexes comprising a catalytic α subunit</text>
  </TERM>
  <TERM end="195" id="V189443" paragraph="paragraph2" rule="-SIMPLE-REF" start="170" uttnum="9">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>heterotrimeric complexes</text>
  </TERM>
  <TERM dbid="GO:0016301" end="315" id="V199387" paragraph="paragraph2" rule="-SIMPLE-REF" start="295" uttnum="10">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>by upstream kinases</text>
  </TERM>
  <TERM end="374" id="V199424" paragraph="paragraph2" rule="-INEVENT2B,-SIMPLE-REF" start="318" uttnum="10">
    <type>ONT::RESIDUE</type>
    <features>
      <inevent>
        <event id="V199416"/>
      </inevent>
    </features>
    <name>RESIDUE</name>
    <text>conserved threonine residues within the activation loop</text>
  </TERM>
  <EVENT end="374" id="V199416" paragraph="paragraph2" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="318" uttnum="10">
    <type>ONT::NO-CHANGE</type>
    <force>ONT::TRUE</force>
    <predicate end="374" id="V199416" start="318">
      <type>ONT::NO-CHANGE</type>
      <text>conserved threonine residues within the activation loop</text>
    </predicate>
    <arg2 id="V199424" role=":AFFECTED"/>
    <text>conserved threonine residues within the activation loop</text>
  </EVENT>
  <TERM end="338" id="V199421" paragraph="paragraph2" rule="-SIMPLE-REF" start="328" uttnum="10">
    <type>ONT::AMINO-ACID</type>
    <name>THREONINE</name>
    <text>threonine</text>
  </TERM>
  <TERM end="374" id="V199452" paragraph="paragraph2" rule="-SIMPLE-REF" start="354" uttnum="10">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the activation loop</text>
  </TERM>
  <TERM end="396" id="V199460" paragraph="paragraph2" rule="-SIMPLE-REF" start="375" uttnum="10">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr172 in</text>
  </TERM>
  <TERM end="405" id="V199518" paragraph="paragraph2" rule="-SIMPLE-REF" start="396" uttnum="10">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat α1/α2</text>
  </TERM>
  <TERM dbid="GO:0016301" end="493" id="V214379" paragraph="paragraph2" rule="-INEVENT2B,-SIMPLE-REF" start="458" uttnum="11">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V214398"/>
      </inevent>
    </features>
    <name>KINASES</name>
    <text>Kinases that phosphorylate Thr</text>
  </TERM>
  <EVENT end="493" id="V214398" paragraph="paragraph2" rule="-RULE60_AGENT_AFFECTED-LOC13" start="458" uttnum="11">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="493" id="V214398" start="458">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Kinases that phosphorylate Thr</text>
    </predicate>
    <arg1 id="V214379" role=":AGENT"/>
    <site end="493" id="V214403" start="485">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>Kinases that phosphorylate Thr</text>
  </EVENT>
  <TERM end="493" id="V214403" paragraph="paragraph2" rule="-SIMPLE-REF" start="485" uttnum="11">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="556" id="V214448" paragraph="paragraph2" rule="-SIMPLE-REF" start="533" uttnum="11">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1 (liver kinase B1)</text>
  </TERM>
  <TERM dbid="UP:Q15831|XFAM:PF00069|HGNC:11389" end="554" id="V214510" paragraph="paragraph2" rule="-SIMPLE-REF" start="539" uttnum="11">
    <type>ONT::PROTEIN</type>
    <name>LIVER-KINASE-B-1</name>
    <text>liver kinase B1</text>
  </TERM>
  <TERM dbid="GO:0016301" end="707" id="V214582" paragraph="paragraph2" rule="-EXPLICIT-REF-ROBUST" start="613" uttnum="11">
    <type>ONT::PROTEIN</type>
    <name>CAMKKΒ</name>
    <text>dependent kinase CaMKKβ (calmodulin-dependent kinase kinase β) [6–8]</text>
  </TERM>
  <TERM dbid="UP:P02593" end="648" id="V214619" paragraph="paragraph2" rule="-SIMPLE-REF" start="638" uttnum="11">
    <type>ONT::PROTEIN</type>
    <name>CALMODULIN</name>
    <text>calmodulin</text>
  </TERM>
  <TERM dbid="GO:0016301" end="674" id="V214644" paragraph="paragraph2" rule="-SIMPLE-REF" start="649" uttnum="11">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>dependent kinase kinase β</text>
  </TERM>
  <TERM end="674" id="V214628" paragraph="paragraph2" rule="-SIMPLE-REF" start="649" uttnum="11">
    <type>ONT::PERSON</type>
    <name>DEPENDENT</name>
    <text>dependent kinase kinase β</text>
  </TERM>
  <TERM dbid="GO:0016301" end="666" id="V214639" paragraph="paragraph2" rule="-SIMPLE-REF" start="659" uttnum="11">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="796" id="V228071" paragraph="paragraph2" rule="-INEVENT2B,-SIMPLE-REF" start="738" uttnum="12">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>three sites where ADP or AMP bind in competition with ATP</text>
  </TERM>
  <EVENT end="796" id="V228114" paragraph="paragraph2" rule="-RULE20C_AGENT_AFFECTED-LOC4-AGENT" start="738" uttnum="12">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="796" id="V228114" start="738">
      <type>ONT::BIND</type>
      <text>three sites where ADP or AMP bind in competition with ATP</text>
    </predicate>
    <arg1 id="V228094" role=":AGENT"/>
    <site end="796" id="V228071" start="738">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">three sites where ADP or AMP bind in competition with ATP</text>
    </site>
    <text>three sites where ADP or AMP bind in competition with ATP</text>
  </EVENT>
  <TERM end="767" id="V228094" paragraph="paragraph2" rule="-LOGICALOP-REF" start="756" uttnum="12">
    <type>ONT::MOLECULE</type>
    <aggregate operator="OR">
      <member id="V228090"/>
      <member id="V228103"/>
    </aggregate>
    <text normalization="">ADP or AMP</text>
  </TERM>
  <TERM dbid="CHEBI:73342|CHEBI:456216|CHEBI:16761" end="760" id="V228090" paragraph="paragraph2" rule="-SIMPLE-REF" start="756" uttnum="12">
    <type>ONT::MOLECULE</type>
    <name>ADP</name>
    <text>ADP</text>
  </TERM>
  <TERM dbid="CHEBI:16027|CHEBI:456215|CHEBI:28971" end="767" id="V228103" paragraph="paragraph2" rule="-SIMPLE-REF" start="763" uttnum="12">
    <type>ONT::MOLECULE</type>
    <name>AMP</name>
    <text>AMP</text>
  </TERM>
  <TERM dbid="MESH:D000255" end="796" id="V228187" paragraph="paragraph2" rule="-SIMPLE-REF" start="792" uttnum="12">
    <type>ONT::MOLECULE</type>
    <name>ATP</name>
    <text>ATP</text>
  </TERM>
  <CC end="926" id="V238228" paragraph="paragraph2" rule="-RULE5B_AGENT_AFFECTED" start="830" uttnum="13">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V238189" role=":FACTOR"/>
    <arg id="V238244" role=":OUTCOME"/>
    <text>Binding of AMP or ADP causes conformational changes that enhance net phosphorylation at Thr</text>
  </CC>
  <TERM dbid="GO:0005488" end="852" id="V238189" paragraph="paragraph2" rule="-SIMPLE-REF" start="830" uttnum="13">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>BINDING</name>
    <text>Binding of AMP or ADP</text>
  </TERM>
  <EVENT end="926" id="V238244" paragraph="paragraph2" rule="-INEVENT2B,-RULE5_AFFECTED_AFFECTED1-NONE" start="859" uttnum="13">
    <type>ONT::TRANSFORM</type>
    <predicate end="926" id="V238244" start="859">
      <type>ONT::TRANSFORM</type>
      <text>conformational changes that enhance net phosphorylation at Thr</text>
    </predicate>
    <text>conformational changes that enhance net phosphorylation at Thr</text>
  </EVENT>
  <TERM end="852" id="V238211" paragraph="paragraph2" rule="-LOGICALOP-REF" start="841" uttnum="13">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="OR">
      <member id="V238204"/>
      <member id="V238220"/>
    </aggregate>
    <text normalization="">AMP or ADP</text>
  </TERM>
  <TERM dbid="CHEBI:16027|CHEBI:456215|CHEBI:28971" end="845" id="V238204" paragraph="paragraph2" rule="-SIMPLE-REF" start="841" uttnum="13">
    <type>ONT::MOLECULE</type>
    <name>AMP</name>
    <text>AMP</text>
  </TERM>
  <TERM dbid="UP:P24935|HGNC:29175|UP:Q8N5D0|XFAM:PF05393" end="852" id="V238220" paragraph="paragraph2" rule="-SIMPLE-REF" start="848" uttnum="13">
    <type>ONT::GENE-PROTEIN</type>
    <name>ADP</name>
    <text>ADP</text>
  </TERM>
  <EVENT end="926" id="V238266" paragraph="paragraph2" rule="-RULE30_AGENT_AFFECTED" start="859" uttnum="13">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="926" id="V238266" start="859">
      <type>ONT::STIMULATE</type>
      <text>conformational changes that enhance net phosphorylation at Thr</text>
    </predicate>
    <arg1 id="V238244" role=":AGENT"/>
    <arg2 id="V238280" role=":AFFECTED"/>
    <text>conformational changes that enhance net phosphorylation at Thr</text>
  </EVENT>
  <EVENT end="926" id="V238280" paragraph="paragraph2" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="895" uttnum="13">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="926" id="V238280" start="895">
      <type>ONT::PHOSPHORYLATION</type>
      <text>net phosphorylation at Thr</text>
    </predicate>
    <arg2 id="V238275" role=":AFFECTED"/>
    <arg id="R000012" role=":RESULT"/>
    <text>net phosphorylation at Thr</text>
  </EVENT>
  <TERM dbid="UP:P54762" end="899" id="V238275" paragraph="paragraph2" rule="-SIMPLE-REF" start="895" uttnum="13">
    <type>ONT::PROTEIN</type>
    <name>NET</name>
    <text>net</text>
    <not-features>
      <ptm event="V238280" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="926" id="V238303" paragraph="paragraph2" rule="-SIMPLE-REF" start="918" uttnum="13">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="968" id="V238334" paragraph="paragraph2" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="936" uttnum="13">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="968" id="V238334" start="936">
      <type>ONT::INHIBIT</type>
      <text>by inhibiting dephosphorylation,</text>
    </predicate>
    <arg2 id="V238349" role=":AFFECTED"/>
    <text>by inhibiting dephosphorylation,</text>
  </EVENT>
  <TERM dbid="GO:0016311" end="968" id="V238349" paragraph="paragraph2" rule="-SIMPLE-REF" start="950" uttnum="13">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>DEPHOSPHORYLATION</name>
    <text>dephosphorylation,</text>
  </TERM>
  <TERM end="1006" id="V254826" paragraph="paragraph2" rule="-SIMPLE-REF" start="977" uttnum="13">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>BINDING</name>
    <text>binding of AMP, but not ADP,</text>
  </TERM>
  <EVENT end="1031" id="V254892" paragraph="paragraph2" rule="-RULE60_AGENT_AFFECTED-LOC5-GD-NONE" start="985" uttnum="13">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1031" id="V254892" start="985">
      <type>ONT::PHOSPHORYLATION</type>
      <text>of AMP, but not ADP, promotes phosphorylation</text>
    </predicate>
    <site end="1006" id="V254826" start="977">
      <type>ONT::MANUFACTURED-OBJECT</type>
      <text normalization="">binding of AMP, but not ADP,</text>
    </site>
    <text>of AMP, but not ADP, promotes phosphorylation</text>
  </EVENT>
  <TERM dbid="CHEBI:16027|CHEBI:456215|CHEBI:28971" end="991" id="V254841" paragraph="paragraph2" rule="-SIMPLE-REF" start="988" uttnum="13">
    <type>ONT::MOLECULE</type>
    <name>AMP</name>
    <text>AMP</text>
  </TERM>
  <TERM dbid="CHEBI:73342|CHEBI:456216|CHEBI:16761" end="1004" id="V254879" paragraph="paragraph2" rule="-SIMPLE-REF" start="1001" uttnum="13">
    <type>ONT::MOLECULE</type>
    <name>ADP</name>
    <text>ADP</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="1039" id="V254926" paragraph="paragraph2" rule="-SIMPLE-REF" start="1034" uttnum="13">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1</text>
  </TERM>
  <TERM end="1140" id="V271757" paragraph="paragraph2" rule="-EXPLICIT-REF1-REV" start="1123" uttnum="14">
    <type>ONT::MEDICATION</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <assoc-with id="X283852"/>
    <text>The drug A769662</text>
  </TERM>
  <TERM dbid="MESH:C082026" end="1181" id="V271801" paragraph="paragraph2" rule="-SIMPLE-REF" start="1144" uttnum="14">
    <type>ONT::PHARMACOLOGIC-SUBSTANCE</type>
    <name>MIMIC</name>
    <text>the natural product salicylate mimic</text>
  </TERM>
  <TERM end="1181" id="V271784" paragraph="paragraph2" rule="-SIMPLE-REF" start="1144" uttnum="14">
    <type>ONT::PRODUCT</type>
    <name>PRODUCT</name>
    <text>the natural product salicylate mimic</text>
  </TERM>
  <TERM dbid="CHEBI:30762|CHEBI:16914" end="1175" id="V271793" paragraph="paragraph2" rule="-SIMPLE-REF" start="1164" uttnum="14">
    <type>ONT::MOLECULE</type>
    <name>SALICYLATE</name>
    <text>salicylate</text>
  </TERM>
  <TERM end="1140" id="X283852" paragraph="paragraph2" rule="-EXPLICIT-REF1-REV-BASE" start="1123" uttnum="14">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>The drug A769662</text>
  </TERM>
  <TERM end="1219" id="V271882" paragraph="paragraph2" rule="-SIMPLE-REF" start="1181" uttnum="14">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>the ability of AMP to inhibit Thr</text>
  </TERM>
  <TERM dbid="CHEBI:16027|CHEBI:456215|CHEBI:28971" end="1200" id="V271842" paragraph="paragraph2" rule="-SIMPLE-REF" start="1193" uttnum="14">
    <type>ONT::MOLECULE</type>
    <name>AMP</name>
    <text>of AMP</text>
  </TERM>
  <TERM dbid="GO:0016311" end="1247" id="V271898" paragraph="paragraph2" rule="-SIMPLE-REF" start="1229" uttnum="14">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>DEPHOSPHORYLATION</name>
    <text>dephosphorylation</text>
  </TERM>
  <EVENT end="1366" id="V283757" paragraph="paragraph2" rule="-RULE20C_AFFECTED_AFFECTED1-LOC7-GD-NONE" start="1284" uttnum="14">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1366" id="V283757" start="1284">
      <type>ONT::BIND</type>
      <text>bind at a different site involving the β subunit [16–18]</text>
    </predicate>
    <site end="1366" id="V283824" start="1292">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">a different site involving the β subunit [16–18]</text>
    </site>
    <text>bind at a different site involving the β subunit [16–18]</text>
  </EVENT>
  <TERM end="1366" id="V283824" paragraph="paragraph2" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="1292" uttnum="14">
    <type>ONT::MOLECULAR-SITE</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>DIFFERENT</value>
      </mod>
    </mods>
    <name>SITE</name>
    <text>a different site involving the β subunit [16–18]</text>
  </TERM>
  <EVENT end="90" id="V297725" paragraph="paragraph3" rule="-RULE40A_AGENT_AFFECTED" start="3" uttnum="15">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="90" id="V297725" start="3">
      <type>ONT::ACTIVATE</type>
      <text>AMPK is thus activated by metabolic stresses that deplete ATP, and increase ADP and AMP</text>
    </predicate>
    <arg2 id="V297694" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000147"/>
    <text>AMPK is thus activated by metabolic stresses that deplete ATP, and increase ADP and AMP</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="8" id="V297694" paragraph="paragraph3" rule="-SIMPLE-REF" start="3" uttnum="15">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="90" id="V297834" paragraph="paragraph3" rule="-LOGICALOP-REF" start="61" uttnum="15">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="AND">
      <member id="V297826"/>
      <member id="V297845"/>
    </aggregate>
    <text normalization="">ATP, and increase ADP and AMP</text>
  </TERM>
  <TERM dbid="UP:P24935|HGNC:29175|UP:Q8N5D0|XFAM:PF05393" end="83" id="V297826" paragraph="paragraph3" rule="-SIMPLE-REF" start="61" uttnum="15">
    <type>ONT::GENE-PROTEIN</type>
    <name>ADP</name>
    <text>ATP, and increase ADP</text>
  </TERM>
  <TERM dbid="CHEBI:16027|CHEBI:456215|CHEBI:28971" end="90" id="V297845" paragraph="paragraph3" rule="-SIMPLE-REF" start="87" uttnum="15">
    <type>ONT::MOLECULE</type>
    <name>AMP</name>
    <text>AMP</text>
  </TERM>
  <TERM dbid="MESH:D000255" end="66" id="V297797" paragraph="paragraph3" rule="-SIMPLE-REF" start="61" uttnum="15">
    <type>ONT::MOLECULE</type>
    <name>ATP</name>
    <text>ATP,</text>
  </TERM>
  <TERM end="124" id="V309919" paragraph="paragraph3" rule="-SIMPLE-REF" start="114" uttnum="16">
    <type>ONT::GENERAL-STRUCTURE</type>
    <name>COMPOUND</name>
    <text>compounds</text>
  </TERM>
  <TERM dbid="GO:0006754" end="172" id="V309945" paragraph="paragraph3" rule="-SIMPLE-REF" start="149" uttnum="16">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>ATP-SYNTHESIS</name>
    <text>ATP synthesis, such as</text>
  </TERM>
  <TERM end="220" id="V310041" paragraph="paragraph3" rule="-LOGICALOP-REF" start="172" uttnum="16">
    <type>ONT::MOLECULE</type>
    <aggregate operator="AND">
      <member id="V310037"/>
      <member id="V310052"/>
    </aggregate>
    <text normalization="">the anti-diabetic drugs metformin and phenformin</text>
  </TERM>
  <TERM dbid="CHEBI:6801" end="206" id="V310037" paragraph="paragraph3" rule="-EXPLICIT-REF1-REV" start="172" uttnum="16">
    <type>ONT::MEDICATION</type>
    <name>METFORMIN</name>
    <assoc-with id="X324790"/>
    <text>the anti-diabetic drugs metformin</text>
  </TERM>
  <TERM dbid="CHEBI:8064" end="220" id="V310052" paragraph="paragraph3" rule="-SIMPLE-REF" start="210" uttnum="16">
    <type>ONT::MOLECULE</type>
    <name>PHENFORMIN</name>
    <text>phenformin</text>
  </TERM>
  <TERM dbid="CHEBI:35526" end="190" id="V310024" paragraph="paragraph3" rule="-SIMPLE-REF" start="176" uttnum="16">
    <type>ONT::CHEMICAL</type>
    <name>ANTI-DIABETIC</name>
    <text>anti-diabetic</text>
  </TERM>
  <TERM dbid="CHEBI:6801" end="206" id="X324790" paragraph="paragraph3" rule="-EXPLICIT-REF1-REV-BASE" start="172" uttnum="16">
    <type>ONT::MOLECULE</type>
    <name>METFORMIN</name>
    <text>the anti-diabetic drugs metformin</text>
  </TERM>
  <TERM dbid="MESH:C074315" end="255" id="V310087" paragraph="paragraph3" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="226" uttnum="16">
    <type>ONT::PHARMACOLOGIC-SUBSTANCE</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>GALEGINE</name>
    <text>the natural products galegine</text>
  </TERM>
  <TERM dbid="MESH:C059514" end="269" id="V310099" paragraph="paragraph3" rule="-SIMPLE-REF" start="257" uttnum="16">
    <type>ONT::PHARMACOLOGIC-SUBSTANCE</type>
    <name>RESVERATROL</name>
    <text>resveratrol</text>
  </TERM>
  <TERM dbid="CHEBI:16118" end="300" id="V310118" paragraph="paragraph3" rule="-SIMPLE-REF" start="273" uttnum="16">
    <type>ONT::MOLECULE</type>
    <name>BERBERINE</name>
    <text>berberine [19]</text>
  </TERM>
  <TERM end="255" id="V310078" paragraph="paragraph3" rule="-SIMPLE-REF" start="226" uttnum="16">
    <type>ONT::PRODUCT</type>
    <name>PRODUCT</name>
    <text>the natural products galegine</text>
  </TERM>
  <EVENT end="500" id="V322229" paragraph="paragraph3" rule="-RULE10C_AGENT_AFFECTED" start="302" uttnum="17">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="500" id="V322229" start="302">
      <type>ONT::TRANSLOCATE</type>
      <text>Once activated, AMPK switches on catabolic pathways that generate ATP while switching off anabolic pathways and other ATP-requiring processes such as progress through the cell cycle [1]</text>
    </predicate>
    <arg1 id="V322176" role=":AGENT"/>
    <arg2 id="V322243" role=":AFFECTED"/>
    <text>Once activated, AMPK switches on catabolic pathways that generate ATP while switching off anabolic pathways and other ATP-requiring processes such as progress through the cell cycle [1]</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="323" id="V322176" paragraph="paragraph3" rule="-SIMPLE-REF" start="318" uttnum="17">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="500" id="V322243" paragraph="paragraph3" rule="-SIMPLE-REF" start="335" uttnum="17">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>catabolic pathways that generate ATP while switching off anabolic pathways and other ATP-requiring processes such as progress through the cell cycle [1]</text>
  </TERM>
  <EVENT end="323" id="V322167" paragraph="paragraph3" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="302" uttnum="17">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="323" id="V322167" start="302">
      <type>ONT::ACTIVATE</type>
      <text>Once activated, AMPK</text>
    </predicate>
    <arg2 id="V322176" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000152"/>
    <text>Once activated, AMPK</text>
  </EVENT>
  <EVENT end="500" id="V322280" paragraph="paragraph3" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="368" uttnum="17">
    <type>ONT::TRANSFORM</type>
    <predicate end="500" id="V322280" start="368">
      <type>ONT::TRANSFORM</type>
      <text>ATP while switching off anabolic pathways and other ATP-requiring processes such as progress through the cell cycle [1]</text>
    </predicate>
    <arg2 id="V322267" role=":AFFECTED"/>
    <text>ATP while switching off anabolic pathways and other ATP-requiring processes such as progress through the cell cycle [1]</text>
  </EVENT>
  <TERM dbid="MESH:D000255" end="372" id="V322267" paragraph="paragraph3" rule="-SIMPLE-REF" start="368" uttnum="17">
    <type>ONT::MOLECULE</type>
    <name>ATP</name>
    <text>ATP</text>
  </TERM>
  <TERM end="410" id="V322329" paragraph="paragraph3" rule="-SIMPLE-REF" start="392" uttnum="17">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>anabolic pathways</text>
  </TERM>
  <EVENT end="500" id="V322419" paragraph="paragraph3" rule="-RULE5_AGENT_AFFECTED-MODA1_1-AFFECTED" start="414" uttnum="17">
    <type>ONT::TRANSFORM</type>
    <mods>
      <mod>
        <type>ONT::VIA</type>
        <value>THROUGH</value>
      </mod>
    </mods>
    <predicate end="500" id="V322419" start="414">
      <type>ONT::TRANSFORM</type>
      <text>other ATP-requiring processes such as progress through the cell cycle [1]</text>
    </predicate>
    <arg2 id="V322347" role=":AFFECTED"/>
    <text>other ATP-requiring processes such as progress through the cell cycle [1]</text>
  </EVENT>
  <TERM dbid="MESH:D000255" end="423" id="V322347" paragraph="paragraph3" rule="-SIMPLE-REF" start="420" uttnum="17">
    <type>ONT::MOLECULE</type>
    <name>ATP</name>
    <text>ATP</text>
  </TERM>
  <TERM end="452" id="V322364" paragraph="paragraph3" rule="-SIMPLE-REF" start="434" uttnum="17">
    <type>ONT::PROCESS</type>
    <name>PROCESS</name>
    <text>processes such as</text>
  </TERM>
  <TERM dbid="GO:0007049" end="500" id="V322482" paragraph="paragraph3" rule="-SIMPLE-REF" start="469" uttnum="17">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-CYCLE</name>
    <text>the cell cycle [1]</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="512" id="V335723" paragraph="paragraph3" rule="-SIMPLE-REF" start="507" uttnum="18">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <EVENT end="536" id="V335788" paragraph="paragraph3" rule="-RULE10_AGENT_AFFECTED-AGENT" start="516" uttnum="18">
    <type>ONT::MODULATE</type>
    <predicate end="536" id="V335788" start="516">
      <type>ONT::MODULATE</type>
      <text>a cytostatic effect</text>
    </predicate>
    <arg1 id="V335785" role=":AGENT"/>
    <text>a cytostatic effect</text>
  </EVENT>
  <TERM dbid="CHEBI:35610" end="529" id="V335785" paragraph="paragraph3" rule="-SIMPLE-REF" start="518" uttnum="18">
    <type>ONT::CHEMICAL</type>
    <name>CYTOSTATIC</name>
    <text>cytostatic</text>
  </TERM>
  <EVENT end="560" id="V335832" paragraph="paragraph3" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="539" uttnum="18">
    <type>ONT::INCREASE</type>
    <predicate end="560" id="V335832" start="539">
      <type>ONT::INCREASE</type>
      <text>proliferating cells,</text>
    </predicate>
    <arg2 id="V335843" role=":AFFECTED"/>
    <text>proliferating cells,</text>
  </EVENT>
  <TERM end="558" id="V335843" paragraph="paragraph3" rule="-SIMPLE-REF" start="553" uttnum="18">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="579" id="V335876" paragraph="paragraph3" rule="-SIMPLE-REF" start="576" uttnum="18">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>it</text>
  </TERM>
  <TERM end="621" id="V336101" paragraph="paragraph3" rule="-SIMPLE-REF" start="591" uttnum="18">
    <type>ONT::PERSON</type>
    <name>SUPPRESSOR</name>
    <text>some of the tumour suppressor</text>
  </TERM>
  <TERM end="621" id="V335923" paragraph="paragraph3" rule="-SIMPLE-REF" start="596" uttnum="18">
    <type>ONT::PERSON</type>
    <name>SUPPRESSOR</name>
    <text>of the tumour suppressor</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="657" id="V335975" paragraph="paragraph3" rule="-EXPLICIT-REF1-REV" start="632" uttnum="18">
    <type>ONT::PROTEIN</type>
    <name>LKB-1</name>
    <assoc-with id="X353760"/>
    <text>its upstream kinase, LKB1</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="657" id="V335945" paragraph="paragraph3" rule="-EXPLICIT-REF1-REV" start="632" uttnum="18">
    <type>ONT::PROTEIN</type>
    <name>LKB-1</name>
    <assoc-with id="X353761"/>
    <text>its upstream kinase, LKB1</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="657" id="X353761" paragraph="paragraph3" rule="-EXPLICIT-REF1-REV-BASE" start="632" uttnum="18">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>its upstream kinase, LKB1</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="657" id="X353760" paragraph="paragraph3" rule="-EXPLICIT-REF1-REV-BASE" start="632" uttnum="18">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>its upstream kinase, LKB1</text>
  </TERM>
  <EPI end="729" id="V350122" paragraph="paragraph3" rule="-RULE50_0_AGENT_FORMAL-NONE" start="659" uttnum="19">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V350099" role=":NEUTRAL"/>
    <text>This was supported by recent studies of a mouse B-cell lymphoma model,</text>
  </EPI>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="664" id="V350099" paragraph="paragraph3" rule="-SIMPLE-REF" start="659" uttnum="19">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>This</text>
  </TERM>
  <TERM end="729" id="V350309" paragraph="paragraph3" rule="-SIMPLE-REF" start="696" uttnum="19">
    <type>ONT::PRODUCT-MODEL</type>
    <name>MODEL</name>
    <text>of a mouse B-cell lymphoma model,</text>
  </TERM>
  <TERM dbid="BTO:0000776|CO:0000819|CO:0000236" end="729" id="V350281" paragraph="paragraph3" rule="-SIMPLE-REF" start="696" uttnum="19">
    <type>ONT::CELL</type>
    <name>B-CELL</name>
    <text>of a mouse B-cell lymphoma model,</text>
  </TERM>
  <TERM end="729" id="V350232" paragraph="paragraph3" rule="-SIMPLE-REF" start="696" uttnum="19">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>MOUSE</name>
    <text>of a mouse B-cell lymphoma model,</text>
  </TERM>
  <TERM end="784" id="V362743" paragraph="paragraph3" rule="-SIMPLE-REF" start="763" uttnum="19">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>REGULATOR</name>
    <text>a negative regulator</text>
  </TERM>
  <TERM end="830" id="V362779" paragraph="paragraph3" rule="-SIMPLE-REF" start="792" uttnum="19">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>GLYCOLYSIS</name>
    <text>the rapid glycolysis (Warburg effect)</text>
  </TERM>
  <TERM end="28" id="V375890" paragraph="paragraph4" rule="-EXPLICIT-REF-SEQ0A" start="6" uttnum="20">
    <type>ONT::SIGNALING-PATHWAY</type>
    <components>
      <component id="V375797"/>
      <component id="V375805"/>
    </components>
    <text normalization="">the LKB1–AMPK pathway</text>
  </TERM>
  <TERM end="56" id="V375991" paragraph="paragraph4" rule="-SIMPLE-REF" start="36" uttnum="20">
    <type>ONT::PERSON</type>
    <name>SUPPRESSOR</name>
    <text>a tumour suppressor,</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="28" id="V375797" paragraph="paragraph4" rule="-EXPLICIT-REF-SEQ0A-TERM" start="6" uttnum="20">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>the LKB1–AMPK pathway</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="20" id="V375805" paragraph="paragraph4" rule="-SIMPLE-REF" start="15" uttnum="20">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="61" id="V390968" paragraph="paragraph4" rule="-ROBUSTPRO" start="57" uttnum="20">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>one</text>
  </TERM>
  <TERM end="150" id="V391105" paragraph="paragraph4" rule="-SIMPLE-REF" start="118" uttnum="20">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>mechanisms that down-regulate it</text>
  </TERM>
  <TERM end="246" id="V393730" paragraph="paragraph4" rule="-INEVENT2B,-SIMPLE-REF" start="198" uttnum="21">
    <type>ONT::GENE</type>
    <features>
      <inevent>
        <event id="V393736"/>
      </inevent>
    </features>
    <name>GENE</name>
    <text>the gene encoding LKB1 (STK11)</text>
  </TERM>
  <EVENT end="246" id="V393736" paragraph="paragraph4" rule="-RULE10_AGENT_AFFECTED" start="198" uttnum="21">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="246" id="V393736" start="198">
      <type>ONT::MODULATE</type>
      <text>the gene encoding LKB1 (STK11)</text>
    </predicate>
    <arg1 id="V393730" role=":AGENT"/>
    <arg2 id="V393748" role=":AFFECTED"/>
    <text>the gene encoding LKB1 (STK11)</text>
  </EVENT>
  <TERM dbid="UP:Q15831|HGNC:11389" end="244" id="V393761" paragraph="paragraph4" rule="-SIMPLE-REF" start="230" uttnum="21">
    <type>ONT::GENE</type>
    <name>STK-11</name>
    <text>STK11</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="221" id="V393748" paragraph="paragraph4" rule="-SIMPLE-REF" start="216" uttnum="21">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1</text>
  </TERM>
  <TERM end="403" id="V405050" paragraph="paragraph4" rule="-SIMPLE-REF" start="388" uttnum="22">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>the HeLa cell,</text>
  </TERM>
  <TERM dbid="EFO:0001185|CVCL:0030" end="397" id="V405044" paragraph="paragraph4" rule="-SIMPLE-REF" start="392" uttnum="22">
    <type>ONT::CELL-LINE</type>
    <name>HELA</name>
    <text>HeLa</text>
  </TERM>
  <TERM dbid="UP:Q15831|HGNC:11389" end="513" id="V405289" paragraph="paragraph4" rule="-SIMPLE-REF" start="481" uttnum="22">
    <type>ONT::GENE</type>
    <name>STK-11</name>
    <text>STK11 [23]</text>
  </TERM>
  <EVENT end="573" id="V417888" paragraph="paragraph4" rule="-RULE30_AGENT_AFFECTED" start="528" uttnum="22">
    <type>ONT::STIMULATE</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <modality>ONT::DO</modality>
    <predicate end="573" id="V417888" start="528">
      <type>ONT::STIMULATE</type>
      <text>AMP and ADP do not enhance Thr172</text>
    </predicate>
    <arg1 id="V417837" role=":AGENT"/>
    <arg2 id="V417893" role=":AFFECTED"/>
    <text>AMP and ADP do not enhance Thr172</text>
  </EVENT>
  <TERM end="540" id="V417837" paragraph="paragraph4" rule="-LOGICALOP-REF" start="528" uttnum="22">
    <type>ONT::MOLECULE</type>
    <aggregate operator="AND">
      <member id="V417829"/>
      <member id="V417851"/>
    </aggregate>
    <text normalization="">AMP and ADP</text>
  </TERM>
  <TERM end="563" id="V417893" paragraph="paragraph4" rule="-SIMPLE-REF" start="555" uttnum="22">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="CHEBI:16027|CHEBI:456215|CHEBI:28971" end="532" id="V417829" paragraph="paragraph4" rule="-SIMPLE-REF" start="528" uttnum="22">
    <type>ONT::MOLECULE</type>
    <name>AMP</name>
    <text>AMP</text>
  </TERM>
  <TERM dbid="CHEBI:73342|CHEBI:456216|CHEBI:16761" end="540" id="V417851" paragraph="paragraph4" rule="-SIMPLE-REF" start="536" uttnum="22">
    <type>ONT::MOLECULE</type>
    <name>ADP</name>
    <text>ADP</text>
  </TERM>
  <MODALITY end="573" id="X430201" paragraph="paragraph4" rule="-MODALITY" start="528" uttnum="22">
    <type>ONT::DO</type>
    <arg2 id="V417888" role=":EVENT"/>
    <text>AMP and ADP do not enhance Thr172</text>
  </MODALITY>
  <TERM end="670" id="V430206" paragraph="paragraph4" rule="-LOGICALOP-REF" start="665" uttnum="22">
    <type>ONT::MOLECULE</type>
    <aggregate operator="AND">
      <member id="V417829"/>
      <member id="V417851"/>
    </aggregate>
    <text normalization="">this</text>
  </TERM>
  <TERM dbid="GO:0005622" end="691" id="V430217" paragraph="paragraph4" rule="-SIMPLE-REF" start="677" uttnum="22">
    <type>ONT::CELL-PART</type>
    <name>INTRACELLULAR</name>
    <text>intracellular</text>
  </TERM>
  <TERM end="784" id="V443876" paragraph="paragraph4" rule="-INEVENT2B,-SIMPLE-REF" start="764" uttnum="23">
    <type>ONT::GENE</type>
    <features>
      <inevent>
        <event id="V443880"/>
      </inevent>
    </features>
    <name>GENE</name>
    <text>genes encoding AMPK</text>
  </TERM>
  <EVENT end="784" id="V443880" paragraph="paragraph4" rule="-RULE10_AGENT_AFFECTED" start="764" uttnum="23">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="784" id="V443880" start="764">
      <type>ONT::MODULATE</type>
      <text>genes encoding AMPK</text>
    </predicate>
    <arg1 id="V443876" role=":AGENT"/>
    <arg2 id="V443887" role=":AFFECTED"/>
    <text>genes encoding AMPK</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="784" id="V443887" paragraph="paragraph4" rule="-SIMPLE-REF" start="779" uttnum="23">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM dbid="UP:Q15831|HGNC:11389" end="858" id="V444074" paragraph="paragraph4" rule="-SIMPLE-REF" start="844" uttnum="23">
    <type>ONT::GENE</type>
    <name>STK-11</name>
    <text>STK11</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="908" id="V444154" paragraph="paragraph4" rule="-SIMPLE-REF" start="903" uttnum="23">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="1024" id="V457694" paragraph="paragraph4" rule="-INEVENT2B,-SIMPLE-REF" start="940" uttnum="24">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>epigenetic or non-genetic mechanisms by which AMPK is down-regulated in tumour cells</text>
  </TERM>
  <EVENT end="1024" id="V457842" paragraph="paragraph4" rule="-RULE30_AGENT_FORMAL-NONE" start="977" uttnum="24">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="1024" id="V457842" start="977">
      <type>ONT::INHIBIT</type>
      <text>by which AMPK is down-regulated in tumour cells</text>
    </predicate>
    <text>by which AMPK is down-regulated in tumour cells</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="991" id="V457730" paragraph="paragraph4" rule="-SIMPLE-REF" start="986" uttnum="24">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="1024" id="V457937" paragraph="paragraph4" rule="-SIMPLE-REF" start="1012" uttnum="24">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>tumour cells</text>
  </TERM>
  <TERM end="62" id="V487481" paragraph="paragraph5" rule="-SIMPLE-REF-MUTATION1,-SIMPLE-REF" start="3" uttnum="26">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <mutation id="V487432"/>
    </features>
    <name>PUNC-EN-DASH-AKT</name>
    <text normalization="">The PI3K (phosphoinositide 3-kinase)–Akt (protein kinase B)</text>
  </TERM>
  <TERM end="39" id="V487432" paragraph="paragraph5" rule="-SIMPLE-REF" start="9" uttnum="26">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>3</pos>
      <aa-to>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">3K (phosphoinositide 3-kinase)</text>
  </TERM>
  <TERM dbid="UP:P31749" end="61" id="V487528" paragraph="paragraph5" rule="-SIMPLE-REF" start="45" uttnum="26">
    <type>ONT::GENE-PROTEIN</type>
    <name>PROTEIN-KINASE-B</name>
    <text>protein kinase B</text>
  </TERM>
  <TERM dbid="XFAM:PF00454.24|GO:0035004" end="38" id="V487464" paragraph="paragraph5" rule="-SIMPLE-REF" start="13" uttnum="26">
    <type>ONT::GENE-PROTEIN</type>
    <name>PHOSPHOINOSITIDE-3-KINASE</name>
    <text>phosphoinositide 3-kinase</text>
  </TERM>
  <TERM end="82" id="V488247" paragraph="paragraph5" rule="-SIMPLE-REF" start="63" uttnum="26">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>signalling pathway</text>
  </TERM>
  <TERM dbid="GO:0023052" end="74" id="V488244" paragraph="paragraph5" rule="-SIMPLE-REF" start="63" uttnum="26">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>SIGNALLING</name>
    <text>signalling</text>
  </TERM>
  <TERM end="123" id="V488341" paragraph="paragraph5" rule="-SIMPLE-REF" start="109" uttnum="26">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>tumour cells,</text>
  </TERM>
  <TERM end="163" id="V488393" paragraph="paragraph5" rule="-SIMPLE-REF" start="138" uttnum="26">
    <type>ONT::PERSON</type>
    <name>SUPPRESSOR</name>
    <text>of the tumour suppressor</text>
  </TERM>
  <TERM dbid="UP:P60484" end="168" id="V488404" paragraph="paragraph5" rule="-SIMPLE-REF" start="163" uttnum="26">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>PTEN</text>
  </TERM>
  <TERM end="192" id="V488420" paragraph="paragraph5" rule="-LOGICALOP-REF" start="169" uttnum="26">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V488412"/>
      <member id="V488431"/>
    </aggregate>
    <text normalization="">phosphatase and tensin</text>
  </TERM>
  <TERM dbid="XFAM:PF00328.19|GO:0016791|XFAM:PF15698.2" end="181" id="V488412" paragraph="paragraph5" rule="-SIMPLE-REF" start="169" uttnum="26">
    <type>ONT::GENE-PROTEIN</type>
    <name>PHOSPHATASE</name>
    <text>phosphatase</text>
  </TERM>
  <TERM dbid="UP:Q9HBL0|HGNC:11973" end="192" id="V488431" paragraph="paragraph5" rule="-SIMPLE-REF" start="185" uttnum="26">
    <type>ONT::GENE</type>
    <name>TENSIN</name>
    <text>tensin</text>
  </TERM>
  <TERM dbid="UP:SL-0468|GO:0005694" end="224" id="V488475" paragraph="paragraph5" rule="-INEVENT2B,-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="202" uttnum="26">
    <type>ONT::CELL-PART</type>
    <features>
      <active>TRUE</active>
      <inevent>
        <event id="V488441"/>
      </inevent>
    </features>
    <name>CHROMOSOME</name>
    <text>deleted on chromosome</text>
  </TERM>
  <EVENT end="224" id="V488441" paragraph="paragraph5" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="202" uttnum="26">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="224" id="V488441" start="202">
      <type>ONT::MODULATE</type>
      <text>deleted on chromosome</text>
    </predicate>
    <arg2 id="V488475" role=":AFFECTED"/>
    <text>deleted on chromosome</text>
  </EVENT>
  <EVENT end="322" id="V488508" paragraph="paragraph5" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="242" uttnum="26">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="322" id="V488508" start="242">
      <type>ONT::ACTIVATE</type>
      <text>activating mutations in subunits of PI3K or upstream receptors [26]</text>
    </predicate>
    <arg2 id="V488516" role=":AFFECTED"/>
    <text>activating mutations in subunits of PI3K or upstream receptors [26]</text>
  </EVENT>
  <TERM end="263" id="V488516" paragraph="paragraph5" rule="-SIMPLE-REF-MUTATION8" start="253" uttnum="26">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>mutations</text>
  </TERM>
  <TERM dbid="GO:0004872" end="322" id="V488641" paragraph="paragraph5" rule="-SIMPLE-REF" start="286" uttnum="26">
    <type>ONT::PROTEIN</type>
    <name>RECEPTORS</name>
    <text>upstream receptors [26]</text>
  </TERM>
  <TERM end="283" id="V488621" paragraph="paragraph5" rule="-SIMPLE-REF" start="278" uttnum="26">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <TERM end="343" id="V501366" paragraph="paragraph5" rule="-SIMPLE-REF" start="339" uttnum="27">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="385" id="V501412" paragraph="paragraph5" rule="-SIMPLE-REF" start="376" uttnum="27">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>rat AMPK</text>
  </TERM>
  <TERM end="385" id="V501407" paragraph="paragraph5" rule="-SIMPLE-REF" start="376" uttnum="27">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat AMPK</text>
  </TERM>
  <TERM end="396" id="V501435" paragraph="paragraph5" rule="-SIMPLE-REF" start="388" uttnum="27">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="450" id="V501467" paragraph="paragraph5" rule="-SIMPLE-REF" start="407" uttnum="27">
    <type>ONT::MENTAL-OBJECT</type>
    <name>EQUIVALENT</name>
    <text>equivalent to Ser487 in human α1</text>
  </TERM>
  <TERM dbid="CVCL:U692" end="429" id="V501523" paragraph="paragraph5" rule="-SIMPLE-REF" start="418" uttnum="27">
    <type>ONT::CELL-LINE</type>
    <name>TO-SER</name>
    <text>to Ser</text>
  </TERM>
  <TERM dbid="CVCL:U692" end="462" id="V513148" paragraph="paragraph5" rule="-SIMPLE-REF" start="457" uttnum="27">
    <type>ONT::CELL-LINE</type>
    <name>TO-SER</name>
    <text>this</text>
  </TERM>
  <TERM end="504" id="V513218" paragraph="paragraph5" rule="-SIMPLE-REF" start="485" uttnum="27">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>subsequent Thr</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="570" id="V513273" paragraph="paragraph5" rule="-SIMPLE-REF" start="548" uttnum="27">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1 [27]</text>
  </TERM>
  <TERM dbid="GO:0004691" end="652" id="V520167" paragraph="paragraph5" rule="-SIMPLE-REF" start="591" uttnum="28">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN-KINASE-A</name>
    <text>protein kinase A; also known as cAMP-dependent protein kinase</text>
  </TERM>
  <TERM dbid="GO:0004691" end="652" id="V520323" paragraph="paragraph5" rule="-SIMPLE-REF" start="623" uttnum="28">
    <type>ONT::PROTEIN</type>
    <name>CAMP-DEPENDENT-PROTEIN-KINASE</name>
    <text>cAMP-dependent protein kinase</text>
  </TERM>
  <TERM end="692" id="V533186" paragraph="paragraph5" rule="-SIMPLE-REF" start="684" uttnum="28">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="755" id="V534377" paragraph="paragraph5" rule="-SIMPLE-REF" start="742" uttnum="29">
    <type>ONT::SUBSTANCE</type>
    <name>GLUCOSE</name>
    <text>High glucose</text>
  </TERM>
  <TERM dbid="UP:P05019" end="765" id="V534400" paragraph="paragraph5" rule="-SIMPLE-REF" start="759" uttnum="29">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <TERM dbid="BTO:0004578" end="895" id="V534692" paragraph="paragraph5" rule="-SIMPLE-REF" start="838" uttnum="29">
    <type>ONT::CELL</type>
    <name>VASCULAR-SMOOTH-MUSCLE-CELLS</name>
    <text>Ser487 in porcine vascular smooth muscle cells</text>
  </TERM>
  <TERM end="846" id="V534558" paragraph="paragraph5" rule="-SIMPLE-REF" start="838" uttnum="29">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="952" id="V547619" paragraph="paragraph5" rule="-RULE20C_AFFECTED_AFFECTED1-LOC13" start="901" uttnum="29">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="952" id="V547619" start="901">
      <type>ONT::BIND</type>
      <text>this was associated with reduced Thr172</text>
    </predicate>
    <arg2 id="V547596" role=":AFFECTED"/>
    <site end="942" id="V547648" start="921">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">with reduced Thr</text>
    </site>
    <text>this was associated with reduced Thr172</text>
  </EVENT>
  <TERM dbid="UP:P05019" end="906" id="V547596" paragraph="paragraph5" rule="-SIMPLE-REF" start="901" uttnum="29">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>this</text>
  </TERM>
  <TERM end="942" id="V547648" paragraph="paragraph5" rule="-INEVENT2B,-SIMPLE-REF" start="921" uttnum="29">
    <type>ONT::AMINO-ACID</type>
    <features>
      <inevent>
        <event id="V547641"/>
      </inevent>
    </features>
    <name>THR</name>
    <text>with reduced Thr</text>
  </TERM>
  <EVENT end="942" id="V547641" paragraph="paragraph5" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="921" uttnum="29">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="942" id="V547641" start="921">
      <type>ONT::DECREASE</type>
      <text>with reduced Thr</text>
    </predicate>
    <arg2 id="V547648" role=":AFFECTED"/>
    <text>with reduced Thr</text>
  </EVENT>
  <TERM dbid="CHEBI:6801" end="1010" id="V547740" paragraph="paragraph5" rule="-SIMPLE-REF" start="983" uttnum="29">
    <type>ONT::MOLECULE</type>
    <name>METFORMIN</name>
    <text>metformin [29]</text>
  </TERM>
  <TERM end="1027" id="V560822" paragraph="paragraph5" rule="-SIMPLE-REF" start="1012" uttnum="30">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>This mechanism</text>
  </TERM>
  <EVENT end="1121" id="V561035" paragraph="paragraph5" rule="-INEVENT2B,-RULE30_AGENT_AFFECTED-AFFECTED" start="1064" uttnum="30">
    <type>ONT::INHIBIT</type>
    <predicate end="1121" id="V561035" start="1064">
      <type>ONT::INHIBIT</type>
      <text>down-regulation of AMPK in human hepatoma cells infected</text>
    </predicate>
    <arg2 id="V561082" role=":AFFECTED"/>
    <text>down-regulation of AMPK in human hepatoma cells infected</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1088" id="V561082" paragraph="paragraph5" rule="-SIMPLE-REF" start="1080" uttnum="30">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
  </TERM>
  <EVENT end="1121" id="V561169" paragraph="paragraph5" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1064" uttnum="30">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1121" id="V561169" start="1064">
      <type>ONT::MODULATE</type>
      <text>down-regulation of AMPK in human hepatoma cells infected</text>
    </predicate>
    <arg2 id="V561035" role=":AFFECTED"/>
    <text>down-regulation of AMPK in human hepatoma cells infected</text>
  </EVENT>
  <TERM dbid="BTO:0000608" end="1112" id="V561164" paragraph="paragraph5" rule="-SIMPLE-REF" start="1091" uttnum="30">
    <type>ONT::CELL</type>
    <name>HEPATOMA-CELLS</name>
    <text>human hepatoma cells</text>
  </TERM>
  <TERM end="1144" id="V561223" paragraph="paragraph5" rule="-SIMPLE-REF" start="1138" uttnum="30">
    <type>ONT::HARMFUL-AGENCY</type>
    <name>VIRUS</name>
    <text>virus</text>
  </TERM>
  <TERM end="1186" id="V574951" paragraph="paragraph5" rule="-SIMPLE-REF" start="1172" uttnum="31">
    <type>ONT::MENTAL-OBJECT</type>
    <name>STUDIES</name>
    <text>these studies</text>
  </TERM>
  <TERM end="1224" id="V575040" paragraph="paragraph5" rule="-ROBUSTPRO" start="1219" uttnum="31">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>that</text>
  </TERM>
  <TERM end="1236" id="V575058" paragraph="paragraph5" rule="-SIMPLE-REF" start="1224" uttnum="31">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>the Ser</text>
  </TERM>
  <TERM end="1254" id="V575069" paragraph="paragraph5" rule="-SIMPLE-REF" start="1246" uttnum="31">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="1342" id="V575106" paragraph="paragraph5" rule="-INEVENT2B,-SIMPLE-REF" start="1284" uttnum="31">
    <type>ONT::AMINO-ACID</type>
    <features>
      <inevent>
        <event id="V575097"/>
      </inevent>
    </features>
    <name>THR</name>
    <text>the reduced Thr172 phosphorylation observed in</text>
  </TERM>
  <EVENT end="1342" id="V575097" paragraph="paragraph5" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="1284" uttnum="31">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="1342" id="V575097" start="1284">
      <type>ONT::DECREASE</type>
      <text>the reduced Thr172 phosphorylation observed in</text>
    </predicate>
    <arg2 id="V575106" role=":AFFECTED"/>
    <text>the reduced Thr172 phosphorylation observed in</text>
  </EVENT>
  <TERM end="1359" id="V575190" paragraph="paragraph5" rule="-SIMPLE-REF" start="1342" uttnum="31">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>the intact cells</text>
  </TERM>
  <TERM end="11" id="V588739" paragraph="paragraph6" rule="-SIMPLE-REF" start="3" uttnum="32">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="72" id="V588869" paragraph="paragraph6" rule="-SIMPLE-REF" start="35" uttnum="32">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>a loop (residues 472–525 in human α1)</text>
  </TERM>
  <TERM end="71" id="V588875" paragraph="paragraph6" rule="-SIMPLE-REF" start="43" uttnum="32">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>residues 472–525 in human α1</text>
  </TERM>
  <TERM end="78" id="V602032" paragraph="paragraph6" rule="-SIMPLE-REF" start="73" uttnum="32">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>that</text>
  </TERM>
  <TERM dbid="CHEBI:30216|CHEBI:669" end="120" id="V602150" paragraph="paragraph6" rule="-SIMPLE-REF" start="106" uttnum="32">
    <type>ONT::MOLECULE</type>
    <name>Α</name>
    <text>of α subunits</text>
  </TERM>
  <TERM end="137" id="V602171" paragraph="paragraph6" rule="-SIMPLE-REF" start="125" uttnum="32">
    <type>ONT::VERTEBRATE</type>
    <name>VERTEBRATES</name>
    <text>vertebrates</text>
  </TERM>
  <TERM end="263" id="V602297" paragraph="paragraph6" rule="-SIMPLE-REF" start="212" uttnum="32">
    <type>ONT::INSECT</type>
    <name>INSECT</name>
    <text>insects (Drosophila melanogaster)</text>
  </TERM>
  <TERM dbid="BTO:0001494" end="317" id="V602385" paragraph="paragraph6" rule="-SIMPLE-REF" start="267" uttnum="32">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>FUNGI</name>
    <text>fungi (Saccharomyces cerevisiae)</text>
  </TERM>
  <TERM end="261" id="V602318" paragraph="paragraph6" rule="-SIMPLE-REF" start="229" uttnum="32">
    <type>ONT::INSECT</type>
    <name>DROSOPHILA-MELANOGASTER</name>
    <text>Drosophila melanogaster</text>
  </TERM>
  <TERM end="315" id="V602406" paragraph="paragraph6" rule="-SIMPLE-REF" start="274" uttnum="32">
    <type>ONT::FUNGUS</type>
    <name>SACCHAROMYCES-CEREVISIAE</name>
    <text>Saccharomyces cerevisiae</text>
  </TERM>
  <TERM end="342" id="V602448" paragraph="paragraph6" rule="-SIMPLE-REF" start="318" uttnum="32">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>1</pos>
      </site>
    </features>
    <name>S-1</name>
    <text>Supplementary Figure S1</text>
  </TERM>
  <TERM end="342" id="V602428" paragraph="paragraph6" rule="-SIMPLE-REF" start="318" uttnum="32">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure S1</text>
  </TERM>
  <TERM end="369" id="V614360" paragraph="paragraph6" rule="-SIMPLE-REF" start="359" uttnum="33">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>This loop</text>
  </TERM>
  <TERM end="483" id="V614453" paragraph="paragraph6" rule="-SIMPLE-REF" start="387" uttnum="33">
    <type>ONT::GENERAL-STRUCTURE</type>
    <name>STRUCTURE</name>
    <text>the crystal structure of a partial mammalian αβγ complex expressed in bacteria [11]</text>
  </TERM>
  <TERM end="483" id="V614449" paragraph="paragraph6" rule="-SIMPLE-REF" start="387" uttnum="33">
    <type>ONT::MATERIAL</type>
    <name>CRYSTAL</name>
    <text>the crystal structure of a partial mammalian αβγ complex expressed in bacteria [11]</text>
  </TERM>
  <TERM end="483" id="V614622" paragraph="paragraph6" rule="-SIMPLE-REF" start="457" uttnum="33">
    <type>ONT::BACTERIUM</type>
    <name>BACTERIUM</name>
    <text>bacteria [11]</text>
  </TERM>
  <TERM end="488" id="V628858" paragraph="paragraph6" rule="-ROBUSTPRO" start="485" uttnum="34">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="504" id="V628901" paragraph="paragraph6" rule="-SIMPLE-REF" start="498" uttnum="34">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>to it</text>
  </TERM>
  <TERM end="492" id="V628862" paragraph="paragraph6" rule="-ROBUSTPRO" start="488" uttnum="34">
    <type>ONT::DATE-OBJECT</type>
    <text>now</text>
  </TERM>
  <TERM end="521" id="V628981" paragraph="paragraph6" rule="-SIMPLE-REF" start="507" uttnum="34">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ‘ST loop’</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="515" id="V628972" paragraph="paragraph6" rule="-SIMPLE-REF" start="512" uttnum="34">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="572" id="V629095" paragraph="paragraph6" rule="-SIMPLE-REF" start="543" uttnum="34">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>serine and threonine residues</text>
  </TERM>
  <TERM end="564" id="V629081" paragraph="paragraph6" rule="-LOGICALOP-REF" start="543" uttnum="34">
    <type>ONT::AMINO-ACID</type>
    <aggregate operator="AND">
      <member id="V629077"/>
      <member id="V629092"/>
    </aggregate>
    <text normalization="">serine and threonine</text>
  </TERM>
  <TERM end="550" id="V629077" paragraph="paragraph6" rule="-SIMPLE-REF" start="543" uttnum="34">
    <type>ONT::AMINO-ACID</type>
    <name>SERINE</name>
    <text>serine</text>
  </TERM>
  <TERM end="564" id="V629092" paragraph="paragraph6" rule="-SIMPLE-REF" start="554" uttnum="34">
    <type>ONT::AMINO-ACID</type>
    <name>THREONINE</name>
    <text>threonine</text>
  </TERM>
  <TERM end="581" id="V641765" paragraph="paragraph6" rule="-SIMPLE-REF" start="578" uttnum="34">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>it</text>
  </TERM>
  <TERM dbid="FA:03087" end="663" id="V641895" paragraph="paragraph6" rule="-SIMPLE-REF" start="626" uttnum="34">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">by GSK3 (glycogen synthase kinase 3)</text>
  </TERM>
  <TERM end="674" id="V641957" paragraph="paragraph6" rule="-SIMPLE-REF" start="666" uttnum="34">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="696" id="V641975" paragraph="paragraph6" rule="-SIMPLE-REF" start="688" uttnum="34">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="713" id="V641984" paragraph="paragraph6" rule="-SIMPLE-REF" start="707" uttnum="34">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>human</text>
  </TERM>
  <TERM end="769" id="V656289" paragraph="paragraph6" rule="-ROBUSTPRO" start="725" uttnum="34">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>which appeared to promote Thr172</text>
  </TERM>
  <TERM end="759" id="V656341" paragraph="paragraph6" rule="-SIMPLE-REF" start="751" uttnum="34">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="GO:0016311" end="804" id="V656357" paragraph="paragraph6" rule="-SIMPLE-REF" start="769" uttnum="34">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>DEPHOSPHORYLATION</name>
    <text>dephosphorylation [31]</text>
  </TERM>
  <TERM end="831" id="V658525" paragraph="paragraph6" rule="-ROBUSTPRO" start="828" uttnum="35">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <CC end="929" id="V658576" paragraph="paragraph6" rule="-RULE5B_AGENT_AFFECTED" start="853" uttnum="35">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V658555" role=":FACTOR"/>
    <arg id="V658669" role=":OUTCOME"/>
    <text>phosphorylation of this loop causes down-regulation of AMPK in tumour cells</text>
  </CC>
  <EVENT end="882" id="V658555" paragraph="paragraph6" rule="-RULE60_AGENT_AFFECTED-NONE" start="853" uttnum="35">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="882" id="V658555" start="853">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of this loop</text>
    </predicate>
    <text>phosphorylation of this loop</text>
  </EVENT>
  <EVENT end="929" id="V658669" paragraph="paragraph6" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="889" uttnum="35">
    <type>ONT::INHIBIT</type>
    <predicate end="929" id="V658669" start="889">
      <type>ONT::INHIBIT</type>
      <text>down-regulation of AMPK in tumour cells</text>
    </predicate>
    <arg2 id="V658716" role=":AFFECTED"/>
    <text>down-regulation of AMPK in tumour cells</text>
  </EVENT>
  <TERM end="882" id="V658572" paragraph="paragraph6" rule="-SIMPLE-REF" start="872" uttnum="35">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>this loop</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="929" id="V658716" paragraph="paragraph6" rule="-SIMPLE-REF" start="905" uttnum="35">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK in tumour cells</text>
  </TERM>
  <TERM end="929" id="V658777" paragraph="paragraph6" rule="-SIMPLE-REF" start="916" uttnum="35">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>tumour cells</text>
  </TERM>
  <TERM end="954" id="V658859" paragraph="paragraph6" rule="-EXPLICIT-REF-SEQ0" start="938" uttnum="35">
    <type>ONT::SIGNALING-PATHWAY</type>
    <components>
      <component id="V658856"/>
    </components>
    <text normalization="">the Akt pathway</text>
  </TERM>
  <TERM end="954" id="V658856" paragraph="paragraph6" rule="-EXPLICIT-REF-SEQ0-TERM" start="938" uttnum="35">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">the Akt pathway</text>
  </TERM>
  <TERM end="976" id="V677354" paragraph="paragraph6" rule="-ROBUSTPRO" start="973" uttnum="36">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="1003" id="V677377" paragraph="paragraph6" rule="-SIMPLE-REF" start="998" uttnum="36">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>that</text>
  </TERM>
  <TERM end="998" id="V677369" paragraph="paragraph6" rule="-SIMPLE-REF" start="989" uttnum="36">
    <type>ONT::INFORMATION</type>
    <name>EVIDENCE</name>
    <text>evidence</text>
  </TERM>
  <TERM end="1015" id="V677404" paragraph="paragraph6" rule="-SIMPLE-REF" start="1003" uttnum="36">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM end="1042" id="V677451" paragraph="paragraph6" rule="-SIMPLE-REF" start="1021" uttnum="36">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>to the kinase domain</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="1010" id="V677395" paragraph="paragraph6" rule="-SIMPLE-REF" start="1007" uttnum="36">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM dbid="GO:0016301" end="1035" id="V677448" paragraph="paragraph6" rule="-SIMPLE-REF" start="1028" uttnum="36">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <EVENT end="1073" id="V677469" paragraph="paragraph6" rule="-RULE60_AGENT_AFFECTED-LOC4-GD-NONE" start="1047" uttnum="36">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1073" id="V677469" start="1047">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylated at Ser</text>
    </predicate>
    <site end="1073" id="V677492" start="1065">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>phosphorylated at Ser</text>
  </EVENT>
  <TERM end="1073" id="V677492" paragraph="paragraph6" rule="-SIMPLE-REF" start="1065" uttnum="36">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="1161" id="V690244" paragraph="paragraph6" rule="-SIMPLE-REF" start="1153" uttnum="36">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="58" id="V693710" paragraph="paragraph7" rule="-SIMPLE-REF" start="50" uttnum="37">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="86" id="V693765" paragraph="paragraph7" rule="-SIMPLE-REF" start="78" uttnum="37">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="189" id="V693866" paragraph="paragraph7" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="125" uttnum="37">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="189" id="V693866" start="125">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Akt phosphorylation [39]</text>
    </predicate>
    <arg2 id="V693863" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000017"/>
    <text>Akt phosphorylation [39]</text>
  </EVENT>
  <TERM end="129" id="V693863" paragraph="paragraph7" rule="-SIMPLE-REF" start="125" uttnum="37">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <not-features>
      <ptm event="V693866" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="243" id="V693945" paragraph="paragraph7" rule="-SIMPLE-REF" start="227" uttnum="37">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>Akt target sites</text>
  </TERM>
  <TERM end="243" id="V693940" paragraph="paragraph7" rule="-SIMPLE-REF" start="227" uttnum="37">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>Akt target sites</text>
  </TERM>
  <TERM end="231" id="V693933" paragraph="paragraph7" rule="-SIMPLE-REF" start="227" uttnum="37">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="267" id="V703174" paragraph="paragraph7" rule="-SIMPLE-REF" start="245" uttnum="38">
    <type>ONT::SHAPE-OBJECT</type>
    <name>COLUMN</name>
    <text>The right-hand column</text>
  </TERM>
  <EPI end="466" id="V703181" paragraph="paragraph7" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="267" uttnum="38">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V703233" role=":FORMAL"/>
    <text>shows the percentile score for the sequence as a potential Akt target computed using Scansite (http://scansite.mit.edu/)</text>
  </EPI>
  <TERM end="288" id="V703208" paragraph="paragraph7" rule="-SIMPLE-REF" start="273" uttnum="38">
    <type>ONT::MENTAL-OBJECT</type>
    <name>PERCENTILE</name>
    <text>the percentile</text>
  </TERM>
  <TERM end="294" id="V703233" paragraph="paragraph7" rule="-SIMPLE-REF" start="288" uttnum="38">
    <type>ONT::MENTAL-OBJECT</type>
    <name>SCORE</name>
    <text>score</text>
  </TERM>
  <TERM end="466" id="V703362" paragraph="paragraph7" rule="-SIMPLE-REF" start="314" uttnum="38">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>a potential Akt target computed using Scansite (http://scansite.mit.edu/)</text>
  </TERM>
  <TERM end="330" id="V703355" paragraph="paragraph7" rule="-SIMPLE-REF" start="326" uttnum="38">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <EPI end="466" id="V703369" paragraph="paragraph7" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="337" uttnum="38">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V703362" role=":FORMAL"/>
    <text>computed using Scansite (http://scansite.mit.edu/)</text>
  </EPI>
  <TERM end="483" id="V714661" paragraph="paragraph7" rule="-SIMPLE-REF" start="475" uttnum="39">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM dbid="GO:0016310" end="510" id="V714672" paragraph="paragraph7" rule="-SIMPLE-REF" start="485" uttnum="39">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PHOSPHORYLATION</name>
    <text>Phosphorylation of GSK3β</text>
  </TERM>
  <TERM dbid="FA:03087" end="508" id="V714690" paragraph="paragraph7" rule="-SIMPLE-REF" start="504" uttnum="39">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <TERM end="541" id="V714753" paragraph="paragraph7" rule="-SIMPLE-REF" start="535" uttnum="39">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
  </TERM>
  <TERM end="580" id="V715794" paragraph="paragraph7" rule="-SIMPLE-REF" start="572" uttnum="40">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>WESTERN</name>
    <text>Western</text>
  </TERM>
  <TERM dbid="GO:0042571" end="618" id="V715854" paragraph="paragraph7" rule="-SIMPLE-REF" start="608" uttnum="40">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="667" id="V715928" paragraph="paragraph7" rule="-SIMPLE-REF" start="657" uttnum="40">
    <type>ONT::SUBSTANCE</type>
    <name>P</name>
    <text>32P</text>
  </TERM>
  <TERM end="722" id="V727296" paragraph="paragraph7" rule="-SIMPLE-REF" start="714" uttnum="41">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <EPI end="779" id="V727322" paragraph="paragraph7" rule="-RULE50_0_AGENT_FORMAL-FORMAL" start="729" uttnum="41">
    <type>ONT::TEST</type>
    <arg2 id="V727345" role=":FORMAL"/>
    <text>analysing phosphorylation of AMPK (α1β2γ1 complex)</text>
  </EPI>
  <EVENT end="779" id="V727345" paragraph="paragraph7" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE60_AGENT_AFFECTED-AFFECTED" start="729" uttnum="41">
    <type>ONT::PHOSPHORYLATION</type>
    <epistemic-modality id="V727322"/>
    <predicate end="779" id="V727345" start="729">
      <type>ONT::PHOSPHORYLATION</type>
      <text>analysing phosphorylation of AMPK (α1β2γ1 complex)</text>
    </predicate>
    <arg2 id="V727357" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000022"/>
    <text>analysing phosphorylation of AMPK (α1β2γ1 complex)</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="779" id="V727357" paragraph="paragraph7" rule="-SIMPLE-REF" start="755" uttnum="41">
    <type>ONT::PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK (α1β2γ1 complex)</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V727345"/>
    </not-features>
  </TERM>
  <TERM end="796" id="V736803" paragraph="paragraph7" rule="-SIMPLE-REF" start="788" uttnum="42">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <TERM end="821" id="V736869" paragraph="paragraph7" rule="-SIMPLE-REF" start="813" uttnum="42">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <EPI end="878" id="V736895" paragraph="paragraph7" rule="-RULE50_0_AGENT_FORMAL-FORMAL" start="828" uttnum="42">
    <type>ONT::TEST</type>
    <arg2 id="V736918" role=":FORMAL"/>
    <text>analysing phosphorylation of AMPK (α2β2γ1 complex)</text>
  </EPI>
  <EVENT end="878" id="V736918" paragraph="paragraph7" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE60_AGENT_AFFECTED-AFFECTED" start="828" uttnum="42">
    <type>ONT::PHOSPHORYLATION</type>
    <epistemic-modality id="V736895"/>
    <predicate end="878" id="V736918" start="828">
      <type>ONT::PHOSPHORYLATION</type>
      <text>analysing phosphorylation of AMPK (α2β2γ1 complex)</text>
    </predicate>
    <arg2 id="V736930" role=":AFFECTED"/>
    <arg id="R000027" role=":RESULT"/>
    <text>analysing phosphorylation of AMPK (α2β2γ1 complex)</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="878" id="V736930" paragraph="paragraph7" rule="-SIMPLE-REF" start="854" uttnum="42">
    <type>ONT::PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK (α2β2γ1 complex)</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V736918"/>
    </not-features>
  </TERM>
  <TERM end="895" id="V747118" paragraph="paragraph7" rule="-SIMPLE-REF" start="887" uttnum="43">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>E</text>
  </TERM>
  <EVENT end="929" id="V747145" paragraph="paragraph7" rule="-RULE60_AGENT_AFFECTED-AGENT" start="905" uttnum="43">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="929" id="V747145" start="905">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation by LKB1</text>
    </predicate>
    <arg1 id="V747179" role=":AGENT"/>
    <text>phosphorylation by LKB1</text>
  </EVENT>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="929" id="V747179" paragraph="paragraph7" rule="-SIMPLE-REF" start="921" uttnum="43">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1</text>
  </TERM>
  <TERM end="952" id="V747231" paragraph="paragraph7" rule="-SIMPLE-REF" start="943" uttnum="43">
    <type>ONT::ICON</type>
    <name>P</name>
    <text>an anti-p</text>
  </TERM>
  <TERM end="952" id="V747215" paragraph="paragraph7" rule="-SIMPLE-REF" start="943" uttnum="43">
    <type>ONT::PERSON</type>
    <name>ANTI</name>
    <text>an anti-p</text>
  </TERM>
  <EVENT end="1003" id="V747301" paragraph="paragraph7" rule="-RULE50_AGENT_AFFECTED-LOC9-AFFECTED" start="952" uttnum="43">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="1003" id="V747301" start="952">
      <type>ONT::EXPRESS</type>
      <text>T172 antibody expressed as a ratio of signal using</text>
    </predicate>
    <arg2 id="V747288" role=":AFFECTED"/>
    <site end="957" id="V747265" start="952">
      <type>ONT::MUTATION</type>
      <text normalization="">T172</text>
    </site>
    <text>T172 antibody expressed as a ratio of signal using</text>
  </EVENT>
  <TERM dbid="GO:0042571" end="966" id="V747288" paragraph="paragraph7" rule="-SIMPLE-REF-MUTATION1,-SIMPLE-REF" start="952" uttnum="43">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <mutation id="V747265"/>
    </features>
    <name>ANTIBODY</name>
    <text>T172 antibody</text>
  </TERM>
  <TERM end="957" id="V747265" paragraph="paragraph7" rule="-SIMPLE-REF" start="952" uttnum="43">
    <type>ONT::MUTATION</type>
    <mutation>ONT::TRUE</mutation>
    <text normalization="">T172</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1026" id="V747423" paragraph="paragraph7" rule="-SIMPLE-REF" start="1006" uttnum="43">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODY</name>
    <text>anti-AMPK-α antibody</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1015" id="V746316" paragraph="paragraph7" rule="-SIMPLE-REF" start="1011" uttnum="43">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="1086" id="V759539" paragraph="paragraph7" rule="-SIMPLE-REF-MUTATION8" start="1057" uttnum="43">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>mutants of the α1β2γ1 complex</text>
  </TERM>
  <TERM end="1096" id="V763678" paragraph="paragraph7" rule="-SIMPLE-REF" start="1088" uttnum="44">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Results</text>
  </TERM>
  <EVENT end="1186" id="V770902" paragraph="paragraph7" rule="-RULE60_AGENT_AFFECTED-AGENT" start="1162" uttnum="46">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1186" id="V770902" start="1162">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation by LKB1</text>
    </predicate>
    <arg1 id="V770936" role=":AGENT"/>
    <text>phosphorylation by LKB1</text>
  </EVENT>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="1186" id="V770936" paragraph="paragraph7" rule="-SIMPLE-REF" start="1178" uttnum="46">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1</text>
  </TERM>
  <EVENT end="1269" id="V770962" paragraph="paragraph7" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="1194" uttnum="46">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1269" id="V770962" start="1194">
      <type>ONT::BIND</type>
      <text>obtained using an anti-pT172 antibody expressed as a ratio of signal using</text>
    </predicate>
    <arg2 id="V770967" role=":AFFECTED"/>
    <text>obtained using an anti-pT172 antibody expressed as a ratio of signal using</text>
  </EVENT>
  <CC end="1218" id="V770967" paragraph="paragraph7" rule="-RULE5B_AGENT_RESULT-NONE" start="1203" uttnum="46">
    <type>ONT::CAUSE</type>
    <arg id="V770993" role=":AFFECTED"/>
    <text>using an anti-p</text>
  </CC>
  <EVENT end="1242" id="V771062" paragraph="paragraph7" rule="-RULE50_AGENT_AFFECTED-RESULT" start="1203" uttnum="46">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="1242" id="V771062" start="1203">
      <type>ONT::EXPRESS</type>
      <text>using an anti-pT172 antibody expressed</text>
    </predicate>
    <arg1 id="V771050" role=":AGENT"/>
    <arg2 id="V770967" role=":AFFECTED-RESULT"/>
    <text>using an anti-pT172 antibody expressed</text>
  </EVENT>
  <TERM end="1218" id="V770993" paragraph="paragraph7" rule="-SIMPLE-REF" start="1209" uttnum="46">
    <type>ONT::ICON</type>
    <name>P</name>
    <text>an anti-p</text>
  </TERM>
  <TERM end="1218" id="V770977" paragraph="paragraph7" rule="-SIMPLE-REF" start="1209" uttnum="46">
    <type>ONT::PERSON</type>
    <name>ANTI</name>
    <text>an anti-p</text>
  </TERM>
  <TERM end="1242" id="V771050" paragraph="paragraph7" rule="-SIMPLE-REF-MUTATION1,-SIMPLE-REF" start="1218" uttnum="46">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <mutation id="V771027"/>
    </features>
    <name>ANTIBODY</name>
    <text>T172 antibody expressed</text>
  </TERM>
  <TERM end="1223" id="V771027" paragraph="paragraph7" rule="-SIMPLE-REF" start="1218" uttnum="46">
    <type>ONT::MUTATION</type>
    <mutation>ONT::TRUE</mutation>
    <text normalization="">T172</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1292" id="V771185" paragraph="paragraph7" rule="-SIMPLE-REF" start="1272" uttnum="46">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODY</name>
    <text>anti-AMPK-α antibody</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1281" id="V769458" paragraph="paragraph7" rule="-SIMPLE-REF" start="1277" uttnum="46">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <EVENT end="1346" id="V783882" paragraph="paragraph7" rule="-RULE10C_AGENT_AFFECTED-LOC5-GD-NONE" start="1294" uttnum="46">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1346" id="V783882" start="1294">
      <type>ONT::TRANSLOCATE</type>
      <text>following pre-incubation with MgATP with or without</text>
    </predicate>
    <site end="1319" id="V783897" start="1304">
      <type>ONT::EVENT-DEFINED-BY-ACTIVITY</type>
      <text normalization="INCUBATION">pre-incubation</text>
    </site>
    <text>following pre-incubation with MgATP with or without</text>
  </EVENT>
  <TERM dbid="MESH:D000255" end="1330" id="V783931" paragraph="paragraph7" rule="-SIMPLE-REF" start="1324" uttnum="46">
    <type>ONT::MOLECULE</type>
    <name>MGATP</name>
    <text>MgATP</text>
  </TERM>
  <TERM end="1364" id="V783959" paragraph="paragraph7" rule="-SIMPLE-REF" start="1346" uttnum="46">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt (30 units/ml,</text>
  </TERM>
  <TERM dbid="CVCL:E777" end="1370" id="V783996" paragraph="paragraph7" rule="-SIMPLE-REF" start="1367" uttnum="46">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>min</text>
  </TERM>
  <TERM end="1396" id="V784121" paragraph="paragraph7" rule="-SIMPLE-REF" start="1391" uttnum="46">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>157</pos>
      <aa-from>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">D157A</text>
  </TERM>
  <TERM end="1444" id="V784192" paragraph="paragraph7" rule="-SIMPLE-REF-MUTATION8" start="1416" uttnum="46">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>an S487A/D157A double mutant</text>
  </TERM>
  <TERM end="1431" id="V784206" paragraph="paragraph7" rule="-EXPLICIT-REF-SEQ0B" start="1419" uttnum="46">
    <type>ONT::MUTATION</type>
    <components>
      <component id="V783479"/>
      <component id="V783556"/>
    </components>
    <text normalization="">S487A/D157A</text>
  </TERM>
  <TERM end="1431" id="V783479" paragraph="paragraph7" rule="-EXPLICIT-REF-SEQ0B-TERM" start="1419" uttnum="46">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A/D157A</text>
  </TERM>
  <TERM end="1431" id="V783556" paragraph="paragraph7" rule="-SIMPLE-REF" start="1425" uttnum="46">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>157</pos>
      <aa-from>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">D157A</text>
  </TERM>
  <TERM end="1454" id="V797233" paragraph="paragraph7" rule="-SIMPLE-REF" start="1446" uttnum="47">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Results</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="52" id="V805107" paragraph="paragraph8" rule="-SIMPLE-REF" start="20" uttnum="49">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK (α1β2γ1 or α2β2γ1 complex)</text>
  </TERM>
  <EVENT end="66" id="V805218" paragraph="paragraph8" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="20" uttnum="49">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="66" id="V805218" start="20">
      <type>ONT::TRANSFORM</type>
      <text>AMPK (α1β2γ1 or α2β2γ1 complex) was incubated</text>
    </predicate>
    <arg2 id="V805107" role=":AFFECTED"/>
    <text>AMPK (α1β2γ1 or α2β2γ1 complex) was incubated</text>
  </EVENT>
  <TERM dbid="MESH:D000255" end="77" id="V805249" paragraph="paragraph8" rule="-SIMPLE-REF" start="71" uttnum="49">
    <type>ONT::MOLECULE</type>
    <name>MGATP</name>
    <text>MgATP</text>
  </TERM>
  <TERM end="124" id="V805297" paragraph="paragraph8" rule="-SIMPLE-REF" start="110" uttnum="49">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt for 20 </text>
  </TERM>
  <TERM dbid="CVCL:E777" end="128" id="V805331" paragraph="paragraph8" rule="-SIMPLE-REF" start="124" uttnum="49">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>min</text>
  </TERM>
  <EPI end="193" id="V819849" paragraph="paragraph8" rule="-RULE50_0_AGENT_FORMAL" start="141" uttnum="49">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V819912" role=":FORMAL"/>
    <text>aliquots (20 μl) analysed by Western blotting using</text>
  </EPI>
  <EVENT end="193" id="V819912" paragraph="paragraph8" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE5_AGENT_AFFECTED-AFFECTED" start="141" uttnum="49">
    <type>ONT::TRANSFORM</type>
    <epistemic-modality id="V819849"/>
    <predicate end="193" id="V819912" start="141">
      <type>ONT::TRANSFORM</type>
      <text>aliquots (20 μl) analysed by Western blotting using</text>
    </predicate>
    <arg2 id="V819927" role=":AFFECTED"/>
    <text>aliquots (20 μl) analysed by Western blotting using</text>
  </EVENT>
  <CC end="193" id="V819927" paragraph="paragraph8" rule="-RULE5B_AGENT_RESULT-NONE" start="187" uttnum="49">
    <type>ONT::CAUSE</type>
    <text>using</text>
  </CC>
  <TERM end="178" id="V819900" paragraph="paragraph8" rule="-SIMPLE-REF" start="170" uttnum="49">
    <type>ONT::FOOD</type>
    <name>WESTERN</name>
    <text>Western</text>
  </TERM>
  <TERM dbid="GO:0042571" end="217" id="V819958" paragraph="paragraph8" rule="-SIMPLE-REF" start="207" uttnum="49">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="234" id="V833405" paragraph="paragraph8" rule="-SIMPLE-REF" start="226" uttnum="50">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="241" id="V833415" paragraph="paragraph8" rule="-SIMPLE-REF" start="236" uttnum="50">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="263" id="V833491" paragraph="paragraph8" rule="-SIMPLE-REF-MUTATION7" start="260" uttnum="50">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILDTYPE</name>
    <text>WT</text>
  </TERM>
  <TERM end="287" id="V833585" paragraph="paragraph8" rule="-SIMPLE-REF-MODACTIVE2,-SIMPLE-REF-MUTATION8" start="266" uttnum="50">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <active>FALSE</active>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>inactive D157A mutant</text>
  </TERM>
  <TERM end="281" id="V833582" paragraph="paragraph8" rule="-SIMPLE-REF" start="275" uttnum="50">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>157</pos>
      <aa-from>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">D157A</text>
  </TERM>
  <TERM dbid="MESH:D000255" end="314" id="V833644" paragraph="paragraph8" rule="-SIMPLE-REF" start="308" uttnum="50">
    <type>ONT::MOLECULE</type>
    <name>MGATP</name>
    <text>MgATP</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="352" id="V833689" paragraph="paragraph8" rule="-SIMPLE-REF" start="344" uttnum="50">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>of LKB1</text>
  </TERM>
  <TERM dbid="CVCL:K252" end="359" id="V833707" paragraph="paragraph8" rule="-SIMPLE-REF" start="356" uttnum="50">
    <type>ONT::CELL-LINE</type>
    <name>8.2</name>
    <text>8.2</text>
  </TERM>
  <TERM end="396" id="V833758" paragraph="paragraph8" rule="-SIMPLE-REF" start="388" uttnum="50">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt (0,</text>
  </TERM>
  <TERM dbid="CVCL:E777" end="442" id="V833894" paragraph="paragraph8" rule="-SIMPLE-REF" start="438" uttnum="50">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>min</text>
  </TERM>
  <EVENT end="542" id="V847682" paragraph="paragraph8" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="468" uttnum="51">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="542" id="V847682" start="468">
      <type>ONT::TRANSFORM</type>
      <text>AMPK (α2β2γ1 complex, WT, S491A or S491D mutant) was incubated with MgATP</text>
    </predicate>
    <arg2 id="V847489" role=":AFFECTED"/>
    <text>AMPK (α2β2γ1 complex, WT, S491A or S491D mutant) was incubated with MgATP</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="517" id="V847489" paragraph="paragraph8" rule="-SIMPLE-REF" start="468" uttnum="51">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK (α2β2γ1 complex, WT, S491A or S491D mutant)</text>
  </TERM>
  <TERM end="488" id="V847531" paragraph="paragraph8" rule="-SIMPLE-REF" start="474" uttnum="51">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>α2β2γ1 complex</text>
  </TERM>
  <TERM end="492" id="V847542" paragraph="paragraph8" rule="-SIMPLE-REF-MUTATION7" start="490" uttnum="51">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILDTYPE</name>
    <text>WT</text>
  </TERM>
  <TERM end="500" id="V847606" paragraph="paragraph8" rule="-SIMPLE-REF" start="494" uttnum="51">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>491</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S491A</text>
  </TERM>
  <TERM end="515" id="V847654" paragraph="paragraph8" rule="-SIMPLE-REF-MUTATION8" start="503" uttnum="51">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>S491D mutant</text>
  </TERM>
  <TERM end="509" id="V847651" paragraph="paragraph8" rule="-SIMPLE-REF" start="503" uttnum="51">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>491</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S491D</text>
  </TERM>
  <TERM dbid="MESH:D000255" end="542" id="V847713" paragraph="paragraph8" rule="-SIMPLE-REF" start="536" uttnum="51">
    <type>ONT::MOLECULE</type>
    <name>MGATP</name>
    <text>MgATP</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="599" id="V847757" paragraph="paragraph8" rule="-SIMPLE-REF" start="570" uttnum="51">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1 in a final volume of 20 </text>
  </TERM>
  <TERM dbid="CVCL:E777" end="620" id="V847931" paragraph="paragraph8" rule="-SIMPLE-REF" start="606" uttnum="51">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>10 min at 30°C</text>
  </TERM>
  <EVENT end="650" id="V860783" paragraph="paragraph8" rule="-RULE50_0_AGENT_FORMAL-EVENT,-ACTIVITY1" start="626" uttnum="51">
    <type>ONT::ACTIVITY</type>
    <epistemic-modality id="V860790"/>
    <predicate end="650" id="V860783" start="626">
      <type>ONT::ACTIVITY</type>
      <text>AMPK activity determined</text>
    </predicate>
    <arg1 id="V860779" role=":AGENT"/>
    <text>AMPK activity determined</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="631" id="V860779" paragraph="paragraph8" rule="-SIMPLE-REF" start="626" uttnum="51">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <EPI end="650" id="V860790" paragraph="paragraph8" rule="-RULE50_0_AGENT_FORMAL-FORMAL" start="626" uttnum="51">
    <type>ONT::LEARN</type>
    <force>ONT::TRUE</force>
    <arg2 id="V860783" role=":FORMAL"/>
    <text>AMPK activity determined</text>
  </EPI>
  <TERM end="667" id="V861089" paragraph="paragraph8" rule="-SIMPLE-REF" start="659" uttnum="52">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <EVENT end="746" id="V861098" paragraph="paragraph8" rule="-RULE60_AGENT_AFFECTED" start="669" uttnum="52">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="746" id="V861098" start="669">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Phosphorylation of synthetic peptides by three different preparations of AMPK</text>
    </predicate>
    <arg2 id="V861118" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000032"/>
    <text>Phosphorylation of synthetic peptides by three different preparations of AMPK</text>
  </EVENT>
  <TERM dbid="CHEBI:16670" end="707" id="V861118" paragraph="paragraph8" rule="-SIMPLE-REF" start="685" uttnum="52">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDES</name>
    <text>of synthetic peptides</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V861098"/>
    </not-features>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="746" id="V861176" paragraph="paragraph8" rule="-SIMPLE-REF" start="739" uttnum="52">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="764" id="V869506" paragraph="paragraph8" rule="-SIMPLE-REF" start="748" uttnum="53">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK (0.1 unit,</text>
  </TERM>
  <TERM end="796" id="V869607" paragraph="paragraph8" rule="-SIMPLE-REF" start="786" uttnum="53">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complexes</text>
  </TERM>
  <TERM end="864" id="V869643" paragraph="paragraph8" rule="-SIMPLE-REF" start="813" uttnum="53">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>LIVER</name>
    <text>rat liver [2]</text>
  </TERM>
  <TERM end="864" id="V869640" paragraph="paragraph8" rule="-SIMPLE-REF" start="813" uttnum="53">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat liver [2]</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="927" id="V869773" paragraph="paragraph8" rule="-SIMPLE-REF" start="892" uttnum="53">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDES</name>
    <text>of the SAMS, S485 or S491 peptides</text>
  </TERM>
  <TERM end="918" id="V869749" paragraph="paragraph8" rule="-LOGICALOP-REF" start="895" uttnum="53">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="OR">
      <member id="V869768"/>
      <member id="V869728"/>
      <member id="V869746"/>
    </aggregate>
    <text normalization="">the SAMS, S485 or S491</text>
  </TERM>
  <TERM dbid="UP:Q00266|HGNC:6903" end="903" id="V869728" paragraph="paragraph8" rule="-SIMPLE-REF" start="895" uttnum="53">
    <type>ONT::GENE</type>
    <name>SAMS</name>
    <text>the SAMS</text>
  </TERM>
  <TERM end="910" id="V869746" paragraph="paragraph8" rule="-SIMPLE-REF" start="905" uttnum="53">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>485</pos>
      </site>
    </features>
    <name>S-485</name>
    <text>S485</text>
  </TERM>
  <TERM end="918" id="V869768" paragraph="paragraph8" rule="-SIMPLE-REF" start="913" uttnum="53">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>491</pos>
      </site>
    </features>
    <name>S-491</name>
    <text>S491</text>
  </TERM>
  <TERM end="968" id="V869921" paragraph="paragraph8" rule="-SIMPLE-REF" start="953" uttnum="53">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>CL</name>
    <text>Cl2</text>
  </TERM>
  <TERM end="996" id="V870010" paragraph="paragraph8" rule="-SIMPLE-REF" start="995" uttnum="53">
    <type>ONT::SUBSTANCE</type>
    <name>P</name>
    <text>P</text>
  </TERM>
  <TERM dbid="MESH:D000255" end="1001" id="V870021" paragraph="paragraph8" rule="-SIMPLE-REF" start="997" uttnum="53">
    <type>ONT::MOLECULE</type>
    <name>ATP</name>
    <text>ATP</text>
  </TERM>
  <TERM dbid="CVCL:E777" end="1039" id="V870195" paragraph="paragraph8" rule="-SIMPLE-REF" start="1035" uttnum="53">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>min</text>
  </TERM>
  <TERM dbid="UP:Q9Y3A5|HGNC:19440|HGNC:10691|UP:P20132" end="1058" id="V870282" paragraph="paragraph8" rule="-SIMPLE-REF" start="1055" uttnum="53">
    <type>ONT::GENE</type>
    <name>SDS</name>
    <text>SDS</text>
  </TERM>
  <TERM end="1064" id="V870296" paragraph="paragraph8" rule="-SIMPLE-REF" start="1059" uttnum="53">
    <type>ONT::INFO-MEDIUM</type>
    <name>PAGE</name>
    <text>PAGE</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="45" id="V881607" paragraph="paragraph9" rule="-SIMPLE-REF" start="3" uttnum="54">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK (α1β2γ1 complex, WT or S487A mutant)</text>
  </TERM>
  <TERM end="23" id="V881651" paragraph="paragraph9" rule="-SIMPLE-REF" start="9" uttnum="54">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>α1β2γ1 complex</text>
  </TERM>
  <TERM end="28" id="V881662" paragraph="paragraph9" rule="-SIMPLE-REF-MUTATION7" start="25" uttnum="54">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILDTYPE</name>
    <text>WT</text>
  </TERM>
  <TERM end="43" id="V881733" paragraph="paragraph9" rule="-SIMPLE-REF-MUTATION8" start="31" uttnum="54">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>S487A mutant</text>
  </TERM>
  <TERM end="37" id="V881730" paragraph="paragraph9" rule="-SIMPLE-REF" start="31" uttnum="54">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="89" id="V881809" paragraph="paragraph9" rule="-LOGICALOP-REF" start="68" uttnum="54">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="AND">
      <member id="V881805"/>
      <member id="V881820"/>
    </aggregate>
    <text normalization="">MgATP and Akt for 30 </text>
  </TERM>
  <TERM dbid="MESH:D000255" end="74" id="V881805" paragraph="paragraph9" rule="-SIMPLE-REF" start="68" uttnum="54">
    <type>ONT::MOLECULE</type>
    <name>MGATP</name>
    <text>MgATP</text>
  </TERM>
  <TERM end="89" id="V881820" paragraph="paragraph9" rule="-SIMPLE-REF" start="78" uttnum="54">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt for 30 </text>
  </TERM>
  <TERM dbid="CVCL:E777" end="94" id="V881854" paragraph="paragraph9" rule="-SIMPLE-REF" start="89" uttnum="54">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>min,</text>
  </TERM>
  <TERM end="103" id="V881874" paragraph="paragraph9" rule="-ROBUSTPRO" start="98" uttnum="54">
    <type>ONT::DATE-OBJECT</type>
    <text>then</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="113" id="V881910" paragraph="paragraph9" rule="-SIMPLE-REF" start="108" uttnum="54">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1</text>
  </TERM>
  <TERM dbid="CVCL:E777" end="158" id="V882008" paragraph="paragraph9" rule="-SIMPLE-REF" start="143" uttnum="54">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>10 min at 30°C</text>
  </TERM>
  <EVENT end="268" id="V894851" paragraph="paragraph9" rule="-RULE60_AGENT_AFFECTED" start="203" uttnum="55">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="268" id="V894851" start="203">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Phosphorylation of AMPK by LKB1 in the absence or presence of Akt</text>
    </predicate>
    <arg1 id="V894901" role=":AGENT"/>
    <arg2 id="V894867" role=":AFFECTED"/>
    <arg id="R000037" role=":RESULT"/>
    <text>Phosphorylation of AMPK by LKB1 in the absence or presence of Akt</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="227" id="V894867" paragraph="paragraph9" rule="-SIMPLE-REF" start="219" uttnum="55">
    <type>ONT::PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V894851"/>
    </not-features>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="235" id="V894901" paragraph="paragraph9" rule="-SIMPLE-REF" start="227" uttnum="55">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1 </text>
  </TERM>
  <TERM end="268" id="V894991" paragraph="paragraph9" rule="-SIMPLE-REF" start="262" uttnum="55">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
  </TERM>
  <TERM end="285" id="V904524" paragraph="paragraph9" rule="-SIMPLE-REF" start="277" uttnum="56">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <EVENT end="347" id="V904532" paragraph="paragraph9" rule="-RULE40A_AGENT_AFFECTED" start="287" uttnum="56">
    <type>ONT::ACTIVATE</type>
    <predicate end="347" id="V904532" start="287">
      <type>ONT::ACTIVATE</type>
      <text>Activation of AMPK by LKB1 in the absence or presence of Akt</text>
    </predicate>
    <arg1 id="V904583" role=":AGENT"/>
    <arg2 id="V904549" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000157"/>
    <text>Activation of AMPK by LKB1 in the absence or presence of Akt</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="306" id="V904549" paragraph="paragraph9" rule="-SIMPLE-REF" start="298" uttnum="56">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="314" id="V904583" paragraph="paragraph9" rule="-SIMPLE-REF" start="306" uttnum="56">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1 </text>
  </TERM>
  <TERM end="347" id="V904673" paragraph="paragraph9" rule="-SIMPLE-REF" start="341" uttnum="56">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="400" id="V913895" paragraph="paragraph9" rule="-SIMPLE-REF" start="396" uttnum="57">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1</text>
  </TERM>
  <TERM end="441" id="V914241" paragraph="paragraph9" rule="-SIMPLE-REF" start="435" uttnum="57">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
  </TERM>
  <EPI end="604" id="V921847" paragraph="paragraph9" rule="-RULE50_0_AGENT_FORMAL-NONE" start="443" uttnum="58">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V921736" role=":NEUTRAL"/>
    <text>Phosphorylation (A and C) was assessed in duplicate samples by Western blotting, and AMPK activity (B and C)</text>
  </EPI>
  <TERM dbid="GO:0016310" end="495" id="V921736" paragraph="paragraph9" rule="-SIMPLE-REF" start="443" uttnum="58">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PHOSPHORYLATION</name>
    <text>Phosphorylation (A and C)</text>
  </TERM>
  <TERM end="604" id="V921912" paragraph="paragraph9" rule="-SIMPLE-REF" start="511" uttnum="58">
    <type>ONT::GEO-SAMPLE</type>
    <name>SAMPLE</name>
    <text>duplicate samples by Western blotting, and AMPK activity (B and C)</text>
  </TERM>
  <TERM end="604" id="V921906" paragraph="paragraph9" rule="-SIMPLE-REF" start="511" uttnum="58">
    <type>ONT::PHYS-REPRESENTATION</type>
    <name>DUPLICATE</name>
    <text>duplicate samples by Western blotting, and AMPK activity (B and C)</text>
  </TERM>
  <EVENT end="604" id="V921989" paragraph="paragraph9" rule="-ACTIVITY1" start="554" uttnum="58">
    <type>ONT::ACTIVITY</type>
    <predicate end="604" id="V921989" start="554">
      <type>ONT::ACTIVITY</type>
      <text>AMPK activity (B and C)</text>
    </predicate>
    <arg1 id="V921986" role=":AGENT"/>
    <text>AMPK activity (B and C)</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="559" id="V921986" paragraph="paragraph9" rule="-SIMPLE-REF" start="554" uttnum="58">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="620" id="V922095" paragraph="paragraph9" rule="-SIMPLE-REF" start="607" uttnum="58">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>kinase assays</text>
  </TERM>
  <TERM dbid="GO:0016301" end="614" id="V922084" paragraph="paragraph9" rule="-SIMPLE-REF" start="607" uttnum="58">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="648" id="V936067" paragraph="paragraph9" rule="-SIMPLE-REF" start="640" uttnum="59">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM end="43" id="V942974" paragraph="paragraph10" rule="-INEVENT2B,-SIMPLE-REF" start="3" uttnum="61">
    <type>ONT::CELL</type>
    <features>
      <inevent>
        <event id="V943004"/>
      </inevent>
    </features>
    <name>CELL</name>
    <text>HEK-293 cells stably expressing WT AMPK</text>
  </TERM>
  <TERM dbid="EFO:0001182|CVCL:0045" end="11" id="V942970" paragraph="paragraph10" rule="-SIMPLE-REF" start="3" uttnum="61">
    <type>ONT::CELL-LINE</type>
    <name>HEK-293</name>
    <text>HEK-293</text>
  </TERM>
  <EVENT end="43" id="V943004" paragraph="paragraph10" rule="-RULE50_AGENT_AFFECTED-RESULT" start="3" uttnum="61">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="43" id="V943004" start="3">
      <type>ONT::EXPRESS</type>
      <text>HEK-293 cells stably expressing WT AMPK</text>
    </predicate>
    <arg2 id="V943021" role=":AFFECTED-RESULT"/>
    <text>HEK-293 cells stably expressing WT AMPK</text>
    <location id="V942974" mod="IN-LOC"/>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="43" id="V943021" paragraph="paragraph10" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="35" uttnum="61">
    <type>ONT::GENE-PROTEIN</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>AMPK</name>
    <text>WT AMPK</text>
  </TERM>
  <TERM end="96" id="V943137" paragraph="paragraph10" rule="-SIMPLE-REF-MUTATION8" start="63" uttnum="61">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>an S487A mutant (B)</text>
  </TERM>
  <TERM end="72" id="V943134" paragraph="paragraph10" rule="-SIMPLE-REF" start="66" uttnum="61">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="94" id="V943158" paragraph="paragraph10" rule="-SIMPLE-REF" start="86" uttnum="61">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM end="106" id="V943185" paragraph="paragraph10" rule="-SIMPLE-REF" start="101" uttnum="61">
    <type>ONT::BODILY-FLUID</type>
    <name>SERUM</name>
    <text>serum</text>
  </TERM>
  <TERM dbid="UP:P05019" end="192" id="V943271" paragraph="paragraph10" rule="-SIMPLE-REF" start="149" uttnum="61">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1 in the presence or absence of MK2206</text>
  </TERM>
  <TERM dbid="CHEBI:67271" end="192" id="V943366" paragraph="paragraph10" rule="-SIMPLE-REF" start="185" uttnum="61">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>MK2206</text>
  </TERM>
  <EVENT end="278" id="V955507" paragraph="paragraph10" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="234" uttnum="62">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="278" id="V955507" start="234">
      <type>ONT::MODULATE</type>
      <text>The cells were then treated with or without</text>
    </predicate>
    <arg2 id="V955473" role=":AFFECTED"/>
    <text>The cells were then treated with or without</text>
  </EVENT>
  <TERM end="244" id="V955473" paragraph="paragraph10" rule="-SIMPLE-REF" start="234" uttnum="62">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>The cells</text>
  </TERM>
  <TERM end="286" id="V955614" paragraph="paragraph10" rule="-SIMPLE-REF" start="278" uttnum="62">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662</text>
  </TERM>
  <TERM dbid="CVCL:E777" end="304" id="V955690" paragraph="paragraph10" rule="-SIMPLE-REF" start="301" uttnum="62">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>min</text>
  </TERM>
  <TERM end="362" id="V961368" paragraph="paragraph10" rule="-SIMPLE-REF" start="331" uttnum="62">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAY</name>
    <text>immunoprecipitate kinase assay</text>
  </TERM>
  <TERM dbid="GO:0016301" end="356" id="V961353" paragraph="paragraph10" rule="-SIMPLE-REF" start="349" uttnum="62">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="374" id="V961399" paragraph="paragraph10" rule="-SIMPLE-REF" start="366" uttnum="62">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>WESTERN</name>
    <text>Western</text>
  </TERM>
  <TERM end="387" id="V966848" paragraph="paragraph10" rule="-SIMPLE-REF" start="381" uttnum="63">
    <type>ONT::LOC-DEFINED-BY-CONTRAST</type>
    <name>BLOTS</name>
    <text>Blots</text>
  </TERM>
  <TERM end="443" id="V966901" paragraph="paragraph10" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="404" uttnum="63">
    <type>ONT::TABLEWARE</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>SEPARATE</value>
      </mod>
    </mods>
    <name>DISH</name>
    <text>separate dishes (n=2),</text>
  </TERM>
  <TERM end="466" id="V972297" paragraph="paragraph10" rule="-SIMPLE-REF" start="452" uttnum="63">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>activity data</text>
  </TERM>
  <TERM end="503" id="V982888" paragraph="paragraph10" rule="-SIMPLE-REF" start="492" uttnum="64">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>N</name>
    <text>n=</text>
  </TERM>
  <TERM end="528" id="V982935" paragraph="paragraph10" rule="-SIMPLE-REF" start="507" uttnum="64">
    <type>ONT::SUBSTANCE</type>
    <name>P</name>
    <text>***P</text>
  </TERM>
  <TERM end="597" id="V983083" paragraph="paragraph10" rule="-SIMPLE-REF" start="577" uttnum="64">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662; †††</text>
  </TERM>
  <TERM dbid="UP:P05019" end="648" id="V996629" paragraph="paragraph10" rule="-SIMPLE-REF" start="643" uttnum="64">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <EVENT end="777" id="V1009753" paragraph="paragraph10" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="714" uttnum="65">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="777" id="V1009753" start="714">
      <type>ONT::MODULATE</type>
      <text>Cells expressing WT AMPK-α1 or AMPK-α2 were treated with IGF-1</text>
    </predicate>
    <arg2 id="V1009669" role=":AFFECTED"/>
    <text>Cells expressing WT AMPK-α1 or AMPK-α2 were treated with IGF-1</text>
  </EVENT>
  <TERM dbid="GO:0005623|CO:0000000" end="753" id="V1009669" paragraph="paragraph10" rule="-SIMPLE-REF" start="714" uttnum="65">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cells expressing WT AMPK-α1 or AMPK-α2</text>
  </TERM>
  <TERM dbid="UP:P05019" end="777" id="V1009777" paragraph="paragraph10" rule="-SIMPLE-REF" start="771" uttnum="65">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="749" id="V1009278" paragraph="paragraph10" rule="-SIMPLE-REF" start="745" uttnum="65">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM dbid="CHEBI:16118" end="810" id="V1009841" paragraph="paragraph10" rule="-SIMPLE-REF" start="791" uttnum="65">
    <type>ONT::MOLECULE</type>
    <name>BERBERINE</name>
    <text>berberine (300 μM)</text>
  </TERM>
  <TERM dbid="GO:0016301" end="859" id="V1009984" paragraph="paragraph10" rule="-SIMPLE-REF" start="834" uttnum="65">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>immunoprecipitate kinase</text>
  </TERM>
  <TERM end="866" id="V1009991" paragraph="paragraph10" rule="-SIMPLE-REF" start="859" uttnum="65">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>assays</text>
  </TERM>
  <TERM end="907" id="V1010068" paragraph="paragraph10" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="888" uttnum="65">
    <type>ONT::TABLEWARE</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>SEPARATE</value>
      </mod>
    </mods>
    <name>DISH</name>
    <text>two separate dishes</text>
  </TERM>
  <TERM end="924" id="V1022762" paragraph="paragraph10" rule="-SIMPLE-REF" start="910" uttnum="66">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>Activity data</text>
  </TERM>
  <TERM end="961" id="V1023504" paragraph="paragraph10" rule="-SIMPLE-REF" start="950" uttnum="67">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>N</name>
    <text>n=</text>
  </TERM>
  <TERM end="1066" id="V1023698" paragraph="paragraph10" rule="-LOGICALOP-REF" start="1048" uttnum="67">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="OR">
      <member id="V1023695"/>
      <member id="V1023707"/>
    </aggregate>
    <text normalization="">IGF-1 or berberine</text>
  </TERM>
  <TERM dbid="UP:P05019" end="1054" id="V1023695" paragraph="paragraph10" rule="-SIMPLE-REF" start="1048" uttnum="67">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <TERM dbid="CHEBI:16118" end="1066" id="V1023707" paragraph="paragraph10" rule="-SIMPLE-REF" start="1057" uttnum="67">
    <type>ONT::MOLECULE</type>
    <name>BERBERINE</name>
    <text>berberine</text>
  </TERM>
  <TERM end="1083" id="V1038748" paragraph="paragraph10" rule="-SIMPLE-REF" start="1075" uttnum="68">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <TERM dbid="GO:0005623|CO:0000000" end="1091" id="V1038758" paragraph="paragraph10" rule="-SIMPLE-REF" start="1085" uttnum="68">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cells</text>
  </TERM>
  <TERM end="1105" id="V1038777" paragraph="paragraph10" rule="-SIMPLE-REF-MUTATION7" start="1102" uttnum="68">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILDTYPE</name>
    <text>WT</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1120" id="V1037867" paragraph="paragraph10" rule="-SIMPLE-REF" start="1116" uttnum="68">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM dbid="UP:P05019" end="1148" id="V1038866" paragraph="paragraph10" rule="-SIMPLE-REF" start="1142" uttnum="68">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1 </text>
  </TERM>
  <TERM dbid="CHEBI:9168" end="1197" id="V1038956" paragraph="paragraph10" rule="-SIMPLE-REF" start="1178" uttnum="68">
    <type>ONT::MOLECULE</type>
    <name>RAPAMYCIN</name>
    <text>rapamycin (100 μM)</text>
  </TERM>
  <TERM dbid="GO:0016301" end="1246" id="V1039099" paragraph="paragraph10" rule="-SIMPLE-REF" start="1218" uttnum="68">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>by immunoprecipitate kinase</text>
  </TERM>
  <TERM end="1253" id="V1039114" paragraph="paragraph10" rule="-SIMPLE-REF" start="1246" uttnum="68">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>assays</text>
  </TERM>
  <TERM end="1265" id="V1039145" paragraph="paragraph10" rule="-SIMPLE-REF" start="1257" uttnum="68">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>WESTERN</name>
    <text>Western</text>
  </TERM>
  <TERM end="1289" id="V1052362" paragraph="paragraph10" rule="-SIMPLE-REF" start="1275" uttnum="69">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>Activity data</text>
  </TERM>
  <TERM end="1340" id="V1061788" paragraph="paragraph10" rule="-SIMPLE-REF" start="1330" uttnum="70">
    <type>ONT::PHYS-REPRESENTATION</type>
    <name>DUPLICATE</name>
    <text>duplicate</text>
  </TERM>
  <TERM end="1371" id="V1061842" paragraph="paragraph10" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="1356" uttnum="70">
    <type>ONT::TABLEWARE</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>SEPARATE</value>
      </mod>
    </mods>
    <name>DISH</name>
    <text>separate dishes</text>
  </TERM>
  <TERM dbid="BTO:0001584" end="14" id="V1066461" paragraph="paragraph11" rule="-SIMPLE-REF" start="3" uttnum="71">
    <type>ONT::CELL-LINE</type>
    <name>G-361-CELLS</name>
    <text>G361 cells</text>
  </TERM>
  <TERM dbid="UP:P05019" end="110" id="V1066569" paragraph="paragraph11" rule="-SIMPLE-REF" start="67" uttnum="71">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1 in the presence or absence of MK2206</text>
  </TERM>
  <TERM dbid="CHEBI:67271" end="110" id="V1066664" paragraph="paragraph11" rule="-SIMPLE-REF" start="103" uttnum="71">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>MK2206</text>
  </TERM>
  <EVENT end="192" id="V1079190" paragraph="paragraph11" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="152" uttnum="72">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="192" id="V1079190" start="152">
      <type>ONT::MODULATE</type>
      <text>Cells were then treated with or without</text>
    </predicate>
    <arg2 id="V1079156" role=":AFFECTED"/>
    <text>Cells were then treated with or without</text>
  </EVENT>
  <TERM dbid="GO:0005623|CO:0000000" end="158" id="V1079156" paragraph="paragraph11" rule="-SIMPLE-REF" start="152" uttnum="72">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cells</text>
  </TERM>
  <TERM end="199" id="V1079297" paragraph="paragraph11" rule="-SIMPLE-REF" start="192" uttnum="72">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>23817</pos>
      </site>
    </features>
    <name>A-23817</name>
    <text>A23817</text>
  </TERM>
  <TERM end="204" id="V1079304" paragraph="paragraph11" rule="-SIMPLE-REF" start="200" uttnum="72">
    <type>ONT::CARDINAL-POINT</type>
    <name>N</name>
    <text>30 n</text>
  </TERM>
  <TERM dbid="CVCL:E777" end="216" id="V1079381" paragraph="paragraph11" rule="-SIMPLE-REF" start="213" uttnum="72">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>min</text>
  </TERM>
  <TERM end="274" id="V1083546" paragraph="paragraph11" rule="-SIMPLE-REF" start="243" uttnum="72">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAY</name>
    <text>immunoprecipitate kinase assay</text>
  </TERM>
  <TERM dbid="GO:0016301" end="268" id="V1083531" paragraph="paragraph11" rule="-SIMPLE-REF" start="261" uttnum="72">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="286" id="V1083577" paragraph="paragraph11" rule="-SIMPLE-REF" start="278" uttnum="72">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>WESTERN</name>
    <text>Western</text>
  </TERM>
  <TERM end="299" id="V1089026" paragraph="paragraph11" rule="-SIMPLE-REF" start="293" uttnum="73">
    <type>ONT::LOC-DEFINED-BY-CONTRAST</type>
    <name>BLOTS</name>
    <text>Blots</text>
  </TERM>
  <TERM end="332" id="V1089079" paragraph="paragraph11" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="316" uttnum="73">
    <type>ONT::TABLEWARE</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>SEPARATE</value>
      </mod>
    </mods>
    <name>DISH</name>
    <text>separate dishes,</text>
  </TERM>
  <TERM end="355" id="V1089813" paragraph="paragraph11" rule="-SIMPLE-REF" start="341" uttnum="73">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>activity data</text>
  </TERM>
  <TERM end="392" id="V1100404" paragraph="paragraph11" rule="-SIMPLE-REF" start="381" uttnum="74">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>N</name>
    <text>n=</text>
  </TERM>
  <TERM end="476" id="V1100451" paragraph="paragraph11" rule="-SIMPLE-REF" start="396" uttnum="74">
    <type>ONT::SUBSTANCE</type>
    <name>P</name>
    <text>***P&amp;lt;0.001 compared with the relevant control without A23187</text>
  </TERM>
  <TERM end="476" id="V1100607" paragraph="paragraph11" rule="-SIMPLE-REF" start="470" uttnum="74">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>23187</pos>
      </site>
    </features>
    <name>A-23187</name>
    <text>A23187</text>
  </TERM>
  <TERM dbid="UP:P05019" end="540" id="V1113827" paragraph="paragraph11" rule="-SIMPLE-REF" start="535" uttnum="74">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <EVENT end="74" id="V1126597" paragraph="paragraph12" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="20" uttnum="75">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="74" id="V1126597" start="20">
      <type>ONT::TRANSFORM</type>
      <text>Glioblastoma (DBTRG-05MG) cells were incubated for 20 </text>
    </predicate>
    <arg2 id="V1126571" role=":AFFECTED"/>
    <text>Glioblastoma (DBTRG-05MG) cells were incubated for 20 </text>
  </EVENT>
  <TERM end="52" id="V1126571" paragraph="paragraph12" rule="-SIMPLE-REF" start="20" uttnum="75">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Glioblastoma (DBTRG-05MG) cells</text>
  </TERM>
  <TERM dbid="CVCL:1169" end="44" id="V1126560" paragraph="paragraph12" rule="-SIMPLE-REF" start="34" uttnum="75">
    <type>ONT::CELL-LINE</type>
    <name>DBTRG-5-MG</name>
    <text>DBTRG-05MG</text>
  </TERM>
  <TERM dbid="CVCL:E777" end="78" id="V1126636" paragraph="paragraph12" rule="-SIMPLE-REF" start="74" uttnum="75">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>min</text>
  </TERM>
  <TERM dbid="CHEBI:67271" end="107" id="V1126673" paragraph="paragraph12" rule="-SIMPLE-REF" start="94" uttnum="75">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>MK2206 (3 μM)</text>
  </TERM>
  <TERM dbid="CVCL:E777" end="128" id="V1141705" paragraph="paragraph12" rule="-SIMPLE-REF" start="124" uttnum="75">
    <type>ONT::CELL-LINE</type>
    <name>MIN</name>
    <text>min</text>
  </TERM>
  <TERM end="160" id="V1141816" paragraph="paragraph12" rule="-SIMPLE-REF" start="144" uttnum="75">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662 (300 μM)</text>
  </TERM>
  <EVENT end="206" id="V1143205" paragraph="paragraph12" rule="-ACTIVITY1" start="193" uttnum="76">
    <type>ONT::ACTIVITY</type>
    <predicate end="206" id="V1143205" start="193">
      <type>ONT::ACTIVITY</type>
      <text>AMPK activity</text>
    </predicate>
    <arg1 id="V1143201" role=":AGENT"/>
    <text>AMPK activity</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="198" id="V1143201" paragraph="paragraph12" rule="-SIMPLE-REF" start="193" uttnum="76">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="216" id="V1147025" paragraph="paragraph12" rule="-SIMPLE-REF" start="208" uttnum="77">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Results</text>
  </TERM>
  <TERM end="334" id="V1161492" paragraph="paragraph12" rule="-SIMPLE-REF" start="326" uttnum="79">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <EPI end="360" id="V1161500" paragraph="paragraph12" rule="-RULE50_0_AGENT_FORMAL-NONE" start="336" uttnum="79">
    <type>ONT::TEST</type>
    <arg2 id="V1161522" role=":NEUTRAL"/>
    <text>Analysis of the samples</text>
  </EPI>
  <TERM end="360" id="V1161522" paragraph="paragraph12" rule="-SIMPLE-REF" start="345" uttnum="79">
    <type>ONT::GEO-SAMPLE</type>
    <name>SAMPLE</name>
    <text>of the samples</text>
  </TERM>
  <TERM dbid="GO:0042571" end="451" id="V1161659" paragraph="paragraph12" rule="-SIMPLE-REF" start="422" uttnum="79">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>antibodies (duplicate dishes)</text>
  </TERM>
  <TERM end="450" id="V1161686" paragraph="paragraph12" rule="-SIMPLE-REF" start="444" uttnum="79">
    <type>ONT::TABLEWARE</type>
    <name>DISH</name>
    <text>dishes</text>
  </TERM>
  <TERM dbid="UP:P60484" end="478" id="V1166106" paragraph="paragraph12" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="470" uttnum="80">
    <type>ONT::PROTEIN</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>PTEN</name>
    <text>WT PTEN</text>
  </TERM>
  <TERM dbid="XFAM:PF00328.19|GO:0016791|XFAM:PF15698.2" end="512" id="V1166159" paragraph="paragraph12" rule="-SIMPLE-REF-MODACTIVE2,-SIMPLE-REF" start="483" uttnum="80">
    <type>ONT::GENE-PROTEIN</type>
    <features>
      <active>FALSE</active>
      <mutation id="V1166241"/>
    </features>
    <name>PHOSPHATASE</name>
    <text>phosphatase-inactive (C124S)</text>
  </TERM>
  <TERM end="510" id="V1166241" paragraph="paragraph12" rule="-SIMPLE-REF" start="505" uttnum="80">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>124</pos>
      <aa-from>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">C124S</text>
  </TERM>
  <TERM end="519" id="V1166247" paragraph="paragraph12" rule="-SIMPLE-REF-MUTATION8" start="512" uttnum="80">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>mutant</text>
  </TERM>
  <TERM end="579" id="V1166371" paragraph="paragraph12" rule="-SIMPLE-REF" start="537" uttnum="80">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>DBTRG-05MG cells using lentiviral vectors,</text>
  </TERM>
  <TERM dbid="CVCL:1169" end="548" id="V1166363" paragraph="paragraph12" rule="-SIMPLE-REF" start="537" uttnum="80">
    <type>ONT::CELL-LINE</type>
    <name>DBTRG-5-MG</name>
    <text>DBTRG-05MG</text>
  </TERM>
  <TERM end="578" id="V1166398" paragraph="paragraph12" rule="-SIMPLE-REF" start="560" uttnum="80">
    <type>ONT::MENTAL-OBJECT</type>
    <name>VECTORS</name>
    <text>lentiviral vectors</text>
  </TERM>
  <TERM end="607" id="V1179930" paragraph="paragraph12" rule="-SIMPLE-REF" start="599" uttnum="80">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662</text>
  </TERM>
  <TERM end="646" id="V1181161" paragraph="paragraph12" rule="-SIMPLE-REF" start="638" uttnum="81">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Results</text>
  </TERM>
  <TERM end="692" id="V1186720" paragraph="paragraph12" rule="-SIMPLE-REF-MUTATION7" start="689" uttnum="82">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILDTYPE</name>
    <text>WT</text>
  </TERM>
  <TERM dbid="UP:P60484" end="734" id="V1186730" paragraph="paragraph12" rule="-SIMPLE-REF" start="692" uttnum="82">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>PTEN, n=4 for C124S PTEN)</text>
  </TERM>
  <TERM dbid="UP:P60484" end="733" id="V1186851" paragraph="paragraph12" rule="-SIMPLE-REF-MUTATION1,-SIMPLE-REF" start="723" uttnum="82">
    <type>ONT::PROTEIN</type>
    <features>
      <mutation id="V1186846"/>
    </features>
    <name>PTEN</name>
    <text>C124S PTEN</text>
  </TERM>
  <TERM end="729" id="V1186846" paragraph="paragraph12" rule="-SIMPLE-REF" start="723" uttnum="82">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>124</pos>
      <aa-from>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">C124S</text>
  </TERM>
  <TERM end="813" id="V1196890" paragraph="paragraph12" rule="-SIMPLE-REF" start="805" uttnum="83">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <EPI end="839" id="V1196900" paragraph="paragraph12" rule="-RULE50_0_AGENT_FORMAL-NONE" start="815" uttnum="83">
    <type>ONT::TEST</type>
    <arg2 id="V1196922" role=":NEUTRAL"/>
    <text>Analysis of the samples</text>
  </EPI>
  <TERM end="839" id="V1196922" paragraph="paragraph12" rule="-SIMPLE-REF" start="824" uttnum="83">
    <type>ONT::GEO-SAMPLE</type>
    <name>SAMPLE</name>
    <text>of the samples</text>
  </TERM>
  <TERM dbid="GO:0042571" end="926" id="V1197057" paragraph="paragraph12" rule="-SIMPLE-REF" start="887" uttnum="83">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>the antibodies shown (duplicate dishes)</text>
  </TERM>
  <EPI end="908" id="V1197065" paragraph="paragraph12" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="902" uttnum="83">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1197057" role=":FORMAL"/>
    <text>shown</text>
  </EPI>
  <TERM end="925" id="V1197087" paragraph="paragraph12" rule="-SIMPLE-REF" start="919" uttnum="83">
    <type>ONT::TABLEWARE</type>
    <name>DISH</name>
    <text>dishes</text>
  </TERM>
  <TERM end="944" id="V1209828" paragraph="paragraph12" rule="-SIMPLE-REF" start="935" uttnum="84">
    <type>ONT::SUBSTANCE</type>
    <name>E</name>
    <text>E</text>
  </TERM>
  <TERM end="962" id="V1209850" paragraph="paragraph12" rule="-SIMPLE-REF" start="954" uttnum="84">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>F</name>
    <text>F</text>
  </TERM>
  <TERM end="993" id="V1209922" paragraph="paragraph12" rule="-SIMPLE-REF" start="964" uttnum="84">
    <type>ONT::DEVICE</type>
    <name>CELL</name>
    <text>Glioblastoma (U373-MG) cells</text>
  </TERM>
  <TERM dbid="CVCL:2219" end="985" id="V1209906" paragraph="paragraph12" rule="-SIMPLE-REF" start="978" uttnum="84">
    <type>ONT::CELL-LINE</type>
    <name>373-MG</name>
    <text>U373-MG</text>
  </TERM>
  <TERM end="1061" id="V1210144" paragraph="paragraph12" rule="-SIMPLE-REF" start="1053" uttnum="84">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM end="1098" id="V1226621" paragraph="paragraph12" rule="-SIMPLE-REF" start="1090" uttnum="85">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>H</text>
  </TERM>
  <EPI end="1167" id="V1226730" paragraph="paragraph12" rule="-RULE50_0_AGENT_FORMAL-NONE" start="1100" uttnum="85">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1226677" role=":NEUTRAL"/>
    <text>Breast cancer (MDA-MB-468) cells were incubated and analysed as in</text>
  </EPI>
  <EVENT end="1167" id="V1226701" paragraph="paragraph12" rule="-RULE40_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="1100" uttnum="85">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="1167" id="V1226701" start="1100">
      <type>ONT::PRODUCE</type>
      <text>Breast cancer (MDA-MB-468) cells were incubated and analysed as in</text>
    </predicate>
    <arg2 id="V1226677" role=":AFFECTED-RESULT"/>
    <text>Breast cancer (MDA-MB-468) cells were incubated and analysed as in</text>
  </EVENT>
  <TERM end="1133" id="V1226677" paragraph="paragraph12" rule="-SIMPLE-REF" start="1100" uttnum="85">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Breast cancer (MDA-MB-468) cells</text>
  </TERM>
  <TERM end="1201" id="V1226900" paragraph="paragraph12" rule="-SIMPLE-REF" start="1193" uttnum="85">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM end="1223" id="V1238452" paragraph="paragraph12" rule="-SIMPLE-REF" start="1215" uttnum="86">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>E</text>
  </TERM>
  <TERM end="1255" id="V1238490" paragraph="paragraph12" rule="-SIMPLE-REF" start="1247" uttnum="86">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>results</text>
  </TERM>
  <EVENT end="84" id="V1252815" paragraph="paragraph13" rule="-RULE40_AGENT_AFFECTED-RESULT-LOC5-GD-NONE" start="20" uttnum="88">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="84" id="V1252815" start="20">
      <type>ONT::PRODUCE</type>
      <text>Model for the structure of an AMPK heterotrimer (PDB code 2Y8L,</text>
    </predicate>
    <site end="84" id="V1252860" start="30">
      <type>ONT::GENERAL-STRUCTURE</type>
      <text normalization="">the structure of an AMPK heterotrimer (PDB code 2Y8L,</text>
    </site>
    <text>Model for the structure of an AMPK heterotrimer (PDB code 2Y8L,</text>
  </EVENT>
  <TERM end="84" id="V1252860" paragraph="paragraph13" rule="-SIMPLE-REF" start="30" uttnum="88">
    <type>ONT::GENERAL-STRUCTURE</type>
    <name>STRUCTURE</name>
    <text>the structure of an AMPK heterotrimer (PDB code 2Y8L,</text>
  </TERM>
  <TERM end="84" id="V1252884" paragraph="paragraph13" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="47" uttnum="88">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>HETERO-</value>
      </mod>
    </mods>
    <name>TRIMER</name>
    <text>an AMPK heterotrimer (PDB code 2Y8L,</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="55" id="V1252876" paragraph="paragraph13" rule="-SIMPLE-REF" start="50" uttnum="88">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="82" id="V1252903" paragraph="paragraph13" rule="-SIMPLE-REF" start="69" uttnum="88">
    <type>ONT::IDENTIFICATION</type>
    <name>CODE</name>
    <text>PDB code 2Y8L</text>
  </TERM>
  <TERM dbid="CHEBI:28618" end="73" id="V1252900" paragraph="paragraph13" rule="-SIMPLE-REF" start="69" uttnum="88">
    <type>ONT::MOLECULE</type>
    <name>PDB</name>
    <text>PDB</text>
  </TERM>
  <TERM end="186" id="V1253060" paragraph="paragraph13" rule="-SIMPLE-REF" start="182" uttnum="88">
    <type>ONT::PROTOCOL</type>
    <name>HTTP</name>
    <text>http</text>
  </TERM>
  <TERM end="260" id="V1263907" paragraph="paragraph13" rule="-SIMPLE-REF" start="220" uttnum="88">
    <type>ONT::LOCATION</type>
    <name>LOCATION</name>
    <text>the location of the ends of the ST loop</text>
  </TERM>
  <TERM end="260" id="V1263965" paragraph="paragraph13" rule="-SIMPLE-REF" start="245" uttnum="88">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>of the ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="255" id="V1263956" paragraph="paragraph13" rule="-SIMPLE-REF" start="252" uttnum="88">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="269" id="V1263973" paragraph="paragraph13" rule="-SIMPLE-REF" start="261" uttnum="88">
    <type>ONT::AMINO-ACID</type>
    <name>GLU</name>
    <text>Glu</text>
  </TERM>
  <TERM end="291" id="V1263991" paragraph="paragraph13" rule="-SIMPLE-REF" start="283" uttnum="88">
    <type>ONT::AMINO-ACID</type>
    <name>VAL</name>
    <text>Val</text>
  </TERM>
  <TERM end="316" id="V1264016" paragraph="paragraph13" rule="-SIMPLE-REF" start="308" uttnum="88">
    <type>ONT::AMINO-ACID</type>
    <name>GLU</name>
    <text>Glu</text>
  </TERM>
  <TERM end="356" id="V1264077" paragraph="paragraph13" rule="-SIMPLE-REF" start="348" uttnum="88">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="469" id="V1264147" paragraph="paragraph13" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="367" uttnum="88">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="469" id="V1264147" start="367">
      <type>ONT::MODULATE</type>
      <text>the intervening residues of the ST loop were deleted from the construct used to produce this structure</text>
    </predicate>
    <arg2 id="V1264097" role=":AFFECTED"/>
    <text>the intervening residues of the ST loop were deleted from the construct used to produce this structure</text>
  </EVENT>
  <TERM end="407" id="V1264097" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="367" uttnum="88">
    <type>ONT::RESIDUE</type>
    <features>
      <inevent>
        <event id="V1264094"/>
      </inevent>
    </features>
    <name>RESIDUE</name>
    <text>the intervening residues of the ST loop</text>
  </TERM>
  <TERM end="469" id="V1264178" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="420" uttnum="88">
    <type>ONT::MENTAL-OBJECT</type>
    <features>
      <inevent>
        <event id="V1264196"/>
      </inevent>
    </features>
    <name>CONSTRUCT</name>
    <text>from the construct used to produce this structure</text>
  </TERM>
  <EVENT end="407" id="V1264094" paragraph="paragraph13" rule="-RULE30_AGENT_FORMAL-AGENT" start="367" uttnum="88">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="407" id="V1264094" start="367">
      <type>ONT::INHIBIT</type>
      <text>the intervening residues of the ST loop</text>
    </predicate>
    <arg1 id="V1264097" role=":AGENT"/>
    <text>the intervening residues of the ST loop</text>
  </EVENT>
  <TERM end="407" id="V1264125" paragraph="paragraph13" rule="-SIMPLE-REF" start="395" uttnum="88">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="402" id="V1264116" paragraph="paragraph13" rule="-SIMPLE-REF" start="399" uttnum="88">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <CC end="469" id="V1264196" paragraph="paragraph13" rule="-RULE5B_AGENT_RESULT-NONE" start="439" uttnum="88">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1264178" role=":AFFECTED"/>
    <text>used to produce this structure</text>
  </CC>
  <TERM end="486" id="V1279475" paragraph="paragraph13" rule="-SIMPLE-REF" start="478" uttnum="89">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <EVENT end="533" id="V1279483" paragraph="paragraph13" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="488" uttnum="89">
    <type>ONT::INHIBIT</type>
    <predicate end="533" id="V1279483" start="488">
      <type>ONT::INHIBIT</type>
      <text>Inhibition of activation of the human α1β2γ1</text>
    </predicate>
    <arg2 id="V1279499" role=":AFFECTED"/>
    <text>Inhibition of activation of the human α1β2γ1</text>
  </EVENT>
  <CC end="533" id="V1279499" paragraph="paragraph13" rule="-RULE5B_AGENT_RESULT-NONE" start="499" uttnum="89">
    <type>ONT::CAUSE</type>
    <text>of activation of the human α1β2γ1</text>
  </CC>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="603" id="V1279601" paragraph="paragraph13" rule="-SIMPLE-REF" start="544" uttnum="89">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1 by peptide corresponding to the sequence from Arg</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="560" id="V1279630" paragraph="paragraph13" rule="-SIMPLE-REF" start="552" uttnum="89">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>peptide</text>
  </TERM>
  <TERM dbid="UP:P42684" end="603" id="V1279686" paragraph="paragraph13" rule="-SIMPLE-REF" start="595" uttnum="89">
    <type>ONT::PROTEIN</type>
    <name>ARG</name>
    <text>Arg</text>
  </TERM>
  <TERM end="624" id="V1279718" paragraph="paragraph13" rule="-SIMPLE-REF" start="616" uttnum="89">
    <type>ONT::AMINO-ACID</type>
    <name>ASP</name>
    <text>Asp</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="657" id="V1279769" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="648" uttnum="89">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>P-peptide</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1279749"/>
    </features>
  </TERM>
  <EVENT end="657" id="V1279749" paragraph="paragraph13" rule="-PHOSPHO" start="648" uttnum="89">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="657" id="V1279749" start="648">
      <type>ONT::PHOSPHORYLATION</type>
      <text>P-peptide</text>
    </predicate>
    <arg2 id="V1279769" role=":RESULT"/>
    <arg id="R000006" role=":AFFECTED"/>
    <text>P-peptide</text>
  </EVENT>
  <TERM dbid="CHEBI:16670" end="682" id="V1279844" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="673" uttnum="89">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>P-peptide</text>
    <features>
      <ptm event="V1279811" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT end="682" id="V1279811" paragraph="paragraph13" rule="-PHOSPHO" start="673" uttnum="89">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="682" id="V1279811" start="673">
      <type>ONT::PHOSPHORYLATION</type>
      <text>P-peptide</text>
    </predicate>
    <arg2 id="V1279844" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000007"/>
    <text>P-peptide</text>
  </EVENT>
  <EVENT end="712" id="V1279862" paragraph="paragraph13" rule="-RULE60_AGENT_AFFECTED-AGENT" start="684" uttnum="89">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="712" id="V1279862" start="684">
      <type>ONT::PHOSPHORYLATION</type>
      <text>prior phosphorylation by Akt</text>
    </predicate>
    <arg1 id="V1279891" role=":AGENT"/>
    <text>prior phosphorylation by Akt</text>
  </EVENT>
  <TERM end="712" id="V1279891" paragraph="paragraph13" rule="-SIMPLE-REF" start="706" uttnum="89">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">by Akt</text>
  </TERM>
  <TERM end="722" id="V1289201" paragraph="paragraph13" rule="-SIMPLE-REF" start="714" uttnum="90">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Results</text>
  </TERM>
  <EVENT end="868" id="V1295206" paragraph="paragraph13" rule="-RULE30_AGENT_AFFECTED" start="780" uttnum="92">
    <type>ONT::INHIBIT</type>
    <predicate end="868" id="V1295206" start="780">
      <type>ONT::INHIBIT</type>
      <text>Inhibition of activation and phosphorylation by LKB1 of α1β2γ1 complex (left-hand side)</text>
    </predicate>
    <arg1 id="V1295270" role=":AGENT"/>
    <text>Inhibition of activation and phosphorylation by LKB1 of α1β2γ1 complex (left-hand side)</text>
  </EVENT>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="833" id="V1295270" paragraph="paragraph13" rule="-SIMPLE-REF" start="825" uttnum="92">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1</text>
  </TERM>
  <TERM end="866" id="V1295396" paragraph="paragraph13" rule="-SIMPLE-REF" start="852" uttnum="92">
    <type>ONT::OBJECT-DEPENDENT-LOCATION</type>
    <name>SIDE</name>
    <text>left-hand side</text>
  </TERM>
  <TERM end="866" id="V1295366" paragraph="paragraph13" rule="-SIMPLE-REF" start="852" uttnum="92">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>HAND</name>
    <text>left-hand side</text>
  </TERM>
  <TERM dbid="HGNC:11405|UP:Q8IWQ3" end="896" id="V1295442" paragraph="paragraph13" rule="-SIMPLE-REF" start="872" uttnum="92">
    <type>ONT::GENE</type>
    <name>BRSK-2</name>
    <text>BRSK2 (right-hand side)</text>
  </TERM>
  <TERM end="894" id="V1295499" paragraph="paragraph13" rule="-SIMPLE-REF" start="879" uttnum="92">
    <type>ONT::OBJECT-DEPENDENT-LOCATION</type>
    <name>SIDE</name>
    <text>right-hand side</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="909" id="V1295566" paragraph="paragraph13" rule="-SIMPLE-REF" start="899" uttnum="92">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>P-peptide</text>
  </TERM>
  <TERM end="909" id="V1295554" paragraph="paragraph13" rule="-SIMPLE-REF" start="899" uttnum="92">
    <type>ONT::SUBSTANCE</type>
    <name>P</name>
    <text>P-peptide</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="931" id="V1295633" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="915" uttnum="92">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>P-peptide as in</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1295600"/>
    </features>
  </TERM>
  <EVENT end="931" id="V1295600" paragraph="paragraph13" rule="-PHOSPHO" start="915" uttnum="92">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="931" id="V1295600" start="915">
      <type>ONT::PHOSPHORYLATION</type>
      <text>P-peptide as in</text>
    </predicate>
    <arg2 id="V1295633" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000008"/>
    <text>P-peptide as in</text>
  </EVENT>
  <TERM end="946" id="V1295739" paragraph="paragraph13" rule="-SIMPLE-REF" start="938" uttnum="92">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM end="977" id="V1304599" paragraph="paragraph13" rule="-SIMPLE-REF" start="949" uttnum="93">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Results for kinase activity</text>
  </TERM>
  <EVENT end="991" id="V1304671" paragraph="paragraph13" rule="-RULE50_AGENT_AFFECTED-RESULT-NONE" start="981" uttnum="93">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="991" id="V1304671" start="981">
      <type>ONT::EXPRESS</type>
      <text>expressed</text>
    </predicate>
    <arg2 id="V1304599" role=":AFFECTED"/>
    <text>expressed</text>
  </EVENT>
  <EVENT end="977" id="V1304636" paragraph="paragraph13" rule="-ACTIVITY1" start="961" uttnum="93">
    <type>ONT::ACTIVITY</type>
    <predicate end="977" id="V1304636" start="961">
      <type>ONT::ACTIVITY</type>
      <text>kinase activity</text>
    </predicate>
    <arg1 id="V1304633" role=":AGENT"/>
    <text>kinase activity</text>
  </EVENT>
  <TERM end="968" id="V1304633" paragraph="paragraph13" rule="-SIMPLE-REF" start="961" uttnum="93">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="1052" id="V1304788" paragraph="paragraph13" rule="-SIMPLE-REF" start="1045" uttnum="93">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>peptide</text>
  </TERM>
  <EVENT end="1233" id="V1320559" paragraph="paragraph13" rule="-RULE10_AGENT_AFFECTED-NONE" start="1142" uttnum="94">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1233" id="V1320559" start="1142">
      <type>ONT::MODULATE</type>
      <text>controls without LKB1; †††P&amp;lt;0.001 relative to control without P-peptide</text>
    </predicate>
    <text>controls without LKB1; †††P&amp;lt;0.001 relative to control without P-peptide</text>
  </EVENT>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="1163" id="V1320576" paragraph="paragraph13" rule="-SIMPLE-REF" start="1159" uttnum="94">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1</text>
  </TERM>
  <EVENT end="1233" id="V1320671" paragraph="paragraph13" rule="-RULE10_AGENT_AFFECTED-NONE" start="1208" uttnum="94">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1233" id="V1320671" start="1208">
      <type>ONT::MODULATE</type>
      <text>control without P-peptide</text>
    </predicate>
    <text>control without P-peptide</text>
  </EVENT>
  <TERM dbid="CHEBI:16670" end="1233" id="V1320705" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="1224" uttnum="94">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>P-peptide</text>
    <features>
      <ptm event="V1320685" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT end="1233" id="V1320685" paragraph="paragraph13" rule="-PHOSPHO" start="1224" uttnum="94">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1233" id="V1320685" start="1224">
      <type>ONT::PHOSPHORYLATION</type>
      <text>P-peptide</text>
    </predicate>
    <arg2 id="V1320705" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000009"/>
    <text>P-peptide</text>
  </EVENT>
  <CC end="1233" id="X1337437" paragraph="paragraph13" rule="-PURPOSE" start="1142" uttnum="94">
    <type>ONT::BY-MEANS-OF</type>
    <arg id="V1320559" role=":FACTOR"/>
    <arg id="V1320671" role=":OUTCOME"/>
    <text>controls without LKB1; †††P&amp;lt;0.001 relative to control without P-peptide</text>
  </CC>
  <TERM end="1260" id="V1331610" paragraph="paragraph13" rule="-SIMPLE-REF" start="1235" uttnum="95">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Results of Western blots</text>
  </TERM>
  <TERM end="1260" id="V1331642" paragraph="paragraph13" rule="-SIMPLE-REF" start="1243" uttnum="95">
    <type>ONT::LOC-DEFINED-BY-CONTRAST</type>
    <name>BLOTS</name>
    <text>of Western blots</text>
  </TERM>
  <TERM end="1290" id="V1331692" paragraph="paragraph13" rule="-SIMPLE-REF" start="1269" uttnum="95">
    <type>ONT::TREATMENT</type>
    <name>INCUBATIONS</name>
    <text>duplicate incubations</text>
  </TERM>
  <TERM end="1290" id="V1331685" paragraph="paragraph13" rule="-SIMPLE-REF" start="1269" uttnum="95">
    <type>ONT::PHYS-REPRESENTATION</type>
    <name>DUPLICATE</name>
    <text>duplicate incubations</text>
  </TERM>
  <TERM end="1307" id="V1345223" paragraph="paragraph13" rule="-SIMPLE-REF" start="1299" uttnum="96">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1320" id="V1345241" paragraph="paragraph13" rule="-SIMPLE-REF" start="1309" uttnum="96">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>Human AMPK</text>
  </TERM>
  <TERM end="1320" id="V1345232" paragraph="paragraph13" rule="-SIMPLE-REF" start="1309" uttnum="96">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>Human AMPK</text>
  </TERM>
  <TERM end="1348" id="V1345285" paragraph="paragraph13" rule="-SIMPLE-REF-MUTATION4B,-SIMPLE-REF" start="1328" uttnum="96">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>COMPLEX</name>
    <text>complex, either WT,</text>
  </TERM>
  <TERM end="1346" id="V1345301" paragraph="paragraph13" rule="-SIMPLE-REF-MUTATION7" start="1337" uttnum="96">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILDTYPE</name>
    <text>either WT</text>
  </TERM>
  <TERM end="1354" id="V1345365" paragraph="paragraph13" rule="-SIMPLE-REF" start="1348" uttnum="96">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM dbid="XFAM:PF00004.26" end="1361" id="V1345377" paragraph="paragraph13" rule="-SIMPLE-REF" start="1357" uttnum="96">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>AAA</name>
    <text>AAA</text>
  </TERM>
  <TERM end="1367" id="V1345384" paragraph="paragraph13" rule="-SIMPLE-REF-MUTATION8" start="1361" uttnum="96">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>mutant</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="1429" id="V1345438" paragraph="paragraph13" rule="-SIMPLE-REF" start="1388" uttnum="96">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1 following prior incubation with ATP</text>
  </TERM>
  <TERM end="1420" id="V1345459" paragraph="paragraph13" rule="-SIMPLE-REF" start="1403" uttnum="96">
    <type>ONT::TREATMENT</type>
    <name>INCUBATION</name>
    <text>prior incubation</text>
  </TERM>
  <TERM dbid="MESH:D000255" end="1429" id="V1345476" paragraph="paragraph13" rule="-SIMPLE-REF" start="1425" uttnum="96">
    <type>ONT::MOLECULE</type>
    <name>ATP</name>
    <text>ATP</text>
  </TERM>
  <TERM end="1448" id="V1345504" paragraph="paragraph13" rule="-SIMPLE-REF" start="1445" uttnum="96">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <EVENT end="1478" id="V1359710" paragraph="paragraph13" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1450" uttnum="97">
    <type>ONT::ACTIVATE</type>
    <predicate end="1478" id="V1359710" start="1450">
      <type>ONT::ACTIVATE</type>
      <text>AMPK activation (top panel)</text>
    </predicate>
    <arg2 id="V1359707" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000162"/>
    <text>AMPK activation (top panel)</text>
  </EVENT>
  <EVENT end="1509" id="V1359742" paragraph="paragraph13" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="1482" uttnum="97">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1509" id="V1359742" start="1482">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of Thr</text>
    </predicate>
    <site end="1509" id="V1359754" start="1501">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>phosphorylation of Thr</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1455" id="V1359707" paragraph="paragraph13" rule="-SIMPLE-REF" start="1450" uttnum="97">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="1476" id="V1359726" paragraph="paragraph13" rule="-SIMPLE-REF" start="1467" uttnum="97">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panel</text>
  </TERM>
  <TERM end="1509" id="V1359754" paragraph="paragraph13" rule="-SIMPLE-REF" start="1501" uttnum="97">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="1531" id="V1359772" paragraph="paragraph13" rule="-SIMPLE-REF" start="1523" uttnum="97">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="1554" id="V1359790" paragraph="paragraph13" rule="-SIMPLE-REF" start="1542" uttnum="97">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>bottom panel</text>
  </TERM>
  <TERM end="7" id="V1365812" paragraph="paragraph14" rule="-SIMPLE-REF" start="3" uttnum="98">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="29" id="V1365821" paragraph="paragraph14" rule="-SIMPLE-REF" start="22" uttnum="98">
    <type>ONT::AMINO-ACID</type>
    <name>SERINE</name>
    <text>serine</text>
  </TERM>
  <TERM end="51" id="V1365836" paragraph="paragraph14" rule="-SIMPLE-REF" start="32" uttnum="98">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>threonine residues</text>
  </TERM>
  <TERM end="42" id="V1365833" paragraph="paragraph14" rule="-SIMPLE-REF" start="32" uttnum="98">
    <type>ONT::AMINO-ACID</type>
    <name>THREONINE</name>
    <text>threonine</text>
  </TERM>
  <TERM end="87" id="V1365864" paragraph="paragraph14" rule="-SIMPLE-REF" start="58" uttnum="98">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>MOTIF</name>
    <text>the sequence motif RXRXXS/TΦ,</text>
  </TERM>
  <TERM end="144" id="V1376740" paragraph="paragraph14" rule="-SIMPLE-REF" start="99" uttnum="98">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>a bulky hydrophobic residue [39]</text>
  </TERM>
  <EPI end="267" id="V1385476" paragraph="paragraph14" rule="-RULE50_0_NEUTRAL_FORMAL" start="152" uttnum="99">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg1 id="V1385413" role=":NEUTRAL"/>
    <arg2 id="V1385567" role=":FORMAL"/>
    <text>Figure 1(A) shows an alignment of this consensus with sequences around some established Akt targets, the ST</text>
  </EPI>
  <TERM end="171" id="V1385413" paragraph="paragraph14" rule="-SIMPLE-REF" start="152" uttnum="99">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 1(A)</text>
  </TERM>
  <EVENT end="267" id="V1385567" paragraph="paragraph14" rule="-RULE50_0_NEUTRAL_FORMAL-EVENT,-RULE10_NEUTRAL_NEUTRAL1" start="152" uttnum="99">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V1385476"/>
    <predicate end="267" id="V1385567" start="152">
      <type>ONT::MODULATE</type>
      <text>Figure 1(A) shows an alignment of this consensus with sequences around some established Akt targets, the ST</text>
    </predicate>
    <text>Figure 1(A) shows an alignment of this consensus with sequences around some established Akt targets, the ST</text>
  </EVENT>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="267" id="V1385585" paragraph="paragraph14" rule="-SIMPLE-REF" start="260" uttnum="99">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>the ST</text>
  </TERM>
  <TERM end="251" id="V1385562" paragraph="paragraph14" rule="-SIMPLE-REF" start="230" uttnum="99">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">some established Akt</text>
  </TERM>
  <TERM end="313" id="V1385606" paragraph="paragraph14" rule="-SIMPLE-REF" start="267" uttnum="99">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>loop sequence containing Ser487 in</text>
  </TERM>
  <TERM end="313" id="V1385594" paragraph="paragraph14" rule="-SIMPLE-REF" start="267" uttnum="99">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>loop sequence containing Ser487 in</text>
  </TERM>
  <TERM end="347" id="V1385706" paragraph="paragraph14" rule="-SIMPLE-REF" start="327" uttnum="99">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>the equivalent site</text>
  </TERM>
  <TERM end="362" id="V1385756" paragraph="paragraph14" rule="-SIMPLE-REF" start="354" uttnum="99">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM dbid="CHEBI:32848" end="505" id="V1398009" paragraph="paragraph14" rule="-SIMPLE-REF" start="400" uttnum="100">
    <type>ONT::MOLECULE</type>
    <name>SERINE-RESIDUE</name>
    <text>serine residue at P-2, with Akt having a preference for the serine or threonine residue at this position</text>
  </TERM>
  <TERM dbid="CVCL:Z997|CVCL:U050" end="423" id="V1398061" paragraph="paragraph14" rule="-SIMPLE-REF" start="418" uttnum="100">
    <type>ONT::CELL-LINE</type>
    <name>P-2</name>
    <text>P-2,</text>
  </TERM>
  <TERM end="432" id="V1398088" paragraph="paragraph14" rule="-SIMPLE-REF" start="428" uttnum="100">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="467" id="V1398190" paragraph="paragraph14" rule="-SIMPLE-REF" start="456" uttnum="100">
    <type>ONT::AMINO-ACID</type>
    <name>SERINE</name>
    <text>the serine</text>
  </TERM>
  <TERM dbid="CHEBI:32835" end="505" id="V1398210" paragraph="paragraph14" rule="-SIMPLE-REF" start="470" uttnum="100">
    <type>ONT::MOLECULE</type>
    <name>THREONINE-RESIDUE</name>
    <text>threonine residue at this position</text>
  </TERM>
  <TERM end="505" id="V1398239" paragraph="paragraph14" rule="-SIMPLE-REF" start="491" uttnum="100">
    <type>ONT::MOLECULAR-SITE</type>
    <name>POSITION</name>
    <text>this position</text>
  </TERM>
  <TERM end="566" id="V1408304" paragraph="paragraph14" rule="-SIMPLE-REF" start="548" uttnum="101">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>a proline residue</text>
  </TERM>
  <TERM end="558" id="V1408301" paragraph="paragraph14" rule="-SIMPLE-REF" start="550" uttnum="101">
    <type>ONT::AMINO-ACID</type>
    <name>PROLINE</name>
    <text>proline</text>
  </TERM>
  <TERM end="587" id="V1408324" paragraph="paragraph14" rule="-SIMPLE-REF" start="578" uttnum="101">
    <type>ONT::AMINO-ACID</type>
    <name>ARGININE</name>
    <text>arginine</text>
  </TERM>
  <TERM dbid="UP:Q15084|HGNC:9137|HGNC:30168|UP:Q06265" end="607" id="V1408389" paragraph="paragraph14" rule="-EXPLICIT-REF1" start="590" uttnum="101">
    <type>ONT::MOLECULAR-SITE</type>
    <name>P-5</name>
    <assoc-with id="V1408383"/>
    <text>the P-5 position,</text>
  </TERM>
  <TERM dbid="UP:Q15084|HGNC:9137|HGNC:30168|UP:Q06265" end="598" id="V1408383" paragraph="paragraph14" rule="-SIMPLE-REF" start="594" uttnum="101">
    <type>ONT::GENE</type>
    <name>P-5</name>
    <text>P-5</text>
  </TERM>
  <TERM end="620" id="V1413399" paragraph="paragraph14" rule="-SIMPLE-REF" start="612" uttnum="101">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="658" id="V1413434" paragraph="paragraph14" rule="-SIMPLE-REF" start="639" uttnum="101">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>an alanine residue</text>
  </TERM>
  <TERM end="650" id="V1413431" paragraph="paragraph14" rule="-SIMPLE-REF" start="642" uttnum="101">
    <type>ONT::AMINO-ACID</type>
    <name>ALANINE</name>
    <text>alanine</text>
  </TERM>
  <TERM end="698" id="V1413501" paragraph="paragraph14" rule="-SIMPLE-REF" start="670" uttnum="101">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>a bulky hydrophobic residue</text>
  </TERM>
  <TERM end="752" id="V1427381" paragraph="paragraph14" rule="-SIMPLE-REF" start="748" uttnum="102">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="813" id="V1437600" paragraph="paragraph14" rule="-SIMPLE-REF" start="805" uttnum="102">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="847" id="V1437685" paragraph="paragraph14" rule="-EXPLICIT-REF1" start="826" uttnum="102">
    <type>ONT::MOLECULAR-SITE</type>
    <name>AKT</name>
    <assoc-with id="V1437682"/>
    <text>a potential Akt site</text>
  </TERM>
  <TERM end="842" id="V1437682" paragraph="paragraph14" rule="-SIMPLE-REF" start="838" uttnum="102">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="886" id="V1437754" paragraph="paragraph14" rule="-SIMPLE-REF" start="878" uttnum="102">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="55" id="V1452688" paragraph="paragraph15" rule="-RULE60_AGENT_AFFECTED-MODA1_2-NONE" start="33" uttnum="103">
    <type>ONT::PHOSPHORYLATION</type>
    <mods>
      <mod>
        <type>ONT::MANNER-REFL</type>
        <value>AUTO-</value>
      </mod>
    </mods>
    <predicate end="55" id="V1452688" start="33">
      <type>ONT::PHOSPHORYLATION</type>
      <text>by autophosphorylation</text>
    </predicate>
    <text>by autophosphorylation</text>
  </EVENT>
  <TERM end="60" id="V1466369" paragraph="paragraph15" rule="-ROBUSTPRO" start="57" uttnum="103">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="116" id="V1466392" paragraph="paragraph15" rule="-SIMPLE-REF-MODACTIVE2,-SIMPLE-REF-MUTATION8" start="75" uttnum="103">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <active>FALSE</active>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>inactive mutants of human AMPK complexes</text>
  </TERM>
  <TERM end="116" id="V1466418" paragraph="paragraph15" rule="-EXPLICIT-REF-SEQ0" start="95" uttnum="103">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <components>
      <component id="V1466411"/>
    </components>
    <text normalization="">human AMPK complexes</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="116" id="V1466411" paragraph="paragraph15" rule="-EXPLICIT-REF-SEQ0-TERM" start="95" uttnum="103">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>human AMPK complexes</text>
  </TERM>
  <TERM end="125" id="V1466263" paragraph="paragraph15" rule="-SIMPLE-REF" start="120" uttnum="103">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>159</pos>
      <aa-from>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">D159A</text>
  </TERM>
  <TERM dbid="XFAM:PF00010|UP:Q60867|XFAM:PF12533" end="128" id="V1465936" paragraph="paragraph15" rule="-SIMPLE-REF" start="126" uttnum="103">
    <type>ONT::PROTEIN</type>
    <name>Β-2</name>
    <text>β2</text>
  </TERM>
  <TERM end="144" id="V1465727" paragraph="paragraph15" rule="-SIMPLE-REF" start="139" uttnum="103">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>157</pos>
      <aa-from>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">D157A</text>
  </TERM>
  <TERM dbid="XFAM:PF00010|UP:Q60867|XFAM:PF12533" end="147" id="V1465394" paragraph="paragraph15" rule="-SIMPLE-REF" start="145" uttnum="103">
    <type>ONT::PROTEIN</type>
    <name>Β-2</name>
    <text>β2</text>
  </TERM>
  <TERM end="247" id="V1466482" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="169" uttnum="103">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>α1-S487A or α2-S491A mutations, as substrates for phosphorylation by human Akt</text>
  </TERM>
  <TERM end="247" id="V1466523" paragraph="paragraph15" rule="-SIMPLE-REF" start="204" uttnum="103">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATES</name>
    <text>substrates for phosphorylation by human Akt</text>
  </TERM>
  <TERM end="247" id="V1466589" paragraph="paragraph15" rule="-SIMPLE-REF" start="238" uttnum="103">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">human Akt</text>
  </TERM>
  <TERM end="178" id="V1465264" paragraph="paragraph15" rule="-SIMPLE-REF" start="172" uttnum="103">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="190" id="V1464953" paragraph="paragraph15" rule="-SIMPLE-REF" start="184" uttnum="103">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>491</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S491A</text>
  </TERM>
  <TERM end="268" id="V1476125" paragraph="paragraph15" rule="-ROBUSTPRO" start="265" uttnum="104">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="291" id="V1476220" paragraph="paragraph15" rule="-SIMPLE-REF" start="286" uttnum="104">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>200</pos>
      <aa-from>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">D200A</text>
  </TERM>
  <TERM end="300" id="V1476226" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="293" uttnum="104">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>mutant</text>
  </TERM>
  <TERM dbid="FA:03087" end="332" id="V1476285" paragraph="paragraph15" rule="-SIMPLE-REF" start="303" uttnum="104">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">the known Akt substrate GSK3β</text>
  </TERM>
  <TERM end="317" id="V1476267" paragraph="paragraph15" rule="-SIMPLE-REF" start="313" uttnum="104">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <EVENT end="392" id="V1476324" paragraph="paragraph15" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="350" uttnum="104">
    <type>ONT::TRANSFORM</type>
    <predicate end="392" id="V1476324" start="350">
      <type>ONT::TRANSFORM</type>
      <text>mutation of the Akt site (Ser9)</text>
    </predicate>
    <arg2 id="V1476346" role=":AFFECTED"/>
    <text>mutation of the Akt site (Ser9)</text>
  </EVENT>
  <TERM end="392" id="V1476346" paragraph="paragraph15" rule="-EXPLICIT-REF1" start="359" uttnum="104">
    <type>ONT::MOLECULAR-SITE</type>
    <name>AKT</name>
    <assoc-with id="V1476343"/>
    <text>of the Akt site (Ser9)</text>
  </TERM>
  <TERM end="370" id="V1476343" paragraph="paragraph15" rule="-SIMPLE-REF" start="366" uttnum="104">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="384" id="V1476356" paragraph="paragraph15" rule="-SIMPLE-REF" start="376" uttnum="104">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="444" id="V1486259" paragraph="paragraph15" rule="-SIMPLE-REF" start="421" uttnum="105">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATE</name>
    <text>a reasonable substrate</text>
  </TERM>
  <TERM end="452" id="V1486291" paragraph="paragraph15" rule="-SIMPLE-REF" start="448" uttnum="105">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM dbid="FA:03087" end="481" id="V1486395" paragraph="paragraph15" rule="-SIMPLE-REF" start="476" uttnum="105">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3,</text>
  </TERM>
  <TERM end="523" id="V1502601" paragraph="paragraph15" rule="-SIMPLE-REF" start="502" uttnum="105">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATE</name>
    <text>a very poor substrate</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="494" id="V1502322" paragraph="paragraph15" rule="-SIMPLE-REF" start="490" uttnum="105">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="547" id="V1506860" paragraph="paragraph15" rule="-SIMPLE-REF" start="538" uttnum="106">
    <type>ONT::ICON</type>
    <name>P</name>
    <text>an anti-p</text>
  </TERM>
  <TERM end="547" id="V1506844" paragraph="paragraph15" rule="-SIMPLE-REF" start="538" uttnum="106">
    <type>ONT::PERSON</type>
    <name>ANTI</name>
    <text>an anti-p</text>
  </TERM>
  <TERM dbid="GO:0042571" end="559" id="V1506924" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION1,-SIMPLE-REF" start="547" uttnum="106">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <mutation id="V1506898"/>
    </features>
    <name>ANTIBODY</name>
    <text>S9 antibody</text>
  </TERM>
  <TERM end="550" id="V1506898" paragraph="paragraph15" rule="-SIMPLE-REF" start="547" uttnum="106">
    <type>ONT::MUTATION</type>
    <mutation>ONT::TRUE</mutation>
    <text normalization="">S9</text>
  </TERM>
  <TERM end="579" id="V1506960" paragraph="paragraph15" rule="-SIMPLE-REF" start="570" uttnum="106">
    <type>ONT::ICON</type>
    <name>P</name>
    <text>32P</text>
  </TERM>
  <TERM dbid="FA:03087" end="614" id="V1507021" paragraph="paragraph15" rule="-SIMPLE-REF" start="610" uttnum="106">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <TERM end="648" id="V1507121" paragraph="paragraph15" rule="-SIMPLE-REF" start="645" uttnum="106">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="757" id="V1521764" paragraph="paragraph15" rule="-SIMPLE-REF" start="741" uttnum="106">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>B</name>
    <text>Figure 1B</text>
  </TERM>
  <TERM end="757" id="V1521742" paragraph="paragraph15" rule="-SIMPLE-REF" start="741" uttnum="106">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 1B</text>
  </TERM>
  <TERM end="914" id="V1551623" paragraph="paragraph15" rule="-SIMPLE-REF" start="898" uttnum="107">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 1C</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="940" id="V1567579" paragraph="paragraph15" rule="-SIMPLE-REF" start="936" uttnum="108">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <EVENT end="972" id="V1567637" paragraph="paragraph15" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="957" uttnum="108">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="972" id="V1567637" start="957">
      <type>ONT::BIND</type>
      <text>obtained using</text>
    </predicate>
    <arg2 id="V1567642" role=":AFFECTED"/>
    <text>obtained using</text>
  </EVENT>
  <CC end="972" id="V1567642" paragraph="paragraph15" rule="-RULE5B_AGENT_RESULT-NONE" start="966" uttnum="108">
    <type>ONT::CAUSE</type>
    <text>using</text>
  </CC>
  <TERM dbid="GO:0042571" end="1000" id="V1567698" paragraph="paragraph15" rule="-SIMPLE-REF" start="989" uttnum="108">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="1029" id="V1567833" paragraph="paragraph15" rule="-SIMPLE-REF" start="1020" uttnum="108">
    <type>ONT::ICON</type>
    <name>P</name>
    <text>32P</text>
  </TERM>
  <TERM end="1091" id="V1567940" paragraph="paragraph15" rule="-SIMPLE-REF" start="1067" uttnum="108">
    <type>ONT::AREA-DEF-BY-USE</type>
    <name>SITE</name>
    <text>of the respective sites</text>
  </TERM>
  <TERM end="1113" id="V1567970" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION2,-SIMPLE-REF" start="1094" uttnum="108">
    <type>ONT::AMINO-ACID</type>
    <features>
      <mutation id="V1567988"/>
    </features>
    <name>ALANINE</name>
    <text>alanine (S9A/S487A)</text>
  </TERM>
  <TERM end="1112" id="V1567988" paragraph="paragraph15" rule="-EXPLICIT-REF-SEQ0B" start="1103" uttnum="108">
    <type>ONT::MUTATION</type>
    <components>
      <component id="V1565682"/>
      <component id="V1565741"/>
    </components>
    <text normalization="">S9A/S487A</text>
  </TERM>
  <TERM end="1112" id="V1565682" paragraph="paragraph15" rule="-EXPLICIT-REF-SEQ0B-TERM" start="1103" uttnum="108">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>9</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S9A/S487A</text>
  </TERM>
  <TERM end="1112" id="V1565741" paragraph="paragraph15" rule="-SIMPLE-REF" start="1107" uttnum="108">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <EVENT end="1175" id="V1580592" paragraph="paragraph15" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="1143" uttnum="109">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1175" id="V1580592" start="1143">
      <type>ONT::PHOSPHORYLATION</type>
      <text>less phosphorylation of Ser</text>
    </predicate>
    <site end="1175" id="V1580604" start="1167">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>less phosphorylation of Ser</text>
  </EVENT>
  <TERM end="1175" id="V1580604" paragraph="paragraph15" rule="-SIMPLE-REF" start="1167" uttnum="109">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="1225" id="V1580679" paragraph="paragraph15" rule="-SIMPLE-REF" start="1218" uttnum="109">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="1234" id="V1580704" paragraph="paragraph15" rule="-SIMPLE-REF" start="1225" uttnum="109">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>1D</text>
  </TERM>
  <TERM end="1348" id="V1596829" paragraph="paragraph15" rule="-SIMPLE-REF" start="1339" uttnum="110">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt at 30</text>
  </TERM>
  <TERM dbid="FA:03087" end="1460" id="V1596970" paragraph="paragraph15" rule="-SIMPLE-REF" start="1456" uttnum="110">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <EPI end="1541" id="V1610039" paragraph="paragraph15" rule="-RULE50_0_AGENT_FORMAL" start="1485" uttnum="111">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <modality>ONT::DO</modality>
    <arg1 id="V1610017" role=":AGENT"/>
    <arg2 id="V1610050" role=":FORMAL"/>
    <text>we did detect some phosphorylation of Ser491</text>
  </EPI>
  <TERM end="1488" id="V1610017" paragraph="paragraph15" rule="-ROBUSTPRO" start="1485" uttnum="111">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="1541" id="V1610050" paragraph="paragraph15" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="1485" uttnum="111">
    <type>ONT::PHOSPHORYLATION</type>
    <epistemic-modality id="V1610039"/>
    <predicate end="1541" id="V1610050" start="1485">
      <type>ONT::PHOSPHORYLATION</type>
      <text>we did detect some phosphorylation of Ser491</text>
    </predicate>
    <site end="1531" id="V1610062" start="1523">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>we did detect some phosphorylation of Ser491</text>
  </EVENT>
  <TERM end="1531" id="V1610062" paragraph="paragraph15" rule="-SIMPLE-REF" start="1523" uttnum="111">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM dbid="FA:03087" end="1584" id="V1610183" paragraph="paragraph15" rule="-SIMPLE-REF" start="1579" uttnum="111">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">this</text>
  </TERM>
  <TERM end="1616" id="V1610358" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="1601" uttnum="111">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>a S491A mutant,</text>
  </TERM>
  <TERM end="1609" id="V1610355" paragraph="paragraph15" rule="-SIMPLE-REF" start="1603" uttnum="111">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>491</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S491A</text>
  </TERM>
  <MODALITY end="1616" id="X1627977" paragraph="paragraph15" rule="-RULE50_0_AGENT_NEUTRAL-MODALITY" start="1476" uttnum="111">
    <type>ONT::DO</type>
    <arg2 id="V1610039" role=":EPI"/>
    <text>Although we did detect some phosphorylation of Ser491 using a phospho-specific antibody and this was abolished in a S491A mutant,</text>
  </MODALITY>
  <EVENT end="1681" id="V1625761" paragraph="paragraph15" rule="-RULE10_AGENT_AFFECTED" start="1622" uttnum="111">
    <type>ONT::MODULATE</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <predicate end="1681" id="V1625761" start="1622">
      <type>ONT::MODULATE</type>
      <text>32P-labelling was not affected by the S491A mutation,</text>
    </predicate>
    <arg1 id="V1625851" role=":AGENT"/>
    <text>32P-labelling was not affected by the S491A mutation,</text>
  </EVENT>
  <EVENT end="1681" id="V1625851" paragraph="paragraph15" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="1659" uttnum="111">
    <type>ONT::TRANSFORM</type>
    <predicate end="1681" id="V1625851" start="1659">
      <type>ONT::TRANSFORM</type>
      <text>by the S491A mutation,</text>
    </predicate>
    <arg2 id="V1625848" role=":AFFECTED"/>
    <text>by the S491A mutation,</text>
  </EVENT>
  <TERM end="1631" id="V1625687" paragraph="paragraph15" rule="-SIMPLE-REF" start="1622" uttnum="111">
    <type>ONT::ICON</type>
    <name>P</name>
    <text>32P</text>
  </TERM>
  <TERM end="1672" id="V1625848" paragraph="paragraph15" rule="-SIMPLE-REF" start="1666" uttnum="111">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>491</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S491A</text>
  </TERM>
  <TERM end="1741" id="V1641363" paragraph="paragraph15" rule="-SIMPLE-REF" start="1734" uttnum="111">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">by Akt</text>
  </TERM>
  <TERM end="1798" id="V1641498" paragraph="paragraph15" rule="-SIMPLE-REF" start="1785" uttnum="111">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>other site(s)</text>
  </TERM>
  <TERM end="6" id="V1656317" paragraph="paragraph16" rule="-ROBUSTPRO" start="3" uttnum="112">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="107" id="V1656440" paragraph="paragraph16" rule="-SIMPLE-REF" start="86" uttnum="112">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr172 in</text>
  </TERM>
  <TERM end="128" id="V1655883" paragraph="paragraph16" rule="-SIMPLE-REF" start="123" uttnum="112">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>157</pos>
      <aa-from>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">D157A</text>
  </TERM>
  <EVENT end="183" id="V1669622" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED-AGENT" start="159" uttnum="113">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="183" id="V1669622" start="159">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation by Akt,</text>
    </predicate>
    <arg1 id="V1669651" role=":AGENT"/>
    <text>phosphorylation by Akt,</text>
  </EVENT>
  <TERM end="181" id="V1669651" paragraph="paragraph16" rule="-SIMPLE-REF" start="175" uttnum="113">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">by Akt</text>
  </TERM>
  <EVENT end="252" id="V1669680" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="192" uttnum="113">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="252" id="V1669680" start="192">
      <type>ONT::PHOSPHORYLATION</type>
      <text>of phosphorylation of Thr172 by the LKB1 complex</text>
    </predicate>
    <site end="252" id="V1669692" start="214">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr172 by the LKB1 complex</text>
    </site>
    <text>of phosphorylation of Thr172 by the LKB1 complex</text>
  </EVENT>
  <TERM end="252" id="V1669692" paragraph="paragraph16" rule="-SIMPLE-REF" start="214" uttnum="113">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr172 by the LKB1 complex</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="244" id="V1669736" paragraph="paragraph16" rule="-SIMPLE-REF" start="235" uttnum="113">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>the LKB1</text>
  </TERM>
  <EVENT end="288" id="V1669858" paragraph="paragraph16" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="270" uttnum="113">
    <type>ONT::TRANSFORM</type>
    <predicate end="288" id="V1669858" start="270">
      <type>ONT::TRANSFORM</type>
      <text>an S487A mutation,</text>
    </predicate>
    <arg2 id="V1669855" role=":AFFECTED"/>
    <text>an S487A mutation,</text>
  </EVENT>
  <TERM end="279" id="V1669855" paragraph="paragraph16" rule="-SIMPLE-REF" start="273" uttnum="113">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <EVENT end="316" id="V1684855" paragraph="paragraph16" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="298" uttnum="113">
    <type>ONT::TRANSFORM</type>
    <predicate end="316" id="V1684855" start="298">
      <type>ONT::TRANSFORM</type>
      <text>an S487D mutation</text>
    </predicate>
    <arg2 id="V1684852" role=":AFFECTED"/>
    <text>an S487D mutation</text>
  </EVENT>
  <TERM end="307" id="V1684852" paragraph="paragraph16" rule="-SIMPLE-REF" start="301" uttnum="113">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487D</text>
  </TERM>
  <TERM end="344" id="V1684892" paragraph="paragraph16" rule="-SIMPLE-REF" start="333" uttnum="113">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>of Thr</text>
  </TERM>
  <TERM end="414" id="V1684962" paragraph="paragraph16" rule="-SIMPLE-REF" start="398" uttnum="113">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>Figure 1E</text>
  </TERM>
  <TERM end="414" id="V1684945" paragraph="paragraph16" rule="-SIMPLE-REF" start="398" uttnum="113">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 1E</text>
  </TERM>
  <TERM end="441" id="V1699829" paragraph="paragraph16" rule="-SIMPLE-REF" start="436" uttnum="114">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>157</pos>
      <aa-from>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">D157A</text>
  </TERM>
  <TERM end="458" id="V1699847" paragraph="paragraph16" rule="-SIMPLE-REF-MUTATION5,-SIMPLE-REF" start="443" uttnum="114">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>COMPLEX</name>
    <text>mutant complex</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1699883"/>
    </not-features>
  </TERM>
  <EVENT end="507" id="V1699883" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED" start="443" uttnum="114">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="507" id="V1699883" start="443">
      <type>ONT::PHOSPHORYLATION</type>
      <text>mutant complex was first phosphorylated by Akt under conditions</text>
    </predicate>
    <arg1 id="V1699912" role=":AGENT"/>
    <arg2 id="V1699847" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000042"/>
    <text>mutant complex was first phosphorylated by Akt under conditions</text>
  </EVENT>
  <TERM end="490" id="V1699912" paragraph="paragraph16" rule="-SIMPLE-REF" start="483" uttnum="114">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">by Akt</text>
  </TERM>
  <TERM end="512" id="V1699937" paragraph="paragraph16" rule="-SIMPLE-REF" start="507" uttnum="114">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">that</text>
  </TERM>
  <TERM end="543" id="V1699959" paragraph="paragraph16" rule="-SIMPLE-REF" start="520" uttnum="114">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>stoichiometric Ser</text>
  </TERM>
  <TERM end="608" id="V1714935" paragraph="paragraph16" rule="-SIMPLE-REF" start="600" uttnum="114">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="693" id="V1715108" paragraph="paragraph16" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="675" uttnum="114">
    <type>ONT::TRANSFORM</type>
    <predicate end="693" id="V1715108" start="675">
      <type>ONT::TRANSFORM</type>
      <text>an S487A mutation</text>
    </predicate>
    <arg2 id="V1715105" role=":AFFECTED"/>
    <text>an S487A mutation</text>
  </EVENT>
  <TERM end="684" id="V1715105" paragraph="paragraph16" rule="-SIMPLE-REF" start="678" uttnum="114">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="707" id="V1715119" paragraph="paragraph16" rule="-SIMPLE-REF" start="700" uttnum="114">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="6" id="V1728566" paragraph="paragraph17" rule="-ROBUSTPRO" start="3" uttnum="115">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="37" id="V1728616" paragraph="paragraph17" rule="-SIMPLE-REF" start="33" uttnum="115">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="49" id="V1728651" paragraph="paragraph17" rule="-SIMPLE-REF-MUTATION7" start="40" uttnum="115">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILDTYPE</name>
    <text>either WT</text>
  </TERM>
  <TERM end="57" id="V1728718" paragraph="paragraph17" rule="-SIMPLE-REF" start="51" uttnum="115">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="91" id="V1728784" paragraph="paragraph17" rule="-SIMPLE-REF-MUTATION8" start="60" uttnum="115">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>S491A mutants of active α1β2γ1</text>
  </TERM>
  <TERM end="66" id="V1728781" paragraph="paragraph17" rule="-SIMPLE-REF" start="60" uttnum="115">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>491</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S491A</text>
  </TERM>
  <TERM end="111" id="V1728875" paragraph="paragraph17" rule="-SIMPLE-REF" start="102" uttnum="115">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complexes</text>
  </TERM>
  <TERM end="138" id="V1741090" paragraph="paragraph17" rule="-SIMPLE-REF" start="119" uttnum="116">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 2(A)</text>
  </TERM>
  <EVENT end="217" id="V1741272" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="183" uttnum="116">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="217" id="V1741272" start="183">
      <type>ONT::PHOSPHORYLATION</type>
      <text>slight phosphorylation of Ser</text>
    </predicate>
    <site end="217" id="V1741284" start="209">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>slight phosphorylation of Ser</text>
  </EVENT>
  <TERM end="217" id="V1741284" paragraph="paragraph17" rule="-SIMPLE-REF" start="209" uttnum="116">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="253" id="V1741369" paragraph="paragraph17" rule="-SIMPLE-REF" start="247" uttnum="116">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
  </TERM>
  <EVENT end="331" id="V1755594" paragraph="paragraph17" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="264" uttnum="116">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="331" id="V1755594" start="264">
      <type>ONT::INCREASE</type>
      <text>phosphorylation of this site increased markedly with increasing Akt</text>
    </predicate>
    <arg1 id="V1755571" role=":AFFECTED"/>
    <arg2 id="V1755618" role=":FORMAL"/>
    <text>phosphorylation of this site increased markedly with increasing Akt</text>
  </EVENT>
  <EVENT end="293" id="V1755571" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="264" uttnum="116">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="293" id="V1755571" start="264">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of this site</text>
    </predicate>
    <site end="293" id="V1755586" start="280">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">of this site</text>
    </site>
    <text>phosphorylation of this site</text>
  </EVENT>
  <EVENT end="331" id="V1755618" paragraph="paragraph17" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="312" uttnum="116">
    <type>ONT::INCREASE</type>
    <predicate end="331" id="V1755618" start="312">
      <type>ONT::INCREASE</type>
      <text>with increasing Akt</text>
    </predicate>
    <arg2 id="V1755625" role=":AFFECTED"/>
    <text>with increasing Akt</text>
  </EVENT>
  <TERM end="293" id="V1755586" paragraph="paragraph17" rule="-SIMPLE-REF" start="280" uttnum="116">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>of this site</text>
  </TERM>
  <TERM end="331" id="V1755625" paragraph="paragraph17" rule="-SIMPLE-REF" start="328" uttnum="116">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="354" id="V1768578" paragraph="paragraph17" rule="-SIMPLE-REF" start="346" uttnum="117">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="385" id="V1768674" paragraph="paragraph17" rule="-SIMPLE-REF" start="377" uttnum="117">
    <type>ONT::FACILITY</type>
    <name>COMPLEX</name>
    <text>complex</text>
  </TERM>
  <TERM end="442" id="V1768819" paragraph="paragraph17" rule="-SIMPLE-REF" start="436" uttnum="117">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
  </TERM>
  <EVENT end="464" id="V1783607" paragraph="paragraph17" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="448" uttnum="117">
    <type>ONT::INCREASE</type>
    <predicate end="464" id="V1783607" start="448">
      <type>ONT::INCREASE</type>
      <text>addition of Akt</text>
    </predicate>
    <arg2 id="V1783623" role=":AFFECTED"/>
    <text>addition of Akt</text>
  </EVENT>
  <TERM end="464" id="V1783623" paragraph="paragraph17" rule="-SIMPLE-REF" start="457" uttnum="117">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
  </TERM>
  <TERM end="501" id="V1789233" paragraph="paragraph17" rule="-SIMPLE-REF" start="487" uttnum="118">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>These results</text>
  </TERM>
  <TERM end="524" id="V1789266" paragraph="paragraph17" rule="-SIMPLE-REF" start="511" uttnum="118">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>that Ser</text>
  </TERM>
  <TERM end="587" id="V1793695" paragraph="paragraph17" rule="-SIMPLE-REF" start="579" uttnum="118">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="665" id="V1793722" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-LOC5-GD-AGENT" start="600" uttnum="118">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="665" id="V1793722" start="600">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylated by Akt, with a small degree of autophosphorylation</text>
    </predicate>
    <arg1 id="V1793751" role=":AGENT"/>
    <site end="665" id="V1793751" start="615">
      <type>ONT::PROTEIN-FAMILY</type>
      <text normalization="">by Akt, with a small degree of autophosphorylation</text>
    </site>
    <text>phosphorylated by Akt, with a small degree of autophosphorylation</text>
  </EVENT>
  <TERM end="665" id="V1793751" paragraph="paragraph17" rule="-SIMPLE-REF" start="615" uttnum="118">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">by Akt, with a small degree of autophosphorylation</text>
  </TERM>
  <EVENT end="751" id="V1807451" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="699" uttnum="119">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="751" id="V1807451" start="699">
      <type>ONT::PHOSPHORYLATION</type>
      <text>substantial phosphorylation of Ser491 in</text>
    </predicate>
    <site end="751" id="V1807463" start="730">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser491 in</text>
    </site>
    <text>substantial phosphorylation of Ser491 in</text>
  </EVENT>
  <TERM end="751" id="V1807463" paragraph="paragraph17" rule="-SIMPLE-REF" start="730" uttnum="119">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser491 in</text>
  </TERM>
  <TERM end="775" id="V1807605" paragraph="paragraph17" rule="-SIMPLE-REF" start="766" uttnum="119">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complex,</text>
  </TERM>
  <EVENT end="813" id="V1807631" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="779" uttnum="119">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="813" id="V1807631" start="779">
      <type>ONT::PHOSPHORYLATION</type>
      <text>slight phosphorylation of Ser</text>
    </predicate>
    <site end="813" id="V1807643" start="805">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>slight phosphorylation of Ser</text>
  </EVENT>
  <TERM end="813" id="V1807643" paragraph="paragraph17" rule="-SIMPLE-REF" start="805" uttnum="119">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="860" id="V1819331" paragraph="paragraph17" rule="-ROBUSTPRO" start="855" uttnum="119">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>they</text>
  </TERM>
  <TERM dbid="MESH:D000255" end="886" id="V1819385" paragraph="paragraph17" rule="-SIMPLE-REF" start="880" uttnum="119">
    <type>ONT::MOLECULE</type>
    <name>MGATP</name>
    <text>MgATP</text>
  </TERM>
  <EVENT end="988" id="V1833178" paragraph="paragraph17" rule="-RULE30_AGENT_FORMAL-AGENT" start="893" uttnum="119">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="988" id="V1833178" start="893">
      <type>ONT::INHIBIT</type>
      <text>these effects were completely abolished by D157A mutations that rendered the complexes inactive</text>
    </predicate>
    <arg1 id="V1833282" role=":AGENT"/>
    <text>these effects were completely abolished by D157A mutations that rendered the complexes inactive</text>
  </EVENT>
  <TERM end="988" id="V1833282" paragraph="paragraph17" rule="-INEVENT2B,-SIMPLE-REF-MUTATION8" start="933" uttnum="119">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
      <inevent>
        <event id="V1833307"/>
      </inevent>
    </features>
    <name>MUTATIONS</name>
    <text>by D157A mutations that rendered the complexes inactive</text>
  </TERM>
  <TERM end="942" id="V1833276" paragraph="paragraph17" rule="-SIMPLE-REF" start="936" uttnum="119">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>157</pos>
      <aa-from>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">D157A</text>
  </TERM>
  <EVENT end="988" id="V1833307" paragraph="paragraph17" rule="-RULE10_AGENT_AFFECTED" start="933" uttnum="119">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="988" id="V1833307" start="933">
      <type>ONT::MODULATE</type>
      <text>by D157A mutations that rendered the complexes inactive</text>
    </predicate>
    <arg1 id="V1833282" role=":AGENT"/>
    <arg2 id="V1833325" role=":AFFECTED"/>
    <text>by D157A mutations that rendered the complexes inactive</text>
  </EVENT>
  <TERM end="980" id="V1833325" paragraph="paragraph17" rule="-SIMPLE-REF" start="966" uttnum="119">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>the complexes</text>
  </TERM>
  <TERM end="1007" id="V1847830" paragraph="paragraph17" rule="-SIMPLE-REF" start="999" uttnum="119">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="1054" id="V1847900" paragraph="paragraph17" rule="-SIMPLE-REF" start="1047" uttnum="119">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">by Akt</text>
  </TERM>
  <TERM end="1078" id="V1847974" paragraph="paragraph17" rule="-SIMPLE-REF-MODACTIVE2,-SIMPLE-REF" start="1057" uttnum="119">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <active>FALSE</active>
    </features>
    <name>COMPLEX</name>
    <text>the inactive complex</text>
  </TERM>
  <TERM end="1092" id="V1847989" paragraph="paragraph17" rule="-SIMPLE-REF" start="1085" uttnum="119">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="1101" id="V1848013" paragraph="paragraph17" rule="-SIMPLE-REF" start="1092" uttnum="119">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>2B</text>
  </TERM>
  <TERM end="1143" id="V1862943" paragraph="paragraph17" rule="-SIMPLE-REF" start="1111" uttnum="120">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>the equivalent α1β2γ1 complexes,</text>
  </TERM>
  <TERM end="1167" id="V1868549" paragraph="paragraph17" rule="-SIMPLE-REF-MUTATION8" start="1150" uttnum="120">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>the S487D mutant</text>
  </TERM>
  <EVENT end="1186" id="V1868573" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-LOC9-AFFECTED" start="1150" uttnum="120">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1186" id="V1868573" start="1150">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the S487D mutant was phosphorylated</text>
    </predicate>
    <arg2 id="V1868549" role=":AFFECTED"/>
    <site end="1160" id="V1868546" start="1154">
      <type>ONT::MUTATION</type>
      <text normalization="">S487D</text>
    </site>
    <text>the S487D mutant was phosphorylated</text>
  </EVENT>
  <TERM end="1160" id="V1868546" paragraph="paragraph17" rule="-SIMPLE-REF" start="1154" uttnum="120">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487D</text>
  </TERM>
  <TERM end="1225" id="V1868678" paragraph="paragraph17" rule="-SIMPLE-REF" start="1209" uttnum="120">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>Figure 1E</text>
  </TERM>
  <TERM end="1225" id="V1868660" paragraph="paragraph17" rule="-SIMPLE-REF" start="1209" uttnum="120">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 1E</text>
  </TERM>
  <TERM end="1234" id="V1883214" paragraph="paragraph17" rule="-SIMPLE-REF-MUTATION7" start="1228" uttnum="120">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILDTYPE</name>
    <text>the WT</text>
  </TERM>
  <TERM end="1242" id="V1883278" paragraph="paragraph17" rule="-SIMPLE-REF" start="1236" uttnum="120">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>491</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S491A</text>
  </TERM>
  <TERM end="1252" id="V1883326" paragraph="paragraph17" rule="-SIMPLE-REF" start="1246" uttnum="120">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>491</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S491D</text>
  </TERM>
  <TERM end="1276" id="V1883371" paragraph="paragraph17" rule="-SIMPLE-REF" start="1266" uttnum="120">
    <type>ONT::FACILITY</type>
    <name>COMPLEX</name>
    <text>complexes</text>
  </TERM>
  <TERM end="1307" id="V1883429" paragraph="paragraph17" rule="-INEVENT2B,-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="1281" uttnum="120">
    <type>ONT::AMINO-ACID</type>
    <features>
      <active>TRUE</active>
    </features>
    <name>THR</name>
    <text>phosphorylated on Thr</text>
  </TERM>
  <EVENT end="1307" id="V1883397" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="1281" uttnum="120">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1307" id="V1883397" start="1281">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylated on Thr</text>
    </predicate>
    <site end="1307" id="V1883429" start="1281">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">phosphorylated on Thr</text>
    </site>
    <text>phosphorylated on Thr</text>
  </EVENT>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="1364" id="V1883497" paragraph="paragraph17" rule="-SIMPLE-REF" start="1335" uttnum="120">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1 (Figure 2C)</text>
  </TERM>
  <TERM end="1363" id="V1883507" paragraph="paragraph17" rule="-SIMPLE-REF" start="1347" uttnum="120">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 2C</text>
  </TERM>
  <TERM end="6" id="V1895264" paragraph="paragraph18" rule="-ROBUSTPRO" start="3" uttnum="121">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="78" id="V1895279" paragraph="paragraph18" rule="-SIMPLE-REF" start="23" uttnum="121">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDES</name>
    <text>peptides corresponding to the sequences around Ser</text>
  </TERM>
  <TERM end="78" id="V1895335" paragraph="paragraph18" rule="-SIMPLE-REF" start="70" uttnum="121">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="131" id="V1895424" paragraph="paragraph18" rule="-SIMPLE-REF" start="123" uttnum="121">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="120" id="V1895368" paragraph="paragraph18" rule="-SIMPLE-REF" start="91" uttnum="121">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat α1 (S485, TPQRSGSISNYRS)</text>
  </TERM>
  <TERM end="105" id="V1895397" paragraph="paragraph18" rule="-SIMPLE-REF" start="99" uttnum="121">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>485</pos>
      </site>
    </features>
    <name>S-485</name>
    <text>S485,</text>
  </TERM>
  <TERM end="178" id="V1895487" paragraph="paragraph18" rule="-SIMPLE-REF" start="158" uttnum="121">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>491</pos>
      </site>
    </features>
    <name>S-491</name>
    <text>S491, TPQRSCSAAGLHR)</text>
  </TERM>
  <TERM end="147" id="V1895195" paragraph="paragraph18" rule="-SIMPLE-REF" start="144" uttnum="121">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat</text>
  </TERM>
  <TERM end="154" id="V1895207" paragraph="paragraph18" rule="-SIMPLE-REF" start="148" uttnum="121">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>human</text>
  </TERM>
  <TERM end="217" id="V1895573" paragraph="paragraph18" rule="-SIMPLE-REF" start="201" uttnum="121">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATES</name>
    <text>AMPK substrates</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="206" id="V1895566" paragraph="paragraph18" rule="-SIMPLE-REF" start="201" uttnum="121">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="266" id="V1895607" paragraph="paragraph18" rule="-SIMPLE-REF" start="222" uttnum="121">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>the classical SAMS peptide [36]</text>
  </TERM>
  <TERM dbid="UP:Q00266|HGNC:6903" end="241" id="V1895602" paragraph="paragraph18" rule="-SIMPLE-REF" start="236" uttnum="121">
    <type>ONT::GENE</type>
    <name>SAMS</name>
    <text>SAMS</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="294" id="V1907323" paragraph="paragraph18" rule="-SIMPLE-REF" start="277" uttnum="122">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>the SAMS peptide</text>
  </TERM>
  <TERM end="324" id="V1907406" paragraph="paragraph18" rule="-SIMPLE-REF" start="305" uttnum="122">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATE</name>
    <text>the best substrate,</text>
  </TERM>
  <TERM dbid="UP:Q00266|HGNC:6903" end="286" id="V1907318" paragraph="paragraph18" rule="-SIMPLE-REF" start="281" uttnum="122">
    <type>ONT::GENE</type>
    <name>SAMS</name>
    <text>SAMS</text>
  </TERM>
  <EVENT end="365" id="V1912015" paragraph="paragraph18" rule="-RULE60_AGENT_AFFECTED-LOC9-AFFECTED" start="325" uttnum="122">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="365" id="V1912015" start="325">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the S491 peptide was also phosphorylated</text>
    </predicate>
    <arg2 id="V1911988" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000047"/>
    <site end="334" id="V1911983" start="329">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">S491</text>
    </site>
    <text>the S491 peptide was also phosphorylated</text>
  </EVENT>
  <TERM dbid="CHEBI:16670" end="342" id="V1911988" paragraph="paragraph18" rule="-SIMPLE-REF" start="325" uttnum="122">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>the S491 peptide</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1912015"/>
    </not-features>
  </TERM>
  <TERM end="334" id="V1911983" paragraph="paragraph18" rule="-SIMPLE-REF" start="329" uttnum="122">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>491</pos>
      </site>
    </features>
    <name>S-491</name>
    <text>S491</text>
  </TERM>
  <EVENT end="421" id="V1912590" paragraph="paragraph18" rule="-RULE60_AGENT_AFFECTED-LOC9-AFFECTED" start="375" uttnum="122">
    <type>ONT::PHOSPHORYLATION</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <predicate end="421" id="V1912590" start="375">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the S485 peptide was not phosphorylated at all</text>
    </predicate>
    <arg2 id="V1912553" role=":AFFECTED"/>
    <site end="384" id="V1912548" start="379">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">S485</text>
    </site>
    <text>the S485 peptide was not phosphorylated at all</text>
  </EVENT>
  <TERM dbid="CHEBI:16670" end="392" id="V1912553" paragraph="paragraph18" rule="-SIMPLE-REF" start="375" uttnum="122">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>the S485 peptide</text>
  </TERM>
  <TERM end="384" id="V1912548" paragraph="paragraph18" rule="-SIMPLE-REF" start="379" uttnum="122">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>485</pos>
      </site>
    </features>
    <name>S-485</name>
    <text>S485</text>
  </TERM>
  <TERM end="435" id="V1921179" paragraph="paragraph18" rule="-SIMPLE-REF" start="423" uttnum="123">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>The results</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="513" id="V1921230" paragraph="paragraph18" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="455" uttnum="123">
    <type>ONT::GENE-PROTEIN</type>
    <features>
      <location id="V1921219"/>
    </features>
    <name>AMPK</name>
    <text>rat liver AMPK (a mixture of α1β1γ1 and α2β1γ1 complexes)</text>
  </TERM>
  <TERM end="513" id="V1921219" paragraph="paragraph18" rule="-SIMPLE-REF" start="455" uttnum="123">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>LIVER</name>
    <text>rat liver AMPK (a mixture of α1β1γ1 and α2β1γ1 complexes)</text>
  </TERM>
  <TERM end="513" id="V1921216" paragraph="paragraph18" rule="-SIMPLE-REF" start="455" uttnum="123">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat liver AMPK (a mixture of α1β1γ1 and α2β1γ1 complexes)</text>
  </TERM>
  <TERM dbid="CHEBI:60004" end="511" id="V1921279" paragraph="paragraph18" rule="-SIMPLE-REF" start="471" uttnum="123">
    <type>ONT::CHEMICAL</type>
    <name>MIXTURE</name>
    <text>a mixture of α1β1γ1 and α2β1γ1 complexes</text>
  </TERM>
  <TERM end="511" id="V1921363" paragraph="paragraph18" rule="-SIMPLE-REF" start="495" uttnum="123">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>α2β1γ1 complexes</text>
  </TERM>
  <TERM end="591" id="V1921478" paragraph="paragraph18" rule="-SIMPLE-REF" start="550" uttnum="123">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>α2β2γ1 complexes (Figure 2D)</text>
  </TERM>
  <TERM end="590" id="V1921516" paragraph="paragraph18" rule="-SIMPLE-REF" start="574" uttnum="123">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 2D</text>
  </TERM>
  <TERM end="590" id="V1921491" paragraph="paragraph18" rule="-SIMPLE-REF" start="574" uttnum="123">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 2D</text>
  </TERM>
  <TERM end="6" id="V1932870" paragraph="paragraph19" rule="-ROBUSTPRO" start="3" uttnum="124">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <EVENT end="133" id="V1932948" paragraph="paragraph19" rule="-RULE20C_AFFECTED_AFFECTED1-AFFECTED1" start="39" uttnum="124">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="133" id="V1932948" start="39">
      <type>ONT::BIND</type>
      <text>complex with Akt under conditions where we obtained stoichiometric phosphorylation of Ser</text>
    </predicate>
    <arg2 id="V1932974" role=":AFFECTED1"/>
    <site end="133" id="V1933027" start="125">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>complex with Akt under conditions where we obtained stoichiometric phosphorylation of Ser</text>
  </EVENT>
  <TERM end="56" id="V1932974" paragraph="paragraph19" rule="-SIMPLE-REF" start="47" uttnum="124">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">with Akt</text>
  </TERM>
  <TERM end="82" id="V1933002" paragraph="paragraph19" rule="-ROBUSTPRO" start="79" uttnum="124">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="133" id="V1933015" paragraph="paragraph19" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="91" uttnum="124">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="133" id="V1933015" start="91">
      <type>ONT::PHOSPHORYLATION</type>
      <text>stoichiometric phosphorylation of Ser</text>
    </predicate>
    <site end="133" id="V1933027" start="125">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>stoichiometric phosphorylation of Ser</text>
  </EVENT>
  <TERM end="133" id="V1933027" paragraph="paragraph19" rule="-SIMPLE-REF" start="125" uttnum="124">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="231" id="V1933088" paragraph="paragraph19" rule="-EXPLICIT-REF-SEQ0" start="174" uttnum="124">
    <type>ONT::FACILITY</type>
    <components>
      <component id="V1933079"/>
    </components>
    <text normalization="">the LKB1 complex under conditions where we could measure</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="231" id="V1933079" paragraph="paragraph19" rule="-EXPLICIT-REF-SEQ0-TERM" start="174" uttnum="124">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>the LKB1 complex under conditions where we could measure</text>
  </TERM>
  <TERM end="217" id="V1933122" paragraph="paragraph19" rule="-ROBUSTPRO" start="214" uttnum="124">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="259" id="V1933181" paragraph="paragraph19" rule="-SIMPLE-REF" start="248" uttnum="124">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>of Thr</text>
  </TERM>
  <TERM end="366" id="V1944548" paragraph="paragraph19" rule="-SIMPLE-REF-MODACTIVE2,-SIMPLE-REF" start="320" uttnum="125">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <active>FALSE</active>
    </features>
    <name>COMPLEX</name>
    <text>the inactive complex (Figure 1F),</text>
  </TERM>
  <TERM end="364" id="V1944579" paragraph="paragraph19" rule="-SIMPLE-REF" start="348" uttnum="125">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>F</name>
    <text>Figure 1F</text>
  </TERM>
  <TERM end="364" id="V1944563" paragraph="paragraph19" rule="-SIMPLE-REF" start="348" uttnum="125">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 1F</text>
  </TERM>
  <EVENT end="442" id="V1952062" paragraph="paragraph19" rule="-RULE20_AGENT_AFFECTED" start="367" uttnum="125">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="442" id="V1952062" start="367">
      <type>ONT::DECREASE</type>
      <text>prior Akt phosphorylation reduced the rate of subsequent Thr172</text>
    </predicate>
    <arg1 id="V1952056" role=":AGENT"/>
    <arg2 id="V1952096" role=":AFFECTED"/>
    <text>prior Akt phosphorylation reduced the rate of subsequent Thr172</text>
  </EVENT>
  <EVENT end="393" id="V1952056" paragraph="paragraph19" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="367" uttnum="125">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="393" id="V1952056" start="367">
      <type>ONT::PHOSPHORYLATION</type>
      <text>prior Akt phosphorylation</text>
    </predicate>
    <arg2 id="V1952053" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000052"/>
    <text>prior Akt phosphorylation</text>
  </EVENT>
  <TERM end="432" id="V1952096" paragraph="paragraph19" rule="-SIMPLE-REF" start="424" uttnum="125">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="377" id="V1952053" paragraph="paragraph19" rule="-SIMPLE-REF" start="367" uttnum="125">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">prior Akt</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1952056"/>
    </not-features>
  </TERM>
  <TERM end="481" id="V1952112" paragraph="paragraph19" rule="-SIMPLE-REF" start="465" uttnum="125">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3A</text>
  </TERM>
  <TERM end="513" id="V1969053" paragraph="paragraph19" rule="-SIMPLE-REF" start="505" uttnum="125">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complex</text>
  </TERM>
  <EPI end="593" id="V1969094" paragraph="paragraph19" rule="-RULE50_0_AGENT_FORMAL-NONE" start="513" uttnum="125">
    <type>ONT::OBSERVE</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::COULD</modality>
    <text>this could also be seen to be associated with a reduction in activation by LKB1</text>
  </EPI>
  <EPI end="593" id="V1969154" paragraph="paragraph19" rule="-RULE50_0_NEUTRAL1_NEUTRAL2-NEUTRAL2" start="540" uttnum="125">
    <type>ONT::ASSOCIATE</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1969308" role=":NEUTRAL"/>
    <text>be associated with a reduction in activation by LKB1</text>
  </EPI>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="593" id="V1969308" paragraph="paragraph19" rule="-SIMPLE-REF" start="585" uttnum="125">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1</text>
  </TERM>
  <MODALITY end="593" id="X1984062" paragraph="paragraph19" rule="-RULE50_0_AGENT_NEUTRAL-MODALITY" start="513" uttnum="125">
    <type>ONT::CONDITIONAL</type>
    <arg2 id="V1969094" role=":EPI"/>
    <text>this could also be seen to be associated with a reduction in activation by LKB1</text>
  </MODALITY>
  <TERM end="628" id="V1969338" paragraph="paragraph19" rule="-SIMPLE-REF" start="621" uttnum="125">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="637" id="V1969362" paragraph="paragraph19" rule="-SIMPLE-REF" start="636" uttnum="125">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <EVENT end="689" id="V1981368" paragraph="paragraph19" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="671" uttnum="125">
    <type>ONT::TRANSFORM</type>
    <predicate end="689" id="V1981368" start="671">
      <type>ONT::TRANSFORM</type>
      <text>an S487A mutation</text>
    </predicate>
    <arg2 id="V1981365" role=":AFFECTED"/>
    <text>an S487A mutation</text>
  </EVENT>
  <TERM end="680" id="V1981365" paragraph="paragraph19" rule="-SIMPLE-REF" start="674" uttnum="125">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="707" id="V1981400" paragraph="paragraph19" rule="-SIMPLE-REF" start="696" uttnum="125">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="703" id="V1981391" paragraph="paragraph19" rule="-SIMPLE-REF" start="700" uttnum="125">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <EPI end="784" id="V1995667" paragraph="paragraph19" rule="-RULE50_0_AGENT_FORMAL" start="715" uttnum="126">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg1 id="V1995618" role=":AGENT"/>
    <arg2 id="V1995706" role=":FORMAL"/>
    <text>Figure 3(C) shows that the inhibitory effect of prior Ser</text>
  </EPI>
  <TERM end="734" id="V1995618" paragraph="paragraph19" rule="-SIMPLE-REF" start="715" uttnum="126">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3(C)</text>
  </TERM>
  <EVENT end="784" id="V1995706" paragraph="paragraph19" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE10_AGENT_AFFECTED-AGENT" start="715" uttnum="126">
    <type>ONT::MODULATE</type>
    <epistemic-modality id="V1995667"/>
    <predicate end="784" id="V1995706" start="715">
      <type>ONT::MODULATE</type>
      <text>Figure 3(C) shows that the inhibitory effect of prior Ser</text>
    </predicate>
    <arg1 id="V1995731" role=":AGENT"/>
    <text>Figure 3(C) shows that the inhibitory effect of prior Ser</text>
  </EVENT>
  <TERM end="784" id="V1995731" paragraph="paragraph19" rule="-SIMPLE-REF" start="767" uttnum="126">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>of prior Ser</text>
  </TERM>
  <EVENT end="821" id="V1995737" paragraph="paragraph19" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="794" uttnum="126">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="821" id="V1995737" start="794">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation on Thr</text>
    </predicate>
    <site end="821" id="V1995769" start="813">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>phosphorylation on Thr</text>
  </EVENT>
  <TERM end="821" id="V1995769" paragraph="paragraph19" rule="-SIMPLE-REF" start="813" uttnum="126">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="856" id="V1995790" paragraph="paragraph19" rule="-SIMPLE-REF" start="851" uttnum="126">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <EVENT end="980" id="V1995793" paragraph="paragraph19" rule="-RULE40A_AGENT_AFFECTED-LOC5-GD-NONE" start="856" uttnum="126">
    <type>ONT::ACTIVATE</type>
    <predicate end="980" id="V1995793" start="856">
      <type>ONT::ACTIVATE</type>
      <text>activation was identical using either LKB1 or CaMKKβ, showing that the effect is independent of the upstream kinase utilized</text>
    </predicate>
    <site end="980" id="V1995885" start="871">
      <type>ONT::CORRELATION</type>
      <text normalization="SHOW">identical using either LKB1 or CaMKKβ, showing that the effect is independent of the upstream kinase utilized</text>
    </site>
    <text>activation was identical using either LKB1 or CaMKKβ, showing that the effect is independent of the upstream kinase utilized</text>
  </EVENT>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="899" id="V1995835" paragraph="paragraph19" rule="-SIMPLE-REF" start="894" uttnum="126">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1</text>
  </TERM>
  <TERM dbid="GO:0016301" end="980" id="V1995977" paragraph="paragraph19" rule="-INEVENT2B,-SIMPLE-REF" start="952" uttnum="126">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V1995988"/>
      </inevent>
    </features>
    <name>KINASE</name>
    <text>the upstream kinase utilized</text>
  </TERM>
  <CC end="980" id="V1995988" paragraph="paragraph19" rule="-RULE5B_AGENT_AFFECTED-AFFECTED" start="952" uttnum="126">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1995977" role=":OUTCOME"/>
    <text>the upstream kinase utilized</text>
  </CC>
  <TERM end="34" id="V2008879" paragraph="paragraph20" rule="-SIMPLE-REF" start="26" uttnum="127">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="75" id="V2008885" paragraph="paragraph20" rule="-RULE60_AGENT_AFFECTED-CELL_LOC2-GD-OTHERS-NONE" start="44" uttnum="127">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="75" id="V2008885" start="44">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation in intact cells</text>
    </predicate>
    <location end="75" id="V2008945" mod="null" start="63">
      <type>ONT::CELL</type>
      <text normalization="">intact cells</text>
    </location>
    <text>phosphorylation in intact cells</text>
  </EVENT>
  <TERM end="75" id="V2008945" paragraph="paragraph20" rule="-SIMPLE-REF" start="63" uttnum="127">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>intact cells</text>
  </TERM>
  <TERM end="80" id="V2011202" paragraph="paragraph20" rule="-ROBUSTPRO" start="77" uttnum="127">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="164" id="V2011242" paragraph="paragraph20" rule="-SIMPLE-REF" start="90" uttnum="127">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>isogenic HEK-293 cells stably expressing FLAG-tagged WT AMPK-α1 or AMPK-α2</text>
  </TERM>
  <TERM dbid="EFO:0001182|CVCL:0045" end="107" id="V2011238" paragraph="paragraph20" rule="-SIMPLE-REF" start="99" uttnum="127">
    <type>ONT::CELL-LINE</type>
    <name>HEK-293</name>
    <text>HEK-293</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="161" id="V2010763" paragraph="paragraph20" rule="-SIMPLE-REF" start="157" uttnum="127">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="198" id="V2011480" paragraph="paragraph20" rule="-SIMPLE-REF" start="193" uttnum="127">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="209" id="V2011496" paragraph="paragraph20" rule="-SIMPLE-REF-MUTATION8" start="200" uttnum="127">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>α1 mutant</text>
  </TERM>
  <TERM end="214" id="V2023668" paragraph="paragraph20" rule="-ROBUSTPRO" start="211" uttnum="128">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="241" id="V2023715" paragraph="paragraph20" rule="-ROBUSTPRO" start="236" uttnum="128">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>that</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="271" id="V2023739" paragraph="paragraph20" rule="-SIMPLE-REF" start="246" uttnum="128">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK-β [16]</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="280" id="V2023781" paragraph="paragraph20" rule="-SIMPLE-REF" start="274" uttnum="128">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK-γ</text>
  </TERM>
  <TERM end="341" id="V2026659" paragraph="paragraph20" rule="-SIMPLE-REF" start="328" uttnum="128">
    <type>ONT::AGENT</type>
    <name>SYSTEM</name>
    <text>this system,</text>
  </TERM>
  <TERM end="443" id="V2026762" paragraph="paragraph20" rule="-SIMPLE-REF" start="431" uttnum="128">
    <type>ONT::FAMILY-RELATION</type>
    <name>PARTNER</name>
    <text>α/β partners</text>
  </TERM>
  <EVENT end="616" id="V2044278" paragraph="paragraph20" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="499" uttnum="129">
    <type>ONT::PPEXPT</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::COULD</modality>
    <predicate end="616" id="V2044278" start="499">
      <type>ONT::PPEXPT</type>
      <text>in the present study because we showed that approximately 70% of the total AMPK activity could be immunoprecipitated</text>
    </predicate>
    <arg2 id="V2052837" role=":AFFECTED"/>
    <text>in the present study because we showed that approximately 70% of the total AMPK activity could be immunoprecipitated</text>
  </EVENT>
  <EVENT end="588" id="V2052837" paragraph="paragraph20" rule="-ACTIVITY1" start="543" uttnum="129">
    <type>ONT::ACTIVITY</type>
    <predicate end="588" id="V2052837" start="543">
      <type>ONT::ACTIVITY</type>
      <text>approximately 70% of the total AMPK activity</text>
    </predicate>
    <arg1 id="V2044240" role=":AGENT"/>
    <text>approximately 70% of the total AMPK activity</text>
  </EVENT>
  <TERM end="531" id="V2044165" paragraph="paragraph20" rule="-ROBUSTPRO" start="528" uttnum="129">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="579" id="V2044240" paragraph="paragraph20" rule="-SIMPLE-REF" start="564" uttnum="129">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>the total AMPK</text>
  </TERM>
  <MODALITY end="616" id="X2061890" paragraph="paragraph20" rule="-MODALITY" start="499" uttnum="129">
    <type>ONT::CONDITIONAL</type>
    <arg2 id="V2044278" role=":EVENT"/>
    <text>in the present study because we showed that approximately 70% of the total AMPK activity could be immunoprecipitated</text>
  </MODALITY>
  <TERM dbid="GO:0042571" end="665" id="V2044331" paragraph="paragraph20" rule="-SIMPLE-REF" start="632" uttnum="129">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODY</name>
    <text>antibody, with the remaining 30%</text>
  </TERM>
  <TERM dbid="CHEBI:30216|CHEBI:669" end="716" id="V2044454" paragraph="paragraph20" rule="-SIMPLE-REF" start="714" uttnum="129">
    <type>ONT::MOLECULE</type>
    <name>Α</name>
    <text>α</text>
  </TERM>
  <TERM dbid="GO:0042571" end="793" id="V2044530" paragraph="paragraph20" rule="-SIMPLE-REF" start="783" uttnum="129">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM dbid="CHEBI:30216|CHEBI:669" end="842" id="V2059004" paragraph="paragraph20" rule="-SIMPLE-REF" start="840" uttnum="130">
    <type>ONT::MOLECULE</type>
    <name>Α</name>
    <text>α</text>
  </TERM>
  <TERM end="903" id="V2059082" paragraph="paragraph20" rule="-SIMPLE-REF" start="882" uttnum="130">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>of the kinase assays</text>
  </TERM>
  <TERM dbid="GO:0016301" end="896" id="V2059067" paragraph="paragraph20" rule="-SIMPLE-REF" start="889" uttnum="130">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="933" id="V2059167" paragraph="paragraph20" rule="-SIMPLE-REF" start="918" uttnum="130">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4</text>
  </TERM>
  <TERM end="997" id="V2074738" paragraph="paragraph20" rule="-SIMPLE-REF" start="935" uttnum="130">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>which were conducted in anti-FLAG antibody immunoprecipitates,</text>
  </TERM>
  <TERM dbid="GO:0042571" end="997" id="V2074851" paragraph="paragraph20" rule="-SIMPLE-REF" start="959" uttnum="130">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODY</name>
    <text>anti-FLAG antibody immunoprecipitates,</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1028" id="V2080573" paragraph="paragraph20" rule="-SIMPLE-REF" start="1024" uttnum="130">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="1064" id="V2080672" paragraph="paragraph20" rule="-SIMPLE-REF" start="1052" uttnum="130">
    <type>ONT::FOOD</type>
    <name>WESTERN</name>
    <text>the Western</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1132" id="V2080862" paragraph="paragraph20" rule="-INEVENT2B,-SIMPLE-REF-MUTATION1,-SIMPLE-REF" start="1108" uttnum="130">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <mutation id="V2080836"/>
      <ptm event="V2080795" type="ONT::PHOSPHORYLATION"/>
    </features>
    <name>ANTIBODY</name>
    <text>the anti-pS487 antibody</text>
  </TERM>
  <EVENT end="1132" id="V2080795" paragraph="paragraph20" rule="-PHOSPHO" start="1108" uttnum="130">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1132" id="V2080795" start="1108">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the anti-pS487 antibody</text>
    </predicate>
    <arg2 id="V2080862" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000010"/>
    <text>the anti-pS487 antibody</text>
  </EVENT>
  <TERM end="1123" id="V2080836" paragraph="paragraph20" rule="-SIMPLE-REF" start="1118" uttnum="130">
    <type>ONT::MUTATION</type>
    <mutation>ONT::TRUE</mutation>
    <text normalization="">S487</text>
  </TERM>
  <TERM end="1172" id="V2080926" paragraph="paragraph20" rule="-INEVENT2B,-SIMPLE-REF" start="1135" uttnum="130">
    <type>ONT::CELL</type>
    <features>
      <inevent>
        <event id="V2080938"/>
      </inevent>
    </features>
    <name>CELL</name>
    <text>the cells expressing the S487A mutant</text>
  </TERM>
  <EVENT end="1172" id="V2080938" paragraph="paragraph20" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC9" start="1135" uttnum="130">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="1172" id="V2080938" start="1135">
      <type>ONT::EXPRESS</type>
      <text>the cells expressing the S487A mutant</text>
    </predicate>
    <arg1 id="V2080926" role=":AGENT"/>
    <arg2 id="V2081008" role=":AFFECTED-RESULT"/>
    <site end="1166" id="V2081005" start="1160">
      <type>ONT::MUTATION</type>
      <text normalization="">S487A</text>
    </site>
    <text>the cells expressing the S487A mutant</text>
  </EVENT>
  <TERM end="1172" id="V2081008" paragraph="paragraph20" rule="-SIMPLE-REF-MUTATION8" start="1156" uttnum="130">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>the S487A mutant</text>
  </TERM>
  <TERM end="1166" id="V2081005" paragraph="paragraph20" rule="-SIMPLE-REF" start="1160" uttnum="130">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="32" id="V2099332" paragraph="paragraph21" rule="-SIMPLE-REF" start="3" uttnum="131">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>The cells expressing AMPK-α1</text>
  </TERM>
  <TERM dbid="UP:P05019" end="90" id="V2100392" paragraph="paragraph21" rule="-SIMPLE-REF" start="84" uttnum="131">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <EVENT end="105" id="V2100421" paragraph="paragraph21" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="93" uttnum="131">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="105" id="V2100421" start="93">
      <type>ONT::ACTIVATE</type>
      <text>activate Akt</text>
    </predicate>
    <arg2 id="V2100428" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000167"/>
    <text>activate Akt</text>
  </EVENT>
  <TERM end="105" id="V2100428" paragraph="paragraph21" rule="-SIMPLE-REF" start="102" uttnum="131">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <CC end="205" id="V2103835" paragraph="paragraph21" rule="-RULE5B_AGENT_AFFECTED" start="120" uttnum="132">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2103830" role=":FACTOR"/>
    <arg id="V2103912" role=":OUTCOME"/>
    <text>IGF-1 resulted in marked increases in phosphorylation of the activating sites on Akt</text>
  </CC>
  <TERM dbid="UP:P05019" end="126" id="V2103830" paragraph="paragraph21" rule="-SIMPLE-REF" start="120" uttnum="132">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <EVENT end="155" id="V2103912" paragraph="paragraph21" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="135" uttnum="132">
    <type>ONT::TRANSFORM</type>
    <predicate end="155" id="V2103912" start="135">
      <type>ONT::TRANSFORM</type>
      <text>in marked increases</text>
    </predicate>
    <text>in marked increases</text>
  </EVENT>
  <EVENT end="205" id="V2103979" paragraph="paragraph21" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="158" uttnum="132">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="205" id="V2103979" start="158">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of the activating sites on Akt</text>
    </predicate>
    <site end="198" id="V2104002" start="174">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">of the activating sites</text>
    </site>
    <text>phosphorylation of the activating sites on Akt</text>
  </EVENT>
  <TERM end="198" id="V2104002" paragraph="paragraph21" rule="-INEVENT2B,-SIMPLE-REF" start="174" uttnum="132">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <inevent>
        <event id="V2103997"/>
      </inevent>
    </features>
    <name>SITE</name>
    <text>of the activating sites</text>
  </TERM>
  <EVENT end="198" id="V2103997" paragraph="paragraph21" rule="-RULE40A_AGENT_AFFECTED-AGENT" start="174" uttnum="132">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="198" id="V2103997" start="174">
      <type>ONT::ACTIVATE</type>
      <text>of the activating sites</text>
    </predicate>
    <arg1 id="V2104002" role=":AGENT"/>
    <text>of the activating sites</text>
  </EVENT>
  <TERM end="205" id="V2104036" paragraph="paragraph21" rule="-SIMPLE-REF" start="201" uttnum="132">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="214" id="V2104044" paragraph="paragraph21" rule="-SIMPLE-REF" start="206" uttnum="132">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="236" id="V2104062" paragraph="paragraph21" rule="-SIMPLE-REF" start="228" uttnum="132">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="313" id="V2117114" paragraph="paragraph21" rule="-ROBUSTPRO" start="248" uttnum="132">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>which were blocked by the Akt inhibitor MK2206 [41],</text>
  </TERM>
  <TERM dbid="CHEBI:67271" end="313" id="V2117192" paragraph="paragraph21" rule="-SIMPLE-REF" start="267" uttnum="132">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>by the Akt inhibitor MK2206 [41],</text>
  </TERM>
  <TERM dbid="CHEBI:35222" end="313" id="V2117182" paragraph="paragraph21" rule="-SIMPLE-REF" start="267" uttnum="132">
    <type>ONT::CHEMICAL</type>
    <name>INHIBITOR</name>
    <text>by the Akt inhibitor MK2206 [41],</text>
  </TERM>
  <TERM end="278" id="V2117177" paragraph="paragraph21" rule="-SIMPLE-REF" start="274" uttnum="132">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <EVENT end="352" id="V2123675" paragraph="paragraph21" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="321" uttnum="132">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="352" id="V2123675" start="321">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the phosphorylation of Ser</text>
    </predicate>
    <site end="352" id="V2123687" start="344">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>the phosphorylation of Ser</text>
  </EVENT>
  <TERM end="352" id="V2123687" paragraph="paragraph21" rule="-SIMPLE-REF" start="344" uttnum="132">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="368" id="V2123698" paragraph="paragraph21" rule="-SIMPLE-REF" start="360" uttnum="132">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="429" id="V2123771" paragraph="paragraph21" rule="-SIMPLE-REF" start="421" uttnum="132">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="473" id="V2123842" paragraph="paragraph21" rule="-SIMPLE-REF" start="457" uttnum="132">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4A</text>
  </TERM>
  <EVENT end="530" id="V2132797" paragraph="paragraph21" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="476" uttnum="133">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="530" id="V2132797" start="476">
      <type>ONT::MODULATE</type>
      <text>When cells expressing WT α1 were treated with A769662,</text>
    </predicate>
    <arg2 id="V2132741" role=":AFFECTED"/>
    <text>When cells expressing WT α1 were treated with A769662,</text>
  </EVENT>
  <TERM end="504" id="V2132741" paragraph="paragraph21" rule="-SIMPLE-REF" start="481" uttnum="133">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells expressing WT α1</text>
  </TERM>
  <TERM end="530" id="V2132892" paragraph="paragraph21" rule="-SIMPLE-REF" start="522" uttnum="133">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662,</text>
  </TERM>
  <EVENT end="555" id="V2146926" paragraph="paragraph21" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="531" uttnum="133">
    <type>ONT::ACTIVATE</type>
    <predicate end="555" id="V2146926" start="531">
      <type>ONT::ACTIVATE</type>
      <text>the activation of AMPK,</text>
    </predicate>
    <arg2 id="V2146940" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000172"/>
    <text>the activation of AMPK,</text>
  </EVENT>
  <TERM end="567" id="V2146958" paragraph="paragraph21" rule="-SIMPLE-REF" start="559" uttnum="133">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="553" id="V2146940" paragraph="paragraph21" rule="-SIMPLE-REF" start="546" uttnum="133">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="666" id="V2147069" paragraph="paragraph21" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="618" uttnum="133">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="666" id="V2147069" start="618">
      <type>ONT::MODULATE</type>
      <text>the cells had been exposed previously to IGF-1,</text>
    </predicate>
    <arg2 id="V2147027" role=":AFFECTED"/>
    <text>the cells had been exposed previously to IGF-1,</text>
  </EVENT>
  <TERM end="628" id="V2147027" paragraph="paragraph21" rule="-SIMPLE-REF" start="618" uttnum="133">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>the cells</text>
  </TERM>
  <TERM dbid="UP:P05019" end="666" id="V2147111" paragraph="paragraph21" rule="-SIMPLE-REF" start="659" uttnum="133">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1,</text>
  </TERM>
  <EVENT end="695" id="V2147131" paragraph="paragraph21" rule="-RULE30_AGENT_FORMAL-AGENT" start="676" uttnum="133">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="695" id="V2147131" start="676">
      <type>ONT::INHIBIT</type>
      <text>abolished by MK2206</text>
    </predicate>
    <arg1 id="V2147165" role=":AGENT"/>
    <text>abolished by MK2206</text>
  </EVENT>
  <TERM dbid="CHEBI:67271" end="695" id="V2147165" paragraph="paragraph21" rule="-SIMPLE-REF" start="686" uttnum="133">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>by MK2206</text>
  </TERM>
  <EVENT end="727" id="V2160366" paragraph="paragraph21" rule="-RULE10_AGENT_AFFECTED-AGENT" start="697" uttnum="134">
    <type>ONT::MODULATE</type>
    <predicate end="727" id="V2160366" start="697">
      <type>ONT::MODULATE</type>
      <text>The effect of IGF-1 to reduce</text>
    </predicate>
    <arg1 id="V2160392" role=":AGENT"/>
    <text>The effect of IGF-1 to reduce</text>
  </EVENT>
  <TERM dbid="UP:P05019" end="727" id="V2160392" paragraph="paragraph21" rule="-INEVENT2B,-SIMPLE-REF" start="708" uttnum="134">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V2160421"/>
      </inevent>
    </features>
    <name>IGF-1</name>
    <text>of IGF-1 to reduce</text>
  </TERM>
  <EVENT end="727" id="V2160421" paragraph="paragraph21" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="708" uttnum="134">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="727" id="V2160421" start="708">
      <type>ONT::DECREASE</type>
      <text>of IGF-1 to reduce</text>
    </predicate>
    <arg2 id="V2160392" role=":AFFECTED"/>
    <text>of IGF-1 to reduce</text>
  </EVENT>
  <EVENT end="743" id="V2160434" paragraph="paragraph21" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="727" uttnum="134">
    <type>ONT::ACTIVATE</type>
    <predicate end="743" id="V2160434" start="727">
      <type>ONT::ACTIVATE</type>
      <text>AMPK activation</text>
    </predicate>
    <arg2 id="V2160430" role=":AFFECTED"/>
    <arg id="R000177" role=":RESULT"/>
    <text>AMPK activation</text>
  </EVENT>
  <EVENT end="818" id="V2160448" paragraph="paragraph21" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="747" uttnum="134">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="818" id="V2160448" start="747">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of Thr172 correlated with increased Ser</text>
    </predicate>
    <site end="818" id="V2160460" start="766">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr172 correlated with increased Ser</text>
    </site>
    <text>phosphorylation of Thr172 correlated with increased Ser</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="732" id="V2160430" paragraph="paragraph21" rule="-SIMPLE-REF" start="727" uttnum="134">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="818" id="V2160460" paragraph="paragraph21" rule="-SIMPLE-REF" start="766" uttnum="134">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr172 correlated with increased Ser</text>
  </TERM>
  <TERM end="818" id="V2160492" paragraph="paragraph21" rule="-INEVENT2B,-SIMPLE-REF" start="795" uttnum="134">
    <type>ONT::AMINO-ACID</type>
    <features>
      <inevent>
        <event id="V2160486"/>
      </inevent>
    </features>
    <name>SER</name>
    <text>with increased Ser</text>
  </TERM>
  <EVENT end="818" id="V2160486" paragraph="paragraph21" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="795" uttnum="134">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="818" id="V2160486" start="795">
      <type>ONT::INCREASE</type>
      <text>with increased Ser</text>
    </predicate>
    <arg2 id="V2160492" role=":AFFECTED"/>
    <text>with increased Ser</text>
  </EVENT>
  <TERM end="921" id="V2160588" paragraph="paragraph21" rule="-INEVENT2B,-SIMPLE-REF" start="863" uttnum="134">
    <type>ONT::CELL</type>
    <features>
      <inevent>
        <event id="V2160600"/>
      </inevent>
    </features>
    <name>CELL</name>
    <text>cells expressing the S487A mutant (Figure 4B)</text>
  </TERM>
  <EVENT end="921" id="V2160600" paragraph="paragraph21" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC9" start="863" uttnum="134">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="921" id="V2160600" start="863">
      <type>ONT::EXPRESS</type>
      <text>cells expressing the S487A mutant (Figure 4B)</text>
    </predicate>
    <arg1 id="V2160588" role=":AGENT"/>
    <arg2 id="V2160670" role=":AFFECTED-RESULT"/>
    <site end="890" id="V2160667" start="884">
      <type>ONT::MUTATION</type>
      <text normalization="">S487A</text>
    </site>
    <text>cells expressing the S487A mutant (Figure 4B)</text>
  </EVENT>
  <TERM end="921" id="V2160670" paragraph="paragraph21" rule="-SIMPLE-REF-MUTATION8" start="880" uttnum="134">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>the S487A mutant (Figure 4B)</text>
  </TERM>
  <TERM end="890" id="V2160667" paragraph="paragraph21" rule="-SIMPLE-REF" start="884" uttnum="134">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="920" id="V2160706" paragraph="paragraph21" rule="-SIMPLE-REF" start="904" uttnum="134">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>Figure 4B</text>
  </TERM>
  <TERM end="920" id="V2160682" paragraph="paragraph21" rule="-SIMPLE-REF" start="904" uttnum="134">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4B</text>
  </TERM>
  <TERM end="28" id="V2173725" paragraph="paragraph22" rule="-SIMPLE-REF" start="9" uttnum="135">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4(C)</text>
  </TERM>
  <TERM end="70" id="V2173791" paragraph="paragraph22" rule="-SIMPLE-REF" start="34" uttnum="135">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>results obtained when serum-starved</text>
  </TERM>
  <TERM end="98" id="V2173840" paragraph="paragraph22" rule="-SIMPLE-REF" start="70" uttnum="135">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells expressing WT AMPK-α1</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="98" id="V2173869" paragraph="paragraph22" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="87" uttnum="135">
    <type>ONT::GENE-PROTEIN</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>AMPK</name>
    <text>WT AMPK-α1</text>
  </TERM>
  <TERM dbid="UP:P05019" end="140" id="V2173953" paragraph="paragraph22" rule="-SIMPLE-REF" start="134" uttnum="135">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <TERM dbid="CHEBI:16118" end="157" id="V2173976" paragraph="paragraph22" rule="-SIMPLE-REF" start="148" uttnum="135">
    <type>ONT::MOLECULE</type>
    <name>BERBERINE</name>
    <text>berberine</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="105" id="V2173280" paragraph="paragraph22" rule="-SIMPLE-REF" start="101" uttnum="135">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="180" id="V2188890" paragraph="paragraph22" rule="-SIMPLE-REF" start="175" uttnum="135">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <EVENT end="239" id="V2188918" paragraph="paragraph22" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="183" uttnum="135">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="239" id="V2188918" start="183">
      <type>ONT::INHIBIT</type>
      <text>inhibiting mitochondrial ATP synthesis [19]</text>
    </predicate>
    <arg2 id="V2188940" role=":AFFECTED"/>
    <text>inhibiting mitochondrial ATP synthesis [19]</text>
  </EVENT>
  <TERM dbid="GO:0006754" end="239" id="V2188940" paragraph="paragraph22" rule="-SIMPLE-REF" start="194" uttnum="135">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>ATP-SYNTHESIS</name>
    <text>mitochondrial ATP synthesis [19]</text>
  </TERM>
  <CC end="342" id="V2191123" paragraph="paragraph22" rule="-RULE5B_AGENT_AFFECTED" start="254" uttnum="136">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2191049" role=":FACTOR"/>
    <arg id="V2191135" role=":OUTCOME"/>
    <text>treatment of α1-expressing cells with IGF-1 caused increased phosphorylation of Ser</text>
  </CC>
  <EVENT end="298" id="V2191049" paragraph="paragraph22" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="254" uttnum="136">
    <type>ONT::MODULATE</type>
    <predicate end="298" id="V2191049" start="254">
      <type>ONT::MODULATE</type>
      <text>treatment of α1-expressing cells with IGF-1</text>
    </predicate>
    <arg2 id="V2191091" role=":AFFECTED"/>
    <text>treatment of α1-expressing cells with IGF-1</text>
  </EVENT>
  <EVENT end="342" id="V2191135" paragraph="paragraph22" rule="-INEVENT2B,-RULE60_AGENT_AFFECTED-LOC5-GD-NONE" start="287" uttnum="136">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="342" id="V2191135" start="287">
      <type>ONT::PHOSPHORYLATION</type>
      <text>with IGF-1 caused increased phosphorylation of Ser</text>
    </predicate>
    <site end="298" id="V2191091" start="264">
      <type>ONT::CELL</type>
      <text normalization="">of α1-expressing cells with IGF-1</text>
    </site>
    <text>with IGF-1 caused increased phosphorylation of Ser</text>
  </EVENT>
  <TERM end="298" id="V2191091" paragraph="paragraph22" rule="-SIMPLE-REF" start="264" uttnum="136">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>of α1-expressing cells with IGF-1</text>
  </TERM>
  <TERM dbid="UP:P05019" end="298" id="V2191118" paragraph="paragraph22" rule="-SIMPLE-REF" start="292" uttnum="136">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <EVENT end="342" id="V2191131" paragraph="paragraph22" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="305" uttnum="136">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="342" id="V2191131" start="305">
      <type>ONT::INCREASE</type>
      <text>increased phosphorylation of Ser</text>
    </predicate>
    <arg2 id="V2191135" role=":AFFECTED"/>
    <text>increased phosphorylation of Ser</text>
  </EVENT>
  <TERM end="342" id="V2191147" paragraph="paragraph22" rule="-SIMPLE-REF" start="334" uttnum="136">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="369" id="V2191181" paragraph="paragraph22" rule="-SIMPLE-REF" start="361" uttnum="136">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <CC end="457" id="V2204234" paragraph="paragraph22" rule="-RULE5B_AGENT_AFFECTED" start="388" uttnum="136">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2204213" role=":FACTOR"/>
    <arg id="V2204246" role=":OUTCOME"/>
    <text>treatment with berberine caused increased phosphorylation of Thr</text>
  </CC>
  <EVENT end="398" id="V2204213" paragraph="paragraph22" rule="-RULE10_AGENT_AFFECTED-NONE" start="388" uttnum="136">
    <type>ONT::MODULATE</type>
    <predicate end="398" id="V2204213" start="388">
      <type>ONT::MODULATE</type>
      <text>treatment</text>
    </predicate>
    <text>treatment</text>
  </EVENT>
  <EVENT end="457" id="V2204246" paragraph="paragraph22" rule="-INEVENT2B,-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="420" uttnum="136">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="457" id="V2204246" start="420">
      <type>ONT::PHOSPHORYLATION</type>
      <text>increased phosphorylation of Thr</text>
    </predicate>
    <site end="457" id="V2204258" start="446">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">of Thr</text>
    </site>
    <text>increased phosphorylation of Thr</text>
  </EVENT>
  <TERM dbid="CHEBI:16118" end="413" id="V2204229" paragraph="paragraph22" rule="-SIMPLE-REF" start="403" uttnum="136">
    <type>ONT::MOLECULE</type>
    <name>BERBERINE</name>
    <text>berberine</text>
  </TERM>
  <EVENT end="457" id="V2204241" paragraph="paragraph22" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="420" uttnum="136">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="457" id="V2204241" start="420">
      <type>ONT::INCREASE</type>
      <text>increased phosphorylation of Thr</text>
    </predicate>
    <arg2 id="V2204246" role=":AFFECTED"/>
    <text>increased phosphorylation of Thr</text>
  </EVENT>
  <TERM end="457" id="V2204258" paragraph="paragraph22" rule="-SIMPLE-REF" start="446" uttnum="136">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>of Thr</text>
  </TERM>
  <EVENT end="500" id="V2204310" paragraph="paragraph22" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="483" uttnum="136">
    <type>ONT::ACTIVATE</type>
    <predicate end="500" id="V2204310" start="483">
      <type>ONT::ACTIVATE</type>
      <text>AMPK activation,</text>
    </predicate>
    <arg2 id="V2204307" role=":AFFECTED"/>
    <arg id="R000182" role=":RESULT"/>
    <text>AMPK activation,</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="488" id="V2204307" paragraph="paragraph22" rule="-SIMPLE-REF" start="483" uttnum="136">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="516" id="V2204343" paragraph="paragraph22" rule="-SIMPLE-REF" start="508" uttnum="136">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EPI end="588" id="V2217054" paragraph="paragraph22" rule="-RULE50_0_AGENT_NEUTRAL-AGENT" start="527" uttnum="137">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg1 id="V2217048" role=":AGENT"/>
    <text>This contrasted markedly with results in α2-expressing cells,</text>
  </EPI>
  <TERM end="532" id="V2217048" paragraph="paragraph22" rule="-SIMPLE-REF" start="527" uttnum="137">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>This</text>
  </TERM>
  <TERM end="565" id="V2217082" paragraph="paragraph22" rule="-SIMPLE-REF" start="557" uttnum="137">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>results</text>
  </TERM>
  <TERM end="588" id="V2217178" paragraph="paragraph22" rule="-SIMPLE-REF" start="568" uttnum="137">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>α2-expressing cells,</text>
  </TERM>
  <EVENT end="669" id="V2230359" paragraph="paragraph22" rule="-RULE20_AGENT_AFFECTED" start="595" uttnum="137">
    <type>ONT::INCREASE</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <modality>ONT::DO</modality>
    <predicate end="669" id="V2230359" start="595">
      <type>ONT::INCREASE</type>
      <text>treatment with IGF-1 did not increase phosphorylation of Ser491</text>
    </predicate>
    <arg1 id="V2230297" role=":AGENT"/>
    <arg2 id="V2230366" role=":AFFECTED"/>
    <text>treatment with IGF-1 did not increase phosphorylation of Ser491</text>
  </EVENT>
  <EVENT end="616" id="V2230297" paragraph="paragraph22" rule="-RULE10_AGENT_AFFECTED-NONE" start="595" uttnum="137">
    <type>ONT::MODULATE</type>
    <predicate end="616" id="V2230297" start="595">
      <type>ONT::MODULATE</type>
      <text>treatment with IGF-1</text>
    </predicate>
    <text>treatment with IGF-1</text>
  </EVENT>
  <EVENT end="660" id="V2230366" paragraph="paragraph22" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="633" uttnum="137">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="660" id="V2230366" start="633">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of Ser</text>
    </predicate>
    <site end="660" id="V2230378" start="649">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">of Ser</text>
    </site>
    <text>phosphorylation of Ser</text>
  </EVENT>
  <TERM dbid="UP:P05019" end="616" id="V2230321" paragraph="paragraph22" rule="-SIMPLE-REF" start="610" uttnum="137">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <TERM end="660" id="V2230378" paragraph="paragraph22" rule="-SIMPLE-REF" start="649" uttnum="137">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>of Ser</text>
  </TERM>
  <TERM end="753" id="V2237589" paragraph="paragraph22" rule="-SIMPLE-REF" start="711" uttnum="137">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>increased phosphorylation of both Ser</text>
  </TERM>
  <TERM dbid="CHEBI:16118" end="704" id="V2237553" paragraph="paragraph22" rule="-SIMPLE-REF" start="694" uttnum="137">
    <type>ONT::MOLECULE</type>
    <name>BERBERINE</name>
    <text>berberine</text>
  </TERM>
  <TERM end="775" id="V2237607" paragraph="paragraph22" rule="-SIMPLE-REF" start="767" uttnum="137">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="815" id="V2237648" paragraph="paragraph22" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="800" uttnum="137">
    <type>ONT::ACTIVATE</type>
    <predicate end="815" id="V2237648" start="800">
      <type>ONT::ACTIVATE</type>
      <text>AMPK activation</text>
    </predicate>
    <arg2 id="V2237644" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000187"/>
    <text>AMPK activation</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="805" id="V2237644" paragraph="paragraph22" rule="-SIMPLE-REF" start="800" uttnum="137">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="860" id="V2251561" paragraph="paragraph22" rule="-SIMPLE-REF" start="817" uttnum="138">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>The results for phosphorylation of Ser</text>
  </TERM>
  <EVENT end="860" id="V2251593" paragraph="paragraph22" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="833" uttnum="138">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="860" id="V2251593" start="833">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of Ser</text>
    </predicate>
    <site end="860" id="V2251605" start="852">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>phosphorylation of Ser</text>
  </EVENT>
  <TERM end="860" id="V2251605" paragraph="paragraph22" rule="-SIMPLE-REF" start="852" uttnum="138">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="882" id="V2251623" paragraph="paragraph22" rule="-SIMPLE-REF" start="874" uttnum="138">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="921" id="V2251656" paragraph="paragraph22" rule="-ROBUSTPRO" start="918" uttnum="138">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="988" id="V2251888" paragraph="paragraph22" rule="-SIMPLE-REF" start="972" uttnum="138">
    <type>ONT::MENTAL-OBJECT</type>
    <name>SPECIFIC</name>
    <text>isoform-specific</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1069" id="V2251963" paragraph="paragraph22" rule="-SIMPLE-REF" start="993" uttnum="138">
    <type>ONT::PROTEIN</type>
    <name>ANTIBODY</name>
    <text>a commercial antibody that recognizes the equivalent sites on both α1 and α2</text>
  </TERM>
  <TERM end="1052" id="V2252006" paragraph="paragraph22" rule="-SIMPLE-REF" start="1031" uttnum="138">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>the equivalent sites</text>
  </TERM>
  <TERM end="1085" id="V2263053" paragraph="paragraph22" rule="-SIMPLE-REF" start="1071" uttnum="139">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>These results</text>
  </TERM>
  <TERM end="1117" id="V2263103" paragraph="paragraph22" rule="-SIMPLE-REF" start="1100" uttnum="139">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>with the results</text>
  </TERM>
  <TERM end="1163" id="V2263164" paragraph="paragraph22" rule="-SIMPLE-REF" start="1126" uttnum="139">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figures 2 and 3,</text>
  </TERM>
  <EVENT end="1251" id="V2263290" paragraph="paragraph22" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1163" uttnum="139">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1251" id="V2263290" start="1163">
      <type>ONT::MODULATE</type>
      <text>showing that Ser491 on α2 is modified by autophosphorylation, and not by Akt</text>
    </predicate>
    <arg2 id="V2263195" role=":AFFECTED"/>
    <text>showing that Ser491 on α2 is modified by autophosphorylation, and not by Akt</text>
  </EVENT>
  <EPI end="1194" id="V2263195" paragraph="paragraph22" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="1163" uttnum="139">
    <type>ONT::SUPPORT</type>
    <text>showing that Ser491</text>
  </EPI>
  <TERM end="1184" id="V2263223" paragraph="paragraph22" rule="-SIMPLE-REF" start="1171" uttnum="139">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>that Ser</text>
  </TERM>
  <TERM end="1251" id="V2263386" paragraph="paragraph22" rule="-SIMPLE-REF" start="1247" uttnum="139">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="1266" id="V2263474" paragraph="paragraph22" rule="-SIMPLE-REF" start="1258" uttnum="139">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="1380" id="V2277896" paragraph="paragraph22" rule="-INEVENT2B,-RULE60_AGENT_AFFECTED-NONE" start="1296" uttnum="140">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1380" id="V2277896" start="1296">
      <type>ONT::PHOSPHORYLATION</type>
      <text>increased phosphorylation of the downstream AMPK target ACC correlated with Thr</text>
    </predicate>
    <text>increased phosphorylation of the downstream AMPK target ACC correlated with Thr</text>
  </EVENT>
  <EVENT end="1380" id="V2277892" paragraph="paragraph22" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="1296" uttnum="140">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="1380" id="V2277892" start="1296">
      <type>ONT::INCREASE</type>
      <text>increased phosphorylation of the downstream AMPK target ACC correlated with Thr</text>
    </predicate>
    <arg2 id="V2277896" role=":AFFECTED"/>
    <text>increased phosphorylation of the downstream AMPK target ACC correlated with Thr</text>
  </EVENT>
  <TERM end="1380" id="V2277928" paragraph="paragraph22" rule="-SIMPLE-REF" start="1325" uttnum="140">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>the downstream AMPK target ACC correlated with Thr</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1345" id="V2277921" paragraph="paragraph22" rule="-SIMPLE-REF" start="1340" uttnum="140">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM dbid="HGNC:84|UP:Q13085" end="1356" id="V2277935" paragraph="paragraph22" rule="-SIMPLE-REF" start="1352" uttnum="140">
    <type>ONT::GENE</type>
    <name>ACC</name>
    <text>ACC</text>
  </TERM>
  <TERM end="1380" id="V2277957" paragraph="paragraph22" rule="-SIMPLE-REF" start="1367" uttnum="140">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>with Thr</text>
  </TERM>
  <EVENT end="1444" id="V2277981" paragraph="paragraph22" rule="-RULE40A_AGENT_AFFECTED-CELL_LINE2-GD-AFFECTED" start="1410" uttnum="140">
    <type>ONT::ACTIVATE</type>
    <predicate end="1444" id="V2277981" start="1410">
      <type>ONT::ACTIVATE</type>
      <text>AMPK activation in both cell lines</text>
    </predicate>
    <arg2 id="V2277978" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000192"/>
    <cell-line end="1444" id="V2278046" start="1429">
      <type>ONT::CELL-LINE</type>
      <text normalization="">both cell lines</text>
    </cell-line>
    <text>AMPK activation in both cell lines</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1415" id="V2277978" paragraph="paragraph22" rule="-SIMPLE-REF" start="1410" uttnum="140">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK </text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="1444" id="V2278046" paragraph="paragraph22" rule="-SIMPLE-REF" start="1429" uttnum="140">
    <type>ONT::CELL-LINE</type>
    <name>CELL-LINE</name>
    <text>both cell lines</text>
  </TERM>
  <TERM end="27" id="V2289695" paragraph="paragraph23" rule="-SIMPLE-REF" start="14" uttnum="141">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>that Ser</text>
  </TERM>
  <TERM end="86" id="V2289754" paragraph="paragraph23" rule="-SIMPLE-REF" start="68" uttnum="141">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt in the cells,</text>
  </TERM>
  <TERM end="84" id="V2289817" paragraph="paragraph23" rule="-SIMPLE-REF" start="75" uttnum="141">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>the cells</text>
  </TERM>
  <TERM dbid="UP:P23443" end="133" id="V2290051" paragraph="paragraph23" rule="-SIMPLE-REF" start="97" uttnum="141">
    <type>ONT::PROTEIN</type>
    <name>S-6-K-1</name>
    <text>a downstream kinase such as p70 S6K1</text>
  </TERM>
  <TERM dbid="UP:P14824|UP:P08133|XFAM:PF00191|HGNC:544" end="129" id="V2290000" paragraph="paragraph23" rule="-SIMPLE-REF" start="125" uttnum="141">
    <type>ONT::PROTEIN</type>
    <name>P-70</name>
    <text>p70</text>
  </TERM>
  <TERM dbid="GO:0016301" end="125" id="V2289924" paragraph="paragraph23" rule="-SIMPLE-REF" start="99" uttnum="141">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>downstream kinase such as</text>
  </TERM>
  <TERM end="138" id="V2302196" paragraph="paragraph23" rule="-ROBUSTPRO" start="135" uttnum="141">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="CHEBI:9168" end="171" id="V2302228" paragraph="paragraph23" rule="-SIMPLE-REF" start="160" uttnum="141">
    <type>ONT::MOLECULE</type>
    <name>RAPAMYCIN</name>
    <text>rapamycin,</text>
  </TERM>
  <TERM dbid="CHEBI:35222" end="193" id="V2302239" paragraph="paragraph23" rule="-SIMPLE-REF" start="174" uttnum="141">
    <type>ONT::CHEMICAL</type>
    <name>INHIBITOR</name>
    <text>inhibitor of mTORC1</text>
  </TERM>
  <TERM dbid="GO:0031931" end="193" id="V2302297" paragraph="paragraph23" rule="-SIMPLE-REF" start="187" uttnum="141">
    <type>ONT::CELL-PART</type>
    <name>MTORC-1</name>
    <text>mTORC1</text>
  </TERM>
  <EVENT end="280" id="V2303837" paragraph="paragraph23" rule="-RULE30_AGENT_AFFECTED" start="195" uttnum="142">
    <type>ONT::INHIBIT</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <modality>ONT::DO</modality>
    <predicate end="280" id="V2303837" start="195">
      <type>ONT::INHIBIT</type>
      <text>Rapamycin did not block the IGF-1-stimulated phosphorylation of Ser487 on</text>
    </predicate>
    <arg1 id="V2303800" role=":AGENT"/>
    <arg2 id="V2303881" role=":AFFECTED"/>
    <text>Rapamycin did not block the IGF-1-stimulated phosphorylation of Ser487 on</text>
  </EVENT>
  <TERM dbid="CHEBI:9168" end="205" id="V2303800" paragraph="paragraph23" rule="-SIMPLE-REF" start="195" uttnum="142">
    <type>ONT::MOLECULE</type>
    <name>RAPAMYCIN</name>
    <text>Rapamycin</text>
  </TERM>
  <EVENT end="267" id="V2303881" paragraph="paragraph23" rule="-INEVENT2B,-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="219" uttnum="142">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="267" id="V2303881" start="219">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the IGF-1-stimulated phosphorylation of Ser</text>
    </predicate>
    <site end="267" id="V2303893" start="256">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">of Ser</text>
    </site>
    <text>the IGF-1-stimulated phosphorylation of Ser</text>
  </EVENT>
  <EVENT end="267" id="V2303869" paragraph="paragraph23" rule="-RULE30_AGENT_AFFECTED" start="219" uttnum="142">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="267" id="V2303869" start="219">
      <type>ONT::STIMULATE</type>
      <text>the IGF-1-stimulated phosphorylation of Ser</text>
    </predicate>
    <arg1 id="V2303860" role=":AGENT"/>
    <arg2 id="V2303881" role=":AFFECTED"/>
    <text>the IGF-1-stimulated phosphorylation of Ser</text>
  </EVENT>
  <TERM end="267" id="V2303893" paragraph="paragraph23" rule="-SIMPLE-REF" start="256" uttnum="142">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>of Ser</text>
  </TERM>
  <TERM dbid="UP:P05019" end="240" id="V2303860" paragraph="paragraph23" rule="-SIMPLE-REF" start="223" uttnum="142">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1-stimulated</text>
  </TERM>
  <MODALITY end="280" id="X2320919" paragraph="paragraph23" rule="-MODALITY" start="195" uttnum="142">
    <type>ONT::DO</type>
    <arg2 id="V2303837" role=":EVENT"/>
    <text>Rapamycin did not block the IGF-1-stimulated phosphorylation of Ser487 on</text>
  </MODALITY>
  <TERM end="294" id="V2303945" paragraph="paragraph23" rule="-SIMPLE-REF" start="286" uttnum="142">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="311" id="V2303980" paragraph="paragraph23" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="304" uttnum="142">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>AKT</name>
    <text normalization="">on Akt</text>
  </TERM>
  <EVENT end="397" id="V2320689" paragraph="paragraph23" rule="-RULE30_AGENT_AFFECTED" start="334" uttnum="142">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="397" id="V2320689" start="334">
      <type>ONT::INHIBIT</type>
      <text>it blocked phosphorylation of an established mTORC1 substrate,</text>
    </predicate>
    <arg1 id="V2320682" role=":AGENT"/>
    <arg2 id="V2320694" role=":AFFECTED"/>
    <text>it blocked phosphorylation of an established mTORC1 substrate,</text>
  </EVENT>
  <TERM end="337" id="V2320682" paragraph="paragraph23" rule="-SIMPLE-REF" start="334" uttnum="142">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>it</text>
  </TERM>
  <EVENT end="397" id="V2320694" paragraph="paragraph23" rule="-RULE60_AGENT_AFFECTED-NONE" start="345" uttnum="142">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="397" id="V2320694" start="345">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of an established mTORC1 substrate,</text>
    </predicate>
    <text>phosphorylation of an established mTORC1 substrate,</text>
  </EVENT>
  <TERM end="397" id="V2320786" paragraph="paragraph23" rule="-SIMPLE-REF" start="364" uttnum="142">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATE</name>
    <text>an established mTORC1 substrate,</text>
  </TERM>
  <TERM dbid="GO:0031931" end="386" id="V2320771" paragraph="paragraph23" rule="-SIMPLE-REF" start="379" uttnum="142">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>MTORC-1</name>
    <text>mTORC1</text>
  </TERM>
  <TERM end="405" id="V2320795" paragraph="paragraph23" rule="-SIMPLE-REF" start="397" uttnum="142">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="430" id="V2320967" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0B" start="422" uttnum="142">
    <type>ONT::PROTEIN</type>
    <components>
      <component id="V2320439"/>
      <component id="V2320473"/>
    </components>
    <text normalization="">p70/p85</text>
  </TERM>
  <TERM dbid="UP:P23443" end="471" id="V2320908" paragraph="paragraph23" rule="-SIMPLE-REF" start="442" uttnum="142">
    <type>ONT::PROTEIN</type>
    <name>S-6-K-1</name>
    <text>S6K1 (Figure 4D)</text>
  </TERM>
  <TERM end="470" id="V2320944" paragraph="paragraph23" rule="-SIMPLE-REF" start="454" uttnum="142">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 4D</text>
  </TERM>
  <TERM end="470" id="V2320918" paragraph="paragraph23" rule="-SIMPLE-REF" start="454" uttnum="142">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4D</text>
  </TERM>
  <TERM dbid="UP:P14824|UP:P08133|XFAM:PF00191|HGNC:544" end="430" id="V2320439" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0B-TERM" start="422" uttnum="142">
    <type>ONT::PROTEIN</type>
    <name>P-70</name>
    <text>p70/p85</text>
  </TERM>
  <TERM end="430" id="V2320473" paragraph="paragraph23" rule="-SIMPLE-REF" start="426" uttnum="142">
    <type>ONT::PROTEIN</type>
    <members>
      <member dbid="UP:P27986" type="ONT::PROTEIN"/>
      <member dbid="UP:O00459" type="ONT::PROTEIN"/>
      <member dbid="UP:Q92569" type="ONT::PROTEIN"/>
    </members>
    <name>P-85</name>
    <text normalization="">p85</text>
  </TERM>
  <EPI end="43" id="V2331723" paragraph="paragraph24" rule="-RULE50_0_AGENT_FORMAL-FORMAL" start="3" uttnum="143">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2331751" role=":FORMAL"/>
    <text>To show that phosphorylation of Ser</text>
  </EPI>
  <TERM end="16" id="V2331742" paragraph="paragraph24" rule="-ROBUSTPRO" start="11" uttnum="143">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>that</text>
  </TERM>
  <EVENT end="43" id="V2331751" paragraph="paragraph24" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="3" uttnum="143">
    <type>ONT::PHOSPHORYLATION</type>
    <epistemic-modality id="V2331723"/>
    <predicate end="43" id="V2331751" start="3">
      <type>ONT::PHOSPHORYLATION</type>
      <text>To show that phosphorylation of Ser</text>
    </predicate>
    <site end="43" id="V2331763" start="35">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>To show that phosphorylation of Ser</text>
  </EVENT>
  <TERM end="43" id="V2331763" paragraph="paragraph24" rule="-SIMPLE-REF" start="35" uttnum="143">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="71" id="V2331853" paragraph="paragraph24" rule="-SIMPLE-REF" start="67" uttnum="143">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="125" id="V2347273" paragraph="paragraph24" rule="-ROBUSTPRO" start="122" uttnum="143">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="BTO:0000848" end="167" id="V2347362" paragraph="paragraph24" rule="-SIMPLE-REF" start="130" uttnum="143">
    <type>ONT::CELL</type>
    <name>MELANOMA-CELL</name>
    <text>the LKB1-null G361 melanoma cell line</text>
  </TERM>
  <TERM dbid="EFO:0006394|CVCL:1220" end="149" id="V2347340" paragraph="paragraph24" rule="-SIMPLE-REF" start="144" uttnum="143">
    <type>ONT::CELL-LINE</type>
    <name>G-361</name>
    <text>G361</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="167" id="V2347300" paragraph="paragraph24" rule="-SIMPLE-REF" start="130" uttnum="143">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>the LKB1-null G361 melanoma cell line</text>
  </TERM>
  <TERM end="179" id="V2349819" paragraph="paragraph24" rule="-SIMPLE-REF" start="169" uttnum="144">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>The cells</text>
  </TERM>
  <TERM dbid="UP:P05019" end="237" id="V2349938" paragraph="paragraph24" rule="-SIMPLE-REF" start="231" uttnum="144">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <EVENT end="252" id="V2349967" paragraph="paragraph24" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="240" uttnum="144">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="252" id="V2349967" start="240">
      <type>ONT::ACTIVATE</type>
      <text>activate Akt</text>
    </predicate>
    <arg2 id="V2349974" role=":AFFECTED"/>
    <arg id="R000197" role=":RESULT"/>
    <text>activate Akt</text>
  </EVENT>
  <TERM end="252" id="V2349974" paragraph="paragraph24" rule="-SIMPLE-REF" start="249" uttnum="144">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:P05019" end="273" id="V2359922" paragraph="paragraph24" rule="-SIMPLE-REF" start="267" uttnum="145">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <EVENT end="332" id="V2360071" paragraph="paragraph24" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="305" uttnum="145">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="332" id="V2360071" start="305">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of Thr</text>
    </predicate>
    <site end="332" id="V2360083" start="324">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>phosphorylation of Thr</text>
  </EVENT>
  <TERM end="332" id="V2360083" paragraph="paragraph24" rule="-SIMPLE-REF" start="324" uttnum="145">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="354" id="V2360101" paragraph="paragraph24" rule="-SIMPLE-REF" start="346" uttnum="145">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="380" id="V2360144" paragraph="paragraph24" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="364" uttnum="145">
    <type>ONT::AMINO-ACID</type>
    <features>
      <active>TRUE</active>
    </features>
    <name>SER</name>
    <text>on Akt, Ser</text>
  </TERM>
  <TERM end="372" id="V2360136" paragraph="paragraph24" rule="-SIMPLE-REF" start="367" uttnum="145">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt,</text>
  </TERM>
  <TERM end="396" id="V2360155" paragraph="paragraph24" rule="-SIMPLE-REF" start="388" uttnum="145">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="428" id="V2360200" paragraph="paragraph24" rule="-SIMPLE-REF" start="420" uttnum="145">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM dbid="FA:03087" end="412" id="V2359683" paragraph="paragraph24" rule="-SIMPLE-REF" start="408" uttnum="145">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <TERM end="520" id="V2374755" paragraph="paragraph24" rule="-ROBUSTPRO" start="457" uttnum="145">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>which were blocked or reduced by MK2206 (Figure 5)</text>
  </TERM>
  <EVENT end="520" id="V2374794" paragraph="paragraph24" rule="-RULE20_AGENT_AFFECTED-AGENT" start="468" uttnum="145">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="520" id="V2374794" start="468">
      <type>ONT::DECREASE</type>
      <text>blocked or reduced by MK2206 (Figure 5)</text>
    </predicate>
    <arg1 id="V2374832" role=":AGENT"/>
    <text>blocked or reduced by MK2206 (Figure 5)</text>
  </EVENT>
  <TERM dbid="CHEBI:67271" end="520" id="V2374832" paragraph="paragraph24" rule="-SIMPLE-REF" start="487" uttnum="145">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>by MK2206 (Figure 5)</text>
  </TERM>
  <TERM end="519" id="V2374846" paragraph="paragraph24" rule="-SIMPLE-REF" start="504" uttnum="145">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 5</text>
  </TERM>
  <EVENT end="555" id="V2387561" paragraph="paragraph24" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="522" uttnum="146">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="555" id="V2387561" start="522">
      <type>ONT::MODULATE</type>
      <text>When the cells were treated with</text>
    </predicate>
    <arg2 id="V2387536" role=":AFFECTED"/>
    <text>When the cells were treated with</text>
  </EVENT>
  <TERM end="537" id="V2387536" paragraph="paragraph24" rule="-SIMPLE-REF" start="527" uttnum="146">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>the cells</text>
  </TERM>
  <TERM end="611" id="V2387679" paragraph="paragraph24" rule="-INEVENT2B,-SIMPLE-REF" start="575" uttnum="146">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>23187</pos>
      </site>
    </features>
    <name>A-23187</name>
    <text>ionophore A23187 to activate CaMKKβ,</text>
  </TERM>
  <TERM dbid="CHEBI:24869" end="585" id="V2387595" paragraph="paragraph24" rule="-SIMPLE-REF" start="575" uttnum="146">
    <type>ONT::CHEMICAL</type>
    <name>IONOPHORE</name>
    <text>ionophore</text>
  </TERM>
  <EVENT end="611" id="V2387713" paragraph="paragraph24" rule="-RULE40A_AGENT_AFFECTED-LOC6-AFFECTED" start="575" uttnum="146">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="611" id="V2387713" start="575">
      <type>ONT::ACTIVATE</type>
      <text>ionophore A23187 to activate CaMKKβ,</text>
    </predicate>
    <arg2 id="V2387595" role=":AFFECTED"/>
    <site end="611" id="V2387679" start="575">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">ionophore A23187 to activate CaMKKβ,</text>
    </site>
    <text>ionophore A23187 to activate CaMKKβ,</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="635" id="V2391101" paragraph="paragraph24" rule="-SIMPLE-REF" start="630" uttnum="146">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="647" id="V2391116" paragraph="paragraph24" rule="-SIMPLE-REF" start="639" uttnum="146">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="751" id="V2391224" paragraph="paragraph24" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="703" uttnum="146">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="751" id="V2391224" start="703">
      <type>ONT::MODULATE</type>
      <text>the cells had been exposed previously to IGF-1,</text>
    </predicate>
    <arg2 id="V2391182" role=":AFFECTED"/>
    <text>the cells had been exposed previously to IGF-1,</text>
  </EVENT>
  <TERM end="713" id="V2391182" paragraph="paragraph24" rule="-SIMPLE-REF" start="703" uttnum="146">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>the cells</text>
  </TERM>
  <TERM dbid="UP:P05019" end="751" id="V2391266" paragraph="paragraph24" rule="-SIMPLE-REF" start="744" uttnum="146">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1,</text>
  </TERM>
  <EVENT end="792" id="V2391293" paragraph="paragraph24" rule="-RULE30_AGENT_FORMAL-AGENT" start="761" uttnum="146">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <mods>
      <degree>
        <type>ONT::DEGREE-MODIFIER-VERYHIGH</type>
        <value>COMPLETELY</value>
      </degree>
    </mods>
    <predicate end="792" id="V2391293" start="761">
      <type>ONT::INHIBIT</type>
      <text>completely abolished by MK2206</text>
    </predicate>
    <arg1 id="V2391327" role=":AGENT"/>
    <text>completely abolished by MK2206</text>
  </EVENT>
  <TERM dbid="CHEBI:67271" end="792" id="V2391327" paragraph="paragraph24" rule="-SIMPLE-REF" start="782" uttnum="146">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>by MK2206</text>
  </TERM>
  <TERM end="806" id="V2391341" paragraph="paragraph24" rule="-SIMPLE-REF" start="799" uttnum="146">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <EVENT end="78" id="V2404638" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="22" uttnum="147">
    <type>ONT::ACTIVATE</type>
    <mods>
      <degree>
        <type>ONT::DEGREE-MODIFIER-HIGH</type>
        <value>HYPER-</value>
      </degree>
    </mods>
    <predicate end="78" id="V2404638" start="22">
      <type>ONT::ACTIVATE</type>
      <text>hyperactivation of Akt in tumour cells due to PTEN loss</text>
    </predicate>
    <arg2 id="V2404656" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000202"/>
    <text>hyperactivation of Akt in tumour cells due to PTEN loss</text>
  </EVENT>
  <TERM end="78" id="V2404656" paragraph="paragraph25" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="38" uttnum="147">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <location id="V2404717"/>
      <active>FALSE</active>
    </features>
    <name>AKT</name>
    <text normalization="">of Akt in tumour cells due to PTEN loss</text>
  </TERM>
  <TERM end="61" id="V2404717" paragraph="paragraph25" rule="-SIMPLE-REF" start="48" uttnum="147">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>tumour cells</text>
  </TERM>
  <TERM dbid="UP:P60484" end="73" id="V2404765" paragraph="paragraph25" rule="-SIMPLE-REF" start="68" uttnum="147">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>PTEN</text>
  </TERM>
  <EVENT end="112" id="V2404796" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="97" uttnum="147">
    <type>ONT::ACTIVATE</type>
    <predicate end="112" id="V2404796" start="97">
      <type>ONT::ACTIVATE</type>
      <text>AMPK activation</text>
    </predicate>
    <arg2 id="V2404792" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000207"/>
    <text>AMPK activation</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="102" id="V2404792" paragraph="paragraph25" rule="-SIMPLE-REF" start="97" uttnum="147">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="117" id="V2421120" paragraph="paragraph25" rule="-ROBUSTPRO" start="114" uttnum="147">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="183" id="V2421174" paragraph="paragraph25" rule="-SIMPLE-REF" start="136" uttnum="147">
    <type>ONT::CELL-LINE</type>
    <name>CELL-LINE</name>
    <text>the PTEN-null glioblastoma cell line DBTRG-05MG</text>
  </TERM>
  <TERM dbid="EFO:0002159" end="183" id="V2421239" paragraph="paragraph25" rule="-SIMPLE-REF" start="173" uttnum="147">
    <type>ONT::CELL-LINE</type>
    <name>DBTRG-5-MG</name>
    <text>DBTRG-05MG</text>
  </TERM>
  <TERM dbid="UP:P60484" end="183" id="V2421142" paragraph="paragraph25" rule="-SIMPLE-REF" start="136" uttnum="147">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>the PTEN-null glioblastoma cell line DBTRG-05MG</text>
  </TERM>
  <TERM end="188" id="V2433956" paragraph="paragraph25" rule="-ROBUSTPRO" start="185" uttnum="148">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM dbid="CHEBI:85053" end="228" id="V2434038" paragraph="paragraph25" rule="-SIMPLE-REF" start="209" uttnum="148">
    <type>ONT::CHEMICAL</type>
    <name>AMPK-ACTIVATORS</name>
    <text>of AMPK activators</text>
  </TERM>
  <EVENT end="277" id="V2434115" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="258" uttnum="148">
    <type>ONT::ACTIVATE</type>
    <predicate end="277" id="V2434115" start="258">
      <type>ONT::ACTIVATE</type>
      <text>with Akt activation</text>
    </predicate>
    <arg2 id="V2434112" role=":AFFECTED"/>
    <arg id="R000212" role=":RESULT"/>
    <text>with Akt activation</text>
  </EVENT>
  <TERM end="267" id="V2434112" paragraph="paragraph25" rule="-SIMPLE-REF" start="263" uttnum="148">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="369" id="V2449284" paragraph="paragraph25" rule="-RULE30_AGENT_AFFECTED" start="279" uttnum="149">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="369" id="V2449284" start="279">
      <type>ONT::INHIBIT</type>
      <text>Surprisingly, phenformin and quercetin blocked phosphorylation of Akt at Ser473</text>
    </predicate>
    <arg1 id="V2449268" role=":AGENT"/>
    <arg2 id="V2449289" role=":AFFECTED"/>
    <text>Surprisingly, phenformin and quercetin blocked phosphorylation of Akt at Ser473</text>
  </EVENT>
  <TERM end="318" id="V2449268" paragraph="paragraph25" rule="-LOGICALOP-REF" start="293" uttnum="149">
    <type>ONT::MOLECULE</type>
    <aggregate operator="AND">
      <member id="V2449264"/>
      <member id="V2449279"/>
    </aggregate>
    <text normalization="">phenformin and quercetin</text>
  </TERM>
  <EVENT end="360" id="V2449289" paragraph="paragraph25" rule="-RULE60_AGENT_AFFECTED-LOC5-GD-NONE" start="326" uttnum="149">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="360" id="V2449289" start="326">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of Akt at Ser</text>
    </predicate>
    <site end="360" id="V2449289" start="326">
      <type>ONT::PHOSPHORYLATION</type>
      <text normalization="">phosphorylation of Akt at Ser</text>
    </site>
    <text>phosphorylation of Akt at Ser</text>
  </EVENT>
  <TERM dbid="CHEBI:8064" end="304" id="V2449264" paragraph="paragraph25" rule="-SIMPLE-REF" start="293" uttnum="149">
    <type>ONT::MOLECULE</type>
    <name>PHENFORMIN</name>
    <text>phenformin</text>
  </TERM>
  <TERM dbid="CHEBI:16243|CHEBI:57694" end="318" id="V2449279" paragraph="paragraph25" rule="-SIMPLE-REF" start="308" uttnum="149">
    <type>ONT::MOLECULE</type>
    <name>QUERCETIN</name>
    <text>quercetin</text>
  </TERM>
  <TERM end="360" id="V2449301" paragraph="paragraph25" rule="-SIMPLE-REF" start="345" uttnum="149">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt at Ser</text>
  </TERM>
  <TERM end="360" id="V2449324" paragraph="paragraph25" rule="-SIMPLE-REF" start="352" uttnum="149">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="410" id="V2463759" paragraph="paragraph25" rule="-LOGICALOP-REF" start="380" uttnum="149">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="AND">
      <member id="V2463849"/>
      <member id="V2463664"/>
      <member id="V2463751"/>
    </aggregate>
    <text normalization="">berberine, A769662 and A23187</text>
  </TERM>
  <TERM dbid="CHEBI:16118" end="389" id="V2463664" paragraph="paragraph25" rule="-SIMPLE-REF" start="380" uttnum="149">
    <type>ONT::MOLECULE</type>
    <name>BERBERINE</name>
    <text>berberine</text>
  </TERM>
  <TERM end="399" id="V2463751" paragraph="paragraph25" rule="-SIMPLE-REF" start="391" uttnum="149">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662</text>
  </TERM>
  <TERM end="410" id="V2463849" paragraph="paragraph25" rule="-SIMPLE-REF" start="403" uttnum="149">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>23187</pos>
      </site>
    </features>
    <name>A-23187</name>
    <text>A23187</text>
  </TERM>
  <TERM end="444" id="V2466787" paragraph="paragraph25" rule="-SIMPLE-REF" start="419" uttnum="149">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure S2A</text>
  </TERM>
  <TERM end="444" id="V2466856" paragraph="paragraph25" rule="-SIMPLE-REF" start="440" uttnum="149">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S2A</text>
  </TERM>
  <TERM end="485" id="V2467642" paragraph="paragraph25" rule="-SIMPLE-REF" start="474" uttnum="150">
    <type>ONT::AGENT</type>
    <name>AGENT</name>
    <text>all agents</text>
  </TERM>
  <EVENT end="539" id="V2467664" paragraph="paragraph25" rule="-RULE60_AGENT_AFFECTED-LOC4-GD-AFFECTED" start="500" uttnum="150">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="539" id="V2467664" start="500">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the phosphorylation of ACC1 at Ser</text>
    </predicate>
    <arg2 id="V2467681" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000057"/>
    <site end="539" id="V2467704" start="531">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>the phosphorylation of ACC1 at Ser</text>
  </EVENT>
  <TERM dbid="HGNC:84|UP:Q5SWU9|XFAM:PF00364|XFAM:PF08326|XFAM:PF00289|XFAM:PF01039|XFAM:PF02785|UP:Q16548|XFAM:PF02786|UP:Q13085|HGNC:991" end="528" id="V2467681" paragraph="paragraph25" rule="-SIMPLE-REF" start="520" uttnum="150">
    <type>ONT::PROTEIN</type>
    <name>ACC-1</name>
    <text>of ACC1</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2467664"/>
    </not-features>
  </TERM>
  <TERM end="539" id="V2467704" paragraph="paragraph25" rule="-SIMPLE-REF" start="531" uttnum="150">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="615" id="V2467722" paragraph="paragraph25" rule="-SIMPLE-REF" start="552" uttnum="150">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK at Thr172 in MEFs (mouse embryonic fibroblasts)</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="615" id="V2467821" paragraph="paragraph25" rule="-SIMPLE-REF" start="560" uttnum="150">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>Thr172 in MEFs (mouse embryonic fibroblasts)</text>
  </TERM>
  <TERM end="568" id="V2467745" paragraph="paragraph25" rule="-SIMPLE-REF" start="560" uttnum="150">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="CO:2000042" end="614" id="V2467856" paragraph="paragraph25" rule="-SIMPLE-REF" start="587" uttnum="150">
    <type>ONT::CELL</type>
    <name>EMBRYONIC-FIBROBLASTS</name>
    <text>mouse embryonic fibroblasts</text>
  </TERM>
  <TERM end="614" id="V2467828" paragraph="paragraph25" rule="-SIMPLE-REF" start="587" uttnum="150">
    <type>ONT::COMPUTER-INPUT-DEVICE</type>
    <name>MOUSE</name>
    <text>mouse embryonic fibroblasts</text>
  </TERM>
  <EVENT end="659" id="V2480751" paragraph="paragraph25" rule="-RULE10_AGENT_AFFECTED" start="626" uttnum="150">
    <type>ONT::MODULATE</type>
    <predicate end="659" id="V2480751" start="626">
      <type>ONT::MODULATE</type>
      <text>the effect of A769662 on Thr</text>
    </predicate>
    <arg1 id="V2480848" role=":AGENT"/>
    <arg2 id="V2480884" role=":AFFECTED"/>
    <text>the effect of A769662 on Thr</text>
  </EVENT>
  <TERM end="648" id="V2480848" paragraph="paragraph25" rule="-SIMPLE-REF" start="637" uttnum="150">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>of A769662</text>
  </TERM>
  <TERM end="659" id="V2480884" paragraph="paragraph25" rule="-SIMPLE-REF" start="648" uttnum="150">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>on Thr</text>
  </TERM>
  <TERM end="791" id="V2483398" paragraph="paragraph25" rule="-SIMPLE-REF" start="741" uttnum="150">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>an allosteric mechanism (Supplementary Figure S2B)</text>
  </TERM>
  <TERM end="790" id="V2483417" paragraph="paragraph25" rule="-SIMPLE-REF" start="766" uttnum="150">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure S2B</text>
  </TERM>
  <TERM end="790" id="V2483463" paragraph="paragraph25" rule="-SIMPLE-REF" start="787" uttnum="150">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S2B</text>
  </TERM>
  <TERM end="844" id="V2487898" paragraph="paragraph25" rule="-LOGICALOP-REF" start="819" uttnum="151">
    <type>ONT::MOLECULE</type>
    <aggregate operator="AND">
      <member id="V2487894"/>
      <member id="V2487909"/>
    </aggregate>
    <text normalization="">phenformin and quercetin</text>
  </TERM>
  <TERM dbid="CHEBI:8064" end="830" id="V2487894" paragraph="paragraph25" rule="-SIMPLE-REF" start="819" uttnum="151">
    <type>ONT::MOLECULE</type>
    <name>PHENFORMIN</name>
    <text>phenformin</text>
  </TERM>
  <TERM dbid="CHEBI:16243|CHEBI:57694" end="844" id="V2487909" paragraph="paragraph25" rule="-SIMPLE-REF" start="834" uttnum="151">
    <type>ONT::MOLECULE</type>
    <name>QUERCETIN</name>
    <text>quercetin</text>
  </TERM>
  <TERM end="859" id="V2487946" paragraph="paragraph25" rule="-SIMPLE-REF" start="847" uttnum="151">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Akt Ser</text>
  </TERM>
  <TERM end="851" id="V2487941" paragraph="paragraph25" rule="-SIMPLE-REF" start="847" uttnum="151">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM dbid="CVCL:L690" end="909" id="V2488068" paragraph="paragraph25" rule="-SIMPLE-REF" start="902" uttnum="151">
    <type>ONT::CELL-LINE</type>
    <name>WT-MEFS</name>
    <text>WT MEFs</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="937" id="V2500146" paragraph="paragraph25" rule="-SIMPLE-REF" start="933" uttnum="151">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="1010" id="V2506118" paragraph="paragraph25" rule="-SIMPLE-REF" start="994" uttnum="151">
    <type>ONT::FEMALE-PERSON</type>
    <name>KNOCKOUT</name>
    <text>double-knockout</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="1085" id="V2506206" paragraph="paragraph25" rule="-SIMPLE-REF" start="1046" uttnum="151">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs (Supplementary Figure S2B and S2C)</text>
  </TERM>
  <EVENT end="1173" id="V2519603" paragraph="paragraph25" rule="-RULE10C_AGENT_AFFECTED-LOC8-GD-NONE" start="1087" uttnum="152">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1173" id="V2519603" start="1087">
      <type>ONT::TRANSLOCATE</type>
      <text>To avoid this complication, in subsequent studies we focused on the effects of A769662</text>
    </predicate>
    <site end="1173" id="V2519858" start="1166">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">A769662</text>
    </site>
    <text>To avoid this complication, in subsequent studies we focused on the effects of A769662</text>
  </EVENT>
  <TERM end="1140" id="V2519710" paragraph="paragraph25" rule="-ROBUSTPRO" start="1137" uttnum="152">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="1173" id="V2519858" paragraph="paragraph25" rule="-SIMPLE-REF" start="1166" uttnum="152">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1223" id="V2538799" paragraph="paragraph25" rule="-SIMPLE-REF" start="1191" uttnum="152">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK by direct binding to the β</text>
  </TERM>
  <TERM end="1214" id="V2538842" paragraph="paragraph25" rule="-SIMPLE-REF" start="1199" uttnum="152">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>BINDING</name>
    <text>direct binding</text>
  </TERM>
  <TERM dbid="GO:0006754" end="1318" id="V2538966" paragraph="paragraph25" rule="-SIMPLE-REF" start="1286" uttnum="152">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>ATP-SYNTHESIS</name>
    <text>ATP synthesis [19]</text>
  </TERM>
  <TERM end="1333" id="V2538992" paragraph="paragraph25" rule="-SIMPLE-REF" start="1321" uttnum="152">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Akt Ser</text>
  </TERM>
  <TERM end="1325" id="V2538987" paragraph="paragraph25" rule="-SIMPLE-REF" start="1321" uttnum="152">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="1383" id="V2539037" paragraph="paragraph25" rule="-SIMPLE-REF" start="1360" uttnum="152">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>2</pos>
      </site>
    </features>
    <name>S-2</name>
    <text>Supplementary Figure S2</text>
  </TERM>
  <TERM end="1383" id="V2539017" paragraph="paragraph25" rule="-SIMPLE-REF" start="1360" uttnum="152">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure S2</text>
  </TERM>
  <EVENT end="52" id="V2552305" paragraph="paragraph26" rule="-RULE40A_AGENT_AFFECTED" start="3" uttnum="153">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="52" id="V2552305" start="3">
      <type>ONT::ACTIVATE</type>
      <text>AMPK in DBTRG-05MG cells was activated by A769662</text>
    </predicate>
    <arg1 id="V2552415" role=":AGENT"/>
    <arg2 id="V2552190" role=":AFFECTED"/>
    <arg id="R000217" role=":RESULT"/>
    <text>AMPK in DBTRG-05MG cells was activated by A769662</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="28" id="V2552190" paragraph="paragraph26" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="3" uttnum="153">
    <type>ONT::GENE-PROTEIN</type>
    <features>
      <location id="V2552280"/>
      <active>FALSE</active>
    </features>
    <name>AMPK</name>
    <text>AMPK in DBTRG-05MG cells</text>
  </TERM>
  <TERM end="52" id="V2552415" paragraph="paragraph26" rule="-SIMPLE-REF" start="42" uttnum="153">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>by A769662</text>
  </TERM>
  <TERM end="28" id="V2552280" paragraph="paragraph26" rule="-SIMPLE-REF" start="11" uttnum="153">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>DBTRG-05MG cells</text>
  </TERM>
  <TERM dbid="CVCL:1169" end="22" id="V2552272" paragraph="paragraph26" rule="-SIMPLE-REF" start="11" uttnum="153">
    <type>ONT::CELL-LINE</type>
    <name>DBTRG-5-MG</name>
    <text>DBTRG-05MG</text>
  </TERM>
  <TERM end="91" id="V2552978" paragraph="paragraph26" rule="-SIMPLE-REF" start="76" uttnum="153">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 6</text>
  </TERM>
  <TERM end="106" id="V2553045" paragraph="paragraph26" rule="-SIMPLE-REF" start="98" uttnum="153">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="154" id="V2553061" paragraph="paragraph26" rule="-SIMPLE-REF" start="139" uttnum="153">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 6</text>
  </TERM>
  <TERM end="155" id="V2553085" paragraph="paragraph26" rule="-SIMPLE-REF" start="154" uttnum="153">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <EVENT end="243" id="V2553188" paragraph="paragraph26" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="184" uttnum="153">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="243" id="V2553188" start="184">
      <type>ONT::INCREASE</type>
      <text>the selective Akt inhibitor MK2206 was added before A769662</text>
    </predicate>
    <arg2 id="V2553162" role=":AFFECTED"/>
    <text>the selective Akt inhibitor MK2206 was added before A769662</text>
  </EVENT>
  <TERM dbid="CHEBI:67271" end="219" id="V2553162" paragraph="paragraph26" rule="-SIMPLE-REF" start="184" uttnum="153">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>the selective Akt inhibitor MK2206</text>
  </TERM>
  <TERM end="219" id="V2553147" paragraph="paragraph26" rule="-SIMPLE-REF" start="184" uttnum="153">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">the selective Akt inhibitor MK2206</text>
  </TERM>
  <TERM dbid="CHEBI:35222" end="212" id="V2553152" paragraph="paragraph26" rule="-SIMPLE-REF" start="202" uttnum="153">
    <type>ONT::CHEMICAL</type>
    <name>INHIBITOR</name>
    <text>inhibitor</text>
  </TERM>
  <TERM end="243" id="V2553287" paragraph="paragraph26" rule="-SIMPLE-REF" start="236" uttnum="153">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662</text>
  </TERM>
  <EVENT end="292" id="V2568060" paragraph="paragraph26" rule="-INEVENT2B,-RULE40A_AGENT_AFFECTED-AFFECTED" start="250" uttnum="154">
    <type>ONT::ACTIVATE</type>
    <predicate end="292" id="V2568060" start="250">
      <type>ONT::ACTIVATE</type>
      <text>reduced activation of AMPK in these cells</text>
    </predicate>
    <arg2 id="V2568074" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000222"/>
    <text>reduced activation of AMPK in these cells</text>
  </EVENT>
  <CC end="309" id="V2568166" paragraph="paragraph26" rule="-RULE5B_NEUTRAL1_NEUTRAL" start="250" uttnum="154">
    <type>ONT::DEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V2568160" role=":FACTOR"/>
    <arg id="V2568060" role=":OUTCOME"/>
    <text>reduced activation of AMPK in these cells was Akt-dependent</text>
  </CC>
  <EVENT end="292" id="V2568053" paragraph="paragraph26" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="250" uttnum="154">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="292" id="V2568053" start="250">
      <type>ONT::DECREASE</type>
      <text>reduced activation of AMPK in these cells</text>
    </predicate>
    <arg2 id="V2568060" role=":AFFECTED"/>
    <text>reduced activation of AMPK in these cells</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="292" id="V2568074" paragraph="paragraph26" rule="-SIMPLE-REF" start="269" uttnum="154">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK in these cells</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="292" id="V2568135" paragraph="paragraph26" rule="-SIMPLE-REF" start="280" uttnum="154">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>these cells</text>
  </TERM>
  <TERM end="309" id="V2568160" paragraph="paragraph26" rule="-SIMPLE-REF" start="296" uttnum="154">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt-dependent</text>
  </TERM>
  <EPI end="404" id="V2584146" paragraph="paragraph26" rule="-RULE50_0_NEUTRAL1_NEUTRAL2" start="324" uttnum="155">
    <type>ONT::ASSOCIATE</type>
    <force>ONT::TRUE</force>
    <text>inhibition of Akt by MK2206 was associated with greatly reduced phosphorylation</text>
  </EPI>
  <EVENT end="352" id="V2584070" paragraph="paragraph26" rule="-RULE30_AGENT_AFFECTED" start="324" uttnum="155">
    <type>ONT::INHIBIT</type>
    <predicate end="352" id="V2584070" start="324">
      <type>ONT::INHIBIT</type>
      <text>inhibition of Akt by MK2206</text>
    </predicate>
    <arg1 id="V2584118" role=":AGENT"/>
    <arg2 id="V2584084" role=":AFFECTED"/>
    <text>inhibition of Akt by MK2206</text>
  </EVENT>
  <EVENT end="404" id="V2584177" paragraph="paragraph26" rule="-INEVENT2B,-RULE50_0_NEUTRAL1_NEUTRAL2-EVENT,-RULE60_AGENT_AFFECTED-NONE" start="324" uttnum="155">
    <type>ONT::PHOSPHORYLATION</type>
    <epistemic-modality id="V2584146"/>
    <predicate end="404" id="V2584177" start="324">
      <type>ONT::PHOSPHORYLATION</type>
      <text>inhibition of Akt by MK2206 was associated with greatly reduced phosphorylation</text>
    </predicate>
    <text>inhibition of Akt by MK2206 was associated with greatly reduced phosphorylation</text>
  </EVENT>
  <TERM end="342" id="V2584084" paragraph="paragraph26" rule="-SIMPLE-REF" start="335" uttnum="155">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
  </TERM>
  <TERM dbid="CHEBI:67271" end="352" id="V2584118" paragraph="paragraph26" rule="-SIMPLE-REF" start="342" uttnum="155">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>by MK2206</text>
  </TERM>
  <EVENT end="404" id="V2584170" paragraph="paragraph26" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="367" uttnum="155">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="404" id="V2584170" start="367">
      <type>ONT::DECREASE</type>
      <text>with greatly reduced phosphorylation</text>
    </predicate>
    <arg2 id="V2584177" role=":AFFECTED"/>
    <text>with greatly reduced phosphorylation</text>
  </EVENT>
  <TERM end="415" id="V2584189" paragraph="paragraph26" rule="-SIMPLE-REF" start="407" uttnum="155">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="456" id="V2584227" paragraph="paragraph26" rule="-EXPLICIT-REF1" start="433" uttnum="155">
    <type>ONT::MOLECULAR-SITE</type>
    <name>AKT</name>
    <assoc-with id="V2584224"/>
    <text>the Akt site on GSK3β,</text>
  </TERM>
  <TERM end="441" id="V2584224" paragraph="paragraph26" rule="-SIMPLE-REF" start="437" uttnum="155">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM dbid="FA:03087" end="453" id="V2584266" paragraph="paragraph26" rule="-SIMPLE-REF" start="449" uttnum="155">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <TERM end="464" id="V2584284" paragraph="paragraph26" rule="-SIMPLE-REF" start="456" uttnum="155">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="494" id="V2584297" paragraph="paragraph26" rule="-SIMPLE-REF" start="479" uttnum="155">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 6</text>
  </TERM>
  <TERM end="495" id="V2584321" paragraph="paragraph26" rule="-SIMPLE-REF" start="494" uttnum="155">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <EVENT end="612" id="V2597543" paragraph="paragraph26" rule="-RULE30_AGENT_AFFECTED" start="540" uttnum="156">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="612" id="V2597543" start="540">
      <type>ONT::INHIBIT</type>
      <text>MK2206 also blocked the phosphorylation of Akt at the activating sites,</text>
    </predicate>
    <arg1 id="V2597529" role=":AGENT"/>
    <arg2 id="V2597555" role=":AFFECTED"/>
    <text>MK2206 also blocked the phosphorylation of Akt at the activating sites,</text>
  </EVENT>
  <TERM dbid="CHEBI:67271" end="547" id="V2597529" paragraph="paragraph26" rule="-SIMPLE-REF" start="540" uttnum="156">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>MK2206</text>
  </TERM>
  <EVENT end="587" id="V2597555" paragraph="paragraph26" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="560" uttnum="156">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="587" id="V2597555" start="560">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the phosphorylation of Akt</text>
    </predicate>
    <arg2 id="V2597567" role=":AFFECTED"/>
    <arg id="R000062" role=":RESULT"/>
    <text>the phosphorylation of Akt</text>
  </EVENT>
  <TERM end="587" id="V2597567" paragraph="paragraph26" rule="-SIMPLE-REF" start="580" uttnum="156">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
    <not-features>
      <ptm event="V2597555" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="612" id="V2597601" paragraph="paragraph26" rule="-INEVENT2B,-SIMPLE-REF" start="590" uttnum="156">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <inevent>
        <event id="V2597596"/>
      </inevent>
    </features>
    <name>SITE</name>
    <text>the activating sites,</text>
  </TERM>
  <EVENT end="612" id="V2597596" paragraph="paragraph26" rule="-RULE40A_AGENT_AFFECTED-AGENT" start="590" uttnum="156">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="612" id="V2597596" start="590">
      <type>ONT::ACTIVATE</type>
      <text>the activating sites,</text>
    </predicate>
    <arg1 id="V2597601" role=":AGENT"/>
    <text>the activating sites,</text>
  </EVENT>
  <TERM end="620" id="V2597611" paragraph="paragraph26" rule="-SIMPLE-REF" start="612" uttnum="156">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="642" id="V2597629" paragraph="paragraph26" rule="-SIMPLE-REF" start="634" uttnum="156">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EPI end="73" id="V2613230" paragraph="paragraph27" rule="-RULE50_0_AGENT_NEUTRAL" start="3" uttnum="157">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg1 id="V2613220" role=":AGENT"/>
    <arg2 id="V2613240" role=":NEUTRAL"/>
    <text>We also examined the effect of re-expressing PTEN in DBTRG-05MG cells,</text>
  </EPI>
  <TERM end="6" id="V2613220" paragraph="paragraph27" rule="-ROBUSTPRO" start="3" uttnum="157">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <EVENT end="73" id="V2613240" paragraph="paragraph27" rule="-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE10_AGENT_AFFECTED-AGENT" start="3" uttnum="157">
    <type>ONT::MODULATE</type>
    <epistemic-modality id="V2613230"/>
    <predicate end="73" id="V2613240" start="3">
      <type>ONT::MODULATE</type>
      <text>We also examined the effect of re-expressing PTEN in DBTRG-05MG cells,</text>
    </predicate>
    <arg1 id="V2613265" role=":AGENT"/>
    <text>We also examined the effect of re-expressing PTEN in DBTRG-05MG cells,</text>
  </EVENT>
  <EVENT end="53" id="V2613265" paragraph="paragraph27" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="31" uttnum="157">
    <type>ONT::EXPRESS</type>
    <mods>
      <frequency>
        <type>ONT::REPETITION</type>
        <value>RE-</value>
      </frequency>
    </mods>
    <predicate end="53" id="V2613265" start="31">
      <type>ONT::EXPRESS</type>
      <text>of re-expressing PTEN</text>
    </predicate>
    <arg2 id="V2613284" role=":AFFECTED-RESULT"/>
    <text>of re-expressing PTEN</text>
  </EVENT>
  <TERM dbid="UP:P60484" end="53" id="V2613284" paragraph="paragraph27" rule="-SIMPLE-REF" start="48" uttnum="157">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>PTEN</text>
  </TERM>
  <TERM end="73" id="V2613374" paragraph="paragraph27" rule="-SIMPLE-REF" start="56" uttnum="157">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>DBTRG-05MG cells,</text>
  </TERM>
  <TERM dbid="CVCL:1169" end="67" id="V2613366" paragraph="paragraph27" rule="-SIMPLE-REF" start="56" uttnum="157">
    <type>ONT::CELL-LINE</type>
    <name>DBTRG-5-MG</name>
    <text>DBTRG-05MG</text>
  </TERM>
  <TERM end="155" id="V2616344" paragraph="paragraph27" rule="-SIMPLE-REF" start="80" uttnum="157">
    <type>ONT::MENTAL-OBJECT</type>
    <name>VECTOR</name>
    <text>a lentiviral vector that gives levels of expression similar to normal cells</text>
  </TERM>
  <TERM end="155" id="V2616439" paragraph="paragraph27" rule="-SIMPLE-REF" start="140" uttnum="157">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>to normal cells</text>
  </TERM>
  <TERM end="174" id="V2630572" paragraph="paragraph27" rule="-ROBUSTPRO" start="171" uttnum="158">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="237" id="V2630693" paragraph="paragraph27" rule="-SIMPLE-REF-MUTATION8" start="184" uttnum="158">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>a C124S mutant that has no lipid phosphatase activity</text>
  </TERM>
  <TERM end="192" id="V2630690" paragraph="paragraph27" rule="-SIMPLE-REF" start="186" uttnum="158">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>124</pos>
      <aa-from>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">C124S</text>
  </TERM>
  <EVENT end="237" id="V2630763" paragraph="paragraph27" rule="-ACTIVITY1" start="208" uttnum="158">
    <type>ONT::ACTIVITY</type>
    <predicate end="237" id="V2630763" start="208">
      <type>ONT::ACTIVITY</type>
      <text>no lipid phosphatase activity</text>
    </predicate>
    <arg1 id="V2630746" role=":AGENT"/>
    <text>no lipid phosphatase activity</text>
  </EVENT>
  <TERM dbid="XFAM:PF04536.11|XFAM:PF00300.19" end="237" id="V2630754" paragraph="paragraph27" rule="-SIMPLE-REF" start="208" uttnum="158">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PHOSPHATASE</name>
    <text>no lipid phosphatase activity</text>
  </TERM>
  <TERM dbid="CHEBI:18059" end="217" id="V2630746" paragraph="paragraph27" rule="-SIMPLE-REF" start="208" uttnum="158">
    <type>ONT::MOLECULE</type>
    <name>LIPID</name>
    <text>no lipid</text>
  </TERM>
  <EVENT end="267" id="V2646139" paragraph="paragraph27" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="239" uttnum="159">
    <type>ONT::EXPRESS</type>
    <predicate end="267" id="V2646139" start="239">
      <type>ONT::EXPRESS</type>
      <text>Prior expression of WT PTEN</text>
    </predicate>
    <arg2 id="V2646164" role=":AFFECTED-RESULT"/>
    <text>Prior expression of WT PTEN</text>
  </EVENT>
  <TERM end="328" id="V2646247" paragraph="paragraph27" rule="-SIMPLE-REF" start="320" uttnum="159">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="314" id="V2646191" paragraph="paragraph27" rule="-SIMPLE-REF" start="298" uttnum="159">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 6C</text>
  </TERM>
  <TERM dbid="UP:P60484" end="267" id="V2646164" paragraph="paragraph27" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="256" uttnum="159">
    <type>ONT::PROTEIN</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>PTEN</name>
    <text>of WT PTEN</text>
  </TERM>
  <TERM end="377" id="V2646288" paragraph="paragraph27" rule="-SIMPLE-REF" start="361" uttnum="159">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 6D</text>
  </TERM>
  <TERM end="377" id="V2646263" paragraph="paragraph27" rule="-SIMPLE-REF" start="361" uttnum="159">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 6D</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="409" id="V2646306" paragraph="paragraph27" rule="-SIMPLE-REF" start="382" uttnum="159">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK in response to A769662</text>
  </TERM>
  <TERM end="399" id="V2646361" paragraph="paragraph27" rule="-SIMPLE-REF" start="390" uttnum="159">
    <type>ONT::INFORMATION</type>
    <name>RESPONSE</name>
    <text>response</text>
  </TERM>
  <TERM end="409" id="V2646471" paragraph="paragraph27" rule="-SIMPLE-REF" start="402" uttnum="159">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662</text>
  </TERM>
  <TERM end="448" id="V2661636" paragraph="paragraph27" rule="-SIMPLE-REF-MUTATION8" start="425" uttnum="160">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>with the C124S mutant,</text>
  </TERM>
  <TERM end="440" id="V2661633" paragraph="paragraph27" rule="-SIMPLE-REF" start="434" uttnum="160">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>124</pos>
      <aa-from>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">C124S</text>
  </TERM>
  <EPI end="527" id="V2661696" paragraph="paragraph27" rule="-RULE50_0_NEUTRAL1_NEUTRAL2" start="448" uttnum="160">
    <type>ONT::ASSOCIATE</type>
    <force>ONT::TRUE</force>
    <text>expression of WT PTEN was associated with decreased phosphorylation of Ser</text>
  </EPI>
  <EVENT end="470" id="V2661647" paragraph="paragraph27" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="448" uttnum="160">
    <type>ONT::EXPRESS</type>
    <predicate end="470" id="V2661647" start="448">
      <type>ONT::EXPRESS</type>
      <text>expression of WT PTEN</text>
    </predicate>
    <arg2 id="V2661672" role=":AFFECTED-RESULT"/>
    <text>expression of WT PTEN</text>
  </EVENT>
  <EVENT end="527" id="V2661719" paragraph="paragraph27" rule="-INEVENT2B,-RULE50_0_NEUTRAL1_NEUTRAL2-EVENT,-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="448" uttnum="160">
    <type>ONT::PHOSPHORYLATION</type>
    <epistemic-modality id="V2661696"/>
    <predicate end="527" id="V2661719" start="448">
      <type>ONT::PHOSPHORYLATION</type>
      <text>expression of WT PTEN was associated with decreased phosphorylation of Ser</text>
    </predicate>
    <site end="527" id="V2661731" start="516">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">of Ser</text>
    </site>
    <text>expression of WT PTEN was associated with decreased phosphorylation of Ser</text>
  </EVENT>
  <TERM dbid="UP:P60484" end="470" id="V2661672" paragraph="paragraph27" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="459" uttnum="160">
    <type>ONT::PROTEIN</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>PTEN</name>
    <text>of WT PTEN</text>
  </TERM>
  <EVENT end="527" id="V2661714" paragraph="paragraph27" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="485" uttnum="160">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="527" id="V2661714" start="485">
      <type>ONT::DECREASE</type>
      <text>with decreased phosphorylation of Ser</text>
    </predicate>
    <arg2 id="V2661719" role=":AFFECTED"/>
    <text>with decreased phosphorylation of Ser</text>
  </EVENT>
  <TERM end="527" id="V2661731" paragraph="paragraph27" rule="-SIMPLE-REF" start="516" uttnum="160">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>of Ser</text>
  </TERM>
  <TERM end="560" id="V2661807" paragraph="paragraph27" rule="-SIMPLE-REF" start="552" uttnum="160">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM dbid="FA:03087" end="575" id="V2661847" paragraph="paragraph27" rule="-SIMPLE-REF" start="571" uttnum="160">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <EVENT end="628" id="V2661888" paragraph="paragraph27" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="601" uttnum="160">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="628" id="V2661888" start="601">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of Thr</text>
    </predicate>
    <site end="628" id="V2661900" start="620">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>phosphorylation of Thr</text>
  </EVENT>
  <TERM end="628" id="V2661900" paragraph="paragraph27" rule="-SIMPLE-REF" start="620" uttnum="160">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="650" id="V2661918" paragraph="paragraph27" rule="-SIMPLE-REF" start="642" uttnum="160">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="691" id="V2661953" paragraph="paragraph27" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="660" uttnum="160">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <active>TRUE</active>
    </features>
    <name>AKT</name>
    <text normalization="">on Akt (Figure 6D)</text>
  </TERM>
  <TERM end="690" id="V2661988" paragraph="paragraph27" rule="-SIMPLE-REF" start="674" uttnum="160">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 6D</text>
  </TERM>
  <TERM end="690" id="V2661963" paragraph="paragraph27" rule="-SIMPLE-REF" start="674" uttnum="160">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 6D</text>
  </TERM>
  <TERM end="6" id="V2676444" paragraph="paragraph28" rule="-ROBUSTPRO" start="3" uttnum="161">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM dbid="UP:P60484" end="39" id="V2676465" paragraph="paragraph28" rule="-SIMPLE-REF" start="19" uttnum="161">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>two other PTEN-null</text>
  </TERM>
  <TERM dbid="EFO:0000322" end="135" id="V2676516" paragraph="paragraph28" rule="-SIMPLE-REF" start="39" uttnum="161">
    <type>ONT::CELL-LINE</type>
    <name>CELL-LINE</name>
    <text>human cell lines, i.e. U373-MG (another glioblastoma line) and MDA-MB-468 (a breast cancer line)</text>
  </TERM>
  <TERM dbid="CVCL:2219" end="98" id="V2676643" paragraph="paragraph28" rule="-SIMPLE-REF" start="62" uttnum="161">
    <type>ONT::CELL-LINE</type>
    <name>U-373-MG</name>
    <text>U373-MG (another glioblastoma line)</text>
  </TERM>
  <TERM dbid="EFO:0001216|CVCL:0419" end="135" id="V2676696" paragraph="paragraph28" rule="-SIMPLE-REF" start="102" uttnum="161">
    <type>ONT::CELL-LINE</type>
    <name>MDA-MB-468</name>
    <text>MDA-MB-468 (a breast cancer line)</text>
  </TERM>
  <TERM end="169" id="V2687650" paragraph="paragraph28" rule="-SIMPLE-REF" start="145" uttnum="162">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>to the DBTRG-05MG cells,</text>
  </TERM>
  <TERM dbid="EFO:0002159" end="163" id="V2687645" paragraph="paragraph28" rule="-SIMPLE-REF" start="152" uttnum="162">
    <type>ONT::CELL-LINE</type>
    <name>DBTRG-5-MG</name>
    <text>DBTRG-05MG</text>
  </TERM>
  <TERM end="258" id="V2692708" paragraph="paragraph28" rule="-SIMPLE-REF" start="250" uttnum="162">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="225" id="V2692668" paragraph="paragraph28" rule="-SIMPLE-REF" start="207" uttnum="162">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>Figures 6E</text>
  </TERM>
  <TERM end="225" id="V2692651" paragraph="paragraph28" rule="-SIMPLE-REF" start="207" uttnum="162">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figures 6E</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="361" id="V2692788" paragraph="paragraph28" rule="-SIMPLE-REF" start="333" uttnum="162">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK in response to A769662,</text>
  </TERM>
  <TERM end="350" id="V2692843" paragraph="paragraph28" rule="-SIMPLE-REF" start="341" uttnum="162">
    <type>ONT::INFORMATION</type>
    <name>RESPONSE</name>
    <text>response</text>
  </TERM>
  <TERM end="360" id="V2692953" paragraph="paragraph28" rule="-SIMPLE-REF" start="353" uttnum="162">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662</text>
  </TERM>
  <EVENT end="420" id="V2705081" paragraph="paragraph28" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="390" uttnum="162">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="420" id="V2705081" start="390">
      <type>ONT::INHIBIT</type>
      <text>Akt was inhibited using MK2206</text>
    </predicate>
    <arg2 id="V2705059" role=":AFFECTED"/>
    <text>Akt was inhibited using MK2206</text>
  </EVENT>
  <TERM end="394" id="V2705059" paragraph="paragraph28" rule="-SIMPLE-REF" start="390" uttnum="162">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM dbid="CHEBI:67271" end="420" id="V2705098" paragraph="paragraph28" rule="-SIMPLE-REF" start="414" uttnum="162">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>MK2206</text>
  </TERM>
  <TERM end="6" id="V2710212" paragraph="paragraph29" rule="-ROBUSTPRO" start="3" uttnum="163">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="35" id="V2710260" paragraph="paragraph29" rule="-SIMPLE-REF" start="21" uttnum="163">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>the mechanism</text>
  </TERM>
  <EVENT end="131" id="V2710306" paragraph="paragraph29" rule="-RULE30_AGENT_AFFECTED" start="62" uttnum="163">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="131" id="V2710306" start="62">
      <type>ONT::INHIBIT</type>
      <text>phosphorylation inhibits subsequent Thr172 phosphorylation</text>
    </predicate>
    <arg1 id="V2710302" role=":AGENT"/>
    <arg2 id="V2710316" role=":AFFECTED"/>
    <text>phosphorylation inhibits subsequent Thr172 phosphorylation</text>
  </EVENT>
  <EVENT end="78" id="V2710302" paragraph="paragraph29" rule="-RULE60_AGENT_AFFECTED-NONE" start="62" uttnum="163">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="78" id="V2710302" start="62">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation</text>
    </predicate>
    <text>phosphorylation</text>
  </EVENT>
  <TERM end="106" id="V2710316" paragraph="paragraph29" rule="-SIMPLE-REF" start="87" uttnum="163">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>subsequent Thr</text>
  </TERM>
  <TERM end="214" id="V2712804" paragraph="paragraph29" rule="-SIMPLE-REF" start="189" uttnum="164">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop from Ile</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="196" id="V2712795" paragraph="paragraph29" rule="-SIMPLE-REF" start="193" uttnum="164">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="214" id="V2712820" paragraph="paragraph29" rule="-SIMPLE-REF" start="206" uttnum="164">
    <type>ONT::AMINO-ACID</type>
    <name>ILE</name>
    <text>Ile</text>
  </TERM>
  <TERM end="235" id="V2712852" paragraph="paragraph29" rule="-SIMPLE-REF" start="227" uttnum="164">
    <type>ONT::AMINO-ACID</type>
    <name>ASP</name>
    <text>Asp</text>
  </TERM>
  <TERM end="250" id="V2712861" paragraph="paragraph29" rule="-SIMPLE-REF" start="246" uttnum="164">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat</text>
  </TERM>
  <EVENT end="337" id="V2722547" paragraph="paragraph29" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="295" uttnum="164">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="337" id="V2722547" start="295">
      <type>ONT::EXPRESS</type>
      <text>the complex had been expressed in bacteria</text>
    </predicate>
    <arg2 id="V2722497" role=":AFFECTED-RESULT"/>
    <text>the complex had been expressed in bacteria</text>
  </EVENT>
  <TERM end="307" id="V2722497" paragraph="paragraph29" rule="-SIMPLE-REF" start="295" uttnum="164">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>the complex</text>
  </TERM>
  <TERM end="337" id="V2722606" paragraph="paragraph29" rule="-SIMPLE-REF" start="329" uttnum="164">
    <type>ONT::BACTERIUM</type>
    <name>BACTERIUM</name>
    <text>bacteria</text>
  </TERM>
  <TERM end="354" id="V2723220" paragraph="paragraph29" rule="-SIMPLE-REF" start="342" uttnum="164">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="349" id="V2723211" paragraph="paragraph29" rule="-SIMPLE-REF" start="346" uttnum="164">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="468" id="V2724062" paragraph="paragraph29" rule="-SIMPLE-REF" start="434" uttnum="165">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>the ST loop was deleted as it was</text>
  </TERM>
  <TERM end="446" id="V2724071" paragraph="paragraph29" rule="-SIMPLE-REF" start="441" uttnum="165">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>loop</text>
  </TERM>
  <TERM end="576" id="V2742604" paragraph="paragraph29" rule="-SIMPLE-REF" start="523" uttnum="166">
    <type>ONT::LOCATION</type>
    <name>LOCATION</name>
    <text>the location of the residues at the ends of the loop</text>
  </TERM>
  <TERM end="552" id="V2742625" paragraph="paragraph29" rule="-SIMPLE-REF" start="536" uttnum="166">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>of the residues</text>
  </TERM>
  <TERM end="576" id="V2742681" paragraph="paragraph29" rule="-SIMPLE-REF" start="564" uttnum="166">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>of the loop</text>
  </TERM>
  <TERM end="585" id="V2742689" paragraph="paragraph29" rule="-SIMPLE-REF" start="577" uttnum="166">
    <type>ONT::AMINO-ACID</type>
    <name>GLU</name>
    <text>Glu</text>
  </TERM>
  <TERM end="607" id="V2742707" paragraph="paragraph29" rule="-SIMPLE-REF" start="599" uttnum="166">
    <type>ONT::AMINO-ACID</type>
    <name>VAL</name>
    <text>Val</text>
  </TERM>
  <TERM end="682" id="V2742943" paragraph="paragraph29" rule="-SIMPLE-REF" start="661" uttnum="166">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>to the kinase domain,</text>
  </TERM>
  <TERM dbid="GO:0016301" end="675" id="V2742940" paragraph="paragraph29" rule="-SIMPLE-REF" start="668" uttnum="166">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="741" id="V2757570" paragraph="paragraph29" rule="-SIMPLE-REF" start="733" uttnum="166">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="787" id="V2757586" paragraph="paragraph29" rule="-SIMPLE-REF" start="771" uttnum="166">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 7A</text>
  </TERM>
  <TERM end="793" id="V2766412" paragraph="paragraph29" rule="-ROBUSTPRO" start="790" uttnum="167">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="823" id="V2766454" paragraph="paragraph29" rule="-SIMPLE-REF" start="811" uttnum="167">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM end="861" id="V2766499" paragraph="paragraph29" rule="-SIMPLE-REF" start="838" uttnum="167">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>with the kinase domain</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="818" id="V2766445" paragraph="paragraph29" rule="-SIMPLE-REF" start="815" uttnum="167">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM dbid="GO:0016301" end="854" id="V2766496" paragraph="paragraph29" rule="-SIMPLE-REF" start="847" uttnum="167">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <EVENT end="892" id="V2766517" paragraph="paragraph29" rule="-RULE60_AGENT_AFFECTED-LOC4-GD-NONE" start="866" uttnum="167">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="892" id="V2766517" start="866">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylated on Ser</text>
    </predicate>
    <site end="892" id="V2766549" start="884">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>phosphorylated on Ser</text>
  </EVENT>
  <TERM end="892" id="V2766549" paragraph="paragraph29" rule="-SIMPLE-REF" start="884" uttnum="167">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="967" id="V2782708" paragraph="paragraph29" rule="-SIMPLE-REF" start="959" uttnum="168">
    <type>ONT::AMINO-ACID</type>
    <name>LYS</name>
    <text>Lys</text>
  </TERM>
  <TERM end="906" id="V2782666" paragraph="paragraph29" rule="-ROBUSTPRO" start="903" uttnum="168">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM dbid="UP:P42684" end="949" id="V2782697" paragraph="paragraph29" rule="-SIMPLE-REF" start="919" uttnum="168">
    <type>ONT::PROTEIN</type>
    <name>ARG</name>
    <text>three basic residues, Arg</text>
  </TERM>
  <TERM end="949" id="V2782689" paragraph="paragraph29" rule="-SIMPLE-REF" start="919" uttnum="168">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>three basic residues, Arg</text>
  </TERM>
  <TERM dbid="UP:P42684" end="988" id="V2782726" paragraph="paragraph29" rule="-SIMPLE-REF" start="980" uttnum="168">
    <type>ONT::PROTEIN</type>
    <name>ARG</name>
    <text>Arg</text>
  </TERM>
  <TERM end="1005" id="V2782735" paragraph="paragraph29" rule="-SIMPLE-REF" start="998" uttnum="168">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat α1</text>
  </TERM>
  <TERM end="1050" id="V2792970" paragraph="paragraph29" rule="-ROBUSTPRO" start="1017" uttnum="168">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>which are located within the ‘αC</text>
  </TERM>
  <TERM dbid="UP:Q96B36|HGNC:28426" end="1095" id="V2793099" paragraph="paragraph29" rule="-SIMPLE-REF" start="1060" uttnum="168">
    <type>ONT::GENE</type>
    <name>LOBE</name>
    <text>the small lobe of the kinase domain</text>
  </TERM>
  <TERM end="1095" id="V2793121" paragraph="paragraph29" rule="-SIMPLE-REF" start="1078" uttnum="168">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the kinase domain</text>
  </TERM>
  <TERM dbid="GO:0016301" end="1089" id="V2793118" paragraph="paragraph29" rule="-SIMPLE-REF" start="1082" uttnum="168">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="1128" id="V2805093" paragraph="paragraph29" rule="-SIMPLE-REF" start="1113" uttnum="169">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>our hypothesis</text>
  </TERM>
  <TERM end="1128" id="V2805089" paragraph="paragraph29" rule="-ROBUSTPRO" start="1113" uttnum="169">
    <type>ONT::PERSON</type>
    <text>our hypothesis</text>
  </TERM>
  <TERM end="1137" id="V2805119" paragraph="paragraph29" rule="-SIMPLE-REF" start="1132" uttnum="169">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>that</text>
  </TERM>
  <TERM end="1207" id="V2805229" paragraph="paragraph29" rule="-SIMPLE-REF" start="1178" uttnum="169">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>CHAIN</name>
    <text>with these basic side chains,</text>
  </TERM>
  <TERM dbid="CHEBI:26078|CHEBI:35780|CHEBI:18367|CHEBI:43474|CHEBI:26020" end="1147" id="V2805130" paragraph="paragraph29" rule="-SIMPLE-REF" start="1137" uttnum="169">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHATE</name>
    <text>phosphate</text>
  </TERM>
  <TERM end="1169" id="V2805190" paragraph="paragraph29" rule="-SIMPLE-REF" start="1157" uttnum="169">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="1164" id="V2805181" paragraph="paragraph29" rule="-SIMPLE-REF" start="1161" uttnum="169">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="1207" id="V2805226" paragraph="paragraph29" rule="-SIMPLE-REF" start="1178" uttnum="169">
    <type>ONT::OBJECT-DEPENDENT-LOCATION</type>
    <name>SIDE</name>
    <text>with these basic side chains,</text>
  </TERM>
  <TERM dbid="CHEBI:26078|CHEBI:35780|CHEBI:18367|CHEBI:43474|CHEBI:26020" end="1287" id="V2818797" paragraph="paragraph29" rule="-SIMPLE-REF" start="1282" uttnum="169">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHATE</name>
    <text>that</text>
  </TERM>
  <TERM end="1260" id="V2818763" paragraph="paragraph29" rule="-SIMPLE-REF" start="1248" uttnum="169">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM end="1282" id="V2818788" paragraph="paragraph29" rule="-SIMPLE-REF" start="1264" uttnum="169">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the kinase domain</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="1255" id="V2818754" paragraph="paragraph29" rule="-SIMPLE-REF" start="1252" uttnum="169">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM dbid="GO:0016301" end="1275" id="V2818785" paragraph="paragraph29" rule="-SIMPLE-REF" start="1268" uttnum="169">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="1323" id="V2818832" paragraph="paragraph29" rule="-SIMPLE-REF" start="1312" uttnum="169">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>of Thr</text>
  </TERM>
  <TERM dbid="GO:0016301" end="1352" id="V2818872" paragraph="paragraph29" rule="-SIMPLE-REF" start="1345" uttnum="169">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>kinases</text>
  </TERM>
  <TERM end="36" id="V2833940" paragraph="paragraph30" rule="-ROBUSTPRO" start="33" uttnum="170">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="53" id="V2834010" paragraph="paragraph30" rule="-SIMPLE-REF" start="41" uttnum="170">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CONSTRUCT</name>
    <text>a construct</text>
  </TERM>
  <EVENT end="89" id="V2834027" paragraph="paragraph30" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="53" uttnum="170">
    <type>ONT::EXPRESS</type>
    <predicate end="89" id="V2834027" start="53">
      <type>ONT::EXPRESS</type>
      <text>expressing the peptide from Arg</text>
    </predicate>
    <arg2 id="V2834043" role=":AFFECTED-RESULT"/>
    <text>expressing the peptide from Arg</text>
  </EVENT>
  <EPI end="31" id="V2833909" paragraph="paragraph30" rule="-RULE50_0_AGENT_FORMAL-NONE" start="6" uttnum="170">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2833932" role=":NEUTRAL"/>
    <text>test the first hypothesis</text>
  </EPI>
  <TERM end="31" id="V2833932" paragraph="paragraph30" rule="-SIMPLE-REF-2" start="11" uttnum="170">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>the first hypothesis</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="76" id="V2834043" paragraph="paragraph30" rule="-SIMPLE-REF" start="64" uttnum="170">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>the peptide</text>
  </TERM>
  <TERM dbid="UP:P42684" end="89" id="V2834059" paragraph="paragraph30" rule="-SIMPLE-REF" start="81" uttnum="170">
    <type>ONT::PROTEIN</type>
    <name>ARG</name>
    <text>Arg</text>
  </TERM>
  <TERM end="110" id="V2834091" paragraph="paragraph30" rule="-SIMPLE-REF" start="102" uttnum="170">
    <type>ONT::AMINO-ACID</type>
    <name>ASP</name>
    <text>Asp</text>
  </TERM>
  <TERM dbid="HGNC:23613|XFAM:PF07648|FA:01669|UP:Q86UG4|XFAM:PF03137" end="141" id="V2834214" paragraph="paragraph30" rule="-SIMPLE-REF" start="137" uttnum="170">
    <type>ONT::GENE-PROTEIN</type>
    <name>GST</name>
    <text>GST</text>
  </TERM>
  <EVENT end="256" id="V2850376" paragraph="paragraph30" rule="-RULE20_AGENT_AFFECTED-AGENT" start="149" uttnum="171">
    <type>ONT::PPEXPT</type>
    <force>ONT::TRUE</force>
    <predicate end="256" id="V2850376" start="149">
      <type>ONT::PPEXPT</type>
      <text>The protein was expressed in and purified from bacteria, the GST domain removed, and the remaining peptide</text>
    </predicate>
    <arg1 id="V2850277" role=":AGENT"/>
    <text>The protein was expressed in and purified from bacteria, the GST domain removed, and the remaining peptide</text>
  </EVENT>
  <TERM end="161" id="V2850277" paragraph="paragraph30" rule="-SIMPLE-REF" start="149" uttnum="171">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>The protein</text>
  </TERM>
  <TERM end="230" id="V2850394" paragraph="paragraph30" rule="-SIMPLE-REF" start="196" uttnum="171">
    <type>ONT::BACTERIUM</type>
    <name>BACTERIUM</name>
    <text>bacteria, the GST domain removed,</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="256" id="V2850453" paragraph="paragraph30" rule="-SIMPLE-REF" start="234" uttnum="171">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>the remaining peptide</text>
  </TERM>
  <TERM dbid="HGNC:23613|XFAM:PF07648|FA:01669|UP:Q86UG4|XFAM:PF03137" end="228" id="V2850412" paragraph="paragraph30" rule="-INEVENT2B,-EXPLICIT-REF1" start="206" uttnum="171">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <features>
      <inevent>
        <event id="V2850417"/>
      </inevent>
    </features>
    <name>GST</name>
    <assoc-with id="V2850409"/>
    <text>the GST domain removed</text>
  </TERM>
  <TERM dbid="HGNC:23613|XFAM:PF07648|FA:01669|UP:Q86UG4|XFAM:PF03137" end="214" id="V2850409" paragraph="paragraph30" rule="-SIMPLE-REF" start="210" uttnum="171">
    <type>ONT::GENE-PROTEIN</type>
    <name>GST</name>
    <text>GST</text>
  </TERM>
  <EVENT end="228" id="V2850417" paragraph="paragraph30" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="206" uttnum="171">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="228" id="V2850417" start="206">
      <type>ONT::INHIBIT</type>
      <text>the GST domain removed</text>
    </predicate>
    <arg2 id="V2850412" role=":AFFECTED"/>
    <text>the GST domain removed</text>
  </EVENT>
  <EVENT end="175" id="V2850306" paragraph="paragraph30" rule="-RULE50_AGENT_AFFECTED-AFFECTED" start="149" uttnum="171">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="175" id="V2850306" start="149">
      <type>ONT::EXPRESS</type>
      <text>The protein was expressed</text>
    </predicate>
    <arg2 id="V2850277" role=":AFFECTED"/>
    <text>The protein was expressed</text>
  </EVENT>
  <TERM dbid="UP:P42684" end="265" id="V2850461" paragraph="paragraph30" rule="-SIMPLE-REF" start="257" uttnum="171">
    <type>ONT::PROTEIN</type>
    <name>ARG</name>
    <text>Arg</text>
  </TERM>
  <TERM end="283" id="V2850472" paragraph="paragraph30" rule="-SIMPLE-REF" start="275" uttnum="171">
    <type>ONT::AMINO-ACID</type>
    <name>ASP</name>
    <text>Asp</text>
  </TERM>
  <TERM dbid="CHEBI:27575" end="332" id="V2850525" paragraph="paragraph30" rule="-SIMPLE-REF" start="326" uttnum="171">
    <type>ONT::MOLECULE</type>
    <name>ATPΓS</name>
    <text>ATPγS</text>
  </TERM>
  <TERM dbid="CHEBI:16335" end="343" id="V2850533" paragraph="paragraph30" rule="-SIMPLE-REF" start="333" uttnum="171">
    <type>ONT::MOLECULE</type>
    <name>ADENOSINE</name>
    <text>adenosine</text>
  </TERM>
  <TERM dbid="CHEBI:18036|CHEBI:39949" end="366" id="V2850590" paragraph="paragraph30" rule="-SIMPLE-REF" start="354" uttnum="171">
    <type>ONT::MOLECULE</type>
    <name>TRIPHOSPHATE</name>
    <text>triphosphate</text>
  </TERM>
  <TERM end="376" id="V2850608" paragraph="paragraph30" rule="-SIMPLE-REF" start="372" uttnum="171">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM dbid="CHEBI:37511|CHEBI:74752" end="391" id="V2850616" paragraph="paragraph30" rule="-SIMPLE-REF" start="377" uttnum="171">
    <type>ONT::MOLECULE</type>
    <name>THIOPHOSPHATE</name>
    <text>thiophosphate</text>
  </TERM>
  <TERM dbid="GO:0004721" end="430" id="V2850680" paragraph="paragraph30" rule="-SIMPLE-REF" start="410" uttnum="171">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN-PHOSPHATASES</name>
    <text>protein phosphatases</text>
  </TERM>
  <TERM end="489" id="V2863486" paragraph="paragraph30" rule="-SIMPLE-REF" start="470" uttnum="172">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>with our hypothesis</text>
  </TERM>
  <TERM end="489" id="V2863482" paragraph="paragraph30" rule="-ROBUSTPRO" start="470" uttnum="172">
    <type>ONT::PERSON</type>
    <text>with our hypothesis</text>
  </TERM>
  <TERM end="580" id="V2863621" paragraph="paragraph30" rule="-SIMPLE-REF" start="572" uttnum="172">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="658" id="V2863744" paragraph="paragraph30" rule="-SIMPLE-REF" start="653" uttnum="172">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1,</text>
  </TERM>
  <TERM end="671" id="V2877817" paragraph="paragraph30" rule="-ROBUSTPRO" start="668" uttnum="172">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="765" id="V2877866" paragraph="paragraph30" rule="-RULE40_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="683" uttnum="172">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="765" id="V2877866" start="683">
      <type>ONT::PRODUCE</type>
      <text>to generate the peptide at high enough concentrations to fully saturate inhibition</text>
    </predicate>
    <arg2 id="V2877878" role=":AFFECTED-RESULT"/>
    <text>to generate the peptide at high enough concentrations to fully saturate inhibition</text>
  </EVENT>
  <TERM dbid="CHEBI:16670" end="707" id="V2877878" paragraph="paragraph30" rule="-SIMPLE-REF" start="695" uttnum="172">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>the peptide</text>
  </TERM>
  <EVENT end="765" id="V2877968" paragraph="paragraph30" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="740" uttnum="172">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="765" id="V2877968" start="740">
      <type>ONT::MODULATE</type>
      <text>fully saturate inhibition</text>
    </predicate>
    <arg2 id="V2877977" role=":AFFECTED"/>
    <text>fully saturate inhibition</text>
  </EVENT>
  <EVENT end="765" id="V2877977" paragraph="paragraph30" rule="-RULE30_AGENT_FORMAL-NONE" start="755" uttnum="172">
    <type>ONT::INHIBIT</type>
    <predicate end="765" id="V2877977" start="755">
      <type>ONT::INHIBIT</type>
      <text>inhibition</text>
    </predicate>
    <text>inhibition</text>
  </EVENT>
  <CC end="765" id="X2893031" paragraph="paragraph30" rule="-PURPOSE" start="683" uttnum="172">
    <type>ONT::BY-MEANS-OF</type>
    <arg id="V2877866" role=":FACTOR"/>
    <arg id="V2877968" role=":OUTCOME"/>
    <text>to generate the peptide at high enough concentrations to fully saturate inhibition</text>
  </CC>
  <TERM dbid="CHEBI:16670" end="809" id="V2892904" paragraph="paragraph30" rule="-INEVENT2B,-SIMPLE-REF" start="780" uttnum="173">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>the unphosphorylated peptide</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2892894"/>
    </not-features>
  </TERM>
  <EVENT end="809" id="V2892894" paragraph="paragraph30" rule="-RULE60_AGENT_AFFECTED-MODN1_2-AFFECTED" start="780" uttnum="173">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <mods>
      <mod>
        <type>ONT::MANNER-UNDO</type>
        <value>UN-</value>
      </mod>
    </mods>
    <predicate end="809" id="V2892894" start="780">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the unphosphorylated peptide</text>
    </predicate>
    <arg2 id="V2892904" role=":AFFECTED"/>
    <text>the unphosphorylated peptide</text>
  </EVENT>
  <TERM end="846" id="V2892982" paragraph="paragraph30" rule="-SIMPLE-REF" start="830" uttnum="173">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>Figure 7B</text>
  </TERM>
  <TERM end="846" id="V2892958" paragraph="paragraph30" rule="-SIMPLE-REF" start="830" uttnum="173">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 7B</text>
  </TERM>
  <EVENT end="915" id="V2901219" paragraph="paragraph30" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="865" uttnum="174">
    <type>ONT::INHIBIT</type>
    <predicate end="915" id="V2901219" start="865">
      <type>ONT::INHIBIT</type>
      <text>the inhibition of activation loop phosphorylation</text>
    </predicate>
    <arg2 id="V2901241" role=":AFFECTED"/>
    <text>the inhibition of activation loop phosphorylation</text>
  </EVENT>
  <EPI end="865" id="V2901186" paragraph="paragraph30" rule="-RULE50_0_AGENT_FORMAL-NONE" start="852" uttnum="174">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2901203" role=":NEUTRAL"/>
    <text>confirm that</text>
  </EPI>
  <TERM dbid="CHEBI:16670" end="865" id="V2901203" paragraph="paragraph30" rule="-SIMPLE-REF" start="860" uttnum="174">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>that</text>
  </TERM>
  <EVENT end="915" id="V2901241" paragraph="paragraph30" rule="-RULE60_AGENT_AFFECTED-NONE" start="880" uttnum="174">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="915" id="V2901241" start="880">
      <type>ONT::PHOSPHORYLATION</type>
      <text>of activation loop phosphorylation</text>
    </predicate>
    <text>of activation loop phosphorylation</text>
  </EVENT>
  <TERM end="915" id="V2901238" paragraph="paragraph30" rule="-SIMPLE-REF" start="880" uttnum="174">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>of activation loop phosphorylation</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="936" id="V2901290" paragraph="paragraph30" rule="-SIMPLE-REF" start="928" uttnum="174">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>to AMPK,</text>
  </TERM>
  <TERM end="940" id="V2904628" paragraph="paragraph30" rule="-ROBUSTPRO" start="937" uttnum="174">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="952" id="V2904654" paragraph="paragraph30" rule="-SIMPLE-REF" start="947" uttnum="174">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>that</text>
  </TERM>
  <TERM dbid="FA:01704" end="973" id="V2904682" paragraph="paragraph30" rule="-SIMPLE-REF" start="960" uttnum="174">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>PHOSPHO</name>
    <text normalization="">the phospho-</text>
  </TERM>
  <EVENT end="1081" id="V2904715" paragraph="paragraph30" rule="-RULE30_AGENT_AFFECTED" start="977" uttnum="174">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="1081" id="V2904715" start="977">
      <type>ONT::INHIBIT</type>
      <text>the dephospho-peptide inhibited activation and phosphorylation of the AMPK-related kinase BRSK2 by LKB1</text>
    </predicate>
    <arg1 id="V2904705" role=":AGENT"/>
    <text>the dephospho-peptide inhibited activation and phosphorylation of the AMPK-related kinase BRSK2 by LKB1</text>
  </EVENT>
  <TERM dbid="CHEBI:16670" end="999" id="V2904705" paragraph="paragraph30" rule="-SIMPLE-REF" start="977" uttnum="174">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>the dephospho-peptide</text>
  </TERM>
  <EVENT end="1073" id="V2904735" paragraph="paragraph30" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="1024" uttnum="174">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1073" id="V2904735" start="1024">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of the AMPK-related kinase BRSK2</text>
    </predicate>
    <arg2 id="V2904787" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000067"/>
    <text>phosphorylation of the AMPK-related kinase BRSK2</text>
  </EVENT>
  <TERM dbid="HGNC:11405|UP:Q8IWQ3" end="1073" id="V2904787" paragraph="paragraph30" rule="-EXPLICIT-REF1-REV" start="1040" uttnum="174">
    <type>ONT::PROTEIN</type>
    <name>BRSK-2</name>
    <assoc-with id="X2920219"/>
    <text>of the AMPK-related kinase BRSK2</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2904735"/>
    </not-features>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1060" id="V2904754" paragraph="paragraph30" rule="-SIMPLE-REF" start="1047" uttnum="174">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK-related</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="1081" id="V2904821" paragraph="paragraph30" rule="-SIMPLE-REF" start="1076" uttnum="174">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1</text>
  </TERM>
  <TERM dbid="HGNC:11405|UP:Q8IWQ3" end="1073" id="X2920219" paragraph="paragraph30" rule="-EXPLICIT-REF1-REV-BASE" start="1040" uttnum="174">
    <type>ONT::GENE</type>
    <name>BRSK-2</name>
    <text>of the AMPK-related kinase BRSK2</text>
  </TERM>
  <TERM end="1095" id="V2904831" paragraph="paragraph30" rule="-SIMPLE-REF" start="1088" uttnum="174">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <EPI end="35" id="V2920271" paragraph="paragraph31" rule="-RULE50_0_AGENT_FORMAL-NONE" start="3" uttnum="175">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2920300" role=":NEUTRAL"/>
    <text>To test the extended hypothesis,</text>
  </EPI>
  <TERM end="35" id="V2920300" paragraph="paragraph31" rule="-SIMPLE-REF" start="11" uttnum="175">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>the extended hypothesis,</text>
  </TERM>
  <TERM end="39" id="V2925466" paragraph="paragraph31" rule="-ROBUSTPRO" start="36" uttnum="175">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="77" id="V2926056" paragraph="paragraph31" rule="-EXPLICIT-REF-SEQ0B" start="63" uttnum="175">
    <type>ONT::MUTATION</type>
    <components>
      <component id="V2924568"/>
      <component id="V2924422"/>
      <component id="V2924491"/>
    </components>
    <text normalization="">R64A/K71A/R74A</text>
  </TERM>
  <TERM end="67" id="V2924422" paragraph="paragraph31" rule="-SIMPLE-REF" start="63" uttnum="175">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>64</pos>
      <aa-from>
        <aa>
          <name>Arginine</name>
          <code>R</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">R64A</text>
  </TERM>
  <TERM end="72" id="V2924491" paragraph="paragraph31" rule="-SIMPLE-REF" start="68" uttnum="175">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>71</pos>
      <aa-from>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">K71A</text>
  </TERM>
  <TERM end="77" id="V2924568" paragraph="paragraph31" rule="-EXPLICIT-REF-SEQ0B-TERM" start="63" uttnum="175">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>74</pos>
      <aa-from>
        <aa>
          <name>Arginine</name>
          <code>R</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">R64A/K71A/R74A</text>
  </TERM>
  <TERM dbid="CHEBI:73313|CHEBI:28515" end="104" id="V2925583" paragraph="paragraph31" rule="-SIMPLE-REF" start="100" uttnum="175">
    <type>ONT::MOLECULE</type>
    <name>AAA</name>
    <text>AAA</text>
  </TERM>
  <TERM end="110" id="V2925587" paragraph="paragraph31" rule="-SIMPLE-REF-MUTATION8" start="104" uttnum="175">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>mutant</text>
  </TERM>
  <TERM end="129" id="V2925666" paragraph="paragraph31" rule="-SIMPLE-REF" start="117" uttnum="175">
    <type>ONT::LINGUISTIC-OBJECT</type>
    <name>CONTEXT</name>
    <text>the context</text>
  </TERM>
  <TERM end="174" id="V2925735" paragraph="paragraph31" rule="-SIMPLE-REF" start="161" uttnum="175">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complex used</text>
  </TERM>
  <TERM end="190" id="V2925809" paragraph="paragraph31" rule="-SIMPLE-REF" start="183" uttnum="175">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="313" id="V2925843" paragraph="paragraph31" rule="-SIMPLE-REF" start="203" uttnum="175">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>the three basic residues in the kinase domain that we propose to interact with phosphate groups on the ST loop</text>
  </TERM>
  <TERM end="249" id="V2925910" paragraph="paragraph31" rule="-SIMPLE-REF" start="231" uttnum="175">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the kinase domain</text>
  </TERM>
  <TERM dbid="GO:0016301" end="242" id="V2925907" paragraph="paragraph31" rule="-SIMPLE-REF" start="235" uttnum="175">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="257" id="V2925927" paragraph="paragraph31" rule="-ROBUSTPRO" start="254" uttnum="175">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="CHEBI:26078|CHEBI:35780|CHEBI:18367|CHEBI:43474|CHEBI:26020" end="292" id="V2925986" paragraph="paragraph31" rule="-SIMPLE-REF" start="282" uttnum="175">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHATE</name>
    <text>phosphate</text>
  </TERM>
  <TERM end="313" id="V2926046" paragraph="paragraph31" rule="-SIMPLE-REF" start="302" uttnum="175">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="309" id="V2926037" paragraph="paragraph31" rule="-SIMPLE-REF" start="306" uttnum="175">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <EVENT end="394" id="V2936549" paragraph="paragraph31" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="347" uttnum="176">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="394" id="V2936549" start="347">
      <type>ONT::PHOSPHORYLATION</type>
      <text>prior phosphorylation of the WT complex by Akt</text>
    </predicate>
    <arg2 id="V2936581" role=":AFFECTED"/>
    <arg id="R000072" role=":RESULT"/>
    <text>prior phosphorylation of the WT complex by Akt</text>
  </EVENT>
  <TERM end="345" id="V2936535" paragraph="paragraph31" rule="-SIMPLE-REF" start="326" uttnum="176">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>with our hypothesis</text>
  </TERM>
  <TERM end="345" id="V2936531" paragraph="paragraph31" rule="-ROBUSTPRO" start="326" uttnum="176">
    <type>ONT::PERSON</type>
    <text>with our hypothesis</text>
  </TERM>
  <TERM end="387" id="V2936581" paragraph="paragraph31" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="369" uttnum="176">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>COMPLEX</name>
    <text>of the WT complex</text>
    <not-features>
      <ptm event="V2936549" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="394" id="V2936615" paragraph="paragraph31" rule="-SIMPLE-REF" start="390" uttnum="176">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="436" id="V2936647" paragraph="paragraph31" rule="-SIMPLE-REF" start="428" uttnum="176">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="469" id="V2936653" paragraph="paragraph31" rule="-RULE60_AGENT_AFFECTED-AGENT" start="446" uttnum="176">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="469" id="V2936653" start="446">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation by LKB1</text>
    </predicate>
    <arg1 id="V2936687" role=":AGENT"/>
    <text>phosphorylation by LKB1</text>
  </EVENT>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="469" id="V2936687" paragraph="paragraph31" rule="-SIMPLE-REF" start="462" uttnum="176">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1</text>
  </TERM>
  <EVENT end="555" id="V2951205" paragraph="paragraph31" rule="-RULE30_AGENT_FORMAL-AGENT" start="475" uttnum="176">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <mods>
      <degree>
        <type>ONT::DEGREE-MODIFIER-VERYHIGH</type>
        <value>COMPLETELY</value>
      </degree>
    </mods>
    <predicate end="555" id="V2951205" start="475">
      <type>ONT::INHIBIT</type>
      <text>this effect was completely abolished by either an S487A mutant or an AAA mutant,</text>
    </predicate>
    <arg1 id="V2951233" role=":AGENT"/>
    <text>this effect was completely abolished by either an S487A mutant or an AAA mutant,</text>
  </EVENT>
  <TERM end="555" id="V2951233" paragraph="paragraph31" rule="-SIMPLE-REF-MUTATION8" start="512" uttnum="176">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>by either an S487A mutant or an AAA mutant,</text>
  </TERM>
  <TERM end="538" id="V2951296" paragraph="paragraph31" rule="-SIMPLE-REF-MUTATION8" start="522" uttnum="176">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>an S487A mutant</text>
  </TERM>
  <TERM dbid="CHEBI:73313|CHEBI:28515" end="555" id="V2951320" paragraph="paragraph31" rule="-EXPLICIT-REF4" start="541" uttnum="176">
    <type>ONT::MOLECULE</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>AAA</name>
    <text>an AAA mutant,</text>
  </TERM>
  <TERM end="531" id="V2951293" paragraph="paragraph31" rule="-SIMPLE-REF" start="525" uttnum="176">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="579" id="V2953271" paragraph="paragraph31" rule="-SIMPLE-REF" start="568" uttnum="176">
    <type>ONT::NONESSENTIAL-CONTRACT</type>
    <name>LATTER</name>
    <text>the latter</text>
  </TERM>
  <TERM end="615" id="V2953337" paragraph="paragraph31" rule="-SIMPLE-REF" start="607" uttnum="176">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="656" id="V2953392" paragraph="paragraph31" rule="-SIMPLE-REF" start="628" uttnum="176">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt (Figure 7D)</text>
  </TERM>
  <TERM end="655" id="V2953427" paragraph="paragraph31" rule="-SIMPLE-REF" start="639" uttnum="176">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 7D</text>
  </TERM>
  <TERM end="655" id="V2953402" paragraph="paragraph31" rule="-SIMPLE-REF" start="639" uttnum="176">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 7D</text>
  </TERM>
  <TERM end="73" id="V2967802" paragraph="paragraph32" rule="-SIMPLE-REF" start="65" uttnum="177">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="90" id="V2967835" paragraph="paragraph32" rule="-SIMPLE-REF" start="86" uttnum="177">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat</text>
  </TERM>
  <TERM end="104" id="V2967895" paragraph="paragraph32" rule="-SIMPLE-REF" start="101" uttnum="177">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="126" id="V2967953" paragraph="paragraph32" rule="-SIMPLE-REF" start="113" uttnum="177">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>a rat α1β1γ1</text>
  </TERM>
  <TERM end="133" id="V2967994" paragraph="paragraph32" rule="-SIMPLE-REF" start="126" uttnum="177">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complex</text>
  </TERM>
  <TERM end="211" id="V2968160" paragraph="paragraph32" rule="-SIMPLE-REF" start="203" uttnum="177">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="265" id="V2968176" paragraph="paragraph32" rule="-RULE40A_AGENT_AFFECTED-AGENT" start="225" uttnum="177">
    <type>ONT::ACTIVATE</type>
    <predicate end="265" id="V2968176" start="225">
      <type>ONT::ACTIVATE</type>
      <text>activation by LKB1 in cell-free assays,</text>
    </predicate>
    <arg1 id="V2968212" role=":AGENT"/>
    <text>activation by LKB1 in cell-free assays,</text>
  </EVENT>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="244" id="V2968212" paragraph="paragraph32" rule="-SIMPLE-REF" start="236" uttnum="177">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1 </text>
  </TERM>
  <TERM end="265" id="V2968331" paragraph="paragraph32" rule="-SIMPLE-REF" start="247" uttnum="177">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>cell-free assays,</text>
  </TERM>
  <TERM end="257" id="V2968270" paragraph="paragraph32" rule="-SIMPLE-REF" start="247" uttnum="177">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell-free</text>
  </TERM>
  <EVENT end="339" id="V2968532" paragraph="paragraph32" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="297" uttnum="177">
    <type>ONT::TRANSFORM</type>
    <predicate end="339" id="V2968532" start="297">
      <type>ONT::TRANSFORM</type>
      <text>a non-phosphorylatable S485A substitution</text>
    </predicate>
    <arg2 id="V2968529" role=":AFFECTED"/>
    <text>a non-phosphorylatable S485A substitution</text>
  </EVENT>
  <TERM end="326" id="V2968529" paragraph="paragraph32" rule="-SIMPLE-REF" start="320" uttnum="177">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>485</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S485A</text>
  </TERM>
  <TERM end="383" id="V2979176" paragraph="paragraph32" rule="-ROBUSTPRO" start="380" uttnum="178">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="446" id="V2979321" paragraph="paragraph32" rule="-SIMPLE-REF" start="426" uttnum="178">
    <type>ONT::CLINICAL-FINDING</type>
    <name>FINDING</name>
    <text>several new findings</text>
  </TERM>
  <TERM end="458" id="V2997598" paragraph="paragraph32" rule="-ROBUSTPRO" start="455" uttnum="179">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="514" id="V2997648" paragraph="paragraph32" rule="-SIMPLE-REF" start="494" uttnum="179">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>the equivalent site</text>
  </TERM>
  <TERM end="523" id="V2997658" paragraph="paragraph32" rule="-SIMPLE-REF" start="515" uttnum="179">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="587" id="V2997774" paragraph="paragraph32" rule="-SIMPLE-REF" start="569" uttnum="179">
    <type>ONT::SUBSTANCE</type>
    <name>F</name>
    <text>Figures 1F</text>
  </TERM>
  <TERM end="587" id="V2997760" paragraph="paragraph32" rule="-SIMPLE-REF" start="569" uttnum="179">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figures 1F</text>
  </TERM>
  <EPI end="632" id="V2997807" paragraph="paragraph32" rule="-RULE50_0_AGENT_FORMAL-FORMAL" start="608" uttnum="179">
    <type>ONT::SUPPORT</type>
    <arg2 id="V2997840" role=":FORMAL"/>
    <text>showing that the effect</text>
  </EPI>
  <EVENT end="645" id="V2997870" paragraph="paragraph32" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="608" uttnum="179">
    <type>ONT::NO-CHANGE</type>
    <force>ONT::TRUE</force>
    <predicate end="645" id="V2997870" start="608">
      <type>ONT::NO-CHANGE</type>
      <text>showing that the effect is conserved</text>
    </predicate>
    <arg2 id="V2997807" role=":AFFECTED"/>
    <text>showing that the effect is conserved</text>
  </EVENT>
  <EVENT end="632" id="V2997840" paragraph="paragraph32" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE10_AGENT_AFFECTED-NONE" start="608" uttnum="179">
    <type>ONT::MODULATE</type>
    <epistemic-modality id="V2997807"/>
    <predicate end="632" id="V2997840" start="608">
      <type>ONT::MODULATE</type>
      <text>showing that the effect</text>
    </predicate>
    <text>showing that the effect</text>
  </EVENT>
  <TERM end="655" id="V2997925" paragraph="paragraph32" rule="-SIMPLE-REF" start="648" uttnum="179">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>humans</text>
  </TERM>
  <TERM end="718" id="V3011639" paragraph="paragraph32" rule="-ROBUSTPRO" start="715" uttnum="180">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="784" id="V3011784" paragraph="paragraph32" rule="-EXPLICIT-REF1-REV" start="755" uttnum="180">
    <type>ONT::PROTEIN</type>
    <name>LKB-1</name>
    <assoc-with id="X3026820"/>
    <text>to the upstream kinase LKB1,</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="784" id="X3026820" paragraph="paragraph32" rule="-EXPLICIT-REF1-REV-BASE" start="755" uttnum="180">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>to the upstream kinase LKB1,</text>
  </TERM>
  <TERM end="831" id="V3011880" paragraph="paragraph32" rule="-SIMPLE-REF" start="824" uttnum="180">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="855" id="V3026800" paragraph="paragraph32" rule="-ROBUSTPRO" start="852" uttnum="181">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="875" id="V3026841" paragraph="paragraph32" rule="-SIMPLE-REF" start="862" uttnum="181">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>that Ser</text>
  </TERM>
  <TERM end="937" id="V3027547" paragraph="paragraph32" rule="-SIMPLE-REF" start="886" uttnum="181">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>the site equivalent to Ser487 in AMPK-α2</text>
  </TERM>
  <TERM end="937" id="V3027583" paragraph="paragraph32" rule="-SIMPLE-REF" start="906" uttnum="181">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>to Ser487 in AMPK-α2</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="934" id="V3027330" paragraph="paragraph32" rule="-SIMPLE-REF" start="930" uttnum="181">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="970" id="V3031210" paragraph="paragraph32" rule="-SIMPLE-REF" start="942" uttnum="181">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATE</name>
    <text>an extremely poor substrate</text>
  </TERM>
  <TERM end="978" id="V3031242" paragraph="paragraph32" rule="-SIMPLE-REF" start="974" uttnum="181">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt,</text>
  </TERM>
  <TERM end="988" id="V3031626" paragraph="paragraph32" rule="-SIMPLE-REF" start="983" uttnum="181">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATE</name>
    <text>that</text>
  </TERM>
  <EVENT end="1085" id="V3031821" paragraph="paragraph32" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="1064" uttnum="181">
    <type>ONT::TRANSFORM</type>
    <predicate end="1085" id="V3031821" start="1064">
      <type>ONT::TRANSFORM</type>
      <text>by an S491A mutation</text>
    </predicate>
    <arg2 id="V3031818" role=":AFFECTED"/>
    <text>by an S491A mutation</text>
  </EVENT>
  <TERM end="1048" id="V3031696" paragraph="paragraph32" rule="-SIMPLE-REF" start="1044" uttnum="181">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="1076" id="V3031818" paragraph="paragraph32" rule="-SIMPLE-REF" start="1070" uttnum="181">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>491</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S491A</text>
  </TERM>
  <TERM end="1099" id="V3031831" paragraph="paragraph32" rule="-SIMPLE-REF" start="1092" uttnum="181">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="1108" id="V3031856" paragraph="paragraph32" rule="-SIMPLE-REF" start="1099" uttnum="181">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>1D</text>
  </TERM>
  <TERM end="1114" id="V3047570" paragraph="paragraph32" rule="-SIMPLE-REF" start="1111" uttnum="182">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>It</text>
  </TERM>
  <EPI end="1185" id="V3047613" paragraph="paragraph32" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="1123" uttnum="182">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V3047632" role=":FORMAL"/>
    <text>shown previously using a bacterially expressed α2β1γ1 complex</text>
  </EPI>
  <CC end="1185" id="V3047632" paragraph="paragraph32" rule="-RULE5B_AGENT_AFFECTED-AFFECTED" start="1129" uttnum="182">
    <type>ONT::CAUSE</type>
    <arg id="V3047735" role=":OUTCOME"/>
    <text>previously using a bacterially expressed α2β1γ1 complex</text>
  </CC>
  <TERM end="1185" id="V3047735" paragraph="paragraph32" rule="-INEVENT2B,-SIMPLE-REF" start="1146" uttnum="182">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <inevent>
        <event id="V3047693"/>
      </inevent>
    </features>
    <name>COMPLEX</name>
    <text>a bacterially expressed α2β1γ1 complex</text>
  </TERM>
  <EVENT end="1185" id="V3047693" paragraph="paragraph32" rule="-RULE50_AGENT_AFFECTED-AFFECTED" start="1146" uttnum="182">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="1185" id="V3047693" start="1146">
      <type>ONT::EXPRESS</type>
      <text>a bacterially expressed α2β1γ1 complex</text>
    </predicate>
    <arg2 id="V3047735" role=":AFFECTED"/>
    <text>a bacterially expressed α2β1γ1 complex</text>
  </EVENT>
  <TERM end="1194" id="V3047759" paragraph="paragraph32" rule="-SIMPLE-REF" start="1185" uttnum="182">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">that Akt</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1213" id="V3046941" paragraph="paragraph32" rule="-SIMPLE-REF" start="1209" uttnum="182">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <EVENT end="1406" id="V3071667" paragraph="paragraph32" rule="-RULE60_AGENT_AFFECTED-LOC7-GD-NONE" start="1365" uttnum="182">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1406" id="V3071667" start="1365">
      <type>ONT::PHOSPHORYLATION</type>
      <text>this phosphorylation occurred at Ser</text>
    </predicate>
    <site end="1406" id="V3071695" start="1398">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>this phosphorylation occurred at Ser</text>
  </EVENT>
  <TERM end="1406" id="V3071695" paragraph="paragraph32" rule="-SIMPLE-REF" start="1398" uttnum="182">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="1430" id="V3073172" paragraph="paragraph32" rule="-SIMPLE-REF" start="1417" uttnum="183">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>That Ser</text>
  </TERM>
  <TERM end="1523" id="V3073320" paragraph="paragraph32" rule="-SIMPLE-REF" start="1495" uttnum="183">
    <type>ONT::CLINICAL-FINDING</type>
    <name>FINDING</name>
    <text>the following findings: (i)</text>
  </TERM>
  <TERM end="1521" id="V3073342" paragraph="paragraph32" rule="-ROBUSTPRO" start="1520" uttnum="183">
    <type>ONT::PERSON</type>
    <text>i</text>
  </TERM>
  <EVENT end="1562" id="V3073360" paragraph="paragraph32" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="1523" uttnum="183">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1562" id="V3073360" start="1523">
      <type>ONT::PHOSPHORYLATION</type>
      <text>substantial phosphorylation of Ser</text>
    </predicate>
    <site end="1562" id="V3073372" start="1554">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>substantial phosphorylation of Ser</text>
  </EVENT>
  <TERM end="1562" id="V3073372" paragraph="paragraph32" rule="-SIMPLE-REF" start="1554" uttnum="183">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="1608" id="V3073406" paragraph="paragraph32" rule="-SIMPLE-REF" start="1586" uttnum="183">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>the recombinant human</text>
  </TERM>
  <TERM dbid="GO:0016301" end="1659" id="V3073534" paragraph="paragraph32" rule="-SIMPLE-REF" start="1638" uttnum="183">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>of exogenous kinases</text>
  </TERM>
  <TERM end="1674" id="V3073543" paragraph="paragraph32" rule="-SIMPLE-REF" start="1666" uttnum="183">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figures</text>
  </TERM>
  <TERM end="1703" id="V3073621" paragraph="paragraph32" rule="-SIMPLE-REF" start="1694" uttnum="183">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>2B</text>
  </TERM>
  <TERM end="1719" id="V3073654" paragraph="paragraph32" rule="-SIMPLE-REF" start="1711" uttnum="183">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="1789" id="V3073795" paragraph="paragraph32" rule="-SIMPLE-REF-MUTATION8" start="1777" uttnum="183">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>D157A mutant</text>
  </TERM>
  <TERM end="1783" id="V3073792" paragraph="paragraph32" rule="-SIMPLE-REF" start="1777" uttnum="183">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>157</pos>
      <aa-from>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">D157A</text>
  </TERM>
  <TERM end="1798" id="V3073810" paragraph="paragraph32" rule="-SIMPLE-REF" start="1791" uttnum="183">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complex</text>
  </TERM>
  <TERM end="1813" id="V3087709" paragraph="paragraph32" rule="-SIMPLE-REF" start="1806" uttnum="183">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="1822" id="V3087718" paragraph="paragraph32" rule="-SIMPLE-REF" start="1813" uttnum="183">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>2B</text>
  </TERM>
  <TERM end="1881" id="V3087769" paragraph="paragraph32" rule="-SIMPLE-REF" start="1831" uttnum="183">
    <type>ONT::SHAPE</type>
    <name>FORM</name>
    <text>various forms of AMPK, including the human α2β2γ1</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1854" id="V3087784" paragraph="paragraph32" rule="-SIMPLE-REF" start="1845" uttnum="183">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK,</text>
  </TERM>
  <TERM end="1888" id="V3087845" paragraph="paragraph32" rule="-SIMPLE-REF" start="1881" uttnum="183">
    <type>ONT::FACILITY</type>
    <name>COMPLEX</name>
    <text>complex</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="1955" id="V3087909" paragraph="paragraph32" rule="-SIMPLE-REF" start="1907" uttnum="183">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>synthetic peptide corresponding to the sequence</text>
  </TERM>
  <TERM end="1970" id="V3087970" paragraph="paragraph32" rule="-SIMPLE-REF" start="1962" uttnum="183">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="1997" id="V3088004" paragraph="paragraph32" rule="-SIMPLE-REF" start="1989" uttnum="183">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="2014" id="V3088037" paragraph="paragraph32" rule="-SIMPLE-REF" start="2010" uttnum="183">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat</text>
  </TERM>
  <TERM end="2031" id="V3088057" paragraph="paragraph32" rule="-SIMPLE-REF" start="2024" uttnum="183">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="2040" id="V3088066" paragraph="paragraph32" rule="-SIMPLE-REF" start="2031" uttnum="183">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>2D</text>
  </TERM>
  <TERM end="2060" id="V3088132" paragraph="paragraph32" rule="-SIMPLE-REF" start="2052" uttnum="183">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM dbid="CHEBI:16118" end="2164" id="V3088282" paragraph="paragraph32" rule="-SIMPLE-REF" start="2118" uttnum="183">
    <type>ONT::MOLECULE</type>
    <name>BERBERINE</name>
    <text>the AMPK activator berberine in HEK-293 cells,</text>
  </TERM>
  <TERM end="2164" id="V3088272" paragraph="paragraph32" rule="-SIMPLE-REF" start="2118" uttnum="183">
    <type>ONT::SUBSTANCE</type>
    <name>ACTIVATOR</name>
    <text>the AMPK activator berberine in HEK-293 cells,</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="2127" id="V3088267" paragraph="paragraph32" rule="-SIMPLE-REF" start="2122" uttnum="183">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM dbid="BTO:0000007" end="2163" id="V3088367" paragraph="paragraph32" rule="-SIMPLE-REF" start="2150" uttnum="183">
    <type>ONT::CELL-LINE</type>
    <name>HEK-293-CELLS</name>
    <text>HEK-293 cells</text>
  </TERM>
  <TERM end="2181" id="V3101063" paragraph="paragraph32" rule="-SIMPLE-REF" start="2173" uttnum="183">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="2233" id="V3101165" paragraph="paragraph32" rule="-SIMPLE-REF" start="2217" uttnum="183">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4C</text>
  </TERM>
  <EVENT end="2317" id="V3105839" paragraph="paragraph32" rule="-RULE60_AGENT_AFFECTED-MODA1_2-NONE" start="2286" uttnum="184">
    <type>ONT::PHOSPHORYLATION</type>
    <mods>
      <mod>
        <type>ONT::MANNER-REFL</type>
        <value>AUTO-</value>
      </mod>
    </mods>
    <predicate end="2317" id="V3105839" start="2286">
      <type>ONT::PHOSPHORYLATION</type>
      <text>autophosphorylation of Ser</text>
    </predicate>
    <site end="2317" id="V3105856" start="2309">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>autophosphorylation of Ser</text>
  </EVENT>
  <TERM end="2317" id="V3105856" paragraph="paragraph32" rule="-SIMPLE-REF" start="2309" uttnum="184">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="2350" id="V3105986" paragraph="paragraph32" rule="-SIMPLE-REF" start="2342" uttnum="184">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="2382" id="V3116759" paragraph="paragraph32" rule="-SIMPLE-REF" start="2377" uttnum="184">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>this</text>
  </TERM>
  <TERM end="2442" id="V3116843" paragraph="paragraph32" rule="-SIMPLE-REF" start="2399" uttnum="184">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>by the results in Figure 2(C),</text>
  </TERM>
  <TERM end="2441" id="V3116905" paragraph="paragraph32" rule="-SIMPLE-REF" start="2423" uttnum="184">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 2(C)</text>
  </TERM>
  <EVENT end="2500" id="V3130744" paragraph="paragraph32" rule="-RULE40A_AGENT_AFFECTED" start="2449" uttnum="184">
    <type>ONT::ACTIVATE</type>
    <predicate end="2500" id="V3130744" start="2449">
      <type>ONT::ACTIVATE</type>
      <text>the activation of the human α2β2γ1 complex by LKB1</text>
    </predicate>
    <arg1 id="V3130845" role=":AGENT"/>
    <arg2 id="V3130806" role=":AFFECTED"/>
    <arg id="R000227" role=":RESULT"/>
    <text>the activation of the human α2β2γ1 complex by LKB1</text>
  </EVENT>
  <TERM end="2492" id="V3130806" paragraph="paragraph32" rule="-SIMPLE-REF" start="2464" uttnum="184">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>of the human α2β2γ1 complex</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="2500" id="V3130845" paragraph="paragraph32" rule="-SIMPLE-REF" start="2492" uttnum="184">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1</text>
  </TERM>
  <EVENT end="2563" id="V3131007" paragraph="paragraph32" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="2534" uttnum="184">
    <type>ONT::TRANSFORM</type>
    <predicate end="2563" id="V3131007" start="2534">
      <type>ONT::TRANSFORM</type>
      <text>phosphomimetic S491D mutation</text>
    </predicate>
    <arg2 id="V3131004" role=":AFFECTED"/>
    <text>phosphomimetic S491D mutation</text>
  </EVENT>
  <TERM end="2555" id="V3131004" paragraph="paragraph32" rule="-SIMPLE-REF" start="2549" uttnum="184">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>491</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S491D</text>
  </TERM>
  <TERM end="2600" id="V3145630" paragraph="paragraph32" rule="-SIMPLE-REF" start="2570" uttnum="185">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>the ability of Akt-activating</text>
  </TERM>
  <EVENT end="2600" id="V3145666" paragraph="paragraph32" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="2582" uttnum="185">
    <type>ONT::ACTIVATE</type>
    <predicate end="2600" id="V3145666" start="2582">
      <type>ONT::ACTIVATE</type>
      <text>of Akt-activating</text>
    </predicate>
    <arg2 id="V3145659" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000232"/>
    <text>of Akt-activating</text>
  </EVENT>
  <TERM end="2588" id="V3145659" paragraph="paragraph32" rule="-SIMPLE-REF" start="2585" uttnum="185">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:P01308" end="2627" id="V3145746" paragraph="paragraph32" rule="-SIMPLE-REF" start="2600" uttnum="185">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>treatments such as insulin</text>
  </TERM>
  <TERM dbid="EFO:0000727" end="2619" id="V3145696" paragraph="paragraph32" rule="-SIMPLE-REF" start="2600" uttnum="185">
    <type>ONT::PROCESS</type>
    <name>TREATMENTS</name>
    <text>treatments such as</text>
  </TERM>
  <EVENT end="2719" id="V3145882" paragraph="paragraph32" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="2631" uttnum="185">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="2719" id="V3145882" start="2631">
      <type>ONT::INHIBIT</type>
      <text>IGF-1 to restrain activation of AMPK by ST loop phosphorylation is limited to complexes</text>
    </predicate>
    <arg2 id="V3145769" role=":AFFECTED"/>
    <text>IGF-1 to restrain activation of AMPK by ST loop phosphorylation is limited to complexes</text>
  </EVENT>
  <TERM dbid="UP:P05019" end="2637" id="V3145769" paragraph="paragraph32" rule="-SIMPLE-REF" start="2631" uttnum="185">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <EVENT end="2695" id="V3145798" paragraph="paragraph32" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="2640" uttnum="185">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="2695" id="V3145798" start="2640">
      <type>ONT::INHIBIT</type>
      <text>restrain activation of AMPK by ST loop phosphorylation</text>
    </predicate>
    <arg2 id="V3145804" role=":AFFECTED"/>
    <text>restrain activation of AMPK by ST loop phosphorylation</text>
  </EVENT>
  <EVENT end="2668" id="V3145804" paragraph="paragraph32" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="2649" uttnum="185">
    <type>ONT::ACTIVATE</type>
    <predicate end="2668" id="V3145804" start="2649">
      <type>ONT::ACTIVATE</type>
      <text>activation of AMPK</text>
    </predicate>
    <arg2 id="V3145817" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000237"/>
    <text>activation of AMPK</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="2668" id="V3145817" paragraph="paragraph32" rule="-SIMPLE-REF" start="2660" uttnum="185">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="2695" id="V3145858" paragraph="paragraph32" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="2671" uttnum="185">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="2695" id="V3145858" start="2671">
      <type>ONT::PHOSPHORYLATION</type>
      <text>ST loop phosphorylation</text>
    </predicate>
    <arg2 id="V3145846" role=":AFFECTED"/>
    <arg id="R000077" role=":RESULT"/>
    <text>ST loop phosphorylation</text>
  </EVENT>
  <TERM end="2695" id="V3145855" paragraph="paragraph32" rule="-SIMPLE-REF" start="2671" uttnum="185">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>ST loop phosphorylation</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="2674" id="V3145846" paragraph="paragraph32" rule="-SIMPLE-REF" start="2671" uttnum="185">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
    <not-features>
      <ptm event="V3145858" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="2719" id="V3145913" paragraph="paragraph32" rule="-SIMPLE-REF" start="2709" uttnum="185">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complexes</text>
  </TERM>
  <CC end="2719" id="X3159813" paragraph="paragraph32" rule="-PURPOSE" start="2631" uttnum="185">
    <type>ONT::BY-MEANS-OF</type>
    <arg id="V3145882" role=":FACTOR"/>
    <arg id="V3145798" role=":OUTCOME"/>
    <text>IGF-1 to restrain activation of AMPK by ST loop phosphorylation is limited to complexes</text>
  </CC>
  <TERM end="33" id="V3159823" paragraph="paragraph33" rule="-SIMPLE-REF" start="12" uttnum="186">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser487 in</text>
  </TERM>
  <TERM end="133" id="V3160192" paragraph="paragraph33" rule="-SIMPLE-REF" start="116" uttnum="186">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>cell-free assays</text>
  </TERM>
  <TERM end="126" id="V3160134" paragraph="paragraph33" rule="-SIMPLE-REF" start="116" uttnum="186">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell-free</text>
  </TERM>
  <TERM end="155" id="V3160210" paragraph="paragraph33" rule="-SIMPLE-REF" start="140" uttnum="186">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 2</text>
  </TERM>
  <TERM end="177" id="V3172868" paragraph="paragraph33" rule="-SIMPLE-REF" start="169" uttnum="186">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="250" id="V3172957" paragraph="paragraph33" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="222" uttnum="186">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="250" id="V3172957" start="222">
      <type>ONT::TRANSFORM</type>
      <text>intact cells were incubated</text>
    </predicate>
    <arg2 id="V3172931" role=":AFFECTED"/>
    <text>intact cells were incubated</text>
  </EVENT>
  <TERM end="235" id="V3172931" paragraph="paragraph33" rule="-SIMPLE-REF" start="222" uttnum="186">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>intact cells</text>
  </TERM>
  <TERM dbid="CHEBI:16118" end="309" id="V3173000" paragraph="paragraph33" rule="-SIMPLE-REF" start="255" uttnum="186">
    <type>ONT::MOLECULE</type>
    <name>BERBERINE</name>
    <text>the AMPK activator berberine (Figure 4C),</text>
  </TERM>
  <TERM dbid="CHEBI:85053" end="274" id="V3172995" paragraph="paragraph33" rule="-SIMPLE-REF" start="259" uttnum="186">
    <type>ONT::CHEMICAL</type>
    <name>AMPK-ACTIVATOR</name>
    <text>AMPK activator</text>
  </TERM>
  <TERM end="307" id="V3173010" paragraph="paragraph33" rule="-SIMPLE-REF" start="291" uttnum="186">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4C</text>
  </TERM>
  <TERM end="357" id="V3187349" paragraph="paragraph33" rule="-SIMPLE-REF" start="349" uttnum="186">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="401" id="V3187450" paragraph="paragraph33" rule="-SIMPLE-REF" start="389" uttnum="186">
    <type>ONT::SHAPE-OBJECT</type>
    <name>CELL</name>
    <text>intact cells</text>
  </TERM>
  <TERM end="446" id="V3191026" paragraph="paragraph33" rule="-SIMPLE-REF" start="438" uttnum="187">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="489" id="V3191099" paragraph="paragraph33" rule="-SIMPLE-REF" start="479" uttnum="187">
    <type>ONT::SHAPE-OBJECT</type>
    <name>CELL</name>
    <text>cell-free</text>
  </TERM>
  <TERM end="496" id="V3191155" paragraph="paragraph33" rule="-SIMPLE-REF" start="489" uttnum="187">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>assays</text>
  </TERM>
  <EVENT end="581" id="V3191298" paragraph="paragraph33" rule="-RULE40A_AGENT_AFFECTED-LOC7-GD-AGENT" start="541" uttnum="187">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="581" id="V3191298" start="541">
      <type>ONT::ACTIVATE</type>
      <text>activated by phosphorylation at Thr</text>
    </predicate>
    <arg1 id="V3191327" role=":AGENT"/>
    <site end="581" id="V3191350" start="573">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>activated by phosphorylation at Thr</text>
  </EVENT>
  <EVENT end="581" id="V3191327" paragraph="paragraph33" rule="-RULE60_AGENT_AFFECTED-LOC7-GD-NONE" start="551" uttnum="187">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="581" id="V3191327" start="551">
      <type>ONT::PHOSPHORYLATION</type>
      <text>by phosphorylation at Thr</text>
    </predicate>
    <site end="581" id="V3191350" start="573">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>by phosphorylation at Thr</text>
  </EVENT>
  <TERM end="581" id="V3191350" paragraph="paragraph33" rule="-SIMPLE-REF" start="573" uttnum="187">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="599" id="V3191387" paragraph="paragraph33" rule="-SIMPLE-REF" start="594" uttnum="187">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1</text>
  </TERM>
  <TERM end="633" id="V3191421" paragraph="paragraph33" rule="-SIMPLE-REF" start="606" uttnum="187">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>Figure 2B, top left)</text>
  </TERM>
  <TERM end="633" id="V3191397" paragraph="paragraph33" rule="-SIMPLE-REF" start="606" uttnum="187">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 2B, top left)</text>
  </TERM>
  <TERM end="632" id="V3191442" paragraph="paragraph33" rule="-SIMPLE-REF" start="624" uttnum="187">
    <type>ONT::LEFT-LOC</type>
    <name>LEFT</name>
    <text>top left</text>
  </TERM>
  <TERM end="659" id="V3206097" paragraph="paragraph33" rule="-SIMPLE-REF" start="646" uttnum="187">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>that Thr</text>
  </TERM>
  <TERM end="747" id="V3206166" paragraph="paragraph33" rule="-SIMPLE-REF" start="727" uttnum="187">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATES</name>
    <text>exogenous substrates</text>
  </TERM>
  <EVENT end="803" id="V3206203" paragraph="paragraph33" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="749" uttnum="187">
    <type>ONT::STIMULATE</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <modality>ONT::DO</modality>
    <predicate end="803" id="V3206203" start="749">
      <type>ONT::STIMULATE</type>
      <text>does not enhance Ser487 autophosphorylation</text>
    </predicate>
    <arg2 id="V3206208" role=":AFFECTED"/>
    <text>does not enhance Ser487 autophosphorylation</text>
  </EVENT>
  <TERM end="774" id="V3206208" paragraph="paragraph33" rule="-SIMPLE-REF" start="766" uttnum="187">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="817" id="V3212600" paragraph="paragraph33" rule="-SIMPLE-REF" start="805" uttnum="188">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Our results</text>
  </TERM>
  <TERM end="835" id="V3212642" paragraph="paragraph33" rule="-SIMPLE-REF" start="822" uttnum="188">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>that Ser</text>
  </TERM>
  <TERM end="817" id="V3212593" paragraph="paragraph33" rule="-ROBUSTPRO" start="805" uttnum="188">
    <type>ONT::PERSON</type>
    <text>Our results</text>
  </TERM>
  <TERM end="854" id="V3212700" paragraph="paragraph33" rule="-SIMPLE-REF" start="848" uttnum="188">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>human</text>
  </TERM>
  <TERM end="886" id="V3212725" paragraph="paragraph33" rule="-SIMPLE-REF" start="865" uttnum="188">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser491 in</text>
  </TERM>
  <TERM end="910" id="V3212879" paragraph="paragraph33" rule="-SIMPLE-REF" start="893" uttnum="188">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATE</name>
    <text>a good substrate</text>
  </TERM>
  <TERM end="917" id="V3212911" paragraph="paragraph33" rule="-SIMPLE-REF" start="914" uttnum="188">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="968" id="V3227251" paragraph="paragraph33" rule="-SIMPLE-REF" start="951" uttnum="189">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>cell-free assays</text>
  </TERM>
  <TERM end="961" id="V3227190" paragraph="paragraph33" rule="-SIMPLE-REF" start="951" uttnum="189">
    <type>ONT::SHAPE-OBJECT</type>
    <name>CELL</name>
    <text>cell-free</text>
  </TERM>
  <TERM end="1012" id="V3227325" paragraph="paragraph33" rule="-SIMPLE-REF" start="1001" uttnum="189">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>of Ser</text>
  </TERM>
  <TERM dbid="FA:03087" end="1030" id="V3227365" paragraph="paragraph33" rule="-SIMPLE-REF" start="1012" uttnum="189">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">9 on GSK3-β</text>
  </TERM>
  <TERM end="1047" id="V3227438" paragraph="paragraph33" rule="-SIMPLE-REF" start="1033" uttnum="189">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">canonical Akt</text>
  </TERM>
  <TERM end="1051" id="V3227442" paragraph="paragraph33" rule="-SIMPLE-REF" start="1047" uttnum="189">
    <type>ONT::AREA-DEF-BY-USE</type>
    <name>SITE</name>
    <text>site</text>
  </TERM>
  <TERM end="1074" id="V3227516" paragraph="paragraph33" rule="-SIMPLE-REF" start="1068" uttnum="189">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <EVENT end="1098" id="V3227540" paragraph="paragraph33" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="1074" uttnum="189">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1098" id="V3227540" start="1074">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the net phosphorylation</text>
    </predicate>
    <arg2 id="V3227535" role=":AFFECTED"/>
    <arg id="R000082" role=":RESULT"/>
    <text>the net phosphorylation</text>
  </EVENT>
  <TERM dbid="UP:P54762" end="1082" id="V3227535" paragraph="paragraph33" rule="-SIMPLE-REF" start="1074" uttnum="189">
    <type>ONT::PROTEIN</type>
    <name>NET</name>
    <text>the net</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3227540"/>
    </not-features>
  </TERM>
  <TERM end="1105" id="V3227549" paragraph="paragraph33" rule="-SIMPLE-REF" start="1098" uttnum="189">
    <type>ONT::NONESSENTIAL-CONTRACT</type>
    <name>STATUS</name>
    <text>status</text>
  </TERM>
  <EVENT end="1168" id="V3227617" paragraph="paragraph33" rule="-ACTIVITY1" start="1128" uttnum="189">
    <type>ONT::ACTIVITY</type>
    <predicate end="1168" id="V3227617" start="1128">
      <type>ONT::ACTIVITY</type>
      <text>by the activity of protein phosphatases</text>
    </predicate>
    <arg1 id="V3227649" role=":AGENT"/>
    <text>by the activity of protein phosphatases</text>
  </EVENT>
  <TERM dbid="GO:0004721" end="1168" id="V3227649" paragraph="paragraph33" rule="-SIMPLE-REF" start="1144" uttnum="189">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN-PHOSPHATASES</name>
    <text>of protein phosphatases</text>
  </TERM>
  <TERM end="1186" id="V3227696" paragraph="paragraph33" rule="-SIMPLE-REF" start="1178" uttnum="189">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="1267" id="V3240385" paragraph="paragraph33" rule="-SIMPLE-REF" start="1197" uttnum="190">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>The results using MK2206 in Figures 4 and 6</text>
  </TERM>
  <TERM end="1296" id="V3240527" paragraph="paragraph33" rule="-SIMPLE-REF" start="1283" uttnum="190">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>that Ser</text>
  </TERM>
  <TERM dbid="CHEBI:67271" end="1267" id="V3240403" paragraph="paragraph33" rule="-SIMPLE-REF" start="1215" uttnum="190">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>MK2206 in Figures 4 and 6</text>
  </TERM>
  <TERM end="1267" id="V3240465" paragraph="paragraph33" rule="-SIMPLE-REF" start="1231" uttnum="190">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figures 4 and 6</text>
  </TERM>
  <EVENT end="1378" id="V3240554" paragraph="paragraph33" rule="-RULE60_AGENT_AFFECTED-CELL_LINE2-GD-NONE" start="1309" uttnum="190">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1378" id="V3240554" start="1309">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylated in four distinct cell lines in an Akt-dependent manner</text>
    </predicate>
    <cell-line end="1378" id="V3240634" start="1327">
      <type>ONT::CELL-LINE</type>
      <text normalization="">four distinct cell lines in an Akt-dependent manner</text>
    </cell-line>
    <text>phosphorylated in four distinct cell lines in an Akt-dependent manner</text>
  </EVENT>
  <TERM dbid="EFO:0000322" end="1378" id="V3240634" paragraph="paragraph33" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="1327" uttnum="190">
    <type>ONT::CELL-LINE</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>DISTINCT</value>
      </mod>
    </mods>
    <name>CELL-LINE</name>
    <text>four distinct cell lines in an Akt-dependent manner</text>
  </TERM>
  <TERM end="1378" id="V3240717" paragraph="paragraph33" rule="-SIMPLE-REF" start="1355" uttnum="190">
    <type>ONT::METHOD</type>
    <name>MANNER</name>
    <text>an Akt-dependent manner</text>
  </TERM>
  <TERM end="1372" id="V3240699" paragraph="paragraph33" rule="-SIMPLE-REF" start="1358" uttnum="190">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt-dependent</text>
  </TERM>
  <TERM end="21" id="V3253994" paragraph="paragraph34" rule="-SIMPLE-REF" start="6" uttnum="191">
    <type>ONT::OFFICIAL-DOCUMENT</type>
    <name>AGREEMENT</name>
    <text>good agreement</text>
  </TERM>
  <TERM end="43" id="V3254016" paragraph="paragraph34" rule="-SIMPLE-REF" start="26" uttnum="191">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>previous results</text>
  </TERM>
  <TERM end="65" id="V3254045" paragraph="paragraph34" rule="-SIMPLE-REF" start="57" uttnum="191">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>the rat</text>
  </TERM>
  <TERM end="97" id="V3254086" paragraph="paragraph34" rule="-SIMPLE-REF" start="72" uttnum="191">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complex [27]</text>
  </TERM>
  <EVENT end="132" id="V3254113" paragraph="paragraph34" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="99" uttnum="191">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="132" id="V3254113" start="99">
      <type>ONT::PHOSPHORYLATION</type>
      <text>prior phosphorylation of Ser</text>
    </predicate>
    <site end="132" id="V3254125" start="124">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>prior phosphorylation of Ser</text>
  </EVENT>
  <TERM end="132" id="V3254125" paragraph="paragraph34" rule="-SIMPLE-REF" start="124" uttnum="191">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="162" id="V3254165" paragraph="paragraph34" rule="-SIMPLE-REF" start="145" uttnum="191">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>the human α1β2γ1</text>
  </TERM>
  <TERM end="170" id="V3254210" paragraph="paragraph34" rule="-SIMPLE-REF" start="162" uttnum="191">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complex</text>
  </TERM>
  <EVENT end="234" id="V3254338" paragraph="paragraph34" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="196" uttnum="191">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="234" id="V3254338" start="196">
      <type>ONT::PHOSPHORYLATION</type>
      <text>subsequent phosphorylation of Thr</text>
    </predicate>
    <site end="234" id="V3254350" start="226">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>subsequent phosphorylation of Thr</text>
  </EVENT>
  <TERM end="234" id="V3254350" paragraph="paragraph34" rule="-SIMPLE-REF" start="226" uttnum="191">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="281" id="V3254428" paragraph="paragraph34" rule="-SIMPLE-REF" start="266" uttnum="191">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3</text>
  </TERM>
  <TERM end="311" id="V3254505" paragraph="paragraph34" rule="-SIMPLE-REF" start="304" uttnum="191">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="338" id="V3254541" paragraph="paragraph34" rule="-EXPLICIT-REF-SEQ0" start="322" uttnum="191">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <components>
      <component id="V3254534"/>
    </components>
    <text normalization="">AMPK complexes,</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="338" id="V3254534" paragraph="paragraph34" rule="-EXPLICIT-REF-SEQ0-TERM" start="322" uttnum="191">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK complexes,</text>
  </TERM>
  <EVENT end="394" id="V3254669" paragraph="paragraph34" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="357" uttnum="191">
    <type>ONT::ACTIVATE</type>
    <predicate end="394" id="V3254669" start="357">
      <type>ONT::ACTIVATE</type>
      <text>the activation of the active complex</text>
    </predicate>
    <arg2 id="V3254701" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000242"/>
    <text>the activation of the active complex</text>
  </EVENT>
  <TERM end="394" id="V3254701" paragraph="paragraph34" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="372" uttnum="191">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <active>TRUE</active>
      <active>FALSE</active>
    </features>
    <name>COMPLEX</name>
    <text>of the active complex</text>
  </TERM>
  <TERM end="408" id="V3254716" paragraph="paragraph34" rule="-SIMPLE-REF" start="401" uttnum="191">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="417" id="V3254740" paragraph="paragraph34" rule="-SIMPLE-REF" start="408" uttnum="191">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>3B</text>
  </TERM>
  <TERM end="567" id="V3270616" paragraph="paragraph34" rule="-SIMPLE-REF" start="510" uttnum="192">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>intact cells (Figures 4 and 6),</text>
  </TERM>
  <TERM end="565" id="V3270628" paragraph="paragraph34" rule="-SIMPLE-REF" start="530" uttnum="192">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figures 4 and 6</text>
  </TERM>
  <TERM dbid="XFAM:PF00328.19|GO:0016791|XFAM:PF15698.2" end="605" id="V3275844" paragraph="paragraph34" rule="-SIMPLE-REF" start="589" uttnum="192">
    <type>ONT::GENE-PROTEIN</type>
    <name>PHOSPHATASES</name>
    <text>of phosphatases</text>
  </TERM>
  <TERM end="657" id="V3275943" paragraph="paragraph34" rule="-SIMPLE-REF" start="646" uttnum="192">
    <type>ONT::OUTCOME</type>
    <name>OUTCOME</name>
    <text>the outcome</text>
  </TERM>
  <TERM end="623" id="V3275895" paragraph="paragraph34" rule="-SIMPLE-REF" start="615" uttnum="192">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="736" id="V3285652" paragraph="paragraph34" rule="-SIMPLE-REF" start="719" uttnum="193">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>cell-free assays</text>
  </TERM>
  <TERM end="753" id="V3285678" paragraph="paragraph34" rule="-SIMPLE-REF" start="740" uttnum="193">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>intact cells</text>
  </TERM>
  <TERM end="729" id="V3285594" paragraph="paragraph34" rule="-SIMPLE-REF" start="719" uttnum="193">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell-free</text>
  </TERM>
  <EVENT end="831" id="V3285826" paragraph="paragraph34" rule="-RULE60_AGENT_AFFECTED-CELL_LOC2-GD-OTHERS-AFFECTED" start="756" uttnum="193">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::MAY</modality>
    <predicate end="831" id="V3285826" start="756">
      <type>ONT::PHOSPHORYLATION</type>
      <text>that other sites in the ST loop may be phosphorylated in the intact cells,</text>
    </predicate>
    <arg2 id="V3285720" role=":AFFECTED"/>
    <arg id="R000087" role=":RESULT"/>
    <location end="831" id="V3285893" mod="null" start="813">
      <type>ONT::CELL</type>
      <text normalization="">the intact cells,</text>
    </location>
    <text>that other sites in the ST loop may be phosphorylated in the intact cells,</text>
  </EVENT>
  <TERM end="788" id="V3285720" paragraph="paragraph34" rule="-SIMPLE-REF" start="761" uttnum="193">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>other sites in the ST loop</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3285826"/>
    </not-features>
  </TERM>
  <TERM end="788" id="V3285795" paragraph="paragraph34" rule="-SIMPLE-REF" start="776" uttnum="193">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="783" id="V3285786" paragraph="paragraph34" rule="-SIMPLE-REF" start="780" uttnum="193">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="831" id="V3285893" paragraph="paragraph34" rule="-SIMPLE-REF" start="813" uttnum="193">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>the intact cells,</text>
  </TERM>
  <TERM dbid="BTO:0000007" end="26" id="V3297820" paragraph="paragraph35" rule="-SIMPLE-REF" start="12" uttnum="194">
    <type>ONT::CELL-LINE</type>
    <name>HEK-293-CELLS</name>
    <text>HEK-293 cells</text>
  </TERM>
  <TERM end="61" id="V3307455" paragraph="paragraph35" rule="-ROBUSTPRO" start="58" uttnum="194">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="118" id="V3307523" paragraph="paragraph35" rule="-RULE10_AGENT_AFFECTED-AGENT" start="82" uttnum="194">
    <type>ONT::MODULATE</type>
    <predicate end="118" id="V3307523" start="82">
      <type>ONT::MODULATE</type>
      <text>the effect of prior IGF-1 treatment</text>
    </predicate>
    <arg1 id="V3307559" role=":AGENT"/>
    <text>the effect of prior IGF-1 treatment</text>
  </EVENT>
  <CC end="189" id="V3307735" paragraph="paragraph35" rule="-RULE5B_NEUTRAL1_NEUTRAL" start="82" uttnum="194">
    <type>ONT::DEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V3307772" role=":FACTOR"/>
    <arg id="V3307523" role=":OUTCOME"/>
    <text>the effect of prior IGF-1 treatment to inhibit subsequent AMPK activation by A769662 was dependent on Akt,</text>
  </CC>
  <EVENT end="118" id="V3307559" paragraph="paragraph35" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="93" uttnum="194">
    <type>ONT::MODULATE</type>
    <predicate end="118" id="V3307559" start="93">
      <type>ONT::MODULATE</type>
      <text>of prior IGF-1 treatment</text>
    </predicate>
    <arg2 id="V3307556" role=":AFFECTED"/>
    <text>of prior IGF-1 treatment</text>
  </EVENT>
  <TERM dbid="UP:P05019" end="108" id="V3307556" paragraph="paragraph35" rule="-SIMPLE-REF" start="102" uttnum="194">
    <type>ONT::PROTEIN</type>
    <name>IGF-1</name>
    <text>IGF-1</text>
  </TERM>
  <EVENT end="167" id="V3307588" paragraph="paragraph35" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="121" uttnum="194">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="167" id="V3307588" start="121">
      <type>ONT::INHIBIT</type>
      <text>inhibit subsequent AMPK activation by A769662</text>
    </predicate>
    <arg2 id="V3307602" role=":AFFECTED"/>
    <text>inhibit subsequent AMPK activation by A769662</text>
  </EVENT>
  <EVENT end="156" id="V3307602" paragraph="paragraph35" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="129" uttnum="194">
    <type>ONT::ACTIVATE</type>
    <predicate end="156" id="V3307602" start="129">
      <type>ONT::ACTIVATE</type>
      <text>subsequent AMPK activation</text>
    </predicate>
    <arg2 id="V3307598" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000247"/>
    <text>subsequent AMPK activation</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="145" id="V3307598" paragraph="paragraph35" rule="-SIMPLE-REF" start="129" uttnum="194">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>subsequent AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="167" id="V3307711" paragraph="paragraph35" rule="-SIMPLE-REF" start="159" uttnum="194">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662</text>
  </TERM>
  <TERM end="189" id="V3307772" paragraph="paragraph35" rule="-SIMPLE-REF" start="181" uttnum="194">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">on Akt,</text>
  </TERM>
  <TERM end="250" id="V3307874" paragraph="paragraph35" rule="-SIMPLE-REF" start="239" uttnum="194">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>of Ser</text>
  </TERM>
  <TERM end="382" id="V3322931" paragraph="paragraph35" rule="-INEVENT2B,-SIMPLE-REF" start="306" uttnum="194">
    <type>ONT::CELL</type>
    <features>
      <inevent>
        <event id="V3322943"/>
      </inevent>
    </features>
    <name>CELL</name>
    <text>cells expressing a non-phosphorylatable S487A mutant (Figure 4)</text>
  </TERM>
  <EVENT end="382" id="V3322943" paragraph="paragraph35" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC9" start="306" uttnum="194">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="382" id="V3322943" start="306">
      <type>ONT::EXPRESS</type>
      <text>cells expressing a non-phosphorylatable S487A mutant (Figure 4)</text>
    </predicate>
    <arg1 id="V3322931" role=":AGENT"/>
    <arg2 id="V3323068" role=":AFFECTED-RESULT"/>
    <site end="352" id="V3323065" start="346">
      <type>ONT::MUTATION</type>
      <text normalization="">S487A</text>
    </site>
    <text>cells expressing a non-phosphorylatable S487A mutant (Figure 4)</text>
  </EVENT>
  <TERM end="382" id="V3323068" paragraph="paragraph35" rule="-SIMPLE-REF-MUTATION8" start="323" uttnum="194">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>a non-phosphorylatable S487A mutant (Figure 4)</text>
  </TERM>
  <TERM end="352" id="V3323065" paragraph="paragraph35" rule="-SIMPLE-REF" start="346" uttnum="194">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S487A</text>
  </TERM>
  <TERM end="381" id="V3323080" paragraph="paragraph35" rule="-SIMPLE-REF" start="366" uttnum="194">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4</text>
  </TERM>
  <TERM end="427" id="V3338055" paragraph="paragraph35" rule="-SIMPLE-REF" start="414" uttnum="195">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>that Ser</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="444" id="V3337782" paragraph="paragraph35" rule="-SIMPLE-REF" start="440" uttnum="195">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM dbid="UP:P23443" end="496" id="V3338193" paragraph="paragraph35" rule="-SIMPLE-REF" start="470" uttnum="195">
    <type>ONT::PROTEIN</type>
    <name>S-6-K-1</name>
    <text>by S6K1 [42],</text>
  </TERM>
  <TERM end="503" id="V3353193" paragraph="paragraph35" rule="-ROBUSTPRO" start="500" uttnum="195">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="543" id="V3353229" paragraph="paragraph35" rule="-SIMPLE-REF" start="530" uttnum="195">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>that Ser</text>
  </TERM>
  <TERM end="638" id="V3353376" paragraph="paragraph35" rule="-LOGICALOP-REF" start="564" uttnum="195">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V3353372"/>
      <member id="V3353538"/>
    </aggregate>
    <text normalization="">been phosphorylated by a kinase downstream of Akt and mTORC1, such as S6K1</text>
  </TERM>
  <TERM end="614" id="V3353372" paragraph="paragraph35" rule="-INEVENT2B,-SIMPLE-REF" start="564" uttnum="195">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">been phosphorylated by a kinase downstream of Akt</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3353277"/>
    </features>
  </TERM>
  <TERM dbid="UP:P23443" end="638" id="V3353538" paragraph="paragraph35" rule="-SIMPLE-REF" start="618" uttnum="195">
    <type>ONT::PROTEIN</type>
    <name>S-6-K-1</name>
    <text>mTORC1, such as S6K1</text>
  </TERM>
  <EVENT end="614" id="V3353277" paragraph="paragraph35" rule="-RULE60_AGENT_AFFECTED" start="564" uttnum="195">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="614" id="V3353277" start="564">
      <type>ONT::PHOSPHORYLATION</type>
      <text>been phosphorylated by a kinase downstream of Akt</text>
    </predicate>
    <arg1 id="V3353347" role=":AGENT"/>
    <arg2 id="V3353372" role=":RESULT"/>
    <arg id="R000011" role=":AFFECTED"/>
    <text>been phosphorylated by a kinase downstream of Akt</text>
  </EVENT>
  <TERM dbid="GO:0016301" end="596" id="V3353347" paragraph="paragraph35" rule="-SIMPLE-REF" start="584" uttnum="195">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>by a kinase</text>
  </TERM>
  <TERM dbid="GO:0031931" end="634" id="V3353431" paragraph="paragraph35" rule="-SIMPLE-REF" start="618" uttnum="195">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>MTORC-1</name>
    <text>mTORC1, such as</text>
  </TERM>
  <TERM end="667" id="V3353585" paragraph="paragraph35" rule="-SIMPLE-REF" start="664" uttnum="195">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <EVENT end="709" id="V3367623" paragraph="paragraph35" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="678" uttnum="196">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="709" id="V3367623" start="678">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the phosphorylation of Ser</text>
    </predicate>
    <site end="709" id="V3367635" start="701">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>the phosphorylation of Ser</text>
  </EVENT>
  <TERM end="709" id="V3367635" paragraph="paragraph35" rule="-SIMPLE-REF" start="701" uttnum="196">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM dbid="CHEBI:9168" end="774" id="V3367704" paragraph="paragraph35" rule="-SIMPLE-REF" start="736" uttnum="196">
    <type>ONT::MOLECULE</type>
    <name>RAPAMYCIN</name>
    <text>by rapamycin (Figure 4D),</text>
  </TERM>
  <TERM end="772" id="V3367739" paragraph="paragraph35" rule="-SIMPLE-REF" start="756" uttnum="196">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 4D</text>
  </TERM>
  <TERM end="772" id="V3367714" paragraph="paragraph35" rule="-SIMPLE-REF" start="756" uttnum="196">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 4D</text>
  </TERM>
  <TERM dbid="GO:0031931" end="844" id="V3381444" paragraph="paragraph35" rule="-SIMPLE-REF" start="838" uttnum="196">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>MTORC-1</name>
    <text>mTORC1</text>
  </TERM>
  <TERM end="824" id="V3381358" paragraph="paragraph35" rule="-LOGICALOP-REF" start="796" uttnum="196">
    <type>ONT::PROTEIN</type>
    <aggregate operator="OR">
      <member id="V3381355"/>
      <member id="V3381375"/>
    </aggregate>
    <text normalization="">by S6K1 or any other kinase</text>
  </TERM>
  <TERM dbid="UP:P23443" end="804" id="V3381355" paragraph="paragraph35" rule="-SIMPLE-REF" start="799" uttnum="196">
    <type>ONT::PROTEIN</type>
    <name>S-6-K-1</name>
    <text>S6K1</text>
  </TERM>
  <TERM dbid="GO:0016301" end="824" id="V3381375" paragraph="paragraph35" rule="-SIMPLE-REF" start="807" uttnum="196">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>any other kinase</text>
  </TERM>
  <TERM end="51" id="V3393025" paragraph="paragraph36" rule="-SIMPLE-REF" start="9" uttnum="197">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Glycine</name>
        <code>G</code>
        <pos>361</pos>
      </site>
    </features>
    <name>G-361</name>
    <text>the LKB1-null G361 cell line treated with</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="17" id="V3392988" paragraph="paragraph36" rule="-SIMPLE-REF" start="13" uttnum="197">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1</text>
  </TERM>
  <TERM dbid="EFO:0000322" end="38" id="V3393060" paragraph="paragraph36" rule="-SIMPLE-REF" start="28" uttnum="197">
    <type>ONT::CELL-LINE</type>
    <name>CELL-LINE</name>
    <text>cell line</text>
  </TERM>
  <TERM end="87" id="V3393187" paragraph="paragraph36" rule="-SIMPLE-REF" start="71" uttnum="197">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>23187</pos>
      </site>
    </features>
    <name>A-23187</name>
    <text>ionophore A23187</text>
  </TERM>
  <TERM dbid="CHEBI:24869" end="81" id="V3393103" paragraph="paragraph36" rule="-SIMPLE-REF" start="71" uttnum="197">
    <type>ONT::CHEMICAL</type>
    <name>IONOPHORE</name>
    <text>ionophore</text>
  </TERM>
  <EPI end="136" id="V3406556" paragraph="paragraph36" rule="-RULE50_0_AGENT_FORMAL" start="89" uttnum="197">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg1 id="V3406542" role=":AGENT"/>
    <arg2 id="V3406582" role=":FORMAL"/>
    <text>we also showed that phosphorylation of Thr</text>
  </EPI>
  <TERM end="92" id="V3406542" paragraph="paragraph36" rule="-ROBUSTPRO" start="89" uttnum="197">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="CHEBI:24869" end="109" id="V3406573" paragraph="paragraph36" rule="-SIMPLE-REF" start="104" uttnum="197">
    <type>ONT::CHEMICAL</type>
    <name>IONOPHORE</name>
    <text>that</text>
  </TERM>
  <EVENT end="136" id="V3406582" paragraph="paragraph36" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="89" uttnum="197">
    <type>ONT::PHOSPHORYLATION</type>
    <epistemic-modality id="V3406556"/>
    <predicate end="136" id="V3406582" start="89">
      <type>ONT::PHOSPHORYLATION</type>
      <text>we also showed that phosphorylation of Thr</text>
    </predicate>
    <site end="136" id="V3406594" start="128">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>we also showed that phosphorylation of Thr</text>
  </EVENT>
  <TERM end="136" id="V3406594" paragraph="paragraph36" rule="-SIMPLE-REF" start="128" uttnum="197">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="181" id="V3406613" paragraph="paragraph36" rule="-RULE40A_AGENT_AFFECTED-ROBUST-AGENT" start="151" uttnum="197">
    <type>ONT::ACTIVATE</type>
    <predicate end="181" id="V3406613" start="151">
      <type>ONT::ACTIVATE</type>
      <text>activation of AMPK, by CaMKKβ</text>
    </predicate>
    <arg1 id="V3406683" role=":AGENT"/>
    <arg2 id="V3406627" role=":AFFECTED"/>
    <arg id="R000252" role=":RESULT"/>
    <text>activation of AMPK, by CaMKKβ</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="171" id="V3406627" paragraph="paragraph36" rule="-SIMPLE-REF" start="162" uttnum="197">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK,</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="181" id="V3406683" paragraph="paragraph36" rule="-RULE40A_AGENT_AFFECTED-ROBUST-AGENT-TERM" start="151" uttnum="197">
    <type>ONT::REFERENTIAL-SEM</type>
    <name>CAMKKΒ</name>
    <text>activation of AMPK, by CaMKKβ</text>
  </TERM>
  <EVENT end="233" id="V3406739" paragraph="paragraph36" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="197" uttnum="197">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="233" id="V3406739" start="197">
      <type>ONT::PHOSPHORYLATION</type>
      <text>by prior phosphorylation of Ser</text>
    </predicate>
    <site end="233" id="V3406751" start="225">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>by prior phosphorylation of Ser</text>
  </EVENT>
  <TERM end="233" id="V3406751" paragraph="paragraph36" rule="-SIMPLE-REF" start="225" uttnum="197">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="319" id="V3420370" paragraph="paragraph36" rule="-SIMPLE-REF" start="258" uttnum="198">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>results obtained in cell-free assays (Figure 3C)</text>
  </TERM>
  <TERM end="319" id="V3420489" paragraph="paragraph36" rule="-SIMPLE-REF" start="278" uttnum="198">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>cell-free assays (Figure 3C)</text>
  </TERM>
  <TERM end="318" id="V3420512" paragraph="paragraph36" rule="-SIMPLE-REF" start="302" uttnum="198">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 3C</text>
  </TERM>
  <TERM end="288" id="V3420436" paragraph="paragraph36" rule="-SIMPLE-REF" start="278" uttnum="198">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell-free</text>
  </TERM>
  <EVENT end="363" id="V3420608" paragraph="paragraph36" rule="-RULE10_AGENT_AFFECTED-NONE" start="336" uttnum="198">
    <type>ONT::MODULATE</type>
    <predicate end="363" id="V3420608" start="336">
      <type>ONT::MODULATE</type>
      <text>the effect in intact cells</text>
    </predicate>
    <text>the effect in intact cells</text>
  </EVENT>
  <CC end="409" id="V3420699" paragraph="paragraph36" rule="-RULE5B_NEUTRAL1_NEUTRAL" start="336" uttnum="198">
    <type>ONT::INDEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V3420734" role=":FACTOR"/>
    <arg id="V3420608" role=":OUTCOME"/>
    <text>the effect in intact cells is independent of the upstream kinase utilized</text>
  </CC>
  <TERM end="363" id="V3420674" paragraph="paragraph36" rule="-SIMPLE-REF" start="350" uttnum="198">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>intact cells</text>
  </TERM>
  <TERM dbid="GO:0016301" end="409" id="V3420734" paragraph="paragraph36" rule="-INEVENT2B,-SIMPLE-REF" start="378" uttnum="198">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V3420745"/>
      </inevent>
    </features>
    <name>KINASE</name>
    <text>of the upstream kinase utilized</text>
  </TERM>
  <CC end="409" id="V3420745" paragraph="paragraph36" rule="-RULE5B_AGENT_AFFECTED-AFFECTED" start="378" uttnum="198">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V3420734" role=":OUTCOME"/>
    <text>of the upstream kinase utilized</text>
  </CC>
  <EPI end="68" id="V3435118" paragraph="paragraph37" rule="-RULE50_0_AGENT_NEUTRAL" start="3" uttnum="199">
    <type>ONT::LEARN</type>
    <force>ONT::TRUE</force>
    <arg1 id="V3435108" role=":AGENT"/>
    <arg2 id="V3435146" role=":NEUTRAL"/>
    <text>Surprisingly, we found that phosphorylation of Akt at the mTORC2</text>
  </EPI>
  <TERM end="20" id="V3435108" paragraph="paragraph37" rule="-ROBUSTPRO" start="17" uttnum="199">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="68" id="V3435146" paragraph="paragraph37" rule="-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE60_AGENT_AFFECTED-CELL_LOC2-GD-OTHERS-AFFECTED" start="3" uttnum="199">
    <type>ONT::PHOSPHORYLATION</type>
    <epistemic-modality id="V3435118"/>
    <predicate end="68" id="V3435146" start="3">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Surprisingly, we found that phosphorylation of Akt at the mTORC2</text>
    </predicate>
    <arg2 id="V3435158" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000092"/>
    <location end="68" id="V3435234" mod="null" start="57">
      <type>ONT::CELL-PART</type>
      <text normalization="">the mTORC2</text>
    </location>
    <text>Surprisingly, we found that phosphorylation of Akt at the mTORC2</text>
  </EVENT>
  <TERM end="54" id="V3435158" paragraph="paragraph37" rule="-SIMPLE-REF" start="47" uttnum="199">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
    <not-features>
      <ptm event="V3435146" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM dbid="GO:0031932" end="68" id="V3435234" paragraph="paragraph37" rule="-SIMPLE-REF" start="57" uttnum="199">
    <type>ONT::CELL-PART</type>
    <name>MTORC-2</name>
    <text>the mTORC2</text>
  </TERM>
  <TERM end="72" id="V3435244" paragraph="paragraph37" rule="-SIMPLE-REF" start="68" uttnum="199">
    <type>ONT::AREA-DEF-BY-USE</type>
    <name>SITE</name>
    <text>site</text>
  </TERM>
  <TERM end="82" id="V3435253" paragraph="paragraph37" rule="-SIMPLE-REF" start="74" uttnum="199">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="167" id="V3435346" paragraph="paragraph37" rule="-LOGICALOP-REF" start="142" uttnum="199">
    <type>ONT::MOLECULE</type>
    <aggregate operator="AND">
      <member id="V3435342"/>
      <member id="V3435357"/>
    </aggregate>
    <text normalization="">phenformin and quercetin,</text>
  </TERM>
  <TERM dbid="CHEBI:85053" end="132" id="V3435331" paragraph="paragraph37" rule="-SIMPLE-REF" start="108" uttnum="199">
    <type>ONT::CHEMICAL</type>
    <name>AMPK-ACTIVATORS</name>
    <text>certain AMPK activators</text>
  </TERM>
  <TERM dbid="CHEBI:8064" end="153" id="V3435342" paragraph="paragraph37" rule="-SIMPLE-REF" start="142" uttnum="199">
    <type>ONT::MOLECULE</type>
    <name>PHENFORMIN</name>
    <text>phenformin</text>
  </TERM>
  <TERM dbid="CHEBI:16243|CHEBI:57694" end="167" id="V3435357" paragraph="paragraph37" rule="-SIMPLE-REF" start="157" uttnum="199">
    <type>ONT::MOLECULE</type>
    <name>QUERCETIN</name>
    <text>quercetin,</text>
  </TERM>
  <TERM end="212" id="V3449659" paragraph="paragraph37" rule="-LOGICALOP-REF" start="184" uttnum="199">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="OR">
      <member id="V3449747"/>
      <member id="V3449565"/>
      <member id="V3449652"/>
    </aggregate>
    <text normalization="">berberine, A769662 or A23817</text>
  </TERM>
  <TERM dbid="CHEBI:16118" end="193" id="V3449565" paragraph="paragraph37" rule="-SIMPLE-REF" start="184" uttnum="199">
    <type>ONT::MOLECULE</type>
    <name>BERBERINE</name>
    <text>berberine</text>
  </TERM>
  <TERM end="203" id="V3449652" paragraph="paragraph37" rule="-SIMPLE-REF" start="195" uttnum="199">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>A769662</text>
  </TERM>
  <TERM end="212" id="V3449747" paragraph="paragraph37" rule="-SIMPLE-REF" start="206" uttnum="199">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>23817</pos>
      </site>
    </features>
    <name>A-23817</name>
    <text>A23817</text>
  </TERM>
  <TERM end="253" id="V3454524" paragraph="paragraph37" rule="-SIMPLE-REF" start="223" uttnum="200">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>the mechanism for this effect</text>
  </TERM>
  <TERM end="273" id="V3458437" paragraph="paragraph37" rule="-SIMPLE-REF" start="270" uttnum="200">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>it</text>
  </TERM>
  <TERM end="298" id="V3458492" paragraph="paragraph37" rule="-SIMPLE-REF-MODACTIVE2,-SIMPLE-REF" start="284" uttnum="200">
    <type>ONT::GOAL</type>
    <features>
      <active>FALSE</active>
    </features>
    <name>TARGET</name>
    <text>an off-target</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="315" id="V3458512" paragraph="paragraph37" rule="-SIMPLE-REF" start="298" uttnum="200">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK-independent</text>
  </TERM>
  <TERM end="334" id="V3460023" paragraph="paragraph37" rule="-SIMPLE-REF" start="331" uttnum="200">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>it</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="400" id="V3460160" paragraph="paragraph37" rule="-SIMPLE-REF" start="356" uttnum="200">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>AMPK-knockout MEFs (Supplementary Figure S2)</text>
  </TERM>
  <TERM end="399" id="V3460199" paragraph="paragraph37" rule="-SIMPLE-REF" start="376" uttnum="200">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>2</pos>
      </site>
    </features>
    <name>S-2</name>
    <text>Supplementary Figure S2</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="360" id="V3460121" paragraph="paragraph37" rule="-SIMPLE-REF" start="356" uttnum="200">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="370" id="V3460132" paragraph="paragraph37" rule="-SIMPLE-REF" start="361" uttnum="200">
    <type>ONT::FEMALE-PERSON</type>
    <name>KNOCKOUT</name>
    <text>knockout</text>
  </TERM>
  <TERM end="399" id="V3460179" paragraph="paragraph37" rule="-SIMPLE-REF" start="376" uttnum="200">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure S2</text>
  </TERM>
  <TERM end="24" id="V3473873" paragraph="paragraph38" rule="-ROBUSTPRO" start="12" uttnum="201">
    <type>ONT::PERSON</type>
    <text>our studies</text>
  </TERM>
  <TERM end="54" id="V3473983" paragraph="paragraph38" rule="-SIMPLE-REF" start="39" uttnum="201">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>of tumour cells</text>
  </TERM>
  <TERM end="59" id="V3488311" paragraph="paragraph38" rule="-ROBUSTPRO" start="56" uttnum="201">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="126" id="V3488460" paragraph="paragraph38" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="82" uttnum="201">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="126" id="V3488460" start="82">
      <type>ONT::INHIBIT</type>
      <text>AMPK activation was down-regulated in three</text>
    </predicate>
    <arg2 id="V3488348" role=":AFFECTED"/>
    <text>AMPK activation was down-regulated in three</text>
  </EVENT>
  <EVENT end="98" id="V3488348" paragraph="paragraph38" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="82" uttnum="201">
    <type>ONT::ACTIVATE</type>
    <predicate end="98" id="V3488348" start="82">
      <type>ONT::ACTIVATE</type>
      <text>AMPK activation</text>
    </predicate>
    <arg2 id="V3488345" role=":AFFECTED"/>
    <arg id="R000257" role=":RESULT"/>
    <text>AMPK activation</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="87" id="V3488345" paragraph="paragraph38" rule="-SIMPLE-REF" start="82" uttnum="201">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:P60484" end="136" id="V3488554" paragraph="paragraph38" rule="-SIMPLE-REF" start="126" uttnum="201">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>PTEN-null</text>
  </TERM>
  <TERM dbid="EFO:0000322" end="180" id="V3488608" paragraph="paragraph38" rule="-INEVENT2B,-SIMPLE-REF" start="136" uttnum="201">
    <type>ONT::CELL-LINE</type>
    <features>
      <inevent>
        <event id="V3488618"/>
      </inevent>
    </features>
    <name>CELL-LINE</name>
    <text>tumour cell lines derived from human cancers</text>
  </TERM>
  <EVENT end="180" id="V3488618" paragraph="paragraph38" rule="-RULE40A_AGENT_AFFECTED-NONE" start="154" uttnum="201">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="180" id="V3488618" start="154">
      <type>ONT::PRODUCE</type>
      <text>derived from human cancers</text>
    </predicate>
    <arg2 id="V3488608" role=":AFFECTED-RESULT"/>
    <text>derived from human cancers</text>
  </EVENT>
  <TERM end="180" id="V3488632" paragraph="paragraph38" rule="-SIMPLE-REF" start="167" uttnum="201">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>human cancers</text>
  </TERM>
  <TERM dbid="BTO:0000356|EFO:0002885" end="275" id="V3503516" paragraph="paragraph38" rule="-SIMPLE-REF" start="234" uttnum="202">
    <type>ONT::CELL-LINE</type>
    <name>BREAST-CANCER-CELL-LINE</name>
    <text>breast cancer cell line in which Akt was</text>
  </TERM>
  <TERM dbid="BTO:0001530" end="228" id="V3503393" paragraph="paragraph38" rule="-SIMPLE-REF" start="200" uttnum="202">
    <type>ONT::CELL-LINE</type>
    <name>GLIOBLASTOMA-CELL-LINES</name>
    <text>two glioblastoma cell lines</text>
  </TERM>
  <TERM end="271" id="V3503580" paragraph="paragraph38" rule="-SIMPLE-REF" start="267" uttnum="202">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM dbid="UP:P60484" end="309" id="V3503669" paragraph="paragraph38" rule="-SIMPLE-REF" start="302" uttnum="202">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>of PTEN</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="316" id="V3516389" paragraph="paragraph38" rule="-SIMPLE-REF" start="311" uttnum="202">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="421" id="V3516594" paragraph="paragraph38" rule="-SIMPLE-REF" start="355" uttnum="202">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Alanine</name>
        <code>A</code>
        <pos>769662</pos>
      </site>
    </features>
    <name>A-769662</name>
    <text>Thr172 phosphorylation induced by the activator A769662</text>
  </TERM>
  <TERM end="363" id="V3516461" paragraph="paragraph38" rule="-SIMPLE-REF" start="355" uttnum="202">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="414" id="V3516510" paragraph="paragraph38" rule="-SIMPLE-REF" start="397" uttnum="202">
    <type>ONT::SUBSTANCE</type>
    <name>ACTIVATOR</name>
    <text>by the activator</text>
  </TERM>
  <EVENT end="484" id="V3523675" paragraph="paragraph38" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="457" uttnum="203">
    <type>ONT::INCREASE</type>
    <predicate end="484" id="V3523675" start="457">
      <type>ONT::INCREASE</type>
      <text>by the addition of MK2206,</text>
    </predicate>
    <arg2 id="V3523696" role=":AFFECTED"/>
    <text>by the addition of MK2206,</text>
  </EVENT>
  <TERM dbid="CHEBI:67271" end="484" id="V3523696" paragraph="paragraph38" rule="-SIMPLE-REF" start="473" uttnum="203">
    <type>ONT::MOLECULE</type>
    <name>MK-2206</name>
    <text>of MK2206,</text>
  </TERM>
  <TERM dbid="CHEBI:35222" end="524" id="V3523753" paragraph="paragraph38" rule="-SIMPLE-REF" start="486" uttnum="203">
    <type>ONT::CHEMICAL</type>
    <name>INHIBITOR</name>
    <text>selective inhibitor of Akt activation</text>
  </TERM>
  <EVENT end="524" id="V3523768" paragraph="paragraph38" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="509" uttnum="203">
    <type>ONT::ACTIVATE</type>
    <predicate end="524" id="V3523768" start="509">
      <type>ONT::ACTIVATE</type>
      <text>Akt activation</text>
    </predicate>
    <arg2 id="V3523765" role=":AFFECTED"/>
    <arg id="R000262" role=":RESULT"/>
    <text>Akt activation</text>
  </EVENT>
  <TERM end="513" id="V3523765" paragraph="paragraph38" rule="-SIMPLE-REF" start="509" uttnum="203">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="CVCL:U693" end="597" id="V3523913" paragraph="paragraph38" rule="-SIMPLE-REF" start="586" uttnum="203">
    <type>ONT::CELL-LINE</type>
    <name>ON-SER</name>
    <text>on Ser</text>
  </TERM>
  <TERM dbid="FA:03087" end="615" id="V3523936" paragraph="paragraph38" rule="-SIMPLE-REF" start="611" uttnum="203">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <TERM dbid="CVCL:U693" end="628" id="V3524001" paragraph="paragraph38" rule="-SIMPLE-REF" start="617" uttnum="203">
    <type>ONT::CELL-LINE</type>
    <name>ON-SER</name>
    <text>on Ser</text>
  </TERM>
  <TERM end="647" id="V3524026" paragraph="paragraph38" rule="-SIMPLE-REF" start="643" uttnum="203">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM end="654" id="V3524029" paragraph="paragraph38" rule="-ROBUSTPRO" start="647" uttnum="203">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>itself</text>
  </TERM>
  <TERM end="665" id="V3524061" paragraph="paragraph38" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF" start="654" uttnum="203">
    <type>ONT::AMINO-ACID</type>
    <features>
      <active>TRUE</active>
    </features>
    <name>THR</name>
    <text>on Thr</text>
  </TERM>
  <TERM end="687" id="V3524079" paragraph="paragraph38" rule="-SIMPLE-REF" start="679" uttnum="203">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="755" id="V3537925" paragraph="paragraph38" rule="-SIMPLE-REF" start="738" uttnum="204">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>DBTRG-05MG cells</text>
  </TERM>
  <TERM dbid="EFO:0002159" end="749" id="V3537920" paragraph="paragraph38" rule="-SIMPLE-REF" start="738" uttnum="204">
    <type>ONT::CELL-LINE</type>
    <name>DBTRG-5-MG</name>
    <text>DBTRG-05MG</text>
  </TERM>
  <EVENT end="781" id="V3537964" paragraph="paragraph38" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="758" uttnum="204">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <mods>
      <frequency>
        <type>ONT::REPETITION</type>
        <value>RE-</value>
      </frequency>
    </mods>
    <predicate end="781" id="V3537964" start="758">
      <type>ONT::EXPRESS</type>
      <text>re-expressing WT PTEN,</text>
    </predicate>
    <arg2 id="V3537991" role=":AFFECTED-RESULT"/>
    <text>re-expressing WT PTEN,</text>
  </EVENT>
  <TERM dbid="UP:P60484" end="781" id="V3537991" paragraph="paragraph38" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="772" uttnum="204">
    <type>ONT::PROTEIN</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>PTEN</name>
    <text>WT PTEN,</text>
  </TERM>
  <TERM end="818" id="V3538145" paragraph="paragraph38" rule="-SIMPLE-REF" start="813" uttnum="204">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>124</pos>
      <aa-from>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">C124S</text>
  </TERM>
  <TERM end="826" id="V3538151" paragraph="paragraph38" rule="-SIMPLE-REF-MUTATION8" start="820" uttnum="204">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>mutant</text>
  </TERM>
  <TERM end="840" id="V3552549" paragraph="paragraph38" rule="-SIMPLE-REF" start="828" uttnum="205">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Our results</text>
  </TERM>
  <TERM end="853" id="V3552571" paragraph="paragraph38" rule="-SIMPLE-REF" start="848" uttnum="205">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>124</pos>
      <aa-from>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">that</text>
  </TERM>
  <TERM end="840" id="V3552542" paragraph="paragraph38" rule="-ROBUSTPRO" start="828" uttnum="205">
    <type>ONT::PERSON</type>
    <text>Our results</text>
  </TERM>
  <TERM dbid="UP:P60484" end="894" id="V3552648" paragraph="paragraph38" rule="-SIMPLE-REF" start="889" uttnum="205">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>PTEN</text>
  </TERM>
  <TERM end="969" id="V3552783" paragraph="paragraph38" rule="-LOGICALOP-REF" start="939" uttnum="205">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <aggregate operator="AND">
      <member id="V3552779"/>
      <member id="V3552795"/>
    </aggregate>
    <text normalization="">cell growth and proliferation</text>
  </TERM>
  <TERM dbid="GO:0016049" end="951" id="V3552779" paragraph="paragraph38" rule="-SIMPLE-REF" start="939" uttnum="205">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-GROWTH</name>
    <text>cell growth</text>
  </TERM>
  <TERM end="969" id="V3552795" paragraph="paragraph38" rule="-SIMPLE-REF" start="955" uttnum="205">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PROLIFERATION</name>
    <text>proliferation</text>
  </TERM>
  <EVENT end="999" id="V3552830" paragraph="paragraph38" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="981" uttnum="205">
    <type>ONT::ACTIVATE</type>
    <predicate end="999" id="V3552830" start="981">
      <type>ONT::ACTIVATE</type>
      <text>activation of AMPK</text>
    </predicate>
    <arg2 id="V3552844" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000267"/>
    <text>activation of AMPK</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="999" id="V3552844" paragraph="paragraph38" rule="-SIMPLE-REF" start="992" uttnum="205">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="1016" id="V3567497" paragraph="paragraph38" rule="-SIMPLE-REF" start="1001" uttnum="206">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>This mechanism</text>
  </TERM>
  <TERM end="1066" id="V3567627" paragraph="paragraph38" rule="-SIMPLE-REF" start="1060" uttnum="206">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <TERM end="1079" id="V3567699" paragraph="paragraph38" rule="-SIMPLE-REF" start="1075" uttnum="206">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <EVENT end="1146" id="V3567731" paragraph="paragraph38" rule="-RULE40A_AGENT_AFFECTED-LOC5-GD-NONE" start="1082" uttnum="206">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <mods>
      <degree>
        <type>ONT::DEGREE-MODIFIER-HIGH</type>
        <value>HYPER-</value>
      </degree>
    </mods>
    <predicate end="1146" id="V3567731" start="1082">
      <type>ONT::ACTIVATE</type>
      <text>hyperactivated due to activating mutations in subunits of PI3K,</text>
    </predicate>
    <site end="1146" id="V3567845" start="1128">
      <type>ONT::MONEY-UNIT</type>
      <text normalization="SUBUNITS">subunits of PI3K,</text>
    </site>
    <text>hyperactivated due to activating mutations in subunits of PI3K,</text>
  </EVENT>
  <EVENT end="1125" id="V3567779" paragraph="paragraph38" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1104" uttnum="206">
    <type>ONT::ACTIVATE</type>
    <predicate end="1125" id="V3567779" start="1104">
      <type>ONT::ACTIVATE</type>
      <text>activating mutations</text>
    </predicate>
    <arg2 id="V3567787" role=":AFFECTED"/>
    <text>activating mutations</text>
  </EVENT>
  <TERM end="1125" id="V3567787" paragraph="paragraph38" rule="-SIMPLE-REF-MUTATION8" start="1115" uttnum="206">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>mutations</text>
  </TERM>
  <TERM end="1144" id="V3567892" paragraph="paragraph38" rule="-SIMPLE-REF" start="1140" uttnum="206">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <CC end="1146" id="X3585158" paragraph="paragraph38" rule="-REASON2-GD" start="1082" uttnum="206">
    <type>ONT::CAUSE</type>
    <arg id="V3567779" role=":FACTOR"/>
    <arg id="V3567731" role=":OUTCOME"/>
    <text>hyperactivated due to activating mutations in subunits of PI3K,</text>
  </CC>
  <EVENT end="1215" id="V3567925" paragraph="paragraph38" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="1161" uttnum="206">
    <type>ONT::EXPRESS</type>
    <mods>
      <degree>
        <type>ONT::DEGREE-MODIFIER-HIGH</type>
        <value>OVER-</value>
      </degree>
    </mods>
    <predicate end="1215" id="V3567925" start="1161">
      <type>ONT::EXPRESS</type>
      <text>overexpression of upstream receptors [26]</text>
    </predicate>
    <arg2 id="V3567955" role=":AFFECTED-RESULT"/>
    <text>overexpression of upstream receptors [26]</text>
  </EVENT>
  <TERM dbid="GO:0004872" end="1215" id="V3567955" paragraph="paragraph38" rule="-SIMPLE-REF" start="1176" uttnum="206">
    <type>ONT::PROTEIN</type>
    <name>RECEPTORS</name>
    <text>of upstream receptors [26]</text>
  </TERM>
  <TERM end="1235" id="V3581917" paragraph="paragraph38" rule="-SIMPLE-REF" start="1217" uttnum="207">
    <type>ONT::INFORMATION</type>
    <name>EVIDENCE</name>
    <text>Previous evidence</text>
  </TERM>
  <TERM end="1310" id="V3582051" paragraph="paragraph38" rule="-SIMPLE-REF" start="1281" uttnum="207">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>human hepatoma (Huh-7) cells</text>
  </TERM>
  <TERM dbid="EFO:0005384|CVCL:0336" end="1302" id="V3582044" paragraph="paragraph38" rule="-SIMPLE-REF" start="1297" uttnum="207">
    <type>ONT::CELL-LINE</type>
    <name>HUH-7</name>
    <text>Huh-7</text>
  </TERM>
  <TERM end="1364" id="V3582120" paragraph="paragraph38" rule="-SIMPLE-REF" start="1324" uttnum="207">
    <type>ONT::HARMFUL-AGENCY</type>
    <name>VIRUS</name>
    <text>the hepatitis C virus [30],</text>
  </TERM>
  <TERM end="1264" id="V3581949" paragraph="paragraph38" rule="-SIMPLE-REF" start="1249" uttnum="207">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>this mechanism</text>
  </TERM>
  <TERM end="1376" id="V3596537" paragraph="paragraph38" rule="-SIMPLE-REF" start="1371" uttnum="207">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <EVENT end="1480" id="V3596601" paragraph="paragraph38" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="1396" uttnum="207">
    <type>ONT::BIND</type>
    <predicate end="1480" id="V3596601" start="1396">
      <type>ONT::BIND</type>
      <text>association with a non-structural protein encoded by the viral RNA [43]</text>
    </predicate>
    <arg1 id="V3596684" role=":AGENT"/>
    <text>association with a non-structural protein encoded by the viral RNA [43]</text>
  </EVENT>
  <TERM end="1480" id="V3596684" paragraph="paragraph38" rule="-INEVENT2B,-SIMPLE-REF" start="1408" uttnum="207">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V3596695"/>
      </inevent>
    </features>
    <name>PROTEIN</name>
    <text>with a non-structural protein encoded by the viral RNA [43]</text>
  </TERM>
  <EVENT end="1480" id="V3596695" paragraph="paragraph38" rule="-RULE10_AGENT_AFFECTED" start="1408" uttnum="207">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1480" id="V3596695" start="1408">
      <type>ONT::MODULATE</type>
      <text>with a non-structural protein encoded by the viral RNA [43]</text>
    </predicate>
    <arg1 id="V3596737" role=":AGENT"/>
    <arg2 id="V3596684" role=":AFFECTED"/>
    <text>with a non-structural protein encoded by the viral RNA [43]</text>
  </EVENT>
  <TERM dbid="CHEBI:18273" end="1480" id="V3596737" paragraph="paragraph38" rule="-SIMPLE-REF" start="1446" uttnum="207">
    <type>ONT::CHEMICAL</type>
    <name>RNA</name>
    <text>by the viral RNA [43]</text>
  </TERM>
  <EVENT end="1525" id="V3610793" paragraph="paragraph38" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="1496" uttnum="208">
    <type>ONT::EXPRESS</type>
    <predicate end="1525" id="V3610793" start="1496">
      <type>ONT::EXPRESS</type>
      <text>expression of viral proteins</text>
    </predicate>
    <arg2 id="V3610813" role=":AFFECTED-RESULT"/>
    <text>expression of viral proteins</text>
  </EVENT>
  <EVENT end="1574" id="V3610840" paragraph="paragraph38" rule="-RULE20_AGENT_AFFECTED" start="1496" uttnum="208">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="1574" id="V3610840" start="1496">
      <type>ONT::DECREASE</type>
      <text>expression of viral proteins was reduced by treating the infected Huh-7 cells</text>
    </predicate>
    <arg1 id="V3610872" role=":AGENT"/>
    <arg2 id="V3610793" role=":AFFECTED"/>
    <text>expression of viral proteins was reduced by treating the infected Huh-7 cells</text>
  </EVENT>
  <TERM end="1525" id="V3610813" paragraph="paragraph38" rule="-SIMPLE-REF" start="1507" uttnum="208">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>of viral proteins</text>
  </TERM>
  <EVENT end="1574" id="V3610872" paragraph="paragraph38" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1537" uttnum="208">
    <type>ONT::MODULATE</type>
    <predicate end="1574" id="V3610872" start="1537">
      <type>ONT::MODULATE</type>
      <text>by treating the infected Huh-7 cells</text>
    </predicate>
    <arg2 id="V3610906" role=":AFFECTED"/>
    <text>by treating the infected Huh-7 cells</text>
  </EVENT>
  <TERM end="1574" id="V3610906" paragraph="paragraph38" rule="-INEVENT2B,-SIMPLE-REF" start="1549" uttnum="208">
    <type>ONT::CELL</type>
    <features>
      <inevent>
        <event id="V3610884"/>
      </inevent>
    </features>
    <name>CELL</name>
    <text>the infected Huh-7 cells</text>
  </TERM>
  <EVENT end="1574" id="V3610884" paragraph="paragraph38" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1549" uttnum="208">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1574" id="V3610884" start="1549">
      <type>ONT::MODULATE</type>
      <text>the infected Huh-7 cells</text>
    </predicate>
    <arg2 id="V3610906" role=":AFFECTED"/>
    <text>the infected Huh-7 cells</text>
  </EVENT>
  <TERM dbid="EFO:0005384|CVCL:0336" end="1568" id="V3610902" paragraph="paragraph38" rule="-SIMPLE-REF" start="1562" uttnum="208">
    <type>ONT::CELL-LINE</type>
    <name>HUH-7</name>
    <text>Huh-7</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1584" id="V3610931" paragraph="paragraph38" rule="-SIMPLE-REF" start="1579" uttnum="208">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="1603" id="V3610936" paragraph="paragraph38" rule="-SIMPLE-REF" start="1584" uttnum="208">
    <type>ONT::SUBSTANCE</type>
    <name>ACTIVATORS</name>
    <text>activators such as</text>
  </TERM>
  <TERM dbid="CHEBI:2030|CHEBI:28498|CHEBI:18406" end="1609" id="V3610991" paragraph="paragraph38" rule="-SIMPLE-REF" start="1603" uttnum="208">
    <type>ONT::MOLECULE</type>
    <name>AICAR</name>
    <text>AICAR</text>
  </TERM>
  <TERM dbid="CHEBI:2030" end="1641" id="V3611018" paragraph="paragraph38" rule="-SIMPLE-REF" start="1610" uttnum="208">
    <type>ONT::MOLECULE</type>
    <name>5-AMINO-4-IMIDAZOLECARBOXAMIDE</name>
    <text>5-amino-4-imidazolecarboxamide</text>
  </TERM>
  <TERM dbid="CHEBI:6801" end="1681" id="V3611038" paragraph="paragraph38" rule="-SIMPLE-REF" start="1654" uttnum="208">
    <type>ONT::MOLECULE</type>
    <name>METFORMIN</name>
    <text>metformin [30]</text>
  </TERM>
  <TERM end="24" id="V3628330" paragraph="paragraph39" rule="-SIMPLE-REF" start="12" uttnum="209">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>our results</text>
  </TERM>
  <TERM end="54" id="V3628394" paragraph="paragraph39" rule="-SIMPLE-REF" start="32" uttnum="209">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>a molecular mechanism</text>
  </TERM>
  <TERM end="24" id="V3628323" paragraph="paragraph39" rule="-ROBUSTPRO" start="12" uttnum="209">
    <type>ONT::PERSON</type>
    <text>our results</text>
  </TERM>
  <TERM end="96" id="V3628458" paragraph="paragraph39" rule="-SIMPLE-REF" start="88" uttnum="209">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="153" id="V3628465" paragraph="paragraph39" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="106" uttnum="209">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="153" id="V3628465" start="106">
      <type>ONT::INHIBIT</type>
      <text>inhibits subsequent phosphorylation of Thr</text>
    </predicate>
    <arg2 id="V3628473" role=":AFFECTED"/>
    <text>inhibits subsequent phosphorylation of Thr</text>
  </EVENT>
  <EVENT end="153" id="V3628473" paragraph="paragraph39" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="115" uttnum="209">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="153" id="V3628473" start="115">
      <type>ONT::PHOSPHORYLATION</type>
      <text>subsequent phosphorylation of Thr</text>
    </predicate>
    <site end="153" id="V3628485" start="145">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>subsequent phosphorylation of Thr</text>
  </EVENT>
  <TERM end="153" id="V3628485" paragraph="paragraph39" rule="-SIMPLE-REF" start="145" uttnum="209">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="GO:0016301" end="205" id="V3628554" paragraph="paragraph39" rule="-SIMPLE-REF" start="189" uttnum="209">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>upstream kinases</text>
  </TERM>
  <TERM end="253" id="V3643369" paragraph="paragraph39" rule="-SIMPLE-REF" start="235" uttnum="210">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>containing rat α1,</text>
  </TERM>
  <TERM end="286" id="V3646408" paragraph="paragraph39" rule="-SIMPLE-REF" start="277" uttnum="210">
    <type>ONT::BACTERIUM</type>
    <name>BACTERIUM</name>
    <text>bacteria</text>
  </TERM>
  <TERM end="304" id="V3646432" paragraph="paragraph39" rule="-SIMPLE-REF" start="296" uttnum="210">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="383" id="V3651412" paragraph="paragraph39" rule="-SIMPLE-REF" start="358" uttnum="210">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop from Glu</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="365" id="V3651403" paragraph="paragraph39" rule="-SIMPLE-REF" start="362" uttnum="210">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="383" id="V3651428" paragraph="paragraph39" rule="-SIMPLE-REF" start="375" uttnum="210">
    <type>ONT::AMINO-ACID</type>
    <name>GLU</name>
    <text>Glu</text>
  </TERM>
  <TERM end="404" id="V3651460" paragraph="paragraph39" rule="-SIMPLE-REF" start="396" uttnum="210">
    <type>ONT::AMINO-ACID</type>
    <name>VAL</name>
    <text>Val</text>
  </TERM>
  <TERM end="451" id="V3652084" paragraph="paragraph39" rule="-SIMPLE-REF" start="448" uttnum="210">
    <type>ONT::AMINO-ACID</type>
    <name>VAL</name>
    <text>it</text>
  </TERM>
  <TERM end="462" id="V3652106" paragraph="paragraph39" rule="-SIMPLE-REF" start="455" uttnum="210">
    <type>ONT::DEVICE</type>
    <name>MOBILE</name>
    <text>mobile</text>
  </TERM>
  <TERM end="498" id="V3652133" paragraph="paragraph39" rule="-SIMPLE-REF" start="469" uttnum="210">
    <type>ONT::MATERIAL</type>
    <name>CRYSTAL</name>
    <text>the crystal [11]</text>
  </TERM>
  <TERM end="515" id="V3653151" paragraph="paragraph39" rule="-SIMPLE-REF" start="500" uttnum="211">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>Our hypothesis</text>
  </TERM>
  <TERM end="515" id="V3653148" paragraph="paragraph39" rule="-ROBUSTPRO" start="500" uttnum="211">
    <type>ONT::PERSON</type>
    <text>Our hypothesis</text>
  </TERM>
  <TERM end="535" id="V3653207" paragraph="paragraph39" rule="-SIMPLE-REF" start="523" uttnum="211">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM end="584" id="V3653232" paragraph="paragraph39" rule="-SIMPLE-REF" start="545" uttnum="211">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>with residues within the kinase domain</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="530" id="V3653198" paragraph="paragraph39" rule="-SIMPLE-REF" start="527" uttnum="211">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="584" id="V3653258" paragraph="paragraph39" rule="-SIMPLE-REF" start="566" uttnum="211">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the kinase domain</text>
  </TERM>
  <TERM dbid="GO:0016301" end="577" id="V3653255" paragraph="paragraph39" rule="-SIMPLE-REF" start="570" uttnum="211">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="597" id="V3653276" paragraph="paragraph39" rule="-SIMPLE-REF" start="589" uttnum="211">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM dbid="GO:0016301" end="668" id="V3668325" paragraph="paragraph39" rule="-SIMPLE-REF" start="648" uttnum="211">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>of upstream kinases</text>
  </TERM>
  <TERM end="694" id="V3668396" paragraph="paragraph39" rule="-SIMPLE-REF" start="686" uttnum="211">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="721" id="V3682432" paragraph="paragraph39" rule="-SIMPLE-REF" start="705" uttnum="212">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>This hypothesis</text>
  </TERM>
  <TERM end="749" id="V3682502" paragraph="paragraph39" rule="-SIMPLE-REF" start="734" uttnum="212">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>by the results</text>
  </TERM>
  <TERM end="774" id="V3682564" paragraph="paragraph39" rule="-SIMPLE-REF" start="758" uttnum="212">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 7,</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="841" id="V3683458" paragraph="paragraph39" rule="-SIMPLE-REF" start="783" uttnum="212">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>that a peptide corresponding to the sequence from Arg</text>
  </TERM>
  <TERM dbid="UP:P42684" end="841" id="V3683514" paragraph="paragraph39" rule="-SIMPLE-REF" start="833" uttnum="212">
    <type>ONT::PROTEIN</type>
    <name>ARG</name>
    <text>Arg</text>
  </TERM>
  <TERM end="862" id="V3683546" paragraph="paragraph39" rule="-SIMPLE-REF" start="854" uttnum="212">
    <type>ONT::AMINO-ACID</type>
    <name>ASP</name>
    <text>Asp</text>
  </TERM>
  <TERM end="881" id="V3683579" paragraph="paragraph39" rule="-SIMPLE-REF" start="875" uttnum="212">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>human</text>
  </TERM>
  <TERM end="916" id="V3683619" paragraph="paragraph39" rule="-SIMPLE-REF" start="908" uttnum="212">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="971" id="V3683625" paragraph="paragraph39" rule="-RULE60_AGENT_AFFECTED" start="926" uttnum="212">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="971" id="V3683625" start="926">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of an α1β2γ1 complex by LKB1,</text>
    </predicate>
    <arg1 id="V3683715" role=":AGENT"/>
    <arg2 id="V3683676" role=":AFFECTED"/>
    <arg id="R000097" role=":RESULT"/>
    <text>phosphorylation of an α1β2γ1 complex by LKB1,</text>
  </EVENT>
  <TERM end="963" id="V3683676" paragraph="paragraph39" rule="-SIMPLE-REF" start="942" uttnum="212">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>of an α1β2γ1 complex</text>
    <not-features>
      <ptm event="V3683625" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="971" id="V3683715" paragraph="paragraph39" rule="-SIMPLE-REF" start="963" uttnum="212">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1,</text>
  </TERM>
  <TERM end="1041" id="V3696772" paragraph="paragraph39" rule="-SIMPLE-REF" start="1030" uttnum="212">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>to Ser</text>
  </TERM>
  <EVENT end="1016" id="V3696700" paragraph="paragraph39" rule="-RULE60_AGENT_AFFECTED-LOC4-GD-NONE" start="986" uttnum="212">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1016" id="V3696700" start="986">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylated on the residue</text>
    </predicate>
    <site end="1016" id="V3696737" start="1004">
      <type>ONT::RESIDUE</type>
      <text normalization="">the residue</text>
    </site>
    <text>phosphorylated on the residue</text>
  </EVENT>
  <TERM end="1016" id="V3696737" paragraph="paragraph39" rule="-SIMPLE-REF" start="1004" uttnum="212">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>the residue</text>
  </TERM>
  <TERM end="1057" id="V3709659" paragraph="paragraph39" rule="-SIMPLE-REF" start="1052" uttnum="213">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>This</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="1117" id="V3710191" paragraph="paragraph39" rule="-SIMPLE-REF" start="1109" uttnum="213">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>peptide</text>
  </TERM>
  <EVENT end="1186" id="V3710289" paragraph="paragraph39" rule="-RULE60_AGENT_AFFECTED" start="1152" uttnum="213">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1186" id="V3710289" start="1152">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation by LKB1 of BRSK2,</text>
    </predicate>
    <arg1 id="V3710323" role=":AGENT"/>
    <arg2 id="V3710340" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000102"/>
    <text>phosphorylation by LKB1 of BRSK2,</text>
  </EVENT>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="1176" id="V3710323" paragraph="paragraph39" rule="-SIMPLE-REF" start="1168" uttnum="213">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1</text>
  </TERM>
  <TERM dbid="HGNC:11405|UP:Q8IWQ3" end="1186" id="V3710340" paragraph="paragraph39" rule="-SIMPLE-REF" start="1176" uttnum="213">
    <type>ONT::PROTEIN</type>
    <name>BRSK-2</name>
    <text>of BRSK2,</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3710289"/>
    </not-features>
  </TERM>
  <TERM dbid="HGNC:18994|UP:Q8TDC3" end="1203" id="V3724635" paragraph="paragraph39" rule="-SIMPLE-REF" start="1198" uttnum="213">
    <type>ONT::GENE</type>
    <name>BRSK-1</name>
    <text>BRSK1</text>
  </TERM>
  <TERM end="1259" id="V3724669" paragraph="paragraph39" rule="-SIMPLE-REF" start="1209" uttnum="213">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the kinase domain most closely related to AMPK-α1</text>
  </TERM>
  <TERM dbid="GO:0016301" end="1220" id="V3724666" paragraph="paragraph39" rule="-SIMPLE-REF" start="1213" uttnum="213">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1259" id="V3724726" paragraph="paragraph39" rule="-SIMPLE-REF" start="1248" uttnum="213">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>to AMPK-α1</text>
  </TERM>
  <TERM end="34" id="V3737770" paragraph="paragraph40" rule="-SIMPLE-REF" start="3" uttnum="214">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>The 54 residues of the ST loop</text>
  </TERM>
  <TERM end="34" id="V3737798" paragraph="paragraph40" rule="-SIMPLE-REF" start="22" uttnum="214">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="29" id="V3737789" paragraph="paragraph40" rule="-SIMPLE-REF" start="26" uttnum="214">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="109" id="V3737903" paragraph="paragraph40" rule="-SIMPLE-REF" start="60" uttnum="214">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>15 serine residues (including Ser487)</text>
  </TERM>
  <TERM end="43" id="V3737853" paragraph="paragraph40" rule="-SIMPLE-REF" start="37" uttnum="214">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>human</text>
  </TERM>
  <TERM end="70" id="V3737900" paragraph="paragraph40" rule="-SIMPLE-REF" start="63" uttnum="214">
    <type>ONT::AMINO-ACID</type>
    <name>SERINE</name>
    <text>serine</text>
  </TERM>
  <TERM end="98" id="V3737917" paragraph="paragraph40" rule="-SIMPLE-REF" start="90" uttnum="214">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="136" id="V3737944" paragraph="paragraph40" rule="-SIMPLE-REF" start="113" uttnum="214">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>five threonine residues</text>
  </TERM>
  <TERM end="128" id="V3737941" paragraph="paragraph40" rule="-SIMPLE-REF" start="118" uttnum="214">
    <type>ONT::AMINO-ACID</type>
    <name>THREONINE</name>
    <text>threonine</text>
  </TERM>
  <TERM end="219" id="V3749126" paragraph="paragraph40" rule="-ROBUSTPRO" start="146" uttnum="214">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>which are conserved in α1 subunits from other vertebrates and in</text>
  </TERM>
  <TERM end="204" id="V3749241" paragraph="paragraph40" rule="-SIMPLE-REF" start="186" uttnum="214">
    <type>ONT::VERTEBRATE</type>
    <name>VERTEBRATES</name>
    <text>other vertebrates</text>
  </TERM>
  <TERM end="263" id="V3749430" paragraph="paragraph40" rule="-SIMPLE-REF" start="240" uttnum="214">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>1</pos>
      </site>
    </features>
    <name>S-1</name>
    <text>Supplementary Figure S1</text>
  </TERM>
  <TERM end="263" id="V3749410" paragraph="paragraph40" rule="-SIMPLE-REF" start="240" uttnum="214">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Supplementary Figure S1</text>
  </TERM>
  <TERM end="331" id="V3761264" paragraph="paragraph40" rule="-SIMPLE-REF" start="319" uttnum="215">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM dbid="FA:03087" end="302" id="V3761229" paragraph="paragraph40" rule="-SIMPLE-REF" start="298" uttnum="215">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="326" id="V3761255" paragraph="paragraph40" rule="-SIMPLE-REF" start="323" uttnum="215">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="350" id="V3761288" paragraph="paragraph40" rule="-SIMPLE-REF" start="334" uttnum="215">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>multiple sites,</text>
  </TERM>
  <TERM end="381" id="V3761342" paragraph="paragraph40" rule="-SIMPLE-REF" start="355" uttnum="215">
    <type>ONT::PHYSICAL-PHENOMENON</type>
    <name>MUTAGENESIS</name>
    <text>site-directed mutagenesis</text>
  </TERM>
  <TERM end="369" id="V3761307" paragraph="paragraph40" rule="-SIMPLE-REF" start="355" uttnum="215">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>site-directed</text>
  </TERM>
  <EVENT end="440" id="V3761391" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-LOC7-GD-NONE" start="397" uttnum="215">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="440" id="V3761391" start="397">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the initial phosphorylation was at Thr</text>
    </predicate>
    <site end="440" id="V3761431" start="432">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>the initial phosphorylation was at Thr</text>
  </EVENT>
  <TERM end="440" id="V3761431" paragraph="paragraph40" rule="-SIMPLE-REF" start="432" uttnum="215">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="471" id="V3761473" paragraph="paragraph40" rule="-SIMPLE-REF" start="463" uttnum="215">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="501" id="V3761501" paragraph="paragraph40" rule="-SIMPLE-REF" start="493" uttnum="215">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="518" id="V3761510" paragraph="paragraph40" rule="-SIMPLE-REF" start="512" uttnum="215">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>human</text>
  </TERM>
  <TERM end="529" id="V3761527" paragraph="paragraph40" rule="-SIMPLE-REF" start="521" uttnum="215">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>residue</text>
  </TERM>
  <TERM end="572" id="V3761614" paragraph="paragraph40" rule="-SIMPLE-REF" start="548" uttnum="215">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>the equivalent residues</text>
  </TERM>
  <TERM end="584" id="V3761636" paragraph="paragraph40" rule="-SIMPLE-REF" start="576" uttnum="215">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="548" id="V3761599" paragraph="paragraph40" rule="-SIMPLE-REF" start="543" uttnum="215">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rats</text>
  </TERM>
  <TERM end="603" id="V3761647" paragraph="paragraph40" rule="-SIMPLE-REF" start="595" uttnum="215">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="625" id="V3761665" paragraph="paragraph40" rule="-SIMPLE-REF" start="617" uttnum="215">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="645" id="V3771634" paragraph="paragraph40" rule="-SIMPLE-REF" start="637" uttnum="216">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="707" id="V3771693" paragraph="paragraph40" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="687" uttnum="216">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="707" id="V3771693" start="687">
      <type>ONT::INHIBIT</type>
      <text>inhibit net Thr</text>
    </predicate>
    <arg2 id="V3771711" role=":AFFECTED"/>
    <text>inhibit net Thr</text>
  </EVENT>
  <TERM end="707" id="V3771711" paragraph="paragraph40" rule="-SIMPLE-REF" start="695" uttnum="216">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>net Thr</text>
  </TERM>
  <TERM dbid="UP:P54762" end="699" id="V3771704" paragraph="paragraph40" rule="-SIMPLE-REF" start="695" uttnum="216">
    <type>ONT::PROTEIN</type>
    <name>NET</name>
    <text>net</text>
  </TERM>
  <EVENT end="800" id="V3771717" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-AGENT" start="717" uttnum="216">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="800" id="V3771717" start="717">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation by enhancing its sensitivity to dephosphorylation [31]</text>
    </predicate>
    <arg1 id="V3771745" role=":AGENT"/>
    <text>phosphorylation by enhancing its sensitivity to dephosphorylation [31]</text>
  </EVENT>
  <EVENT end="800" id="V3771745" paragraph="paragraph40" rule="-RULE30_AGENT_FORMAL-NONE" start="733" uttnum="216">
    <type>ONT::STIMULATE</type>
    <predicate end="800" id="V3771745" start="733">
      <type>ONT::STIMULATE</type>
      <text>by enhancing its sensitivity to dephosphorylation [31]</text>
    </predicate>
    <text>by enhancing its sensitivity to dephosphorylation [31]</text>
  </EVENT>
  <TERM dbid="GO:0016311" end="800" id="V3771788" paragraph="paragraph40" rule="-SIMPLE-REF" start="765" uttnum="216">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>DEPHOSPHORYLATION</name>
    <text>dephosphorylation [31]</text>
  </TERM>
  <EVENT end="848" id="V3785862" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-AGENT" start="824" uttnum="217">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="848" id="V3785862" start="824">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation by GSK3</text>
    </predicate>
    <arg1 id="V3785896" role=":AGENT"/>
    <text>phosphorylation by GSK3</text>
  </EVENT>
  <TERM end="822" id="V3785855" paragraph="paragraph40" rule="-SIMPLE-REF" start="807" uttnum="217">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATES</name>
    <text>most substrates</text>
  </TERM>
  <TERM dbid="FA:03087" end="848" id="V3785896" paragraph="paragraph40" rule="-SIMPLE-REF" start="840" uttnum="217">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">by GSK3</text>
  </TERM>
  <TERM dbid="GO:0016301" end="884" id="V3785951" paragraph="paragraph40" rule="-SIMPLE-REF" start="870" uttnum="217">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>another kinase</text>
  </TERM>
  <EVENT end="1041" id="V3803084" paragraph="paragraph40" rule="-RULE20C_AGENT_AFFECTED-LOC9-AFFECTED" start="886" uttnum="217">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1041" id="V3803084" start="886">
      <type>ONT::BIND</type>
      <text>because the kinase usually phosphorylates a serine or threonine residue located four residues N-terminal to an existing phosphoamino acid [44]</text>
    </predicate>
    <arg2 id="V3803100" role=":AFFECTED"/>
    <site end="991" id="V3803094" start="966">
      <type>ONT::RESIDUE</type>
      <text normalization="">four residues N-terminal</text>
    </site>
    <text>because the kinase usually phosphorylates a serine or threonine residue located four residues N-terminal to an existing phosphoamino acid [44]</text>
  </EVENT>
  <TERM end="991" id="V3803100" paragraph="paragraph40" rule="-SIMPLE-REF" start="966" uttnum="217">
    <type>ONT::TERMINUS</type>
    <name>N-TERMINAL</name>
    <text>four residues N-terminal</text>
  </TERM>
  <EVENT end="958" id="V3803012" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-LOC9" start="894" uttnum="217">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="958" id="V3803012" start="894">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the kinase usually phosphorylates a serine or threonine residue</text>
    </predicate>
    <arg1 id="V3803001" role=":AGENT"/>
    <arg2 id="V3803073" role=":AFFECTED"/>
    <arg id="R000107" role=":RESULT"/>
    <site end="950" id="V3803061" start="930">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">serine or threonine</text>
    </site>
    <text>the kinase usually phosphorylates a serine or threonine residue</text>
  </EVENT>
  <TERM dbid="GO:0016301" end="905" id="V3803001" paragraph="paragraph40" rule="-SIMPLE-REF" start="894" uttnum="217">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>the kinase</text>
  </TERM>
  <TERM end="958" id="V3803073" paragraph="paragraph40" rule="-SIMPLE-REF" start="928" uttnum="217">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>a serine or threonine residue</text>
    <not-features>
      <ptm event="V3803012" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="950" id="V3803061" paragraph="paragraph40" rule="-LOGICALOP-REF" start="930" uttnum="217">
    <type>ONT::AMINO-ACID</type>
    <aggregate operator="OR">
      <member id="V3803058"/>
      <member id="V3803070"/>
    </aggregate>
    <text normalization="">serine or threonine</text>
  </TERM>
  <TERM end="937" id="V3803058" paragraph="paragraph40" rule="-SIMPLE-REF" start="930" uttnum="217">
    <type>ONT::AMINO-ACID</type>
    <name>SERINE</name>
    <text>serine</text>
  </TERM>
  <TERM end="950" id="V3803070" paragraph="paragraph40" rule="-SIMPLE-REF" start="940" uttnum="217">
    <type>ONT::AMINO-ACID</type>
    <name>THREONINE</name>
    <text>threonine</text>
  </TERM>
  <TERM end="991" id="V3803094" paragraph="paragraph40" rule="-SIMPLE-REF" start="966" uttnum="217">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>four residues N-terminal</text>
  </TERM>
  <TERM end="1041" id="V3803185" paragraph="paragraph40" rule="-SIMPLE-REF" start="994" uttnum="217">
    <type>ONT::LIQUID-SUBSTANCE</type>
    <name>ACID</name>
    <text>an existing phosphoamino acid [44]</text>
  </TERM>
  <TERM dbid="CHEBI:46882" end="1019" id="V3803176" paragraph="paragraph40" rule="-SIMPLE-REF" start="1013" uttnum="217">
    <type>ONT::MOLECULE</type>
    <name>AMINO</name>
    <text>amino</text>
  </TERM>
  <CC end="1041" id="X3815969" paragraph="paragraph40" rule="-REASON" start="886" uttnum="217">
    <type>ONT::CAUSE</type>
    <arg id="V3803012" role=":FACTOR"/>
    <arg id="V3803084" role=":OUTCOME"/>
    <text>because the kinase usually phosphorylates a serine or threonine residue located four residues N-terminal to an existing phosphoamino acid [44]</text>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1063" id="V3816215" paragraph="paragraph40" rule="-SIMPLE-REF" start="1058" uttnum="218">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <EVENT end="1111" id="V3816261" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="1079" uttnum="218">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1111" id="V3816261" start="1079">
      <type>ONT::PHOSPHORYLATION</type>
      <text>that phosphorylation of Ser</text>
    </predicate>
    <site end="1111" id="V3816273" start="1103">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>that phosphorylation of Ser</text>
  </EVENT>
  <TERM end="1111" id="V3816273" paragraph="paragraph40" rule="-SIMPLE-REF" start="1103" uttnum="218">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="1177" id="V3816354" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="1150" uttnum="218">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1177" id="V3816354" start="1150">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of Thr</text>
    </predicate>
    <site end="1177" id="V3816366" start="1169">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>phosphorylation of Thr</text>
  </EVENT>
  <TERM end="1136" id="V3816306" paragraph="paragraph40" rule="-SIMPLE-REF" start="1124" uttnum="218">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>RAT</name>
    <text>rat AMPK-α1</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1132" id="V3816311" paragraph="paragraph40" rule="-SIMPLE-REF" start="1128" uttnum="218">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM end="1177" id="V3816366" paragraph="paragraph40" rule="-SIMPLE-REF" start="1169" uttnum="218">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="1253" id="V3829850" paragraph="paragraph40" rule="-SIMPLE-REF" start="1233" uttnum="218">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>the residue spacing</text>
  </TERM>
  <EVENT end="1388" id="V3839751" paragraph="paragraph40" rule="-RULE10_AGENT_AFFECTED" start="1285" uttnum="218">
    <type>ONT::MODULATE</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <predicate end="1388" id="V3839751" start="1285">
      <type>ONT::MODULATE</type>
      <text>phosphorylation was not affected by a GSK3β mutation that reduces phosphorylation of primed substrates</text>
    </predicate>
    <arg2 id="V3839714" role=":AFFECTED"/>
    <text>phosphorylation was not affected by a GSK3β mutation that reduces phosphorylation of primed substrates</text>
  </EVENT>
  <EVENT end="1301" id="V3839714" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-NONE" start="1285" uttnum="218">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1301" id="V3839714" start="1285">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation</text>
    </predicate>
    <text>phosphorylation</text>
  </EVENT>
  <EVENT end="1388" id="V3839857" paragraph="paragraph40" rule="-RULE20_AGENT_AFFECTED" start="1318" uttnum="218">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="1388" id="V3839857" start="1318">
      <type>ONT::DECREASE</type>
      <text>by a GSK3β mutation that reduces phosphorylation of primed substrates</text>
    </predicate>
    <arg2 id="V3839864" role=":AFFECTED"/>
    <text>by a GSK3β mutation that reduces phosphorylation of primed substrates</text>
  </EVENT>
  <TERM dbid="FA:03087" end="1327" id="V3839826" paragraph="paragraph40" rule="-SIMPLE-REF" start="1323" uttnum="218">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <EVENT end="1367" id="V3839864" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-NONE" start="1351" uttnum="218">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1367" id="V3839864" start="1351">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation</text>
    </predicate>
    <text>phosphorylation</text>
  </EVENT>
  <TERM end="1388" id="V3839887" paragraph="paragraph40" rule="-SIMPLE-REF" start="1370" uttnum="218">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATES</name>
    <text>primed substrates</text>
  </TERM>
  <TERM end="1460" id="V3852905" paragraph="paragraph40" rule="-SIMPLE-REF" start="1410" uttnum="219">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>the hypothesis by Suzuki et al. [31]</text>
  </TERM>
  <EVENT end="1548" id="V3863055" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="1472" uttnum="219">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1548" id="V3863055" start="1472">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of Ser487 may lead to additional phosphorylation</text>
    </predicate>
    <site end="1499" id="V3863067" start="1491">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>phosphorylation of Ser487 may lead to additional phosphorylation</text>
  </EVENT>
  <TERM end="1499" id="V3863067" paragraph="paragraph40" rule="-SIMPLE-REF" start="1491" uttnum="219">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="1548" id="V3863132" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="1488" uttnum="219">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1548" id="V3863132" start="1488">
      <type>ONT::PHOSPHORYLATION</type>
      <text>of Ser487 may lead to additional phosphorylation</text>
    </predicate>
    <site end="1499" id="V3863067" start="1491">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser</text>
    </site>
    <text>of Ser487 may lead to additional phosphorylation</text>
  </EVENT>
  <TERM end="1573" id="V3863167" paragraph="paragraph40" rule="-SIMPLE-REF" start="1562" uttnum="219">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="1569" id="V3863158" paragraph="paragraph40" rule="-SIMPLE-REF" start="1566" uttnum="219">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="1580" id="V3867355" paragraph="paragraph40" rule="-SIMPLE-REF" start="1575" uttnum="220">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>This</text>
  </TERM>
  <EPI end="1657" id="V3867381" paragraph="paragraph40" rule="-RULE50_0_AGENT_NEUTRAL" start="1594" uttnum="220">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg1 id="V3867376" role=":AGENT"/>
    <arg2 id="V3867434" role=":NEUTRAL"/>
    <text>why we observed a larger effect on AMPK activation and Thr</text>
  </EPI>
  <TERM end="1601" id="V3867376" paragraph="paragraph40" rule="-ROBUSTPRO" start="1598" uttnum="220">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="1657" id="V3867434" paragraph="paragraph40" rule="-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE10_AGENT_AFFECTED-NONE" start="1594" uttnum="220">
    <type>ONT::MODULATE</type>
    <epistemic-modality id="V3867381"/>
    <predicate end="1657" id="V3867434" start="1594">
      <type>ONT::MODULATE</type>
      <text>why we observed a larger effect on AMPK activation and Thr</text>
    </predicate>
    <text>why we observed a larger effect on AMPK activation and Thr</text>
  </EVENT>
  <EVENT end="1645" id="V3867475" paragraph="paragraph40" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1629" uttnum="220">
    <type>ONT::ACTIVATE</type>
    <predicate end="1645" id="V3867475" start="1629">
      <type>ONT::ACTIVATE</type>
      <text>AMPK activation</text>
    </predicate>
    <arg2 id="V3867472" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000272"/>
    <text>AMPK activation</text>
  </EVENT>
  <TERM end="1657" id="V3867492" paragraph="paragraph40" rule="-SIMPLE-REF" start="1649" uttnum="220">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1634" id="V3867472" paragraph="paragraph40" rule="-SIMPLE-REF" start="1629" uttnum="220">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="1720" id="V3867498" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-AGENT" start="1667" uttnum="220">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1720" id="V3867498" start="1667">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation by modulation of Akt in intact cells</text>
    </predicate>
    <arg1 id="V3867525" role=":AGENT"/>
    <text>phosphorylation by modulation of Akt in intact cells</text>
  </EVENT>
  <EVENT end="1720" id="V3867525" paragraph="paragraph40" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1683" uttnum="220">
    <type>ONT::MODULATE</type>
    <predicate end="1720" id="V3867525" start="1683">
      <type>ONT::MODULATE</type>
      <text>by modulation of Akt in intact cells</text>
    </predicate>
    <arg2 id="V3867537" role=":AFFECTED"/>
    <text>by modulation of Akt in intact cells</text>
  </EVENT>
  <TERM end="1720" id="V3867537" paragraph="paragraph40" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="1697" uttnum="220">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <location id="V3867597"/>
    </features>
    <name>AKT</name>
    <text normalization="">of Akt in intact cells</text>
  </TERM>
  <TERM end="1720" id="V3867597" paragraph="paragraph40" rule="-SIMPLE-REF" start="1707" uttnum="220">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>intact cells</text>
  </TERM>
  <TERM end="1744" id="V3867718" paragraph="paragraph40" rule="-SIMPLE-REF" start="1728" uttnum="220">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAYS</name>
    <text>cell-free assays</text>
  </TERM>
  <TERM end="1738" id="V3867662" paragraph="paragraph40" rule="-SIMPLE-REF" start="1728" uttnum="220">
    <type>ONT::DEVICE</type>
    <name>CELL</name>
    <text>cell-free</text>
  </TERM>
  <TERM end="1796" id="V3879845" paragraph="paragraph40" rule="-SIMPLE-REF" start="1760" uttnum="220">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figures 1 and 3</text>
  </TERM>
  <TERM end="1838" id="V3879883" paragraph="paragraph40" rule="-SIMPLE-REF" start="1796" uttnum="220">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>with Figures 4–6</text>
  </TERM>
  <TERM end="1886" id="V3888465" paragraph="paragraph40" rule="-SIMPLE-REF" start="1878" uttnum="221">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <EVENT end="1982" id="V3888584" paragraph="paragraph40" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="1894" uttnum="221">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <mods>
      <frequency>
        <type>ONT::FREQUENCY</type>
        <value>NORMALLY</value>
      </frequency>
    </mods>
    <predicate end="1982" id="V3888584" start="1894">
      <type>ONT::INHIBIT</type>
      <text>in response to Akt treatment and this normally inhibits GSK3 activity [45],</text>
    </predicate>
    <arg2 id="V3888599" role=":AFFECTED"/>
    <text>in response to Akt treatment and this normally inhibits GSK3 activity [45],</text>
  </EVENT>
  <EVENT end="1982" id="V3888599" paragraph="paragraph40" rule="-ACTIVITY1" start="1950" uttnum="221">
    <type>ONT::ACTIVITY</type>
    <predicate end="1982" id="V3888599" start="1950">
      <type>ONT::ACTIVITY</type>
      <text>GSK3 activity [45],</text>
    </predicate>
    <arg1 id="V3888596" role=":AGENT"/>
    <text>GSK3 activity [45],</text>
  </EVENT>
  <EVENT end="1923" id="V3888557" paragraph="paragraph40" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1909" uttnum="221">
    <type>ONT::MODULATE</type>
    <predicate end="1923" id="V3888557" start="1909">
      <type>ONT::MODULATE</type>
      <text>Akt treatment</text>
    </predicate>
    <arg2 id="V3888554" role=":AFFECTED"/>
    <text>Akt treatment</text>
  </EVENT>
  <TERM end="1932" id="V3888571" paragraph="paragraph40" rule="-SIMPLE-REF" start="1927" uttnum="221">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>this</text>
  </TERM>
  <TERM end="1913" id="V3888554" paragraph="paragraph40" rule="-SIMPLE-REF" start="1909" uttnum="221">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <TERM dbid="FA:03087" end="1955" id="V3888596" paragraph="paragraph40" rule="-SIMPLE-REF" start="1950" uttnum="221">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <TERM end="2059" id="V3903823" paragraph="paragraph40" rule="-SIMPLE-REF" start="2019" uttnum="221">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATES</name>
    <text>‘unprimed’ substrates [46]</text>
  </TERM>
  <TERM end="2083" id="V3903901" paragraph="paragraph40" rule="-SIMPLE-REF" start="2075" uttnum="221">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="2177" id="V3909311" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="2132" uttnum="222">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="2177" id="V3909311" start="2132">
      <type>ONT::PHOSPHORYLATION</type>
      <text>that phosphorylation of Ser487 in</text>
    </predicate>
    <site end="2177" id="V3909323" start="2156">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ser487 in</text>
    </site>
    <text>that phosphorylation of Ser487 in</text>
  </EVENT>
  <TERM end="2177" id="V3909323" paragraph="paragraph40" rule="-SIMPLE-REF" start="2156" uttnum="222">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser487 in</text>
  </TERM>
  <TERM end="2205" id="V3909399" paragraph="paragraph40" rule="-SIMPLE-REF" start="2177" uttnum="222">
    <type>ONT::PROCEDURE</type>
    <name>EXPERIMENT</name>
    <text>our intact cell experiments</text>
  </TERM>
  <EVENT end="2284" id="V3909466" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-LOC2-GD-AFFECTED" start="2214" uttnum="222">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="2284" id="V3909466" start="2214">
      <type>ONT::PHOSPHORYLATION</type>
      <text>additional phosphorylation events, such as phosphorylation of Thr</text>
    </predicate>
    <arg2 id="V3909412" role=":AFFECTED"/>
    <site end="2284" id="V3909478" start="2276">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>additional phosphorylation events, such as phosphorylation of Thr</text>
  </EVENT>
  <TERM end="2205" id="V3909391" paragraph="paragraph40" rule="-SIMPLE-REF" start="2177" uttnum="222">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>our intact cell experiments</text>
  </TERM>
  <TERM end="2205" id="V3909381" paragraph="paragraph40" rule="-ROBUSTPRO" start="2177" uttnum="222">
    <type>ONT::PERSON</type>
    <text>our intact cell experiments</text>
  </TERM>
  <EVENT end="2284" id="V3909412" paragraph="paragraph40" rule="-RULE60_AGENT_AFFECTED-LOC8-GD-NONE" start="2214" uttnum="222">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="2284" id="V3909412" start="2214">
      <type>ONT::PHOSPHORYLATION</type>
      <text>additional phosphorylation events, such as phosphorylation of Thr</text>
    </predicate>
    <site end="2284" id="V3909478" start="2276">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Thr</text>
    </site>
    <text>additional phosphorylation events, such as phosphorylation of Thr</text>
  </EVENT>
  <TERM end="2284" id="V3909478" paragraph="paragraph40" rule="-SIMPLE-REF" start="2276" uttnum="222">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM end="2306" id="V3909496" paragraph="paragraph40" rule="-SIMPLE-REF" start="2298" uttnum="222">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM dbid="FA:03087" end="2323" id="V3909533" paragraph="paragraph40" rule="-SIMPLE-REF" start="2319" uttnum="222">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>GSK-3</name>
    <text normalization="">GSK3</text>
  </TERM>
  <TERM end="42" id="V3921844" paragraph="paragraph41" rule="-ROBUSTPRO" start="39" uttnum="223">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="55" id="V3921859" paragraph="paragraph41" rule="-ROBUSTPRO" start="50" uttnum="223">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>that</text>
  </TERM>
  <TERM end="37" id="V3921836" paragraph="paragraph41" rule="-SIMPLE-REF" start="22" uttnum="223">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>this hypothesis</text>
  </TERM>
  <TERM end="95" id="V3921880" paragraph="paragraph41" rule="-SIMPLE-REF" start="55" uttnum="223">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>CHAIN</name>
    <text>the side chains of three basic residues</text>
  </TERM>
  <TERM end="95" id="V3921877" paragraph="paragraph41" rule="-SIMPLE-REF" start="55" uttnum="223">
    <type>ONT::OBJECT-DEPENDENT-LOCATION</type>
    <name>SIDE</name>
    <text>the side chains of three basic residues</text>
  </TERM>
  <TERM end="95" id="V3921904" paragraph="paragraph41" rule="-SIMPLE-REF" start="74" uttnum="223">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>three basic residues</text>
  </TERM>
  <TERM dbid="UP:Q96B36|HGNC:28426" end="137" id="V3922041" paragraph="paragraph41" rule="-SIMPLE-REF" start="122" uttnum="223">
    <type>ONT::GENE</type>
    <name>LOBE</name>
    <text>the small lobe</text>
  </TERM>
  <TERM end="158" id="V3922063" paragraph="paragraph41" rule="-SIMPLE-REF" start="140" uttnum="223">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the kinase domain</text>
  </TERM>
  <TERM dbid="GO:0016301" end="151" id="V3922060" paragraph="paragraph41" rule="-SIMPLE-REF" start="144" uttnum="223">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM dbid="UP:P42684" end="167" id="V3922071" paragraph="paragraph41" rule="-SIMPLE-REF" start="159" uttnum="223">
    <type>ONT::PROTEIN</type>
    <name>ARG</name>
    <text>Arg</text>
  </TERM>
  <TERM end="185" id="V3922082" paragraph="paragraph41" rule="-SIMPLE-REF" start="177" uttnum="223">
    <type>ONT::AMINO-ACID</type>
    <name>LYS</name>
    <text>Lys</text>
  </TERM>
  <TERM dbid="UP:P42684" end="218" id="V3922100" paragraph="paragraph41" rule="-SIMPLE-REF" start="198" uttnum="223">
    <type>ONT::PROTEIN</type>
    <name>ARG</name>
    <text>Arg74 in</text>
  </TERM>
  <TERM dbid="CHEBI:26078|CHEBI:35780|CHEBI:18367|CHEBI:43474|CHEBI:26020" end="261" id="V3922206" paragraph="paragraph41" rule="-SIMPLE-REF" start="251" uttnum="223">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHATE</name>
    <text>phosphate</text>
  </TERM>
  <TERM end="292" id="V3922287" paragraph="paragraph41" rule="-SIMPLE-REF" start="280" uttnum="223">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop,</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="287" id="V3922278" paragraph="paragraph41" rule="-SIMPLE-REF" start="284" uttnum="223">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="320" id="V3935421" paragraph="paragraph41" rule="-SIMPLE-REF" start="308" uttnum="223">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM end="341" id="V3935460" paragraph="paragraph41" rule="-SIMPLE-REF" start="320" uttnum="223">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>to the kinase domain</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="315" id="V3935412" paragraph="paragraph41" rule="-SIMPLE-REF" start="312" uttnum="223">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM dbid="GO:0016301" end="334" id="V3935457" paragraph="paragraph41" rule="-SIMPLE-REF" start="327" uttnum="223">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="372" id="V3935495" paragraph="paragraph41" rule="-SIMPLE-REF" start="364" uttnum="223">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <TERM dbid="GO:0016301" end="401" id="V3935535" paragraph="paragraph41" rule="-SIMPLE-REF" start="385" uttnum="223">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>upstream kinases</text>
  </TERM>
  <TERM dbid="GO:0016301" end="449" id="V3949696" paragraph="paragraph41" rule="-SIMPLE-REF" start="440" uttnum="224">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>of these</text>
  </TERM>
  <TERM dbid="UP:P42684" end="458" id="V3949705" paragraph="paragraph41" rule="-SIMPLE-REF" start="450" uttnum="224">
    <type>ONT::PROTEIN</type>
    <name>ARG</name>
    <text>Arg</text>
  </TERM>
  <TERM end="478" id="V3949720" paragraph="paragraph41" rule="-SIMPLE-REF" start="470" uttnum="224">
    <type>ONT::AMINO-ACID</type>
    <name>LYS</name>
    <text>Lys</text>
  </TERM>
  <TERM dbid="GO:0016301" end="532" id="V3949900" paragraph="paragraph41" rule="-SIMPLE-REF" start="504" uttnum="224">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>all 12 AMPK-related kinases,</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="524" id="V3949875" paragraph="paragraph41" rule="-SIMPLE-REF" start="511" uttnum="224">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK-related</text>
  </TERM>
  <TERM end="607" id="V3963448" paragraph="paragraph41" rule="-SIMPLE-REF" start="555" uttnum="224">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the archetypal serine/threonine kinase domain of PKA</text>
  </TERM>
  <TERM dbid="GO:0016301" end="607" id="V3963445" paragraph="paragraph41" rule="-SIMPLE-REF" start="555" uttnum="224">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>the archetypal serine/threonine kinase domain of PKA</text>
  </TERM>
  <TERM end="587" id="V3963473" paragraph="paragraph41" rule="-EXPLICIT-REF-SEQ0B" start="570" uttnum="224">
    <type>ONT::AMINO-ACID</type>
    <components>
      <component id="V3963310"/>
      <component id="V3963318"/>
    </components>
    <text normalization="">serine/threonine</text>
  </TERM>
  <TERM end="587" id="V3963310" paragraph="paragraph41" rule="-EXPLICIT-REF-SEQ0B-TERM" start="570" uttnum="224">
    <type>ONT::AMINO-ACID</type>
    <name>SERINE</name>
    <text>serine/threonine</text>
  </TERM>
  <TERM end="587" id="V3963318" paragraph="paragraph41" rule="-SIMPLE-REF" start="577" uttnum="224">
    <type>ONT::AMINO-ACID</type>
    <name>THREONINE</name>
    <text>threonine</text>
  </TERM>
  <TERM end="641" id="V3979487" paragraph="paragraph41" rule="-SIMPLE-REF" start="620" uttnum="225">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>with our hypothesis,</text>
  </TERM>
  <TERM end="641" id="V3979483" paragraph="paragraph41" rule="-ROBUSTPRO" start="620" uttnum="225">
    <type>ONT::PERSON</type>
    <text>with our hypothesis,</text>
  </TERM>
  <TERM end="649" id="V3979535" paragraph="paragraph41" rule="-SIMPLE-REF" start="641" uttnum="225">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>a human</text>
  </TERM>
  <TERM end="664" id="V3979579" paragraph="paragraph41" rule="-SIMPLE-REF" start="656" uttnum="225">
    <type>ONT::FACILITY</type>
    <name>COMPLEX</name>
    <text>complex</text>
  </TERM>
  <TERM end="708" id="V3979870" paragraph="paragraph41" rule="-EXPLICIT-REF-SEQ0B" start="694" uttnum="225">
    <type>ONT::MUTATION</type>
    <components>
      <component id="V3978846"/>
      <component id="V3978708"/>
      <component id="V3978777"/>
    </components>
    <text normalization="">R64A/K71A/K74A</text>
  </TERM>
  <TERM dbid="XFAM:PF00004.26" end="684" id="V3979602" paragraph="paragraph41" rule="-SIMPLE-REF" start="675" uttnum="225">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>AAA</name>
    <text>an ‘AAA’</text>
  </TERM>
  <TERM end="698" id="V3978708" paragraph="paragraph41" rule="-SIMPLE-REF" start="694" uttnum="225">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>64</pos>
      <aa-from>
        <aa>
          <name>Arginine</name>
          <code>R</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">R64A</text>
  </TERM>
  <TERM end="703" id="V3978777" paragraph="paragraph41" rule="-SIMPLE-REF" start="699" uttnum="225">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>71</pos>
      <aa-from>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">K71A</text>
  </TERM>
  <TERM end="708" id="V3978846" paragraph="paragraph41" rule="-EXPLICIT-REF-SEQ0B-TERM" start="694" uttnum="225">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>74</pos>
      <aa-from>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">R64A/K71A/K74A</text>
  </TERM>
  <TERM end="782" id="V3979683" paragraph="paragraph41" rule="-SIMPLE-REF" start="738" uttnum="225">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ABILITY</name>
    <text>the ability of previous Akt phosphorylation</text>
  </TERM>
  <EVENT end="782" id="V3979718" paragraph="paragraph41" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="750" uttnum="225">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="782" id="V3979718" start="750">
      <type>ONT::PHOSPHORYLATION</type>
      <text>of previous Akt phosphorylation</text>
    </predicate>
    <arg2 id="V3979715" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000112"/>
    <text>of previous Akt phosphorylation</text>
  </EVENT>
  <TERM end="766" id="V3979715" paragraph="paragraph41" rule="-SIMPLE-REF" start="762" uttnum="225">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3979718"/>
    </not-features>
  </TERM>
  <TERM end="812" id="V3979779" paragraph="paragraph41" rule="-SIMPLE-REF" start="804" uttnum="225">
    <type>ONT::AMINO-ACID</type>
    <name>THR</name>
    <text>Thr</text>
  </TERM>
  <EVENT end="870" id="V3979785" paragraph="paragraph41" rule="-RULE60_AGENT_AFFECTED-AGENT" start="822" uttnum="225">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="870" id="V3979785" start="822">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation by LKB1 (Figure 7D)</text>
    </predicate>
    <arg1 id="V3979819" role=":AGENT"/>
    <text>phosphorylation by LKB1 (Figure 7D)</text>
  </EVENT>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="870" id="V3979819" paragraph="paragraph41" rule="-SIMPLE-REF" start="838" uttnum="225">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>by LKB1 (Figure 7D)</text>
  </TERM>
  <TERM end="869" id="V3979854" paragraph="paragraph41" rule="-SIMPLE-REF" start="853" uttnum="225">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>Figure 7D</text>
  </TERM>
  <TERM end="869" id="V3979829" paragraph="paragraph41" rule="-SIMPLE-REF" start="853" uttnum="225">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure 7D</text>
  </TERM>
  <TERM end="920" id="V3991303" paragraph="paragraph41" rule="-SIMPLE-REF" start="908" uttnum="226">
    <type>ONT::CLINICAL-FINDING</type>
    <name>FINDING</name>
    <text>our finding</text>
  </TERM>
  <TERM end="920" id="V3991300" paragraph="paragraph41" rule="-ROBUSTPRO" start="908" uttnum="226">
    <type>ONT::PERSON</type>
    <text>our finding</text>
  </TERM>
  <EVENT end="995" id="V3991352" paragraph="paragraph41" rule="-RULE20_AGENT_AFFECTED" start="920" uttnum="226">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="995" id="V3991352" start="920">
      <type>ONT::DECREASE</type>
      <text>that prior Akt phosphorylation reduced activation by both upstream kinases</text>
    </predicate>
    <arg1 id="V3991346" role=":AGENT"/>
    <arg2 id="V3991358" role=":AFFECTED"/>
    <text>that prior Akt phosphorylation reduced activation by both upstream kinases</text>
  </EVENT>
  <EVENT end="951" id="V3991346" paragraph="paragraph41" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="920" uttnum="226">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="951" id="V3991346" start="920">
      <type>ONT::PHOSPHORYLATION</type>
      <text>that prior Akt phosphorylation</text>
    </predicate>
    <arg2 id="V3991343" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000117"/>
    <text>that prior Akt phosphorylation</text>
  </EVENT>
  <EVENT end="970" id="V3991358" paragraph="paragraph41" rule="-RULE40A_AGENT_AFFECTED-NONE" start="959" uttnum="226">
    <type>ONT::ACTIVATE</type>
    <predicate end="970" id="V3991358" start="959">
      <type>ONT::ACTIVATE</type>
      <text>activation</text>
    </predicate>
    <text>activation</text>
  </EVENT>
  <TERM end="935" id="V3991343" paragraph="paragraph41" rule="-SIMPLE-REF" start="925" uttnum="226">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">prior Akt</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3991346"/>
    </not-features>
  </TERM>
  <TERM dbid="GO:0016301" end="995" id="V3991404" paragraph="paragraph41" rule="-SIMPLE-REF" start="973" uttnum="226">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>both upstream kinases</text>
  </TERM>
  <TERM end="1010" id="V3991427" paragraph="paragraph41" rule="-LOGICALOP-REF" start="996" uttnum="226">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V3991423"/>
      <member id="V3991448"/>
    </aggregate>
    <text normalization="">LKB1 and CaMKK</text>
  </TERM>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="1001" id="V3991423" paragraph="paragraph41" rule="-SIMPLE-REF" start="996" uttnum="226">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>LKB1</text>
  </TERM>
  <TERM dbid="UP:Q96RR4|HGNC:1470" end="1010" id="V3991448" paragraph="paragraph41" rule="-SIMPLE-REF" start="1005" uttnum="226">
    <type>ONT::GENE</type>
    <name>CAMKK</name>
    <text>CaMKK</text>
  </TERM>
  <TERM end="1051" id="V3991508" paragraph="paragraph41" rule="-SIMPLE-REF" start="1044" uttnum="226">
    <type>ONT::SHAPE-OBJECT</type>
    <name>FIGURE</name>
    <text>Figure</text>
  </TERM>
  <TERM end="1096" id="V4004977" paragraph="paragraph41" rule="-SIMPLE-REF" start="1063" uttnum="227">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CONFIRMATION</name>
    <text>Final confirmation of this model</text>
  </TERM>
  <EPI end="1202" id="V4005035" paragraph="paragraph41" rule="-RULE50_0_AGENT_FORMAL-NONE" start="1109" uttnum="227">
    <type>ONT::TEST</type>
    <arg2 id="V4005054" role=":NEUTRAL"/>
    <text>structural analysis of AMPK complexes where the ST loop is present in a phosphorylated form,</text>
  </EPI>
  <TERM end="1147" id="V4005054" paragraph="paragraph41" rule="-EXPLICIT-REF-SEQ0" start="1129" uttnum="227">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <components>
      <component id="V4005047"/>
    </components>
    <text normalization="">of AMPK complexes</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1147" id="V4005047" paragraph="paragraph41" rule="-EXPLICIT-REF-SEQ0-TERM" start="1129" uttnum="227">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK complexes</text>
  </TERM>
  <TERM end="1165" id="V4005087" paragraph="paragraph41" rule="-SIMPLE-REF" start="1153" uttnum="227">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the ST loop</text>
  </TERM>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="1160" id="V4005078" paragraph="paragraph41" rule="-SIMPLE-REF" start="1157" uttnum="227">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
  </TERM>
  <TERM end="1202" id="V4005225" paragraph="paragraph41" rule="-SIMPLE-REF" start="1179" uttnum="227">
    <type>ONT::SHAPE</type>
    <name>FORM</name>
    <text>a phosphorylated form,</text>
  </TERM>
  <TERM end="1274" id="V4005371" paragraph="paragraph41" rule="-SIMPLE-REF" start="1254" uttnum="227">
    <type>ONT::GENERAL-STRUCTURE</type>
    <name>STRUCTURE</name>
    <text>existing structures</text>
  </TERM>
  <TERM end="52" id="V4018432" paragraph="paragraph42" rule="-LOGICALOP-REF" start="9" uttnum="228">
    <type>ONT::MOLECULE</type>
    <aggregate operator="OR">
      <member id="V4018429"/>
      <member id="V4018441"/>
    </aggregate>
    <text normalization="">AMPK activators such as AICAR or metformin</text>
  </TERM>
  <TERM dbid="CHEBI:2030|CHEBI:28498|CHEBI:18406" end="39" id="V4018429" paragraph="paragraph42" rule="-SIMPLE-REF" start="9" uttnum="228">
    <type>ONT::MOLECULE</type>
    <name>AICAR</name>
    <text>AMPK activators such as AICAR</text>
  </TERM>
  <TERM dbid="CHEBI:6801" end="52" id="V4018441" paragraph="paragraph42" rule="-SIMPLE-REF" start="42" uttnum="228">
    <type>ONT::MOLECULE</type>
    <name>METFORMIN</name>
    <text>metformin</text>
  </TERM>
  <TERM dbid="CHEBI:85053" end="33" id="V4018379" paragraph="paragraph42" rule="-SIMPLE-REF" start="9" uttnum="228">
    <type>ONT::CHEMICAL</type>
    <name>AMPK-ACTIVATORS</name>
    <text>AMPK activators such as</text>
  </TERM>
  <TERM end="99" id="V4018488" paragraph="paragraph42" rule="-SIMPLE-REF" start="91" uttnum="228">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser</text>
  </TERM>
  <TERM end="182" id="V4018589" paragraph="paragraph42" rule="-SIMPLE-REF" start="140" uttnum="228">
    <type>ONT::HARMFUL-AGENCY</type>
    <name>VIRUS</name>
    <text>of the hepatitis C virus [30]</text>
  </TERM>
  <TERM end="204" id="V4028559" paragraph="paragraph42" rule="-SIMPLE-REF" start="184" uttnum="228">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>our present results</text>
  </TERM>
  <TERM end="204" id="V4028537" paragraph="paragraph42" rule="-ROBUSTPRO" start="184" uttnum="228">
    <type>ONT::PERSON</type>
    <text>our present results</text>
  </TERM>
  <TERM dbid="CHEBI:6801" end="271" id="V4028685" paragraph="paragraph42" rule="-SIMPLE-REF" start="232" uttnum="228">
    <type>ONT::MOLECULE</type>
    <name>METFORMIN</name>
    <text>that AMPK activators such as metformin,</text>
  </TERM>
  <TERM end="261" id="V4028630" paragraph="paragraph42" rule="-SIMPLE-REF" start="237" uttnum="228">
    <type>ONT::SUBSTANCE</type>
    <name>ACTIVATORS</name>
    <text>AMPK activators such as</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="242" id="V4028625" paragraph="paragraph42" rule="-SIMPLE-REF" start="237" uttnum="228">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
  </TERM>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="320" id="V4041530" paragraph="paragraph42" rule="-SIMPLE-REF" start="272" uttnum="228">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>which are already used to treat Type 2 diabetes,</text>
  </TERM>
  <TERM end="396" id="V4045430" paragraph="paragraph42" rule="-EXPLICIT-REF-SEQ0" start="380" uttnum="228">
    <type>ONT::SIGNALING-PATHWAY</type>
    <components>
      <component id="V4045427"/>
    </components>
    <text normalization="">the Akt pathway</text>
  </TERM>
  <EVENT end="413" id="V4045461" paragraph="paragraph42" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="380" uttnum="228">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <mods>
      <degree>
        <type>ONT::DEGREE-MODIFIER-HIGH</type>
        <value>HYPER-</value>
      </degree>
    </mods>
    <predicate end="413" id="V4045461" start="380">
      <type>ONT::ACTIVATE</type>
      <text>the Akt pathway is hyperactivated</text>
    </predicate>
    <arg2 id="V4045430" role=":AFFECTED"/>
    <text>the Akt pathway is hyperactivated</text>
  </EVENT>
  <TERM end="396" id="V4045427" paragraph="paragraph42" rule="-EXPLICIT-REF-SEQ0-TERM" start="380" uttnum="228">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">the Akt pathway</text>
  </TERM>
  <TERM end="418" id="V4060023" paragraph="paragraph42" rule="-SIMPLE-REF" start="415" uttnum="229">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>It</text>
  </TERM>
  <TERM end="542" id="V4060093" paragraph="paragraph42" rule="-SIMPLE-REF" start="440" uttnum="229">
    <type>ONT::MENTAL-OBJECT</type>
    <name>STUDIES</name>
    <text>retrospective studies that treatment of diabetics with metformin is associated with a lower incidence</text>
  </TERM>
  <TERM end="505" id="V4060142" paragraph="paragraph42" rule="-SIMPLE-REF" start="477" uttnum="229">
    <type>ONT::PERSON</type>
    <name>DIABETICS</name>
    <text>of diabetics with metformin</text>
  </TERM>
  <TERM dbid="CHEBI:6801" end="505" id="V4060158" paragraph="paragraph42" rule="-SIMPLE-REF" start="495" uttnum="229">
    <type>ONT::MOLECULE</type>
    <name>METFORMIN</name>
    <text>metformin</text>
  </TERM>
  <TERM end="583" id="V4060294" paragraph="paragraph42" rule="-SIMPLE-REF" start="561" uttnum="229">
    <type>ONT::MEDICATION</type>
    <name>MEDICATION</name>
    <text>with other medications</text>
  </TERM>
  <TERM end="631" id="V4072806" paragraph="paragraph42" rule="-SIMPLE-REF" start="628" uttnum="229">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>it</text>
  </TERM>
  <EVENT end="686" id="V4072910" paragraph="paragraph42" rule="-RULE10_AGENT_AFFECTED" start="650" uttnum="229">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="686" id="V4072910" start="650">
      <type>ONT::MODULATE</type>
      <text>that this effect is mediated by AMPK</text>
    </predicate>
    <arg1 id="V4072939" role=":AGENT"/>
    <arg2 id="V4072880" role=":AFFECTED"/>
    <text>that this effect is mediated by AMPK</text>
  </EVENT>
  <EVENT end="667" id="V4072880" paragraph="paragraph42" rule="-RULE10_AGENT_AFFECTED-NONE" start="655" uttnum="229">
    <type>ONT::MODULATE</type>
    <predicate end="667" id="V4072880" start="655">
      <type>ONT::MODULATE</type>
      <text>this effect</text>
    </predicate>
    <text>this effect</text>
  </EVENT>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="686" id="V4072939" paragraph="paragraph42" rule="-SIMPLE-REF" start="679" uttnum="229">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>by AMPK</text>
  </TERM>
  <TERM end="700" id="V4088239" paragraph="paragraph42" rule="-SIMPLE-REF" start="688" uttnum="230">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>Our results</text>
  </TERM>
  <TERM end="700" id="V4088232" paragraph="paragraph42" rule="-ROBUSTPRO" start="688" uttnum="230">
    <type>ONT::PERSON</type>
    <text>Our results</text>
  </TERM>
  <EPI end="784" id="V4088342" paragraph="paragraph42" rule="-RULE50_0_AGENT_FORMAL-NONE" start="729" uttnum="230">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <text>to test the efficacy of metformin for cancer treatment</text>
  </EPI>
  <TERM dbid="CHEBI:6801" end="763" id="V4088371" paragraph="paragraph42" rule="-SIMPLE-REF" start="750" uttnum="230">
    <type>ONT::MOLECULE</type>
    <name>METFORMIN</name>
    <text>of metformin</text>
  </TERM>
  <TERM end="860" id="V4088587" paragraph="paragraph42" rule="-SIMPLE-REF" start="856" uttnum="230">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
  </TERM>
  <EVENT end="1514" rule="EKR:LocateTerm" start="1491" refid="V154779" paragraph="paragraph1" id="R000001" uttnum="8">
    <text>of Akt in tumour cells </text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V154779"/>
    <location id="V154840"/>
  </EVENT>
  <EVENT id="R000002" uttnum="123" refid="V1921230" start="455" paragraph="paragraph18" rule="EKR:LocateTerm" end="513">
    <type>ONT::LOCALIZATION</type>
    <text>rat liver AMPK (a mixture of α1β1γ1 and α2β1γ1 complexes) </text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V1921230" role=":NEUTRAL"/>
    <location id="V1921219"/>
  </EVENT>
  <EVENT id="R000003" uttnum="147" end="78" rule="EKR:LocateTerm" start="38" refid="V2404656" paragraph="paragraph25">
    <type>ONT::LOCALIZATION</type>
    <text>of Akt in tumour cells due to PTEN loss </text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V2404656" role=":NEUTRAL"/>
    <location id="V2404717"/>
  </EVENT>
  <EVENT refid="V2552190" start="3" paragraph="paragraph26" rule="EKR:LocateTerm" end="28" uttnum="153" id="R000004">
    <text>AMPK in DBTRG-05MG cells </text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V2552190"/>
    <location id="V2552280"/>
  </EVENT>
  <EVENT end="1720" rule="EKR:LocateTerm" start="1697" refid="V3867537" paragraph="paragraph40" uttnum="220" id="R000005">
    <text>of Akt in intact cells </text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V3867537" role=":NEUTRAL"/>
    <location id="V3867597"/>
  </EVENT>
  <TERM dbid="CHEBI:16670" end="657" paragraph="paragraph13" start="648" uttnum="89" id="R000006" refid="V1279769" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>P-peptide</text>
    <not-features>
      <ptm event="V1279749" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM dbid="CHEBI:16670" end="682" paragraph="paragraph13" start="673" uttnum="89" id="R000007" refid="V1279844" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>P-peptide</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1279811"/>
    </not-features>
  </TERM>
  <TERM dbid="CHEBI:16670" end="931" paragraph="paragraph13" start="915" uttnum="92" id="R000008" refid="V1295633" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>P-peptide as in</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1295600"/>
    </not-features>
  </TERM>
  <TERM dbid="CHEBI:16670" end="1233" paragraph="paragraph13" start="1224" uttnum="94" id="R000009" refid="V1320705" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>P-peptide</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1320685"/>
    </not-features>
  </TERM>
  <TERM dbid="GO:0042571" end="1132" paragraph="paragraph20" start="1108" uttnum="130" id="R000010" refid="V2080862" rule="EKR:InEventPTM">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <mutation id="V2080836"/>
    </features>
    <name>ANTIBODY</name>
    <text>the anti-pS487 antibody</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2080795"/>
    </not-features>
  </TERM>
  <TERM end="614" paragraph="paragraph35" start="564" uttnum="195" id="R000011" refid="V3353372" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">been phosphorylated by a kinase downstream of Akt</text>
    <not-features>
      <ptm event="V3353277" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:P54762" end="899" paragraph="paragraph2" start="895" uttnum="13" id="R000012" refid="V238275" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>NET</name>
    <text>net</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V238280"/>
    </features>
  </TERM>
  <EVENT end="926" rule="EKR:PTM" start="895" paragraph="paragraph2" refid="V238280" id="R000013" uttnum="13">
    <type>ONT::INCREASE</type>
    <text>net phosphorylation at Thr&lt;sup&gt;</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000012"/>
  </EVENT>
  <CC uttnum="13" id="R000014" rule="EKR:PTM" end="926" start="895" refid="V238280" paragraph="paragraph2">
    <type>ONT::CAUSE-EFFECT</type>
    <text>net phosphorylation at Thr&lt;sup&gt;</text>
    <arg role=":FACTOR" id="V238280"/>
    <arg role=":OUTCOME" id="R000013"/>
  </CC>
  <EVENT uttnum="13" id="R000015" end="926" rule="EKR:PTM" start="895" paragraph="paragraph2" refid="V238280">
    <text>net phosphorylation at Thr&lt;sup&gt;</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V238275" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="13" id="R000016" rule="EKR:PTM" end="926" refid="V238280" start="895" paragraph="paragraph2">
    <text>net phosphorylation at Thr&lt;sup&gt;</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V238280"/>
    <arg id="R000015" role=":OUTCOME"/>
  </CC>
  <TERM end="129" paragraph="paragraph7" start="125" uttnum="37" id="R000017" refid="V693863" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <ptm event="V693866" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT paragraph="paragraph7" start="125" refid="V693866" end="189" rule="EKR:PTM" uttnum="37" id="R000018">
    <text>Akt phosphorylation [&lt;xref rid="B39" ref-type="bibr"&gt;39&lt;/xref&gt;] </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000017"/>
  </EVENT>
  <CC start="125" paragraph="paragraph7" refid="V693866" end="189" rule="EKR:PTM" uttnum="37" id="R000019">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Akt phosphorylation [&lt;xref rid="B39" ref-type="bibr"&gt;39&lt;/xref&gt;] </text>
    <arg id="V693866" role=":FACTOR"/>
    <arg id="R000018" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000020" uttnum="37" start="125" refid="V693866" paragraph="paragraph7" rule="EKR:PTM" end="189">
    <type>ONT::DECREASE</type>
    <text>Akt phosphorylation [&lt;xref rid="B39" ref-type="bibr"&gt;39&lt;/xref&gt;] </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V693863" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000021" uttnum="37" refid="V693866" start="125" paragraph="paragraph7" rule="EKR:PTM" end="189">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Akt phosphorylation [&lt;xref rid="B39" ref-type="bibr"&gt;39&lt;/xref&gt;] </text>
    <arg id="V693866" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000020"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="779" paragraph="paragraph7" start="755" uttnum="41" id="R000022" refid="V727357" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK (α1β2γ1 complex)</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V727345"/>
    </features>
  </TERM>
  <EVENT id="R000023" uttnum="41" refid="V727345" start="729" paragraph="paragraph7" end="779" rule="EKR:PTM">
    <text>analysing phosphorylation of AMPK (α1β2γ1 complex)</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000022" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" end="779" refid="V727345" start="729" paragraph="paragraph7" id="R000024" uttnum="41">
    <type>ONT::CAUSE-EFFECT</type>
    <text>analysing phosphorylation of AMPK (α1β2γ1 complex)</text>
    <arg id="V727345" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000023"/>
  </CC>
  <EVENT uttnum="41" id="R000025" rule="EKR:PTM" end="779" refid="V727345" start="729" paragraph="paragraph7">
    <text>analysing phosphorylation of AMPK (α1β2γ1 complex)</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V727357" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="41" id="R000026" paragraph="paragraph7" start="729" refid="V727345" end="779" rule="EKR:PTM">
    <text>analysing phosphorylation of AMPK (α1β2γ1 complex)</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V727345" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000025"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="878" paragraph="paragraph7" start="854" uttnum="42" id="R000027" refid="V736930" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK (α2β2γ1 complex)</text>
    <features>
      <ptm event="V736918" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT uttnum="42" id="R000028" start="828" refid="V736918" paragraph="paragraph7" end="878" rule="EKR:PTM">
    <text>analysing phosphorylation of AMPK (α2β2γ1 complex)</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000027" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000029" uttnum="42" refid="V736918" start="828" paragraph="paragraph7" rule="EKR:PTM" end="878">
    <text>analysing phosphorylation of AMPK (α2β2γ1 complex)</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V736918"/>
    <arg id="R000028" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="42" id="R000030" rule="EKR:PTM" end="878" paragraph="paragraph7" start="828" refid="V736918">
    <type>ONT::DECREASE</type>
    <text>analysing phosphorylation of AMPK (α2β2γ1 complex)</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V736930" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph7" start="828" refid="V736918" end="878" rule="EKR:PTM" uttnum="42" id="R000031">
    <type>ONT::CAUSE-EFFECT</type>
    <text>analysing phosphorylation of AMPK (α2β2γ1 complex)</text>
    <arg role=":FACTOR" id="V736918"/>
    <arg id="R000030" role=":OUTCOME"/>
  </CC>
  <TERM dbid="CHEBI:16670" end="707" paragraph="paragraph8" start="685" uttnum="52" id="R000032" refid="V861118" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDES</name>
    <text>of synthetic peptides</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V861098"/>
    </features>
  </TERM>
  <EVENT refid="V861098" start="669" paragraph="paragraph8" rule="EKR:PTM" end="746" id="R000033" uttnum="52">
    <type>ONT::INCREASE</type>
    <text>Phosphorylation of synthetic peptides by three different preparations of AMPK</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000032" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="52" id="R000034" end="746" rule="EKR:PTM" start="669" refid="V861098" paragraph="paragraph8">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Phosphorylation of synthetic peptides by three different preparations of AMPK</text>
    <arg role=":FACTOR" id="V861098"/>
    <arg id="R000033" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="52" id="R000035" start="669" paragraph="paragraph8" refid="V861098" rule="EKR:PTM" end="746">
    <type>ONT::DECREASE</type>
    <text>Phosphorylation of synthetic peptides by three different preparations of AMPK</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V861118"/>
  </EVENT>
  <CC start="669" paragraph="paragraph8" refid="V861098" end="746" rule="EKR:PTM" uttnum="52" id="R000036">
    <text>Phosphorylation of synthetic peptides by three different preparations of AMPK</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V861098"/>
    <arg id="R000035" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="227" paragraph="paragraph9" start="219" uttnum="55" id="R000037" refid="V894867" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V894851"/>
    </features>
  </TERM>
  <EVENT uttnum="55" id="R000038" refid="V894851" start="203" paragraph="paragraph9" end="268" rule="EKR:PTM">
    <type>ONT::INCREASE</type>
    <text>Phosphorylation of AMPK by LKB1 in the absence or presence of Akt</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000037"/>
  </EVENT>
  <CC end="268" rule="EKR:PTM" start="203" paragraph="paragraph9" refid="V894851" uttnum="55" id="R000039">
    <text>Phosphorylation of AMPK by LKB1 in the absence or presence of Akt</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V894851"/>
    <arg id="R000038" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="55" id="R000040" refid="V894851" start="203" paragraph="paragraph9" rule="EKR:PTM" end="268">
    <type>ONT::DECREASE</type>
    <text>Phosphorylation of AMPK by LKB1 in the absence or presence of Akt</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V894867" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="55" id="R000041" refid="V894851" start="203" paragraph="paragraph9" rule="EKR:PTM" end="268">
    <text>Phosphorylation of AMPK by LKB1 in the absence or presence of Akt</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V894851" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000040"/>
  </CC>
  <TERM end="458" paragraph="paragraph16" start="443" uttnum="114" id="R000042" refid="V1699847" rule="EKR:PTM">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <mutation>TRUE</mutation>
      <ptm type="ONT::PHOSPHORYLATION" event="V1699883"/>
    </features>
    <name>COMPLEX</name>
    <text>mutant complex</text>
  </TERM>
  <EVENT rule="EKR:PTM" end="507" start="443" paragraph="paragraph16" refid="V1699883" uttnum="114" id="R000043">
    <text>mutant complex was first phosphorylated by Akt under conditions </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000042" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="114" id="R000044" rule="EKR:PTM" end="507" refid="V1699883" start="443" paragraph="paragraph16">
    <text>mutant complex was first phosphorylated by Akt under conditions </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1699883" role=":FACTOR"/>
    <arg id="R000043" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="114" id="R000045" start="443" paragraph="paragraph16" refid="V1699883" end="507" rule="EKR:PTM">
    <type>ONT::DECREASE</type>
    <text>mutant complex was first phosphorylated by Akt under conditions </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1699847"/>
  </EVENT>
  <CC uttnum="114" id="R000046" paragraph="paragraph16" start="443" refid="V1699883" end="507" rule="EKR:PTM">
    <text>mutant complex was first phosphorylated by Akt under conditions </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1699883"/>
    <arg role=":OUTCOME" id="R000045"/>
  </CC>
  <TERM dbid="CHEBI:16670" end="342" paragraph="paragraph18" start="325" uttnum="122" id="R000047" refid="V1911988" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>PEPTIDE</name>
    <text>the S491 peptide</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1912015"/>
    </features>
  </TERM>
  <EVENT id="R000048" uttnum="122" rule="EKR:PTM" end="365" refid="V1912015" start="325" paragraph="paragraph18">
    <text>the S491 peptide was also phosphorylated</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000047" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000049" uttnum="122" rule="EKR:PTM" end="365" start="325" paragraph="paragraph18" refid="V1912015">
    <text>the S491 peptide was also phosphorylated</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1912015"/>
    <arg id="R000048" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="122" id="R000050" start="325" paragraph="paragraph18" refid="V1912015" rule="EKR:PTM" end="365">
    <text>the S491 peptide was also phosphorylated</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1911988" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="122" id="R000051" rule="EKR:PTM" end="365" refid="V1912015" start="325" paragraph="paragraph18">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the S491 peptide was also phosphorylated</text>
    <arg id="V1912015" role=":FACTOR"/>
    <arg id="R000050" role=":OUTCOME"/>
  </CC>
  <TERM end="377" paragraph="paragraph19" start="367" uttnum="125" id="R000052" refid="V1952053" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">prior Akt</text>
    <features>
      <ptm event="V1952056" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT id="R000053" uttnum="125" start="367" paragraph="paragraph19" refid="V1952056" end="393" rule="EKR:PTM">
    <type>ONT::INCREASE</type>
    <text>prior Akt phosphorylation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000052"/>
  </EVENT>
  <CC id="R000054" uttnum="125" paragraph="paragraph19" start="367" refid="V1952056" rule="EKR:PTM" end="393">
    <text>prior Akt phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1952056" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000053"/>
  </CC>
  <EVENT id="R000055" uttnum="125" refid="V1952056" start="367" paragraph="paragraph19" end="393" rule="EKR:PTM">
    <type>ONT::DECREASE</type>
    <text>prior Akt phosphorylation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1952053"/>
  </EVENT>
  <CC uttnum="125" id="R000056" end="393" rule="EKR:PTM" refid="V1952056" start="367" paragraph="paragraph19">
    <text>prior Akt phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1952056" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000055"/>
  </CC>
  <TERM dbid="HGNC:84|UP:Q5SWU9|XFAM:PF00364|XFAM:PF08326|XFAM:PF00289|XFAM:PF01039|XFAM:PF02785|UP:Q16548|XFAM:PF02786|UP:Q13085|HGNC:991" end="528" paragraph="paragraph25" start="520" uttnum="150" id="R000057" refid="V2467681" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>ACC-1</name>
    <text>of ACC1</text>
    <features>
      <ptm event="V2467664" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT id="R000058" uttnum="150" end="539" rule="EKR:PTM" start="500" refid="V2467664" paragraph="paragraph25">
    <type>ONT::INCREASE</type>
    <text>the phosphorylation of ACC1 at Ser&lt;sup&gt;</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000057"/>
  </EVENT>
  <CC start="500" paragraph="paragraph25" refid="V2467664" end="539" rule="EKR:PTM" uttnum="150" id="R000059">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the phosphorylation of ACC1 at Ser&lt;sup&gt;</text>
    <arg role=":FACTOR" id="V2467664"/>
    <arg id="R000058" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000060" uttnum="150" refid="V2467664" start="500" paragraph="paragraph25" rule="EKR:PTM" end="539">
    <text>the phosphorylation of ACC1 at Ser&lt;sup&gt;</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2467681"/>
  </EVENT>
  <CC id="R000061" uttnum="150" end="539" rule="EKR:PTM" paragraph="paragraph25" start="500" refid="V2467664">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the phosphorylation of ACC1 at Ser&lt;sup&gt;</text>
    <arg role=":FACTOR" id="V2467664"/>
    <arg id="R000060" role=":OUTCOME"/>
  </CC>
  <TERM end="587" paragraph="paragraph26" start="580" uttnum="156" id="R000062" refid="V2597567" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
    <features>
      <ptm event="V2597555" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT id="R000063" uttnum="156" refid="V2597555" start="560" paragraph="paragraph26" end="587" rule="EKR:PTM">
    <text>the phosphorylation of Akt </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000062" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V2597555" start="560" paragraph="paragraph26" rule="EKR:PTM" end="587" uttnum="156" id="R000064">
    <text>the phosphorylation of Akt </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2597555" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000063"/>
  </CC>
  <EVENT end="587" rule="EKR:PTM" paragraph="paragraph26" start="560" refid="V2597555" uttnum="156" id="R000065">
    <type>ONT::DECREASE</type>
    <text>the phosphorylation of Akt </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2597567" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph26" start="560" refid="V2597555" rule="EKR:PTM" end="587" uttnum="156" id="R000066">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the phosphorylation of Akt </text>
    <arg role=":FACTOR" id="V2597555"/>
    <arg role=":OUTCOME" id="R000065"/>
  </CC>
  <TERM dbid="HGNC:11405|UP:Q8IWQ3" end="1073" paragraph="paragraph30" start="1040" uttnum="174" id="R000067" refid="V2904787" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>BRSK-2</name>
    <assoc-with id="X2920219"/>
    <text>of the AMPK-related kinase BRSK2</text>
    <features>
      <ptm event="V2904735" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT end="1073" rule="EKR:PTM" start="1024" refid="V2904735" paragraph="paragraph30" id="R000068" uttnum="174">
    <text>phosphorylation of the AMPK-related kinase BRSK2 </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000067" role=":AFFECTED"/>
  </EVENT>
  <CC end="1073" rule="EKR:PTM" start="1024" refid="V2904735" paragraph="paragraph30" id="R000069" uttnum="174">
    <type>ONT::CAUSE-EFFECT</type>
    <text>phosphorylation of the AMPK-related kinase BRSK2 </text>
    <arg id="V2904735" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000068"/>
  </CC>
  <EVENT paragraph="paragraph30" start="1024" refid="V2904735" end="1073" rule="EKR:PTM" uttnum="174" id="R000070">
    <text>phosphorylation of the AMPK-related kinase BRSK2 </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2904787" role=":AFFECTED"/>
  </EVENT>
  <CC start="1024" refid="V2904735" paragraph="paragraph30" rule="EKR:PTM" end="1073" uttnum="174" id="R000071">
    <type>ONT::CAUSE-EFFECT</type>
    <text>phosphorylation of the AMPK-related kinase BRSK2 </text>
    <arg role=":FACTOR" id="V2904735"/>
    <arg role=":OUTCOME" id="R000070"/>
  </CC>
  <TERM end="387" paragraph="paragraph31" start="369" uttnum="176" id="R000072" refid="V2936581" rule="EKR:PTM">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <mutation>FALSE</mutation>
      <ptm event="V2936549" type="ONT::PHOSPHORYLATION"/>
    </features>
    <name>COMPLEX</name>
    <text>of the WT complex</text>
  </TERM>
  <EVENT start="347" refid="V2936549" paragraph="paragraph31" rule="EKR:PTM" end="394" uttnum="176" id="R000073">
    <text>prior phosphorylation of the WT complex by Akt </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000072"/>
  </EVENT>
  <CC paragraph="paragraph31" start="347" refid="V2936549" end="394" rule="EKR:PTM" uttnum="176" id="R000074">
    <type>ONT::CAUSE-EFFECT</type>
    <text>prior phosphorylation of the WT complex by Akt </text>
    <arg id="V2936549" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000073"/>
  </CC>
  <EVENT uttnum="176" id="R000075" rule="EKR:PTM" end="394" refid="V2936549" start="347" paragraph="paragraph31">
    <text>prior phosphorylation of the WT complex by Akt </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2936581"/>
  </EVENT>
  <CC id="R000076" uttnum="176" end="394" rule="EKR:PTM" start="347" refid="V2936549" paragraph="paragraph31">
    <text>prior phosphorylation of the WT complex by Akt </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2936549" role=":FACTOR"/>
    <arg id="R000075" role=":OUTCOME"/>
  </CC>
  <TERM dbid="UP:P15000|XFAM:PF00685|UP:P52843" end="2674" paragraph="paragraph32" start="2671" uttnum="185" id="R000077" refid="V3145846" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>ST</name>
    <text>ST</text>
    <features>
      <ptm event="V3145858" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT uttnum="185" id="R000078" start="2671" paragraph="paragraph32" refid="V3145858" rule="EKR:PTM" end="2695">
    <text>ST loop phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000077"/>
  </EVENT>
  <CC uttnum="185" id="R000079" rule="EKR:PTM" end="2695" refid="V3145858" start="2671" paragraph="paragraph32">
    <type>ONT::CAUSE-EFFECT</type>
    <text>ST loop phosphorylation </text>
    <arg role=":FACTOR" id="V3145858"/>
    <arg id="R000078" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="185" id="R000080" rule="EKR:PTM" end="2695" start="2671" refid="V3145858" paragraph="paragraph32">
    <text>ST loop phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3145846" role=":AFFECTED"/>
  </EVENT>
  <CC end="2695" rule="EKR:PTM" start="2671" refid="V3145858" paragraph="paragraph32" id="R000081" uttnum="185">
    <text>ST loop phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3145858" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000080"/>
  </CC>
  <TERM dbid="UP:P54762" end="1082" paragraph="paragraph33" start="1074" uttnum="189" id="R000082" refid="V3227535" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>NET</name>
    <text>the net</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3227540"/>
    </features>
  </TERM>
  <EVENT id="R000083" uttnum="189" start="1074" paragraph="paragraph33" refid="V3227540" rule="EKR:PTM" end="1098">
    <text>the net phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000082"/>
  </EVENT>
  <CC rule="EKR:PTM" end="1098" paragraph="paragraph33" start="1074" refid="V3227540" uttnum="189" id="R000084">
    <text>the net phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3227540" role=":FACTOR"/>
    <arg id="R000083" role=":OUTCOME"/>
  </CC>
  <EVENT start="1074" paragraph="paragraph33" refid="V3227540" rule="EKR:PTM" end="1098" uttnum="189" id="R000085">
    <type>ONT::DECREASE</type>
    <text>the net phosphorylation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3227535"/>
  </EVENT>
  <CC id="R000086" uttnum="189" paragraph="paragraph33" start="1074" refid="V3227540" rule="EKR:PTM" end="1098">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the net phosphorylation </text>
    <arg role=":FACTOR" id="V3227540"/>
    <arg id="R000085" role=":OUTCOME"/>
  </CC>
  <TERM end="788" paragraph="paragraph34" start="761" uttnum="193" id="R000087" refid="V3285720" rule="EKR:PTM">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>other sites in the ST loop</text>
    <features>
      <ptm event="V3285826" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT start="756" refid="V3285826" paragraph="paragraph34" rule="EKR:PTM" end="831" id="R000088" uttnum="193">
    <text>that other sites in the ST loop may be phosphorylated in the intact cells, </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000087" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000089" uttnum="193" end="831" rule="EKR:PTM" refid="V3285826" start="756" paragraph="paragraph34">
    <text>that other sites in the ST loop may be phosphorylated in the intact cells, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3285826"/>
    <arg role=":OUTCOME" id="R000088"/>
  </CC>
  <EVENT id="R000090" uttnum="193" paragraph="paragraph34" start="756" refid="V3285826" rule="EKR:PTM" end="831">
    <text>that other sites in the ST loop may be phosphorylated in the intact cells, </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3285720" role=":AFFECTED"/>
  </EVENT>
  <CC start="756" paragraph="paragraph34" refid="V3285826" rule="EKR:PTM" end="831" uttnum="193" id="R000091">
    <text>that other sites in the ST loop may be phosphorylated in the intact cells, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3285826" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000090"/>
  </CC>
  <TERM end="54" paragraph="paragraph37" start="47" uttnum="199" id="R000092" refid="V3435158" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Akt</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3435146"/>
    </features>
  </TERM>
  <EVENT id="R000093" uttnum="199" rule="EKR:PTM" end="68" paragraph="paragraph37" start="3" refid="V3435146">
    <type>ONT::INCREASE</type>
    <text>Surprisingly, we found that phosphorylation of Akt at the mTORC2 </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000092"/>
  </EVENT>
  <CC end="68" rule="EKR:PTM" refid="V3435146" start="3" paragraph="paragraph37" uttnum="199" id="R000094">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Surprisingly, we found that phosphorylation of Akt at the mTORC2 </text>
    <arg id="V3435146" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000093"/>
  </CC>
  <EVENT rule="EKR:PTM" end="68" refid="V3435146" start="3" paragraph="paragraph37" uttnum="199" id="R000095">
    <text>Surprisingly, we found that phosphorylation of Akt at the mTORC2 </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3435158" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="199" id="R000096" start="3" paragraph="paragraph37" refid="V3435146" rule="EKR:PTM" end="68">
    <text>Surprisingly, we found that phosphorylation of Akt at the mTORC2 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3435146" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000095"/>
  </CC>
  <TERM end="963" paragraph="paragraph39" start="942" uttnum="212" id="R000097" refid="V3683676" rule="EKR:PTM">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>of an α1β2γ1 complex</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3683625"/>
    </features>
  </TERM>
  <EVENT paragraph="paragraph39" start="926" refid="V3683625" rule="EKR:PTM" end="971" uttnum="212" id="R000098">
    <text>phosphorylation of an α1β2γ1 complex by LKB1,</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000097"/>
  </EVENT>
  <CC paragraph="paragraph39" start="926" refid="V3683625" rule="EKR:PTM" end="971" uttnum="212" id="R000099">
    <text>phosphorylation of an α1β2γ1 complex by LKB1,</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3683625" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000098"/>
  </CC>
  <EVENT id="R000100" uttnum="212" paragraph="paragraph39" start="926" refid="V3683625" end="971" rule="EKR:PTM">
    <text>phosphorylation of an α1β2γ1 complex by LKB1,</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3683676"/>
  </EVENT>
  <CC uttnum="212" id="R000101" start="926" refid="V3683625" paragraph="paragraph39" end="971" rule="EKR:PTM">
    <text>phosphorylation of an α1β2γ1 complex by LKB1,</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3683625"/>
    <arg role=":OUTCOME" id="R000100"/>
  </CC>
  <TERM dbid="HGNC:11405|UP:Q8IWQ3" end="1186" paragraph="paragraph39" start="1176" uttnum="213" id="R000102" refid="V3710340" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>BRSK-2</name>
    <text>of BRSK2,</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3710289"/>
    </features>
  </TERM>
  <EVENT start="1152" paragraph="paragraph39" refid="V3710289" rule="EKR:PTM" end="1186" uttnum="213" id="R000103">
    <type>ONT::INCREASE</type>
    <text>phosphorylation by LKB1 of BRSK2, </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000102"/>
  </EVENT>
  <CC paragraph="paragraph39" start="1152" refid="V3710289" rule="EKR:PTM" end="1186" id="R000104" uttnum="213">
    <text>phosphorylation by LKB1 of BRSK2, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3710289" role=":FACTOR"/>
    <arg id="R000103" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V3710289" start="1152" paragraph="paragraph39" end="1186" rule="EKR:PTM" id="R000105" uttnum="213">
    <type>ONT::DECREASE</type>
    <text>phosphorylation by LKB1 of BRSK2, </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3710340"/>
  </EVENT>
  <CC start="1152" refid="V3710289" paragraph="paragraph39" end="1186" rule="EKR:PTM" uttnum="213" id="R000106">
    <type>ONT::CAUSE-EFFECT</type>
    <text>phosphorylation by LKB1 of BRSK2, </text>
    <arg id="V3710289" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000105"/>
  </CC>
  <TERM end="958" paragraph="paragraph40" start="928" uttnum="217" id="R000107" refid="V3803073" rule="EKR:PTM">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>a serine or threonine residue</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3803012"/>
    </features>
  </TERM>
  <EVENT end="958" rule="EKR:PTM" start="894" refid="V3803012" paragraph="paragraph40" uttnum="217" id="R000108">
    <type>ONT::INCREASE</type>
    <text>the kinase usually phosphorylates a serine or threonine residue </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000107"/>
  </EVENT>
  <CC uttnum="217" id="R000109" start="894" refid="V3803012" paragraph="paragraph40" rule="EKR:PTM" end="958">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the kinase usually phosphorylates a serine or threonine residue </text>
    <arg role=":FACTOR" id="V3803012"/>
    <arg role=":OUTCOME" id="R000108"/>
  </CC>
  <EVENT uttnum="217" id="R000110" end="958" rule="EKR:PTM" refid="V3803012" start="894" paragraph="paragraph40">
    <text>the kinase usually phosphorylates a serine or threonine residue </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3803073" role=":AFFECTED"/>
  </EVENT>
  <CC end="958" rule="EKR:PTM" refid="V3803012" start="894" paragraph="paragraph40" uttnum="217" id="R000111">
    <text>the kinase usually phosphorylates a serine or threonine residue </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3803012"/>
    <arg role=":OUTCOME" id="R000110"/>
  </CC>
  <TERM end="766" paragraph="paragraph41" start="762" uttnum="225" id="R000112" refid="V3979715" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <ptm event="V3979718" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT end="782" rule="EKR:PTM" paragraph="paragraph41" start="750" refid="V3979718" id="R000113" uttnum="225">
    <text>of previous Akt phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000112"/>
  </EVENT>
  <CC uttnum="225" id="R000114" end="782" rule="EKR:PTM" refid="V3979718" start="750" paragraph="paragraph41">
    <text>of previous Akt phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3979718"/>
    <arg role=":OUTCOME" id="R000113"/>
  </CC>
  <EVENT uttnum="225" id="R000115" end="782" rule="EKR:PTM" paragraph="paragraph41" start="750" refid="V3979718">
    <text>of previous Akt phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3979715" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" end="782" refid="V3979718" start="750" paragraph="paragraph41" id="R000116" uttnum="225">
    <text>of previous Akt phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3979718"/>
    <arg role=":OUTCOME" id="R000115"/>
  </CC>
  <TERM end="935" paragraph="paragraph41" start="925" uttnum="226" id="R000117" refid="V3991343" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">prior Akt</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3991346"/>
    </features>
  </TERM>
  <EVENT refid="V3991346" start="920" paragraph="paragraph41" end="951" rule="EKR:PTM" id="R000118" uttnum="226">
    <text>that prior Akt phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000117" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="226" id="R000119" paragraph="paragraph41" start="920" refid="V3991346" rule="EKR:PTM" end="951">
    <type>ONT::CAUSE-EFFECT</type>
    <text>that prior Akt phosphorylation </text>
    <arg role=":FACTOR" id="V3991346"/>
    <arg id="R000118" role=":OUTCOME"/>
  </CC>
  <EVENT end="951" rule="EKR:PTM" paragraph="paragraph41" start="920" refid="V3991346" id="R000120" uttnum="226">
    <text>that prior Akt phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3991343"/>
  </EVENT>
  <CC uttnum="226" id="R000121" rule="EKR:PTM" end="951" start="920" refid="V3991346" paragraph="paragraph41">
    <text>that prior Akt phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3991346"/>
    <arg role=":OUTCOME" id="R000120"/>
  </CC>
  <TERM end="775" paragraph="paragraph1" start="771" uttnum="4" id="R000122" refid="V77014" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT start="771" refid="V77017" paragraph="paragraph1" rule="EKR:ActivateX" end="786" id="R000123" uttnum="4">
    <text>Akt activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000122"/>
  </EVENT>
  <CC uttnum="4" id="R000124" refid="V77017" start="771" paragraph="paragraph1" end="786" rule="EKR:ActivateX">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Akt activation </text>
    <arg id="V77017" role=":FACTOR"/>
    <arg id="R000123" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph1" start="771" refid="V77017" rule="EKR:ActivateX" end="786" id="R000125" uttnum="4">
    <type>ONT::DECREASE</type>
    <text>Akt activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V77014"/>
  </EVENT>
  <CC uttnum="4" id="R000126" rule="EKR:ActivateX" end="786" start="771" paragraph="paragraph1" refid="V77017">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Akt activation </text>
    <arg role=":FACTOR" id="V77017"/>
    <arg role=":OUTCOME" id="R000125"/>
  </CC>
  <TERM end="1039" paragraph="paragraph1" start="1035" uttnum="5" id="R000127" refid="V101420" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="5" id="R000128" start="1035" refid="V101458" paragraph="paragraph1" end="1061" rule="EKR:ActivateX">
    <text>Akt is thus hyperactivated</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000127"/>
  </EVENT>
  <CC uttnum="5" id="R000129" refid="V101458" start="1035" paragraph="paragraph1" end="1061" rule="EKR:ActivateX">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Akt is thus hyperactivated</text>
    <arg role=":FACTOR" id="V101458"/>
    <arg role=":OUTCOME" id="R000128"/>
  </CC>
  <EVENT uttnum="5" id="R000130" paragraph="paragraph1" start="1035" refid="V101458" end="1061" rule="EKR:ActivateX">
    <text>Akt is thus hyperactivated</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V101420" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V101458" start="1035" paragraph="paragraph1" rule="EKR:ActivateX" end="1061" id="R000131" uttnum="5">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Akt is thus hyperactivated</text>
    <arg role=":FACTOR" id="V101458"/>
    <arg role=":OUTCOME" id="R000130"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1128" paragraph="paragraph1" start="1123" uttnum="6" id="R000132" refid="V126559" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V126563" start="1118" paragraph="paragraph1" end="1139" rule="EKR:ActivateX" uttnum="6" id="R000133">
    <text>full AMPK activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000132"/>
  </EVENT>
  <CC id="R000134" uttnum="6" end="1139" rule="EKR:ActivateX" refid="V126563" start="1118" paragraph="paragraph1">
    <type>ONT::CAUSE-EFFECT</type>
    <text>full AMPK activation </text>
    <arg role=":FACTOR" id="V126563"/>
    <arg id="R000133" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="6" id="R000135" rule="EKR:ActivateX" end="1139" start="1118" paragraph="paragraph1" refid="V126563">
    <type>ONT::DECREASE</type>
    <text>full AMPK activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V126559" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="6" id="R000136" start="1118" paragraph="paragraph1" refid="V126563" rule="EKR:ActivateX" end="1139">
    <type>ONT::CAUSE-EFFECT</type>
    <text>full AMPK activation </text>
    <arg id="V126563" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000135"/>
  </CC>
  <TERM end="1514" paragraph="paragraph1" start="1491" uttnum="8" id="R000137" refid="V154779" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <location id="V154840"/>
      <active>TRUE</active>
    </features>
    <name>AKT</name>
    <text normalization="">of Akt in tumour cells</text>
  </TERM>
  <EVENT id="R000138" uttnum="8" refid="V154761" start="1472" paragraph="paragraph1" rule="EKR:ActivateX" end="1514">
    <type>ONT::INCREASE</type>
    <text>of hyperactivation of Akt in tumour cells </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000137" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph1" start="1472" refid="V154761" end="1514" rule="EKR:ActivateX" uttnum="8" id="R000139">
    <text>of hyperactivation of Akt in tumour cells </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V154761" role=":FACTOR"/>
    <arg id="R000138" role=":OUTCOME"/>
  </CC>
  <EVENT rule="EKR:ActivateX" end="1514" start="1472" paragraph="paragraph1" refid="V154761" uttnum="8" id="R000140">
    <text>of hyperactivation of Akt in tumour cells </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V154779" role=":AFFECTED"/>
  </EVENT>
  <CC start="1472" refid="V154761" paragraph="paragraph1" rule="EKR:ActivateX" end="1514" id="R000141" uttnum="8">
    <type>ONT::CAUSE-EFFECT</type>
    <text>of hyperactivation of Akt in tumour cells </text>
    <arg role=":FACTOR" id="V154761"/>
    <arg id="R000140" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03075|UP:Q15831|XFAM:PF00069|UP:Q9WTK7|HGNC:11389" end="1569" paragraph="paragraph1" start="1540" uttnum="8" id="R000142" refid="V154927" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>LKB-1</name>
    <text>of the LKB1 (liver kinase B1)</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V154901" start="1529" paragraph="paragraph1" rule="EKR:ActivateX" end="1583" id="R000143" uttnum="8">
    <text>activation of the LKB1 (liver kinase B1)–AMPK pathway,</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000142" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000144" uttnum="8" end="1583" rule="EKR:ActivateX" start="1529" refid="V154901" paragraph="paragraph1">
    <text>activation of the LKB1 (liver kinase B1)–AMPK pathway,</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V154901"/>
    <arg id="R000143" role=":OUTCOME"/>
  </CC>
  <EVENT rule="EKR:ActivateX" end="1583" refid="V154901" start="1529" paragraph="paragraph1" uttnum="8" id="R000145">
    <text>activation of the LKB1 (liver kinase B1)–AMPK pathway,</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V154927"/>
  </EVENT>
  <CC rule="EKR:ActivateX" end="1583" start="1529" paragraph="paragraph1" refid="V154901" id="R000146" uttnum="8">
    <text>activation of the LKB1 (liver kinase B1)–AMPK pathway,</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V154901" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000145"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="8" paragraph="paragraph3" start="3" uttnum="15" id="R000147" refid="V297694" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT id="R000148" uttnum="15" start="3" refid="V297725" paragraph="paragraph3" rule="EKR:ActivateX" end="90">
    <text>AMPK is thus activated by metabolic stresses that deplete ATP, and increase ADP and AMP</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000147" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="15" id="R000149" rule="EKR:ActivateX" end="90" paragraph="paragraph3" start="3" refid="V297725">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK is thus activated by metabolic stresses that deplete ATP, and increase ADP and AMP</text>
    <arg role=":FACTOR" id="V297725"/>
    <arg role=":OUTCOME" id="R000148"/>
  </CC>
  <EVENT uttnum="15" id="R000150" start="3" refid="V297725" paragraph="paragraph3" rule="EKR:ActivateX" end="90">
    <type>ONT::DECREASE</type>
    <text>AMPK is thus activated by metabolic stresses that deplete ATP, and increase ADP and AMP</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V297694" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="15" id="R000151" start="3" refid="V297725" paragraph="paragraph3" end="90" rule="EKR:ActivateX">
    <text>AMPK is thus activated by metabolic stresses that deplete ATP, and increase ADP and AMP</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V297725" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000150"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="323" paragraph="paragraph3" start="318" uttnum="17" id="R000152" refid="V322176" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="17" id="R000153" paragraph="paragraph3" start="302" refid="V322167" end="323" rule="EKR:ActivateX">
    <text>Once activated, AMPK </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000152" role=":AFFECTED"/>
  </EVENT>
  <CC end="323" rule="EKR:ActivateX" start="302" refid="V322167" paragraph="paragraph3" uttnum="17" id="R000154">
    <text>Once activated, AMPK </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V322167"/>
    <arg id="R000153" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="17" id="R000155" start="302" paragraph="paragraph3" refid="V322167" end="323" rule="EKR:ActivateX">
    <text>Once activated, AMPK </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V322176" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000156" uttnum="17" start="302" paragraph="paragraph3" refid="V322167" end="323" rule="EKR:ActivateX">
    <text>Once activated, AMPK </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V322167" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000155"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="306" paragraph="paragraph9" start="298" uttnum="56" id="R000157" refid="V904549" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="347" rule="EKR:ActivateX" start="287" paragraph="paragraph9" refid="V904532" id="R000158" uttnum="56">
    <text>Activation of AMPK by LKB1 in the absence or presence of Akt</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000157" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000159" uttnum="56" refid="V904532" start="287" paragraph="paragraph9" rule="EKR:ActivateX" end="347">
    <text>Activation of AMPK by LKB1 in the absence or presence of Akt</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V904532"/>
    <arg id="R000158" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V904532" start="287" paragraph="paragraph9" end="347" rule="EKR:ActivateX" uttnum="56" id="R000160">
    <text>Activation of AMPK by LKB1 in the absence or presence of Akt</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V904549" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:ActivateX" end="347" refid="V904532" start="287" paragraph="paragraph9" id="R000161" uttnum="56">
    <text>Activation of AMPK by LKB1 in the absence or presence of Akt</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V904532" role=":FACTOR"/>
    <arg id="R000160" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1455" paragraph="paragraph13" start="1450" uttnum="97" id="R000162" refid="V1359707" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT id="R000163" uttnum="97" end="1478" rule="EKR:ActivateX" start="1450" paragraph="paragraph13" refid="V1359710">
    <text>AMPK activation (top panel) </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000162"/>
  </EVENT>
  <CC rule="EKR:ActivateX" end="1478" start="1450" paragraph="paragraph13" refid="V1359710" id="R000164" uttnum="97">
    <text>AMPK activation (top panel) </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1359710"/>
    <arg id="R000163" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000165" uttnum="97" start="1450" refid="V1359710" paragraph="paragraph13" end="1478" rule="EKR:ActivateX">
    <type>ONT::DECREASE</type>
    <text>AMPK activation (top panel) </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1359707" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000166" uttnum="97" start="1450" refid="V1359710" paragraph="paragraph13" end="1478" rule="EKR:ActivateX">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation (top panel) </text>
    <arg id="V1359710" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000165"/>
  </CC>
  <TERM end="105" paragraph="paragraph21" start="102" uttnum="131" id="R000167" refid="V2100428" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="131" id="R000168" start="93" refid="V2100421" paragraph="paragraph21" rule="EKR:ActivateX" end="105">
    <text>activate Akt</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000167" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000169" uttnum="131" paragraph="paragraph21" start="93" refid="V2100421" end="105" rule="EKR:ActivateX">
    <text>activate Akt</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2100421" role=":FACTOR"/>
    <arg id="R000168" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="131" id="R000170" end="105" rule="EKR:ActivateX" paragraph="paragraph21" start="93" refid="V2100421">
    <type>ONT::DECREASE</type>
    <text>activate Akt</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2100428" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="131" id="R000171" refid="V2100421" start="93" paragraph="paragraph21" rule="EKR:ActivateX" end="105">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activate Akt</text>
    <arg role=":FACTOR" id="V2100421"/>
    <arg id="R000170" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="553" paragraph="paragraph21" start="546" uttnum="133" id="R000172" refid="V2146940" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT id="R000173" uttnum="133" start="531" paragraph="paragraph21" refid="V2146926" end="555" rule="EKR:ActivateX">
    <type>ONT::INCREASE</type>
    <text>the activation of AMPK, </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000172" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph21" start="531" refid="V2146926" rule="EKR:ActivateX" end="555" id="R000174" uttnum="133">
    <text>the activation of AMPK, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2146926"/>
    <arg role=":OUTCOME" id="R000173"/>
  </CC>
  <EVENT refid="V2146926" start="531" paragraph="paragraph21" rule="EKR:ActivateX" end="555" id="R000175" uttnum="133">
    <type>ONT::DECREASE</type>
    <text>the activation of AMPK, </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2146940" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph21" start="531" refid="V2146926" end="555" rule="EKR:ActivateX" id="R000176" uttnum="133">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the activation of AMPK, </text>
    <arg role=":FACTOR" id="V2146926"/>
    <arg id="R000175" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="732" paragraph="paragraph21" start="727" uttnum="134" id="R000177" refid="V2160430" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V2160434" start="727" paragraph="paragraph21" rule="EKR:ActivateX" end="743" id="R000178" uttnum="134">
    <type>ONT::INCREASE</type>
    <text>AMPK activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000177" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="134" id="R000179" rule="EKR:ActivateX" end="743" start="727" refid="V2160434" paragraph="paragraph21">
    <text>AMPK activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2160434"/>
    <arg role=":OUTCOME" id="R000178"/>
  </CC>
  <EVENT uttnum="134" id="R000180" end="743" rule="EKR:ActivateX" start="727" paragraph="paragraph21" refid="V2160434">
    <type>ONT::DECREASE</type>
    <text>AMPK activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2160430" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V2160434" start="727" paragraph="paragraph21" end="743" rule="EKR:ActivateX" uttnum="134" id="R000181">
    <text>AMPK activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2160434" role=":FACTOR"/>
    <arg id="R000180" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="488" paragraph="paragraph22" start="483" uttnum="136" id="R000182" refid="V2204307" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT id="R000183" uttnum="136" start="483" refid="V2204310" paragraph="paragraph22" rule="EKR:ActivateX" end="500">
    <type>ONT::INCREASE</type>
    <text>AMPK activation, </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000182"/>
  </EVENT>
  <CC end="500" rule="EKR:ActivateX" start="483" refid="V2204310" paragraph="paragraph22" uttnum="136" id="R000184">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation, </text>
    <arg id="V2204310" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000183"/>
  </CC>
  <EVENT paragraph="paragraph22" start="483" refid="V2204310" end="500" rule="EKR:ActivateX" uttnum="136" id="R000185">
    <text>AMPK activation, </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2204307"/>
  </EVENT>
  <CC end="500" rule="EKR:ActivateX" start="483" refid="V2204310" paragraph="paragraph22" id="R000186" uttnum="136">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation, </text>
    <arg id="V2204310" role=":FACTOR"/>
    <arg id="R000185" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="805" paragraph="paragraph22" start="800" uttnum="137" id="R000187" refid="V2237644" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT start="800" paragraph="paragraph22" refid="V2237648" end="815" rule="EKR:ActivateX" uttnum="137" id="R000188">
    <text>AMPK activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000187"/>
  </EVENT>
  <CC rule="EKR:ActivateX" end="815" start="800" refid="V2237648" paragraph="paragraph22" uttnum="137" id="R000189">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation</text>
    <arg id="V2237648" role=":FACTOR"/>
    <arg id="R000188" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="137" id="R000190" start="800" refid="V2237648" paragraph="paragraph22" end="815" rule="EKR:ActivateX">
    <text>AMPK activation</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2237644"/>
  </EVENT>
  <CC id="R000191" uttnum="137" start="800" paragraph="paragraph22" refid="V2237648" rule="EKR:ActivateX" end="815">
    <text>AMPK activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2237648"/>
    <arg role=":OUTCOME" id="R000190"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1415" paragraph="paragraph22" start="1410" uttnum="140" id="R000192" refid="V2277978" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK </text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="140" id="R000193" paragraph="paragraph22" start="1410" refid="V2277981" end="1444" rule="EKR:ActivateX">
    <text>AMPK activation in both cell lines</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000192" role=":AFFECTED"/>
  </EVENT>
  <CC start="1410" paragraph="paragraph22" refid="V2277981" end="1444" rule="EKR:ActivateX" id="R000194" uttnum="140">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation in both cell lines</text>
    <arg id="V2277981" role=":FACTOR"/>
    <arg id="R000193" role=":OUTCOME"/>
  </CC>
  <EVENT start="1410" refid="V2277981" paragraph="paragraph22" end="1444" rule="EKR:ActivateX" id="R000195" uttnum="140">
    <text>AMPK activation in both cell lines</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2277978"/>
  </EVENT>
  <CC uttnum="140" id="R000196" refid="V2277981" start="1410" paragraph="paragraph22" rule="EKR:ActivateX" end="1444">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation in both cell lines</text>
    <arg id="V2277981" role=":FACTOR"/>
    <arg id="R000195" role=":OUTCOME"/>
  </CC>
  <TERM end="252" paragraph="paragraph24" start="249" uttnum="144" id="R000197" refid="V2349974" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="252" rule="EKR:ActivateX" paragraph="paragraph24" start="240" refid="V2349967" uttnum="144" id="R000198">
    <type>ONT::INCREASE</type>
    <text>activate Akt</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000197"/>
  </EVENT>
  <CC start="240" refid="V2349967" paragraph="paragraph24" rule="EKR:ActivateX" end="252" id="R000199" uttnum="144">
    <text>activate Akt</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2349967"/>
    <arg id="R000198" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="144" id="R000200" rule="EKR:ActivateX" end="252" start="240" refid="V2349967" paragraph="paragraph24">
    <text>activate Akt</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2349974"/>
  </EVENT>
  <CC end="252" rule="EKR:ActivateX" paragraph="paragraph24" start="240" refid="V2349967" uttnum="144" id="R000201">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activate Akt</text>
    <arg role=":FACTOR" id="V2349967"/>
    <arg id="R000200" role=":OUTCOME"/>
  </CC>
  <TERM end="78" paragraph="paragraph25" start="38" uttnum="147" id="R000202" refid="V2404656" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <location id="V2404717"/>
      <active>TRUE</active>
    </features>
    <name>AKT</name>
    <text normalization="">of Akt in tumour cells due to PTEN loss</text>
  </TERM>
  <EVENT start="22" refid="V2404638" paragraph="paragraph25" rule="EKR:ActivateX" end="78" id="R000203" uttnum="147">
    <type>ONT::INCREASE</type>
    <text>hyperactivation of Akt in tumour cells due to PTEN loss </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000202" role=":AFFECTED"/>
  </EVENT>
  <CC start="22" paragraph="paragraph25" refid="V2404638" rule="EKR:ActivateX" end="78" uttnum="147" id="R000204">
    <type>ONT::CAUSE-EFFECT</type>
    <text>hyperactivation of Akt in tumour cells due to PTEN loss </text>
    <arg role=":FACTOR" id="V2404638"/>
    <arg id="R000203" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000205" uttnum="147" paragraph="paragraph25" start="22" refid="V2404638" end="78" rule="EKR:ActivateX">
    <text>hyperactivation of Akt in tumour cells due to PTEN loss </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2404656"/>
  </EVENT>
  <CC id="R000206" uttnum="147" paragraph="paragraph25" start="22" refid="V2404638" rule="EKR:ActivateX" end="78">
    <text>hyperactivation of Akt in tumour cells due to PTEN loss </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2404638"/>
    <arg role=":OUTCOME" id="R000205"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="102" paragraph="paragraph25" start="97" uttnum="147" id="R000207" refid="V2404792" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT id="R000208" uttnum="147" rule="EKR:ActivateX" end="112" paragraph="paragraph25" start="97" refid="V2404796">
    <text>AMPK activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000207" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V2404796" start="97" paragraph="paragraph25" end="112" rule="EKR:ActivateX" uttnum="147" id="R000209">
    <text>AMPK activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2404796" role=":FACTOR"/>
    <arg id="R000208" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="147" id="R000210" start="97" paragraph="paragraph25" refid="V2404796" end="112" rule="EKR:ActivateX">
    <type>ONT::DECREASE</type>
    <text>AMPK activation</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2404792"/>
  </EVENT>
  <CC uttnum="147" id="R000211" end="112" rule="EKR:ActivateX" refid="V2404796" start="97" paragraph="paragraph25">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation</text>
    <arg role=":FACTOR" id="V2404796"/>
    <arg role=":OUTCOME" id="R000210"/>
  </CC>
  <TERM end="267" paragraph="paragraph25" start="263" uttnum="148" id="R000212" refid="V2434112" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="277" rule="EKR:ActivateX" start="258" refid="V2434115" paragraph="paragraph25" id="R000213" uttnum="148">
    <text>with Akt activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000212"/>
  </EVENT>
  <CC id="R000214" uttnum="148" rule="EKR:ActivateX" end="277" refid="V2434115" start="258" paragraph="paragraph25">
    <text>with Akt activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2434115"/>
    <arg role=":OUTCOME" id="R000213"/>
  </CC>
  <EVENT id="R000215" uttnum="148" rule="EKR:ActivateX" end="277" start="258" refid="V2434115" paragraph="paragraph25">
    <text>with Akt activation</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2434112"/>
  </EVENT>
  <CC id="R000216" uttnum="148" rule="EKR:ActivateX" end="277" paragraph="paragraph25" start="258" refid="V2434115">
    <text>with Akt activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2434115"/>
    <arg id="R000215" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="28" paragraph="paragraph26" start="3" uttnum="153" id="R000217" refid="V2552190" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <features>
      <location id="V2552280"/>
      <active>TRUE</active>
    </features>
    <name>AMPK</name>
    <text>AMPK in DBTRG-05MG cells</text>
  </TERM>
  <EVENT id="R000218" uttnum="153" rule="EKR:ActivateX" end="52" start="3" paragraph="paragraph26" refid="V2552305">
    <text>AMPK in DBTRG-05MG cells was activated by A769662</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000217" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph26" start="3" refid="V2552305" end="52" rule="EKR:ActivateX" uttnum="153" id="R000219">
    <text>AMPK in DBTRG-05MG cells was activated by A769662</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2552305" role=":FACTOR"/>
    <arg id="R000218" role=":OUTCOME"/>
  </CC>
  <EVENT start="3" refid="V2552305" paragraph="paragraph26" rule="EKR:ActivateX" end="52" uttnum="153" id="R000220">
    <text>AMPK in DBTRG-05MG cells was activated by A769662</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2552190"/>
  </EVENT>
  <CC end="52" rule="EKR:ActivateX" start="3" paragraph="paragraph26" refid="V2552305" id="R000221" uttnum="153">
    <text>AMPK in DBTRG-05MG cells was activated by A769662</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2552305" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000220"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="292" paragraph="paragraph26" start="269" uttnum="154" id="R000222" refid="V2568074" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK in these cells</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" end="292" refid="V2568060" start="250" paragraph="paragraph26" id="R000223" uttnum="154">
    <text>reduced activation of AMPK in these cells </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000222"/>
  </EVENT>
  <CC id="R000224" uttnum="154" rule="EKR:ActivateX" end="292" start="250" refid="V2568060" paragraph="paragraph26">
    <text>reduced activation of AMPK in these cells </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2568060"/>
    <arg role=":OUTCOME" id="R000223"/>
  </CC>
  <EVENT start="250" paragraph="paragraph26" refid="V2568060" rule="EKR:ActivateX" end="292" uttnum="154" id="R000225">
    <type>ONT::DECREASE</type>
    <text>reduced activation of AMPK in these cells </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2568074" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="154" id="R000226" refid="V2568060" start="250" paragraph="paragraph26" rule="EKR:ActivateX" end="292">
    <text>reduced activation of AMPK in these cells </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2568060"/>
    <arg role=":OUTCOME" id="R000225"/>
  </CC>
  <TERM end="2492" paragraph="paragraph32" start="2464" uttnum="184" id="R000227" refid="V3130806" rule="EKR:ActivateX">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>of the human α2β2γ1 complex</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT id="R000228" uttnum="184" start="2449" paragraph="paragraph32" refid="V3130744" end="2500" rule="EKR:ActivateX">
    <text>the activation of the human α2β2γ1 complex by LKB1 </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000227"/>
  </EVENT>
  <CC uttnum="184" id="R000229" start="2449" refid="V3130744" paragraph="paragraph32" rule="EKR:ActivateX" end="2500">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the activation of the human α2β2γ1 complex by LKB1 </text>
    <arg role=":FACTOR" id="V3130744"/>
    <arg role=":OUTCOME" id="R000228"/>
  </CC>
  <EVENT uttnum="184" id="R000230" rule="EKR:ActivateX" end="2500" refid="V3130744" start="2449" paragraph="paragraph32">
    <type>ONT::DECREASE</type>
    <text>the activation of the human α2β2γ1 complex by LKB1 </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3130806" role=":AFFECTED"/>
  </EVENT>
  <CC end="2500" rule="EKR:ActivateX" paragraph="paragraph32" start="2449" refid="V3130744" id="R000231" uttnum="184">
    <text>the activation of the human α2β2γ1 complex by LKB1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3130744"/>
    <arg role=":OUTCOME" id="R000230"/>
  </CC>
  <TERM end="2588" paragraph="paragraph32" start="2585" uttnum="185" id="R000232" refid="V3145659" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="185" id="R000233" end="2600" rule="EKR:ActivateX" paragraph="paragraph32" start="2582" refid="V3145666">
    <type>ONT::INCREASE</type>
    <text>of Akt-activating </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000232"/>
  </EVENT>
  <CC end="2600" rule="EKR:ActivateX" refid="V3145666" start="2582" paragraph="paragraph32" uttnum="185" id="R000234">
    <type>ONT::CAUSE-EFFECT</type>
    <text>of Akt-activating </text>
    <arg role=":FACTOR" id="V3145666"/>
    <arg id="R000233" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="185" id="R000235" rule="EKR:ActivateX" end="2600" refid="V3145666" start="2582" paragraph="paragraph32">
    <text>of Akt-activating </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3145659" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000236" uttnum="185" end="2600" rule="EKR:ActivateX" refid="V3145666" start="2582" paragraph="paragraph32">
    <text>of Akt-activating </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3145666"/>
    <arg id="R000235" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="2668" paragraph="paragraph32" start="2660" uttnum="185" id="R000237" refid="V3145817" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="185" id="R000238" refid="V3145804" start="2649" paragraph="paragraph32" end="2668" rule="EKR:ActivateX">
    <type>ONT::INCREASE</type>
    <text>activation of AMPK </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000237" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="185" id="R000239" rule="EKR:ActivateX" end="2668" start="2649" refid="V3145804" paragraph="paragraph32">
    <text>activation of AMPK </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3145804" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000238"/>
  </CC>
  <EVENT uttnum="185" id="R000240" end="2668" rule="EKR:ActivateX" start="2649" paragraph="paragraph32" refid="V3145804">
    <type>ONT::DECREASE</type>
    <text>activation of AMPK </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3145817" role=":AFFECTED"/>
  </EVENT>
  <CC start="2649" refid="V3145804" paragraph="paragraph32" rule="EKR:ActivateX" end="2668" uttnum="185" id="R000241">
    <text>activation of AMPK </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3145804" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000240"/>
  </CC>
  <TERM end="394" paragraph="paragraph34" start="372" uttnum="191" id="R000242" refid="V3254701" rule="EKR:ActivateX">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <active>TRUE</active>
      <active>TRUE</active>
    </features>
    <name>COMPLEX</name>
    <text>of the active complex</text>
  </TERM>
  <EVENT uttnum="191" id="R000243" rule="EKR:ActivateX" end="394" start="357" paragraph="paragraph34" refid="V3254669">
    <text>the activation of the active complex </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000242" role=":AFFECTED"/>
  </EVENT>
  <CC start="357" refid="V3254669" paragraph="paragraph34" end="394" rule="EKR:ActivateX" uttnum="191" id="R000244">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the activation of the active complex </text>
    <arg role=":FACTOR" id="V3254669"/>
    <arg id="R000243" role=":OUTCOME"/>
  </CC>
  <EVENT start="357" paragraph="paragraph34" refid="V3254669" end="394" rule="EKR:ActivateX" id="R000245" uttnum="191">
    <type>ONT::DECREASE</type>
    <text>the activation of the active complex </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3254701"/>
  </EVENT>
  <CC id="R000246" uttnum="191" refid="V3254669" start="357" paragraph="paragraph34" end="394" rule="EKR:ActivateX">
    <text>the activation of the active complex </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3254669"/>
    <arg id="R000245" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="145" paragraph="paragraph35" start="129" uttnum="194" id="R000247" refid="V3307598" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>subsequent AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" end="156" paragraph="paragraph35" start="129" refid="V3307602" id="R000248" uttnum="194">
    <text>subsequent AMPK activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000247"/>
  </EVENT>
  <CC id="R000249" uttnum="194" rule="EKR:ActivateX" end="156" start="129" refid="V3307602" paragraph="paragraph35">
    <type>ONT::CAUSE-EFFECT</type>
    <text>subsequent AMPK activation </text>
    <arg role=":FACTOR" id="V3307602"/>
    <arg id="R000248" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="194" id="R000250" start="129" refid="V3307602" paragraph="paragraph35" rule="EKR:ActivateX" end="156">
    <text>subsequent AMPK activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3307598"/>
  </EVENT>
  <CC rule="EKR:ActivateX" end="156" start="129" paragraph="paragraph35" refid="V3307602" uttnum="194" id="R000251">
    <text>subsequent AMPK activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3307602"/>
    <arg id="R000250" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="171" paragraph="paragraph36" start="162" uttnum="197" id="R000252" refid="V3406627" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK,</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph36" start="151" refid="V3406613" end="181" rule="EKR:ActivateX" uttnum="197" id="R000253">
    <text>activation of AMPK, by CaMKKβ </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000252" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="197" id="R000254" rule="EKR:ActivateX" end="181" start="151" refid="V3406613" paragraph="paragraph36">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activation of AMPK, by CaMKKβ </text>
    <arg role=":FACTOR" id="V3406613"/>
    <arg id="R000253" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000255" uttnum="197" end="181" rule="EKR:ActivateX" paragraph="paragraph36" start="151" refid="V3406613">
    <type>ONT::DECREASE</type>
    <text>activation of AMPK, by CaMKKβ </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3406627"/>
  </EVENT>
  <CC id="R000256" uttnum="197" start="151" refid="V3406613" paragraph="paragraph36" rule="EKR:ActivateX" end="181">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activation of AMPK, by CaMKKβ </text>
    <arg role=":FACTOR" id="V3406613"/>
    <arg id="R000255" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="87" paragraph="paragraph38" start="82" uttnum="201" id="R000257" refid="V3488345" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph38" start="82" refid="V3488348" rule="EKR:ActivateX" end="98" id="R000258" uttnum="201">
    <text>AMPK activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000257" role=":AFFECTED"/>
  </EVENT>
  <CC end="98" rule="EKR:ActivateX" refid="V3488348" start="82" paragraph="paragraph38" uttnum="201" id="R000259">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation </text>
    <arg role=":FACTOR" id="V3488348"/>
    <arg id="R000258" role=":OUTCOME"/>
  </CC>
  <EVENT end="98" rule="EKR:ActivateX" start="82" refid="V3488348" paragraph="paragraph38" id="R000260" uttnum="201">
    <text>AMPK activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3488345"/>
  </EVENT>
  <CC start="82" refid="V3488348" paragraph="paragraph38" end="98" rule="EKR:ActivateX" uttnum="201" id="R000261">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation </text>
    <arg id="V3488348" role=":FACTOR"/>
    <arg id="R000260" role=":OUTCOME"/>
  </CC>
  <TERM end="513" paragraph="paragraph38" start="509" uttnum="203" id="R000262" refid="V3523765" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Akt</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT start="509" refid="V3523768" paragraph="paragraph38" end="524" rule="EKR:ActivateX" uttnum="203" id="R000263">
    <text>Akt activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000262" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph38" start="509" refid="V3523768" end="524" rule="EKR:ActivateX" id="R000264" uttnum="203">
    <text>Akt activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3523768"/>
    <arg role=":OUTCOME" id="R000263"/>
  </CC>
  <EVENT end="524" rule="EKR:ActivateX" start="509" paragraph="paragraph38" refid="V3523768" id="R000265" uttnum="203">
    <text>Akt activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3523765" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000266" uttnum="203" end="524" rule="EKR:ActivateX" paragraph="paragraph38" start="509" refid="V3523768">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Akt activation </text>
    <arg role=":FACTOR" id="V3523768"/>
    <arg id="R000265" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="999" paragraph="paragraph38" start="992" uttnum="205" id="R000267" refid="V3552844" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>of AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT id="R000268" uttnum="205" paragraph="paragraph38" start="981" refid="V3552830" end="999" rule="EKR:ActivateX">
    <type>ONT::INCREASE</type>
    <text>activation of AMPK</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000267"/>
  </EVENT>
  <CC rule="EKR:ActivateX" end="999" paragraph="paragraph38" start="981" refid="V3552830" id="R000269" uttnum="205">
    <text>activation of AMPK</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3552830" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000268"/>
  </CC>
  <EVENT id="R000270" uttnum="205" refid="V3552830" start="981" paragraph="paragraph38" rule="EKR:ActivateX" end="999">
    <text>activation of AMPK</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3552844" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="205" id="R000271" start="981" paragraph="paragraph38" refid="V3552830" end="999" rule="EKR:ActivateX">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activation of AMPK</text>
    <arg role=":FACTOR" id="V3552830"/>
    <arg id="R000270" role=":OUTCOME"/>
  </CC>
  <TERM dbid="FA:03071|HGNC:9377|UP:P54646" end="1634" paragraph="paragraph40" start="1629" uttnum="220" id="R000272" refid="V3867472" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>AMPK</name>
    <text>AMPK</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT start="1629" paragraph="paragraph40" refid="V3867475" rule="EKR:ActivateX" end="1645" uttnum="220" id="R000273">
    <text>AMPK activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000272" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="220" id="R000274" rule="EKR:ActivateX" end="1645" start="1629" paragraph="paragraph40" refid="V3867475">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation </text>
    <arg id="V3867475" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000273"/>
  </CC>
  <EVENT id="R000275" uttnum="220" start="1629" paragraph="paragraph40" refid="V3867475" end="1645" rule="EKR:ActivateX">
    <type>ONT::DECREASE</type>
    <text>AMPK activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3867472"/>
  </EVENT>
  <CC rule="EKR:ActivateX" end="1645" refid="V3867475" start="1629" paragraph="paragraph40" uttnum="220" id="R000276">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AMPK activation </text>
    <arg id="V3867475" role=":FACTOR"/>
    <arg id="R000275" role=":OUTCOME"/>
  </CC>
</ekb>
